
<html lang="en"     class="pb-page"  data-request-id="0638ec2e-3c9d-4825-99fe-97d8cae2202b"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/acs.jmedchem.1c00442;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2021.64.issue-9;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Synthesis, Molecular Pharmacology, and Structure–Activity Relationships of 3-(Indanoyl)indoles as Selective Cannabinoid Type 2 Receptor Antagonists" /></meta><meta name="dc.Creator" content="Harvey F.  Fulo" /></meta><meta name="dc.Creator" content="Amal  Shoeib" /></meta><meta name="dc.Creator" content="Christian V.  Cabanlong" /></meta><meta name="dc.Creator" content="Alexander H.  Williams" /></meta><meta name="dc.Creator" content="Chang-Guo  Zhan" /></meta><meta name="dc.Creator" content="Paul L.  Prather" /></meta><meta name="dc.Creator" content="Gregory B.  Dudley" /></meta><meta name="dc.Description" content="Synthetic indole cannabinoids characterized by a 2′,2′-dimethylindan-5′-oyl group at the indole C3 position constitute a new class of ligands possessing high affinity for human CB2 receptors at a n..." /></meta><meta name="Description" content="Synthetic indole cannabinoids characterized by a 2′,2′-dimethylindan-5′-oyl group at the indole C3 position constitute a new class of ligands possessing high affinity for human CB2 receptors at a n..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 23, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.1c00442" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00442" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.1c00442" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00442" /></link>
        
    
    

<title>Synthesis, Molecular Pharmacology, and Structure–Activity Relationships of 3-(Indanoyl)indoles as Selective Cannabinoid Type 2 Receptor Antagonists | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.1c00442" /></meta><meta property="og:title" content="Synthesis, Molecular Pharmacology, and Structure–Activity Relationships of 3-(Indanoyl)indoles as Selective Cannabinoid Type 2 Receptor Antagonists" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/large/jm1c00442_0012.jpeg" /></meta><meta property="og:description" content="Synthetic indole cannabinoids characterized by a 2′,2′-dimethylindan-5′-oyl group at the indole C3 position constitute a new class of ligands possessing high affinity for human CB2 receptors at a nanomolar concentration and a good selectivity index. Starting from the neutral antagonist 4, the effects of indole core modification on the pharmacodynamic profile of the ligands were investigated. Several N1 side chains afforded potent and CB2-selective neutral antagonists, notably derivatives 26 (R1 = n-propyl, R2 = H) and 35 (R1 = 4-pentynyl, R2 = H). Addition of a methyl group at C2 improved the selectivity for the CB2 receptor. Moreover, C2 indole substitution may control the CB2 activity as shown by the functionality switch in 35 (antagonist) and 49 (R1 = 4-pentynyl, R2 = CH3, partial agonist)." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.1c00442"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00442">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.1c00442&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.1c00442&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.1c00442&amp;href=/doi/10.1021/acs.jmedchem.1c00442" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 9</span><span class="cit-fg-pageRange">, 6381-6396</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/9" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.1c00382" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.1c00483" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis, Molecular Pharmacology, and Structure–Activity Relationships of 3-(Indanoyl)indoles as Selective Cannabinoid Type 2 Receptor Antagonists</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Harvey F. Fulo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Harvey F. Fulo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">C. Eugene Bennett Department of Chemistry, West Virginia University, Morgantown, West Virginia 26506, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Harvey+F.++Fulo">Harvey F. Fulo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Amal Shoeib</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Amal Shoeib</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Amal++Shoeib">Amal Shoeib</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christian V. Cabanlong</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christian V. Cabanlong</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christian+V.++Cabanlong">Christian V. Cabanlong</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alexander H. Williams</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alexander H. Williams</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences, University of Kentucky, Lexington, Kentucky 40536, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alexander+H.++Williams">Alexander H. Williams</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Chang-Guo Zhan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chang-Guo Zhan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences, University of Kentucky, Lexington, Kentucky 40536, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chang-Guo++Zhan">Chang-Guo Zhan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Paul L. Prather</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Paul L. Prather</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Paul+L.++Prather">Paul L. Prather</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Gregory B. Dudley</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gregory B. Dudley</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">C. Eugene Bennett Department of Chemistry, West Virginia University, Morgantown, West Virginia 26506, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#20475245474f52590e4455444c4559604d41494c0e5756550e454455"><span class="__cf_email__" data-cfemail="35524750525a474c1b51405159504c7558545c591b4243401b505140">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gregory+B.++Dudley">Gregory B. Dudley</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6133-3747" title="Orcid link">http://orcid.org/0000-0001-6133-3747</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00442&amp;href=/doi/10.1021%2Facs.jmedchem.1c00442" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 9</span><span class="cit-pageRange">, 6381–6396</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 23, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>10 March 2021</li><li><span class="item_label"><b>Published</b> online</span>23 April 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 May 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.1c00442" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00442</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6381%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DHarvey%2BF.%2BFulo%252C%2BAmal%2BShoeib%252C%2BChristian%2BV.%2BCabanlong%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D9%26contentID%3Dacs.jmedchem.1c00442%26title%3DSynthesis%252C%2BMolecular%2BPharmacology%252C%2Band%2BStructure%25E2%2580%2593Activity%2BRelationships%2Bof%2B3-%2528Indanoyl%2529indoles%2Bas%2BSelective%2BCannabinoid%2BType%2B2%2BReceptor%2BAntagonists%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6396%26publicationDate%3DMay%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.1c00442"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">771</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.1c00442" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis, Molecular Pharmacology, and Structure–Activity Relationships of 3-(Indanoyl)indoles as Selective Cannabinoid Type 2 Receptor Antagonists&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Harvey&quot;,&quot;last_name&quot;:&quot;F. Fulo&quot;},{&quot;first_name&quot;:&quot;Amal&quot;,&quot;last_name&quot;:&quot;Shoeib&quot;},{&quot;first_name&quot;:&quot;Christian&quot;,&quot;last_name&quot;:&quot;V. Cabanlong&quot;},{&quot;first_name&quot;:&quot;Alexander&quot;,&quot;last_name&quot;:&quot;H. Williams&quot;},{&quot;first_name&quot;:&quot;Chang-Guo&quot;,&quot;last_name&quot;:&quot;Zhan&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;L. Prather&quot;},{&quot;first_name&quot;:&quot;Gregory&quot;,&quot;last_name&quot;:&quot;B. Dudley&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;23&quot;,&quot;issue&quot;:&quot;9&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;6381-6396&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.1c00442&quot;},&quot;abstract&quot;:&quot;Synthetic indole cannabinoids characterized by a 2′,2′-dimethylindan-5′-oyl group at the indole C3 position constitute a new class of ligands possessing high affinity for human CB2 receptors at a nanomolar concentration and a good selectivity index. Starting from the neutral antagonist 4, the effects of indole core modification on the pharmacodynamic profile of the ligands were investigated. Several N1 side chains afforded potent and CB2-selective neutral antagonists, notably derivatives 26 (R1 = n-propyl, R2 = H) and 35 (R1 = 4-pentynyl, R2 = H). Addition of a methyl group at C2 improved the selectivity for the CB2 receptor. Moreover, C2 indole substitution may control the CB2 activity as shown by the functionality switch in 35 (antagonist) and 49 (R1 = 4-pentynyl, R2 = CH3, partial agonist).&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00442&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00442" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00442&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00442" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00442&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00442" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00442&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00442&amp;href=/doi/10.1021/acs.jmedchem.1c00442" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.1c00442" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.1c00442" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.1c00442%26sid%3Dliteratum%253Aachs%26pmid%3D33887913%26genre%3Darticle%26aulast%3DFulo%26date%3D2021%26atitle%3DSynthesis%252C%2BMolecular%2BPharmacology%252C%2Band%2BStructure%25E2%2580%2593Activity%2BRelationships%2Bof%2B3-%2528Indanoyl%2529indoles%2Bas%2BSelective%2BCannabinoid%2BType%2B2%2BReceptor%2BAntagonists%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D9%26spage%3D6381%26epage%3D6396%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291862" title="Indoles">Indoles</a>,</li><li><a href="/action/doSearch?ConceptID=292349" title="Alkyls">Alkyls</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/9" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/jmcmar.2021.64.issue-9/20210513/jmcmar.2021.64.issue-9.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/medium/jm1c00442_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/large/jm1c00442_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00442&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Synthetic indole cannabinoids characterized by a 2′,2′-dimethylindan-5′-oyl group at the indole C3 position constitute a new class of ligands possessing high affinity for human CB<sub>2</sub> receptors at a nanomolar concentration and a good selectivity index. Starting from the neutral antagonist <b>4</b>, the effects of indole core modification on the pharmacodynamic profile of the ligands were investigated. Several N1 side chains afforded potent and CB<sub>2</sub>-selective neutral antagonists, notably derivatives <b>26</b> (R<sup>1</sup> = <i>n</i>-propyl, R<sup>2</sup> = H) and <b>35</b> (R<sup>1</sup> = 4-pentynyl, R<sup>2</sup> = H). Addition of a methyl group at C2 improved the selectivity for the CB<sub>2</sub> receptor. Moreover, C2 indole substitution may control the CB<sub>2</sub> activity as shown by the functionality switch in <b>35</b> (antagonist) and <b>49</b> (R<sup>1</sup> = 4-pentynyl, R<sup>2</sup> = CH<sub>3</sub>, partial agonist).</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51358" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51358" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The endocannabinoid system (ECS) is implicated in a large spectrum of physiological and pathological processes, especially ones related to the central and peripheral nervous systems.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10">(1−10)</a> Part of the complex intercellular communicating system are two types of heptahelical G-protein coupled receptors identified as cannabinoid receptor type 1 (CB<sub>1</sub>) and cannabinoid receptor type 2 (CB<sub>2</sub>).<a onclick="showRef(event, 'ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13 ref14">(11−14)</a> CB<sub>1</sub> is expressed primarily in the central nervous system<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14,15)</a> but can also be found in locations outside the brain.<a onclick="showRef(event, 'ref16 ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18 ref19">(16−19)</a> CB<sub>2</sub>, which is sometimes called the peripheral cannabinoid receptor, is expressed mainly in the cells associated with the immune system.<a onclick="showRef(event, 'ref11 ref14'); return false;" href="javascript:void(0);" class="ref ref11 ref14">(11,14)</a> CB<sub>2</sub> receptors are also found in low concentrations in activated microglia and infiltrated macrophages in the brain,<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20,21)</a> gastrointestinal tract tissues and other cells such as vascular endothelial cells, cardiomyocytes, and bone cells.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><div class="NLM_p">Small-molecule modulators of CB<sub>2</sub> receptor activity are of interest for therapeutic indications including neurological disorders, pain, and inflammation. CB<sub>2</sub> agonists have potential utility for treating neurological disorders such as reperfusion brain injury;<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> amyotrophic lateral<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> and multiple sclerosis;<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35,36)</a> and Alzheimer’s,<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37,38)</a> Parkinson’s,<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37,38)</a> and Huntington’s diseases.<a onclick="showRef(event, 'ref37 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref39">(37−39)</a> CB<sub>2</sub> agonists also exhibit anti-inflammatory effects and antinociceptive effects in acute pain, persistent inflammatory pain, postoperative pain, cancer pain, and neuropathic pain,<a onclick="showRef(event, 'ref6 ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref6 ref40 ref41 ref42">(6,40−42)</a> and they may aid in cardioprotection and treatment of gliomas.<a onclick="showRef(event, 'ref20 ref43 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref20 ref43 ref44 ref45">(20,43−45)</a> Interestingly, CB<sub>2</sub> inverse agonists are also of interest for modulating inflammatory nociception.<a onclick="showRef(event, 'ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref46 ref47">(46,47)</a> This seemingly contradictory potential for agonists and inverse agonists in similar indications stems from the ability of the CB<sub>2</sub> receptors to mediate different processes depending on the conditions: recruitment of immune cells or interference with the action of other chemoattractants.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Neutral antagonists would similarly be of great interest in this regard. CB<sub>2</sub> neutral antagonists are relatively rare<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> and as such have received less attention. However, there is some evidence that CB<sub>2</sub> neutral antagonists may be promising in the treatment of obesity-associated inflammation, insulin resistance, and nonalcoholic fatty liver disease.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Selective CB<sub>2</sub> receptor modulators are needed across the full spectrum of functional activities for therapeutic targeting of the ECS.</div><div class="NLM_p">Medicinal chemistry efforts targeting the ECS have been complicated by psychoactivity of CB<sub>1</sub>-receptor agonists. These side effects are associated with drugs of abuse. Many CB<sub>1</sub> agonists developed in academic and pharmaceutical research labs have been hijacked for abuse in the recreational drug market.<a onclick="showRef(event, 'ref23 ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25 ref26">(23−26)</a> The illicit demand for cannabinoid agonists has been met with regulatory controls on their supply, which incidentally also restricts legitimate pharmaceutical research.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> CB<sub>2</sub>-selective ligands are attractive for chemotherapeutic development due in part to the absence of known psychoactive side effects,<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31,32)</a> but many compounds designed to target CB<sub>2</sub> receptors<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> have nonetheless ended up as Schedule I controlled substances,<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> presumably due to (off-target) CB<sub>1</sub> interactions.</div><div class="NLM_p">While marijuana-like psychoactivity is a primary factor behind the potential for abuse of many ECS modulators, ease of synthesis is an auxiliary supply-side factor behind the illicit production and distribution. For example, the simple two-step synthesis of JWH-018 (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>)<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> increases its potential for abuse.<a onclick="showRef(event, 'ref29 ref52'); return false;" href="javascript:void(0);" class="ref ref29 ref52">(29,52)</a> Many 1,3-disubstituted indoles like JWH-018 can be made from indole and two simple electrophiles (e.g., acyl and alkyl halides), and many similarly have emerged as drugs of abuse.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Conversely, less synthetically accessible cannabinoid ligands are less subject to abuse. Such compounds enable one to explore the chemotherapeutic potential of ECS modulators without the same risk of fueling the recreational drug market.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/medium/jm1c00442_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/large/jm1c00442_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of JWH-018<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/large/jm1c00442_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00442&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) MeMgBr, Et<sub>2</sub>O/THF, 0 °C, then 1-naphthoyl Cl, reflux. (b) <i>n</i>-Pentyl Cl, KOH, DMSO, 80 °C.</p></p></figure><div class="NLM_p">There is a need for novel ECS modulators, particularly ones having low potential for abuse. To this end, we designed ligands that incorporate 2,2-dimethylindane into the known indole cannabinoid framework. 2,2-Dimethylindanes blend the benzenoid ring system of the traditional Huffman-(JWH)-type compounds, with the bulky cycloalkane motifs of influential<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> CB<sub>2</sub>-selective indole cannabinoids from Abbott.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> 2,2-Dimethylindane carboxylates can be crafted using recent synthetic methodologies,<a onclick="showRef(event, 'ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref55 ref56">(55,56)</a> but they are less accessible than the commercially available building blocks needed to prepare many indole cannabinoid drugs of abuse. We expect our designs to support development of novel ECS modulators specifically for legitimate academic and pharmaceutical research endeavors and without risk of “significant diversion”<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> to illicit markets.</div><div class="NLM_p">Indanoylindoles have not been examined previously as cannabinoid ligands. The first two indanoylindoles we considered—GBD-002 and GBD-003, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>—indeed exhibit high affinities for both CB receptors, with GBD-003 showing selectivity for CB<sub>2</sub> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Functional assays showed that GBD-002, like JWH-018, is a full agonist, whereas positional isomer GBD-003 is a neutral antagonist (<named-content content-type="anchor" rid="tbl1" type="simple"></named-content><a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, <i>vide infra</i>). Considering that CB<sub>2</sub> antagonists are promising but rare, we focused on preparing a series of indanoylindoles based on GBD-003 for preliminary molecular pharmacology and structure–activity relationship (SAR) studies. Several CB<sub>2</sub>-selective neutral antagonists are described herein.</div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/medium/jm1c00442_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/large/jm1c00442_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Rational design of a novel class of potent cannabinoids.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/large/jm1c00442_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00442&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Screen of (Dimethylindanoyl)indole Derivatives for Binding to <i>h</i>CB<sub>1</sub> and/or <i>h</i>CB<sub>2</sub> Receptors</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/medium/jm1c00442_0011.gif" alt="" id="GRAPHIC-d7e548-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">% displacement of [<sup>3</sup>H]CP-55,940 (0.2 nM) (1 μM of each compound)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center" char="±"><i>h</i>CB<sub>1</sub></th><th class="colsep0 rowsep0" align="center" char="±"><i>h</i>CB<sub>2</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-002 (<b>3</b>)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">Pentyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">85.7 ± 5.2</td><td class="colsep0 rowsep0" align="char" char="±">94.1 ± 2.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-003 (<b>4</b>)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">pentyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">93.4 ± 5.0</td><td class="colsep0 rowsep0" align="char" char="±">99.8 ± 0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-001 (<b>23</b>)</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">9.4 ± 3.1</td><td class="colsep0 rowsep0" align="char" char="±">22.2 ± 6.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-004 (<b>25</b>)</td><td class="colsep0 rowsep0" align="left">methyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">10.8 ± 1.4</td><td class="colsep0 rowsep0" align="char" char="±">23.9 ± 13.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-005 (<b>26</b>)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">propyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">47.4 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">90.5 ± 2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-006 (<b>27</b>)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">butyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">82.7 ± 0.6</td><td class="colsep0 rowsep0" align="char" char="±">92.9 ± 1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-007 (<b>28</b>)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">hexyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">79.1 ± 3.0</td><td class="colsep0 rowsep0" align="char" char="±">83.6 ± 4.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-008 (<b>29</b>)</td><td class="colsep0 rowsep0" align="left">isobutyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">42.2 ± 4.9</td><td class="colsep0 rowsep0" align="char" char="±">83.1 ± 2.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-009 (<b>30</b>)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">benzyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">69.2 ± 2.3</td><td class="colsep0 rowsep0" align="char" char="±">84.6 ± 3.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-010 (<b>31</b>)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">4-fluorobenzyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">88.0 ± 1.4</td><td class="colsep0 rowsep0" align="char" char="±">92.3 ± 2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-011 (<b>32</b>)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left"><i>E</i>-2-pentenyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">84.2 ± 1.2</td><td class="colsep0 rowsep0" align="char" char="±">86.9 ± 3.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-012 (<b>33</b>)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left"><i>Z</i>-2-pentenyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">60.7 ± 4.8</td><td class="colsep0 rowsep0" align="char" char="±">86.4 ± 5.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-013 (<b>34</b>)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">4-pentenyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">80.0 ± 3.8</td><td class="colsep0 rowsep0" align="char" char="±">95.2 ± 2.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-014 (<b>35</b>)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">4-pentynyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">71.0 ± 6.4</td><td class="colsep0 rowsep0" align="char" char="±">92.8 ± 1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-015 (<b>36</b>)</td><td class="colsep0 rowsep0" align="left">2-pentynyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">55.6 ± 5.7</td><td class="colsep0 rowsep0" align="char" char="±">65.9 ± 2.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-016 (<b>37</b>)</td><td class="colsep0 rowsep0" align="left">allyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">16.0 ± 5.3</td><td class="colsep0 rowsep0" align="char" char="±">60.6 ± 5.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-017 (<b>38</b>)</td><td class="colsep0 rowsep0" align="left">propargyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">33.4 ± 3.3</td><td class="colsep0 rowsep0" align="char" char="±">56.0 ± 3.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-018 (<b>39</b>)</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CO<sub>2</sub>CH<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">19.4 ± 7.7</td><td class="colsep0 rowsep0" align="char" char="±">18.0 ± 10.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-020 (<b>40</b>)</td><td class="colsep0 rowsep0" align="left">propyl</td><td class="colsep0 rowsep0" align="left">methyl</td><td class="colsep0 rowsep0" align="char" char="±">44.4 ± 1.9</td><td class="colsep0 rowsep0" align="char" char="±">73.9 ± 3.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-021 (<b>41</b>)</td><td class="colsep0 rowsep0" align="left">butyl</td><td class="colsep0 rowsep0" align="left">methyl</td><td class="colsep0 rowsep0" align="char" char="±">43.5 ± 0.6</td><td class="colsep0 rowsep0" align="char" char="±">85.4 ± 3.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-022 (<b>42</b>)</td><td class="colsep0 rowsep0" align="left">pentyl</td><td class="colsep0 rowsep0" align="left">methyl</td><td class="colsep0 rowsep0" align="char" char="±">53.8 ± 0.8</td><td class="colsep0 rowsep0" align="char" char="±">83.6 ± 3.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-023 (<b>43</b>)</td><td class="colsep0 rowsep0" align="left">hexyl</td><td class="colsep0 rowsep0" align="left">methyl</td><td class="colsep0 rowsep0" align="char" char="±">26.2 ± 1.6</td><td class="colsep0 rowsep0" align="char" char="±">55.0 ± 5.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-024 (<b>44</b>)</td><td class="colsep0 rowsep0" align="left">benzyl</td><td class="colsep0 rowsep0" align="left">methyl</td><td class="colsep0 rowsep0" align="char" char="±">18.1 ± 13.3</td><td class="colsep0 rowsep0" align="char" char="±">51.2 ± 11.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-025 (<b>45</b>)</td><td class="colsep0 rowsep0" align="left">4-fluorobenzyl</td><td class="colsep0 rowsep0" align="left">methyl</td><td class="colsep0 rowsep0" align="char" char="±">38.4 ± 5.0</td><td class="colsep0 rowsep0" align="char" char="±">48.8 ± 0.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-026 (<b>46</b>)</td><td class="colsep0 rowsep0" align="left"><i>E</i>-2-pentenyl</td><td class="colsep0 rowsep0" align="left">methyl</td><td class="colsep0 rowsep0" align="char" char="±">35.1 ± 3.3</td><td class="colsep0 rowsep0" align="char" char="±">73.7 ± 3.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-027 (<b>47</b>)</td><td class="colsep0 rowsep0" align="left"><i>Z</i>-2-pentenyl</td><td class="colsep0 rowsep0" align="left">methyl</td><td class="colsep0 rowsep0" align="char" char="±">43.0 ± 2.0</td><td class="colsep0 rowsep0" align="char" char="±">82.9 ± 3.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-028 (<b>48</b>)</td><td class="colsep0 rowsep0" align="left">4-pentenyl</td><td class="colsep0 rowsep0" align="left">methyl</td><td class="colsep0 rowsep0" align="char" char="±">38.6 ± 1.8</td><td class="colsep0 rowsep0" align="char" char="±">86.4 ± 3.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-029 (<b>49</b>)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">4-pentynyl</td><td class="colsep0 rowsep0" align="left">methyl</td><td class="colsep0 rowsep0" align="char" char="±">41.9 ± 2.2</td><td class="colsep0 rowsep0" align="char" char="±">93.1 ± 3.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-030 (<b>50</b>)</td><td class="colsep0 rowsep0" align="left">2-pentynyl</td><td class="colsep0 rowsep0" align="left">methyl</td><td class="colsep0 rowsep0" align="char" char="±">16.4 ± 3.1</td><td class="colsep0 rowsep0" align="char" char="±">30.2 ± 2.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-031 (<b>51</b>)</td><td class="colsep0 rowsep0" align="left">propargyl</td><td class="colsep0 rowsep0" align="left">methyl</td><td class="colsep0 rowsep0" align="char" char="±">51.9 ± 0.8</td><td class="colsep0 rowsep0" align="char" char="±">63.0 ± 6.8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">This compound was selected for determination of <i>K</i><sub>i</sub>.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">This compound was selected for screening of functional activity.</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Calculated Binding Free Energies (kcal/mol) Compared to Experimental Binding Free Energy (kcal/mol)</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">rCB<sub>1</sub></th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">rCB<sub>2</sub></th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">ligand</th><th class="colsep0 rowsep0" align="center" char="."><i>K</i><sub>i</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">ΔG<sub>PB</sub><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">Δ<i>G</i><sub>exp</sub><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">Δ<i>G</i><sub>corr</sub><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="."><i>K</i><sub>i</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">Δ<i>G</i><sub>PB</sub><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">Δ<i>G</i><sub>exp</sub><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">Δ<i>G</i><sub>corr</sub><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">ΔΔ<i>G</i><sub>exp</sub><a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center" char=".">ΔΔ<i>G</i><sub>corr</sub><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-002</td><td class="colsep0 rowsep0" align="char" char=".">1.46</td><td class="colsep0 rowsep0" align="char" char=".">–41.92</td><td class="colsep0 rowsep0" align="left">–12.13</td><td class="colsep0 rowsep0" align="char" char=".">–12.65</td><td class="colsep0 rowsep0" align="char" char=".">1.36</td><td class="colsep0 rowsep0" align="char" char=".">–40.79</td><td class="colsep0 rowsep0" align="left">–12.17</td><td class="colsep0 rowsep0" align="char" char=".">–12.28</td><td class="colsep0 rowsep0" align="char" char=".">0.04</td><td class="colsep0 rowsep0" align="char" char=".">0.37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-003</td><td class="colsep0 rowsep0" align="char" char=".">38.80</td><td class="colsep0 rowsep0" align="char" char=".">–34.00</td><td class="colsep0 rowsep0" align="left">–10.17</td><td class="colsep0 rowsep0" align="char" char=".">–10.07</td><td class="colsep0 rowsep0" align="char" char=".">4.90</td><td class="colsep0 rowsep0" align="char" char=".">–35.81</td><td class="colsep0 rowsep0" align="left">–11.41</td><td class="colsep0 rowsep0" align="char" char=".">–10.66</td><td class="colsep0 rowsep0" align="char" char=".">1.23</td><td class="colsep0 rowsep0" align="char" char=".">0.59</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-005</td><td class="colsep0 rowsep0" align="char" char=".">2559.00</td><td class="colsep0 rowsep0" align="char" char=".">–27.79</td><td class="colsep0 rowsep0" align="left">–7.68</td><td class="colsep0 rowsep0" align="char" char=".">–8.04</td><td class="colsep0 rowsep0" align="char" char=".">130.00</td><td class="colsep0 rowsep0" align="char" char=".">–31.10</td><td class="colsep0 rowsep0" align="left">–9.45</td><td class="colsep0 rowsep0" align="char" char=".">–9.12</td><td class="colsep0 rowsep0" align="char" char=".">1.78</td><td class="colsep0 rowsep0" align="char" char=".">1.08</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-013</td><td class="colsep0 rowsep0" align="char" char=".">152.00</td><td class="colsep0 rowsep0" align="char" char=".">–32.25</td><td class="colsep0 rowsep0" align="left">–9.36</td><td class="colsep0 rowsep0" align="char" char=".">–9.50</td><td class="colsep0 rowsep0" align="char" char=".">15.60</td><td class="colsep0 rowsep0" align="char" char=".">–35.26</td><td class="colsep0 rowsep0" align="left">–10.72</td><td class="colsep0 rowsep0" align="char" char=".">–10.48</td><td class="colsep0 rowsep0" align="char" char=".">1.36</td><td class="colsep0 rowsep0" align="char" char=".">0.98</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-014</td><td class="colsep0 rowsep0" align="char" char=".">325.00</td><td class="colsep0 rowsep0" align="char" char=".">–31.22</td><td class="colsep0 rowsep0" align="left">–8.91</td><td class="colsep0 rowsep0" align="char" char=".">–9.16</td><td class="colsep0 rowsep0" align="char" char=".">24.00</td><td class="colsep0 rowsep0" align="char" char=".">–35.93</td><td class="colsep0 rowsep0" align="left">–10.46</td><td class="colsep0 rowsep0" align="char" char=".">–10.70</td><td class="colsep0 rowsep0" align="char" char=".">1.55</td><td class="colsep0 rowsep0" align="char" char=".">1.54</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-029</td><td class="colsep0 rowsep0" align="char" char=".">1904.00</td><td class="colsep0 rowsep0" align="char" char=".">–27.89</td><td class="colsep0 rowsep0" align="left">–7.85</td><td class="colsep0 rowsep0" align="char" char=".">–8.07</td><td class="colsep0 rowsep0" align="char" char=".">62.50</td><td class="colsep0 rowsep0" align="char" char=".">–34.65</td><td class="colsep0 rowsep0" align="left">–9.89</td><td class="colsep0 rowsep0" align="char" char=".">–10.28</td><td class="colsep0 rowsep0" align="char" char=".">2.04</td><td class="colsep0 rowsep0" align="char" char=".">2.21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left">rmsd<a class="ref internalNav" href="#t2fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="char" char=".">0.23</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left">rmsd<a class="ref internalNav" href="#t2fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="char" char=".">0.43</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Calculated binding free energies obtained from the MM-PBSA calculations without any empirical correction.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">The experimental binding free energy was converted from the experimental <i>K</i><sub>i</sub> using the thermodynamic equation Δ<i>G</i><sub>exp</sub> = −<i>RT</i> ln (<i>K</i><sub>i</sub>).</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">Calculated binding free energies after empirical correction using <a class="ref internalNav" href="#eq1" aria-label="eq 1">eq 1</a>.</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">ΔΔG<sub>corr</sub> is the corrected binding free-energy difference [Δ<i>G</i>(CB<sub>1</sub>R) – Δ<i>G</i>(CB<sub>2</sub>R)].</p></div><div class="footnote" id="t2fn5"><sup><sup>e</sup></sup><p class="last">ΔΔ<i>G</i><sub>exp</sub> = −<i>RT</i> ln (<i>K</i><sub>i</sub> (CB<sub>1</sub>R)/<i>K</i><sub>i</sub>(CB<sub>2</sub>R)) = Δ<i>G</i><sub>exp</sub>(CB<sub>1</sub>R) – Δ<i>G</i><sub>exp</sub>(CB<sub>2</sub>R).</p></div><div class="footnote" id="t2fn6"><sup><sup>f</sup></sup><p class="last">The root-mean-square deviation (RMSD) of the corrected Δ<i>G</i> binding energy values versus the experimental Δ<i>G</i> binding energy values.</p></div></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23682" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23682" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Chemistry</h3><div class="NLM_p">We prepared indanoylindoles from carboxylates <b>10</b> and <b>21</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). The synthesis of GBD-002 is outlined in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. Starting from methyl isobutyrate (<b>5</b>), α-substitution with 2-fluorobenzyl bromide generates ester <b>6</b> (81%), which on reduction with DIBAL-H is converted to alcohol <b>7</b> in 88% yield. The alkyl iodide precursor (<b>9</b>) of indane <b>10</b> is obtained through a modified Finkelstein reaction in 81% overall yield. The two-step sequence involves mesylation of the 1° alcohol (<b>7</b>), followed by nucleophilic displacement with NaI-saturated <i>N</i>-methylpyrrolidone (NMP) to provide iodide <b>9</b>.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/medium/jm1c00442_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/large/jm1c00442_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Overview of the Synthetic Approach</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/large/jm1c00442_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00442&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/medium/jm1c00442_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/large/jm1c00442_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Benzoate 10, the Precursor to 3-(Indan-4-oyl)indole GBD-002<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/large/jm1c00442_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00442&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2-fluorobenzyl bromide, LDA, THF, −78 °C to rt, 5 h, 81%. (b) DIBAL-H, THF, −78 °C to rt, 1 h, 88%. (c) MsCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 1 h, 91%. (d) NaI, NMP, 140 °C, 8 h, 89%. (e) (i) <i>t</i>-BuLi, <i>n</i>-pentane-Et<sub>2</sub>O (4:1 by vol), −78 °C, 15 min; (ii) THF, −78 °C; (iii) −78 °C to rt to −78 °C; (iv) ClCO<sub>2</sub>Et, −78 °C (15 min) to rt (15 min).</p></p></figure><div class="NLM_p">Indane-4-carboxylate <b>10</b> is prepared by treating <b>9</b> with <i>tert</i>-butyllithium (<i>t</i>-BuLi), followed by ethyl chloroformate under carefully controlled conditions.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> This transformation is envisioned to proceed by a five-step, one-pot process, starting with lithium–iodine exchange and lithiation ortho to the fluoro substituent to produce a dilithio intermediate. Release of lithium fluoride generates a benzyne-tethered alkyllithium that undergoes 5-<i>exo</i>-dig cyclization to the 4-lithiated indane, which is then trapped with ethyl chloroformate to produce <b>10</b>.</div><div class="NLM_p">Meanwhile, our lab was developing a synthesis of diyne monoester <b>16</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>).<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Dimedone (<b>12</b>) is condensed with triflic anhydride and reacted with the lithium enolate of ethyl acetate for a Claisen-type tandem addition/fragmentation to generate β-keto ester <b>14</b>, which is then dehydrated to give <b>16</b>. Rhodium-catalyzed cyclotrimerization of <b>16</b> with TMS-acetylene provides a mixture of regioisomers (<b>17</b> and <b>18</b>), which can be hydrolyzed to <b>10</b> and then to <b>11</b>. Acid <b>11</b> is converted to the acid chloride and then coupled with <i>N</i>-pentylindole to complete the synthesis of GBD-002 (<b>3</b>).</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/medium/jm1c00442_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/large/jm1c00442_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of the 3-(Indan-4-oyl)indole GBD-002<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/large/jm1c00442_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00442&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Tf<sub>2</sub>O, pyridine, CH<sub>2</sub>Cl<sub>2</sub>, −78 °C to rt, 20 min, 97%. (b) (i) lithio ethyl acetate, THF, −78 °C, 20 min; (ii) LHMDS, 0 °C (10 min) to rt (1 h), 63%. (c) Tf<sub>2</sub>O, aq. LiOH, hexanes, 0 °C to rt, 30 min, 88%. (d) LHMDS, THF, 0 °C to rt, 1 h, 63%. (e) (i) [Rh(cod)<sub>2</sub>]BF<sub>4</sub>, (±)-BINAP, H<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h; (ii) TMS-acetylene, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h, 90%. (f) KI, TMSCl, H<sub>2</sub>O, CH<sub>3</sub>CN, 60 °C, 12 h, 68%. (g) KOH, H<sub>2</sub>O, EtOH, rt, 8 h, 95%. (h) (i) SOCl<sub>2</sub>, DMF, CH<sub>2</sub>Cl<sub>2</sub>, rt, 8 h; (ii) <i>N</i>-pentylindole, HFIP, rt, 24 h, 68%.</p></p></figure><div class="NLM_p">The synthesis of 3-(indan-5-oyl)indoles also begins with dimedone (<b>12</b>, <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>) and builds on prior synthetic methodologies from the Dudley lab.<a onclick="showRef(event, 'ref56 ref58'); return false;" href="javascript:void(0);" class="ref ref56 ref58">(56,58)</a> Vinylogous acyl triflate <b>13</b> is reduced with DIBAL-H to produce hydroxy-cycloalkenyl triflate <b>19</b>, which undergoes tandem fragmentation/olefination to furnish dienyne <b>20</b>. Rhodium-catalyzed cycloisomerization of <b>20</b>, followed by oxidation with DDQ, provides <b>21</b> in a one-pot process. Saponification of <b>21</b> gives acid <b>22</b>, which is converted to the acid chloride for Friedel–Crafts acylation of indole and 2-methylindole (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>, R<sup>2</sup> = H, Me). The resulting 3-acylindoles (<b>23</b> and <b>24</b>) were then <i>N</i>-alkylated to produce a small collection of indanoylindoles, designated as GBD-003 thru GBD-031.</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/medium/jm1c00442_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/large/jm1c00442_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of 3-(Indan-5-oyl)indoles<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/large/jm1c00442_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00442&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Tf<sub>2</sub>O, pyridine, CH<sub>2</sub>Cl<sub>2</sub>, −78 °C to rt, 20 min, 97%. (b) DIBAL-H, THF, −78 °C, 1–2 h, 90%. (c) Ethyl-<i>E</i>-4-(diethoxyphosphoryl)but-2-enoate, LHMDS, THF, −78 °C (15 min) to rt to 60 °C (1 h), 82%. (d) (i) [Rh(nbd)Cl]<sub>2</sub>, AgSbF<sub>6</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h; (ii) DDQ, rt, 2 h, 85%. (e) KOH, H<sub>2</sub>O, EtOH, rt, 8 h, 96%. (f) (i) SOCl<sub>2</sub>, DMF, CH<sub>2</sub>Cl<sub>2</sub>, rt, 8 h; (ii) indole or 2-methylindole, HFIP, rt, 24 h, 53–58%. (g) Alkyl halide, NaH, DMSO, rt, 8 h.</p></p></figure><div class="NLM_p last">We routinely produce gram quantities of indane-5-carboxylate <b>21</b> as a synthetic building block for other projects in the lab, and thus, it serves for us as a readily available and convenient starting point for the synthesis of various indanoylindoles. However, the four-step synthesis effectively ensures that indole cannabinoids derived from <b>21</b> will not be cost-competitive with ones that have been co-opted by the recreational drug market (e.g., JWH-018) and thus are unlikely to be subject to widespread abuse as recreational drugs.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Receptor Binding Affinity and SAR</h3><div class="NLM_p">The indanoylindoles thus prepared are high-affinity cannabinoid ligands. Initially, a screen to detect compounds with affinity for human CB<sub>1</sub> (<i>h</i>CB<sub>1</sub>) and human CB<sub>2</sub> (<i>h</i>CB<sub>2</sub>) receptors was conducted by determining the ability of a relatively high concentration (1 μM) of each compound to displace a 0.2 nM concentration of the well-characterized nonselective CB<sub>1</sub>/CB<sub>2</sub> cannabinoid radioligand [<sup>3</sup>H]CP-55,940 from its binding site (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Under these conditions, the concentration of a compound producing 50% displacement would approximate the affinity (e.g., <i>K</i><sub>i</sub>) for the receptor being examined, with higher displacement associated with greater affinity for the CB receptors. Compounds producing less than 50% displacement are predicted to exhibit low affinity (less than 1 μM). Selected compounds showing promising affinity and/or selectivity were selected for determination of <i>K</i><sub>i</sub> and selectivity index (SI) (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) and/or were screened for functional activity (<i>vide infra</i>; <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>).</div><figure id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/medium/jm1c00442_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/large/jm1c00442_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Affinities (<i>K</i><sub><i>i</i></sub>) of selected derivatives for <i>h</i>CB<sub>1</sub> and <i>h</i>CB<sub>2</sub> receptors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/large/jm1c00442_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00442&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. [<sup>35</sup>S]-GTPγS Binding Assays of Selected and Reference Compounds for Efficacy at the <i>h</i>CB<sub>2</sub> Cannabinoid Receptors</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center" char="±">[<sup>35</sup>S]-GTPγS specific binding (control = 100%)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CP-55,950</td><td class="colsep0 rowsep0" align="char" char="±">131 ± 6**</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AM-630</td><td class="colsep0 rowsep0" align="char" char="±">67 ± 4**</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-002 (<b>3</b>)</td><td class="colsep0 rowsep0" align="char" char="±">134 ± 5*</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-003 (<b>4</b>)</td><td class="colsep0 rowsep0" align="char" char="±">108 ± 9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-005 (<b>26</b>)</td><td class="colsep0 rowsep0" align="char" char="±">99 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-006 (<b>27</b>)</td><td class="colsep0 rowsep0" align="char" char="±">102 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-007 (<b>28</b>)</td><td class="colsep0 rowsep0" align="char" char="±">102 ± 9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-009 (<b>30</b>)</td><td class="colsep0 rowsep0" align="char" char="±">87 ± 8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-010 (<b>31</b>)</td><td class="colsep0 rowsep0" align="char" char="±">90 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-011 (<b>32</b>)</td><td class="colsep0 rowsep0" align="char" char="±">81 ± 2**</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-012 (<b>33</b>)</td><td class="colsep0 rowsep0" align="char" char="±">106 ± 7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-013 (<b>34</b>)</td><td class="colsep0 rowsep0" align="char" char="±">92 ± 2*</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-014 (<b>35</b>)</td><td class="colsep0 rowsep0" align="char" char="±">96 ± 5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBD-029 (<b>49</b>)</td><td class="colsep0 rowsep0" align="char" char="±">121 ± 8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">The results are expressed as the percentages of stimulation of [<sup>35</sup>S]-GTPγS binding (the basal value set at 100%) obtained for a concentration of ligands of 10 μM. Data are the mean ± standard error of the mean of three experiments. Statistical significance from 100% (basal) as assessed by one-sample <i>t</i>-test (*<i>P</i> < 0.05 and **<i>P</i> < 0.01).</p></div></div></div><div class="NLM_p">GBD-002 and GBD-003 produced almost 100% displacement of the radioligand from both <i>h</i>CB<sub>1</sub> and <i>h</i>CB<sub>2</sub> receptors in initial binding screens (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) and (as predicted from these initial screens) were subsequently determined to exhibit high affinity for cannabinoid receptors (CBRs) (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Specifically, GBD-002 exhibited a <i>K</i><sub>i</sub> (<i>h</i>CB<sub>1</sub>) of 1.46 ± 0.49 nM and a <i>K</i><sub>i</sub> (<i>h</i>CB<sub>2</sub>) of 1.36 ± 0.52 nM; however, with an SI of only 1.1 (nonselective). The positional isomer GBD-003 is also a high-affinity ligand for both receptors (<i>h</i>CB<sub>1</sub><i>K</i><sub>i</sub> = 38.8 ± 19.8 nM and <i>h</i>CB<sub>2</sub><i>K</i><sub>i</sub> = 4.9 ± 0.2 nM), with improved selectivity for CB<sub>2</sub> (SI = 7.9). Having determined that GBD-003 binds to CB<sub>2</sub> receptors in a relatively selective manner, we investigated the broader series of indanoylindoles for binding to CB<sub>1</sub> and CB<sub>2</sub> receptors (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The <i>N</i>1-pentyl chain was first replaced with different lipophilic alkyl moieties including chains based on other JWH cannabinoids<a onclick="showRef(event, 'ref28 ref30 ref50 ref53 ref59'); return false;" href="javascript:void(0);" class="ref ref28 ref30 ref50 ref53 ref59">(28,30,50,53,59)</a> and novel <i>N</i>-alkyl groups among reported indole cannabinoids such as <i>Z</i>-2-pentenyl, 2-pentynyl, 4-pentynyl, and propargyl. The analogue lacking the <i>N</i>-substituent (<b>23</b>) showed little affinity for either receptor. A similar activity profile was found when the H was substituted with a methyl group (<b>25</b>). Replacement with longer straight alkyl chains afforded compounds with good to excellent CBR affinities, consistent with previously reported links between chain length and receptor binding in other synthetic indole cannabinoids.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Compounds <b>26</b> (propyl), <b>27</b> (butyl), and <b>4</b> (pentyl) exhibited increasing CBR affinity with increasing chain length until lower affinity was observed for the 6-carbon (<b>28</b>, hexyl) variant.</div><div class="NLM_p">Introduction of an isobutyl substituent (<b>29</b>) led to poor affinity for CB<sub>1</sub> (42% displacement) and good affinity and selectivity for CB<sub>2</sub> (83% displacement). Comparison of isobutyl <b>29</b> with its unbranched isomer (<b>27</b>, <i>n</i>-butyl) and desmethyl analogue (<b>26</b>, <i>n</i>-propyl) suggests that this branching disfavors CB<sub>1</sub> receptor binding and enhances CB<sub>2</sub> selectivity.</div><div class="NLM_p">Compounds <b>30</b> (benzyl) and <b>31</b> (4-fluorobenzyl) bearing aromatic rings in the N-alkyl substituents displayed CBR affinities comparable to those of the aliphatic counterparts <b>27</b> (butyl) and <b>28</b> (hexyl) but less than that of <b>4</b> (pentyl), suggesting some steric tolerance of the receptors. Selectivity for binding to either CB<sub>1</sub> or CB<sub>2</sub> receptors was modest at best in these benzyl variants.</div><div class="NLM_p">Replacement of the alkyl chain with a more hydrophilic group has a profound effect on the pharmacology of the ligands. Compound <b>39</b>, punctuated with an ester group of a similar length [-CH<sub>2</sub>C(O)OCH<sub>2</sub>CH<sub>3</sub>] as compared with <i>n</i>-pentyl, showed a complete loss of affinity and selectivity (only 19 and 18% displacement at CB<sub>1</sub> and CB<sub>2</sub>, respectively). This observation is consistent with the results reported by Hynes et al.,<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> Frost et al.,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and Longworth et al.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> for fenchyl amide indoles, cyclopropanecarbonyl indoles, and adamantyl amide indoles, respectively, in which polar N1 side chains generally cause a decrease in CB<sub>2</sub> receptor binding relative to the <i>n</i>-pentyl analogue.</div><div class="NLM_p">Another set of compounds was synthesized to evaluate the effect of unsaturation in the alkyl chain, starting with unsaturated versions of the three- and five-carbon straight alkyl chains that appear to provide good CB<sub>2</sub> affinity and selectivity. Addition of double bonds to the pentyl chain yielded compounds <b>32–34</b>, bearing the <i>E</i>-2-pentenyl, <i>Z</i>-2-pentenyl, and 4-pentenyl moieties, respectively. Although less potent than the <i>n</i>-pentyl analogue <b>4</b>, the pentenyl compounds still retained good receptor affinities, particularly at CB<sub>2</sub> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The <i>Z</i>-isomer (<b>33</b>) was more selective than the <i>E</i>-isomer (<b>32</b>), and terminal alkene isomer <b>34</b> was more potent and CB<sub>2</sub>-selective. The alkynyl analogues <b>35</b> (4-pentynyl) and <b>36</b> (2-pentynyl) showed slightly lower affinities than the alkenyl analogues, although terminal alkyne <b>35</b> showed promising selectivity for CB<sub>2</sub>. In the three-carbon unsaturated series, the allyl (<b>37</b>) and propargyl (<b>38</b>) analogues exhibited modest CB<sub>2</sub> affinities displacing only 61 and 56% of [<sup>3</sup>H]-CP-55,940, respectively, compared to the corresponding saturated counterpart <b>26</b> (propyl, 90% displacement).</div><div class="NLM_p">We next examined N-substitution in the 2-methylindole series, inspired by the potent CBR ligand WIN-55,212-2. The 2-methylindoles generally showed lower affinity for both receptors but better CB<sub>2</sub> selectivity compared to the analogues devoid of the additional substituent. Like the trend in the indole series, CB<sub>2</sub> binding increased with the length of the <i>N</i>1-alkyl chain up to 5 carbons (<b>40–43</b>), whereas CB<sub>1</sub> affinity was largely unaffected by these modifications in chain length. Aung et al.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> reported that the presence of a methyl group at C2 of the <i>N</i>1-propyl analogue enhanced CB<sub>2</sub> selectivity (JWH-072, SI = 6 vs JWH-015, SI = 24). However, in this indanoylindole scaffold, 2-methylation has a negative impact (<b>26</b> vs <b>40</b>, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Neither of the <i>N</i>-arylmethyl variants (<b>44</b> and <b>45</b>) offered any apparent advantages in these initial assays, nor did the 2-pentynyl (<b>50</b>) or propargyl (<b>51</b>) variants. On the other hand, the pentenyl derivatives (<b>46–48</b>) showed an increase in CB<sub>2</sub> affinity without a substantive effect on CB<sub>1</sub> affinity, leading to enhanced selectivity, and the 4-pentynyl side chain of <b>49</b> showed good affinity and selectivity for CB<sub>2</sub>.</div><div class="NLM_p last">Guided by preliminary screening data from <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, we chose a small set of ligands and determined their binding affinities (<i>K</i><sub>i</sub>) for both CB receptors to determine an SI, as outlined in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>. Data for JWH-018 were reported previously<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> and are provided for reference in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>. The <i>N</i>-pentyl indanoylindoles (<b>3</b> and <b>4</b>) were the most potent, and <i>N</i>-(4-pentynyl)-2-methylindole <b>49</b> was the most CB<sub>2</sub>-selective, having an <i>h</i>CB<sub>2</sub><i>K</i><sub>i</sub> of 62.5 ± 10.0 nM and SI = 30.5.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Molecular Modeling</h3><div class="NLM_p">The six compounds highlighted in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> were also examined computationally in combined molecular docking/molecular dynamics (MD) simulations (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>), which correlated with experimentally measured binding affinities (<i>K</i><sub>i</sub>, cf. <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.1c00442/suppl_file/jm1c00442_si_001.csv" class="ext-link">Figure S1</a>). The good correlation between experimental and computational data suggests that this computational protocol provides the opportunity to test future designs <i>in silico</i>.</div><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/medium/jm1c00442_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/large/jm1c00442_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Binding modes of selected derivatives in CB<sub>1</sub> (A1–F1) and CB<sub>2</sub> (A2–F2) receptors. (A1) GBD-002 (3), CB<sub>1</sub>; (A2) GBD-002 (3), CB<sub>2</sub>; (B1) GBD-003 (4), CB<sub>1</sub>; (B2) GBD-003 (4), CB<sub>2</sub>; (C1) GBD-005 (26), CB<sub>1</sub>; (C2) GBD-005 (26), CB<sub>2</sub>; (D1) GBD-013 (34), CB<sub>1</sub>; (D2) GBD-013 (34), CB<sub>2</sub>; (E1) GBD-014 (35), CB<sub>1</sub>; (E2) GBD-014 (35), CB<sub>2</sub>; (F1) GBD-029 (49), CB<sub>1</sub>; (F2) GBD-029 (49), CB<sub>2</sub>. Original crystal structures of CB<sub>1</sub>R (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5XR8">5XR8</a>) and CB<sub>2</sub>R (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZTY">5ZTY</a>) were obtained from the Protein Data Bank for modeling. Pivotal to the difference in binding modes of these compounds between CB<sub>1</sub>R and CB<sub>2</sub>R are the residue changes L193/I110 and L481/V261 (in CB<sub>1</sub>R and CB<sub>2</sub>R, respectively). These substitutions allow for the central indole scaffold of the GBD compounds to rotate, allowing for the dimethylindane moiety and its connecting ketone to engage in hydrogen bonding with S285. Modifications to the aliphatic chain such as truncation (C1-2) and dehydrogenation (D1-2, E1-2) reduce hydrophobic interactions with the nearby hydrophobic pockets in CB<sub>1</sub>R and CB<sub>2</sub>R. The resulting indole moiety rotation due to the residue changes between CB<sub>1</sub>R and CB<sub>2</sub>R also allows for substitutions (F1–F2) on the indole moiety with CB2R that are otherwise unavailable in CB<sub>1</sub>R.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/large/jm1c00442_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00442&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Binding of GBD-002 with CB<sub>1</sub>R showed a strong hydrogen bond with the nearby S505 via the carbonyl oxygen and π–π stacking interactions between the indole ring with F200 and the indane ring with F268 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A1). In the CB<sub>2</sub>R model, the indane ring interacted similar to the CB<sub>1</sub> receptor in the lipophilic pocket formed by F183, S285, and F87 resulting in the retention of hydrogen bond (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A2). Meanwhile, the nonconserved residues V261 and I110 (substituted with L482 and L193 in the CB<sub>1</sub> receptor, respectively) allowed more room for the indole core to relax and rotate, changing the binding angle in the central transmembrane binding site. The indane ring of the positional isomer GBD-003 induced a steric strain in CB<sub>1</sub>R, shifting the moiety closer to the ECL2 domain (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B1). The shift rotated the carbonyl group away from S505 which makes hydrogen bonding unfavorable. In CB<sub>2</sub>R however, the loss in affinity was not observed as I110 and V261 still allowed strong π–π stacking interactions with F183 and hydrogen bonds with S285 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B2).</div><div class="NLM_p">A >60-fold reduction in CB<sub>1</sub>R affinity was observed in GBD-005, with the propyl tail being too short to occupy the binding pocket delimited by I271, L276, and Y275 and create effective van der Waals interactions (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C1). The truncation of the lipophilic tail is not as deleterious within CB<sub>2</sub>R as the scaffold is still able to retain the hydrogen bond (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C2). The greater loss of CB<sub>1</sub> binding affinity translates into greater CB<sub>2</sub> selectivity. GBD-013 and GBD-014 have similar binding modes to GBD-003. Although the three compounds have N-substituents with similar lengths, the double bond in GBD-013 weakens the hydrophobic interactions in CB<sub>2</sub>R (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D2) and more so in CB<sub>1</sub>R (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D1), resulting in a 10-fold selectivity. Hydrophobic interactions of the 5 C chain with the hydrophobic channel in CB<sub>1</sub>R further reduced with the substitution of a triple bond (GBD-014, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>E1,E2).</div><div class="NLM_p">2-Methylation of the indole core (GBD-029) positioned the ligand such that the additional methyl group clashes with L193 in CB<sub>1</sub>R (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>F1). This crowding disrupts the preferred binding mode and substantially weakens the binding affinity. In CB<sub>2</sub>R (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>F2), on the other hand, the steric constraint is less prominent as the rotation of the indole ring places the methyl group in an open space between transmembrane helices 5 and 6, thereby limiting the steric strain between the ligand and protein, affording a higher potency and selectivity against CB2R.</div><div class="NLM_p">The experimental and computational binding data are compiled in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> and depicted graphically in <a href="/doi/suppl/10.1021/acs.jmedchem.1c00442/suppl_file/jm1c00442_si_001.csv" class="ext-link">Figure S1</a>. Experimental binding affinities (<i>K</i><sub>i</sub>) were converted into free energies of binding (Δ<i>G</i><sub>exp</sub>), and absolute magnitudes of raw calculated protein binding energies (Δ<i>G</i><sub>PB</sub>) were adjusted using a standard correction (Δ<i>G</i><sub>corr</sub>) to align with the experimental data using <a class="ref internalNav" href="#eq1" aria-label="eq 1">eq 1</a><span class="NLM_disp-formula" id="eq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/medium/jm1c00442_m001.gif" alt="" id="_i15" /></img><span class="labelSpan">(1)</span></span></div><div class="NLM_p last">The difference between the CB<sub>1</sub>R and CB<sub>2</sub>R binding energies defines selectivity as measured experimentally (ΔΔ<i>G</i><sub>exp</sub>) and estimated computationally (ΔΔ<i>G</i><sub>corr</sub>). We see good correlation (<i>R</i><sup>2</sup> = 0.94) between the calculated (Δ<i>G</i><sub>PB</sub>) and measured (Δ<i>G</i><sub>exp</sub>) binding energies (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00442/suppl_file/jm1c00442_si_001.csv" class="ext-link">Figure S1</a>, top), suggesting that SARs can be used to estimate binding affinities (and selectivities, <a href="/doi/suppl/10.1021/acs.jmedchem.1c00442/suppl_file/jm1c00442_si_001.csv" class="ext-link">Figure S1</a>, bottom) with a reasonable degree of confidence.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> CB<sub>2</sub>R Functional Activity</h3><div class="NLM_p">Several compounds in the indole series and <b>49</b>, the most selective in the 2-methylindole series, were subjected to <i>in vitro</i> pharmacological evaluation in a [<sup>35</sup>S]GTPγS binding assay to evaluate the intrinsic functional activity. The CBR-mediated G-protein activities of the selected compounds at CB<sub>2</sub>R as well as reference ligands CP-55,940 (CB<sub>2</sub> full agonist) and AM-620 (CB<sub>2</sub> inverse agonist) were measured by examining the ability of a single, high (near receptor-saturating) 10 μM concentration to modulate [<sup>35</sup>S]GTPγS binding in <i>h</i>CB2-transfected CHO-cells as previously described.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a></div><div class="NLM_p">The molecular geometry of the indanoyl moiety has a striking effect on <i>h</i>CB<sub>2</sub>R-mediated G-protein activation (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Consistent with other indole cannabinoids, GBD-002 increased [<sup>35</sup>S]GTPγS binding, indicative of the full agonist property (134 ± 5% basal). When the indane point of attachment was moved from C4 (GBD-002) to C5 (GBD-003), the indanoylindane evoked little if any agonist response (108 ± 9% basal) compared to the reference full agonist CP-55,940 (131 ± 6% basal). This lack of significant agonist activity suggests that GBD-003 may act as a neutral <i>h</i>CB<sub>2</sub>R antagonist. Co-incubation of GBD-003 in CHO-<i>h</i>CB2 membranes produced a concentration-dependent reduction in [<sup>35</sup>S]GTPγS binding elicited by CP-55,940 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). The ability to reverse the response of a full agonist (CP-55,940, IC<sub>50</sub> = 1.8 μM, <i>K</i><sub>b</sub> = 9.7 nM) indicates that GBD-003 is best characterized as a CB<sub>2</sub>R antagonist.</div><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/medium/jm1c00442_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/large/jm1c00442_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. GBD-003 acts as an antagonist at CHO-<i>h</i>CB2 receptors, producing concentration-dependent reduction of G-protein activation produced by the <i>h</i>CB2 receptor agonist CP-55,940.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/large/jm1c00442_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00442&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Other indanoylindoles examined are best broadly characterized functionally as neutral antagonists or perhaps weak inverse agonists. The <i>N</i>-alkyl derivatives (<b>26–28</b>), similar to the results from receptor binding studies, suggest that the length of the alkyl chain does not influence functional activity. Arylmethyl derivatives (<b>30</b>, benzyl and <b>31</b>, <i>p</i>-fluorobenzyl) reduced [<sup>35</sup>S]GTPγS binding to 87 ± 8% and 90 ± 3% of basal, respectively, consistent with weak inverse agonism. Two of the <i>N</i>-pentenyl isomers (<b>32</b> and <b>34</b>) behaved as weak inverse agonists (81 ± 2% basal and 92 ± 2% basal, respectively), whereas <i>Z</i>-isomer <b>33</b> registered as a weak agonist/antagonist (106 ± 7% basal) in our screening, and <i>N</i>-pentynyl <b>35</b> insignificantly altered the basal binding (96 ± 5% basal), consistent with an antagonist profile. Interestingly, the addition of a methyl group to C2 of <b>35</b> to produce compound <b>49</b> shifted the CB<sub>2</sub>R activity from the antagonist to the agonist (121 ± 8% basal).</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80747" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80747" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We identify (2,2-dimethylindanoyl)indoles as a promising new class of indole cannabinoids comprising potent and CB<sub>2</sub>-selective ligands and presumably having lower potential for abuse as recreational drugs compared to other indole cannabinoids. Similar to the reference compound JWH-018, GBD-002 (<b>3</b>) and GBD-003 (<b>4</b>) displayed excellent affinities for both CB receptors. The latter (GBD-003) is moderately selective for CB<sub>2</sub> and, in contrast to most indole cannabinoid ligands, can be characterized as a neutral antagonist. We developed a preliminary SAR profile for these new (2,2-dimethylindanoyl)indoles. The observed patterns on affinities and selectivity in both the indole and methylindole series are generally in accordance with a number of previously reported SAR investigations of indole-derived cannabinoids, with the major exception of their unusual antagonist functional activity. The <i>N</i>-alkyl substituent provides opportunities to alter affinity and selectivity while broadly retaining antagonist activity. Other changes to the indanoylindole core structure had larger effects on functional activity, with GBD-029 (2-methylindole) and GBD-002 (indanoyl positional isomer) exhibiting agonist activity. The indanoylindole derivatives reported here provide a new template for future development of CB<sub>2</sub>-selective neutral antagonists.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27364" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27364" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Chemistry</h3><div class="NLM_p">All the chemicals were used as received unless otherwise stated. Diethyl ether (Et<sub>2</sub>O), tetrahydrofuran (THF), methylene chloride (DCM), and toluene were dried over a column of molecular sieves under argon. All reactions were carried out under an inert nitrogen atmosphere unless otherwise stated. Crude products were purified in a Biotage Isolera One Flash Purification System using Biotage prepacked cartridges (50 μm irregular silica). Yields refer to isolated material following silica gel chromatography. The purity of the compounds tested was determined by quantitative <sup>1</sup>H NMR using the absolute internal calibrant method (see the <a href="/doi/suppl/10.1021/acs.jmedchem.1c00442/suppl_file/jm1c00442_si_001.csv" class="ext-link">Supporting Information</a>). <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were recorded on a JEOL 400 MHz spectrometer using CDCl<sub>3</sub> and dimethyl sulfoxide-<i>d</i><sub>6</sub> (DMSO-<i>d</i><sub>6</sub>) as the deuterated solvent [≥99.8 atom % D, contains 0.03% (v/v) TMS]. The chemical shifts (δ) were reported in parts per million (ppm) relative to the internal standard TMS. High-resolution mass spectroscopy (HRMS) data were obtained on a UHR-TOF maXis 4G instrument (Bruker Daltonics, Bremen, Germany) using electrospray ionization (ESI). Melting points (mp) were taken in open capillaries on a Stuart melting point apparatus SMP11 and are uncorrected.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> Methyl 3-(2-Fluorophenyl)-2,2-dimethylpropanoate (<b>6</b>)<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></h4><div class="NLM_p last">A mixture of diisopropylamine (3.0 mL, 21.5 mmol) and THF (98 mL) was first cooled and stirred at −78 °C for 15 min. Next, <i>n</i>-BuLi (1.6 M in hexanes, 13.5 mL, 21.5 mmol) was added dropwise via a syringe. The mixture was stirred for another 15 min at −78 °C, 25 min at 0 °C, and 15 min at −78 °C. Methyl isobutyrate (2.2 mL, 19.6 mmol) was then added at the same temperature. After 30 min, 2-fluorobenzyl bromide (2.7 mL, 21.5 mmol) was finally added. The mixture was stirred at −78 °C for 1 h and then at ambient temperature for 5 h. After the reaction, the yellow solution was extracted with ether (3 × 50 mL). The organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. Purification by automatic flash column chromatography on silica gel (gradient elution from 2 to 20% EtOAc-hexanes) afforded a colorless, viscous liquid (84% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.19 (s, 6H), 2.92 (s, 2H), 3.67 (s, 3H), 6.98–7.06 (m, 2H), 7.07–7.13 (m, 1H), 7.16–7.23 (m, 1H). <sup>19</sup>FNMR (376 MHz, CDCl<sub>3</sub>): δ −115.90. <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>): δ 24.71, 38.64, 38.65, 43.64, 51.80, 115.21 (d, <i>J</i><sub>C–F</sub> = 20 Hz), 123.64 (d, <i>J</i><sub>C–F</sub> = 4 Hz), 124.88 (d, <i>J</i><sub>C–F</sub> = 16 Hz), 128.30 (d, <i>J</i><sub>C–F</sub> = 8 Hz), 132.21 (d, <i>J</i><sub>C–F</sub> = 5 Hz), 161.46 (d, <i>J</i><sub>C–F</sub> = 244 Hz), 177.79. HRMS (ESI, <i>m</i>/<i>z</i>): for C<sub>12</sub>H<sub>16</sub>FO<sub>2</sub> [M + H]<sup>+</sup> calcd, 211.1129; found, 211.1124.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 3-(2-Fluorophenyl)-2,2-dimethylpropan-1-ol (<b>7</b>)<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></h4><div class="NLM_p last">A mixture of <b>6</b> (2.0 g, 9.5 mmol) and THF (43 mL) was first cooled and stirred at −78 °C for 15 min. At the same temperature, DIBAL-H (1.0 M in toluene, 20.9 mL, 20.9 mmol) was then added dropwise. After stirring for 1 h, the mixture was warmed to ambient temperature and ether (21 mL) was added. The solution was quenched in an ice bath with water (0.8 mL), then 15% NaOH (0.8 mL), and finally water (2.1 mL). The resulting heterogeneous mixture was removed from the bath, dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. Purification by automatic flash column chromatography on silica gel (gradient elution from 5 to 40% EtOAc-hexanes) afforded a white, waxy solid (71% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 0.90 (s, 6H), 1.69 (br s, 1H), 2.63 (s, 2H), 3.31 (d, <i>J</i> = 8 Hz, 2H), 6.99–7.08 (m, 2H), 7.15–7.22 (m, 2H). <sup>19</sup>FNMR (376 MHz, CDCl<sub>3</sub>): δ −116.17. <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>): δ 24.03, 36.92, 36.93, 37.03, 71.02, 115.25 (d, <i>J</i><sub>C-F</sub> = 23 Hz), 123.67 (d, <i>J</i><sub>C–F</sub> = 3 Hz), 125.77 (d, <i>J</i><sub>C–F</sub> = 16 Hz), 127.96 (d, <i>J</i><sub>C–F</sub> = 8 Hz), 133.13 (d, <i>J</i><sub>C–F</sub> = 5 Hz), 161.68 (d, <i>J</i><sub>C–F</sub> = 242 Hz). HRMS (ESI, <i>m</i>/<i>z</i>): for C<sub>11</sub>H<sub>14</sub>FO [M – H]<sup>−</sup> calcd, 181.1034; found, 181.1030.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 3-(2-Fluorophenyl)-2,2-dimethylpropyl Methanesulfonate (<b>8</b>)<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></h4><div class="NLM_p last">Triethylamine (4.6 mL, 32.9 mmol) was added to a solution of <b>7</b> (4.0 g, 22.0 mmol) and dichloromethane (73 mL). The mixture was cooled to 0 °C, and then, methanesulfonyl chloride (2.1 mL, 26.3 mmol) was added. After stirring for 1 h, the mixture was warmed to ambient temperature and diluted with dichloromethane. The mixture was successively washed with cold water, chilled 10% HCl, saturated NaHCO<sub>3</sub>, and brine. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated under reduced pressure, producing a colorless, viscous liquid (91% yield). The product was used immediately in the next step without purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.00 (s, 6H), 2.68 (s, 2H), 3.03 (s, 3H), 3.92 (s, 2H), 7.01–7.11 (m, 2H), 7.13–7.25 (m, 2H). <sup>19</sup>FNMR (376 MHz, CDCl<sub>3</sub>): δ −115.22. <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>): δ 23.84, 35.82, 37.00, 37.11, 76.86, 115.39 (d, <i>J</i><sub>C–F</sub> = 23 Hz), 123.75 (d, <i>J</i><sub>C–F</sub> = 4 Hz), 124.39 (d, <i>J</i><sub>C–F</sub> = 16 Hz), 128.38 (d, <i>J</i><sub>C–F</sub> = 8 Hz), 132.80 (d, <i>J</i><sub>C–F</sub> = 4 Hz), 161.43 (d, <i>J</i><sub>C–F</sub> = 244 Hz).</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 1-Fluoro-2-(3-iodo-2,2-dimethylpropyl)benzene (<b>9</b>)<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></h4><div class="NLM_p last">NaI (16.9 g, 113.0 mmol) was added to a solution of <b>8</b> (5.9 g, 22.6 mmol) and NMP (45 mL). The mixture was heated to 140 °C overnight. After cooling to ambient temperature, the orange mixture was diluted with water, followed by extraction with pentane. The organic layer was then successively washed with saturated Na<sub>S</sub>2O<sub>3</sub>, saturated CuSO<sub>4</sub>, water, and brine. Purification of the crude product by automatic flash column chromatography on silica gel (gradient elution from 2 to 20% EtOAc-hexanes) afforded a colorless, viscous liquid (89% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.05 (s, 6H), 2.72 (s, 2H), 3.20 (s, 2H), 6.99–7.10 (m, 2H), 7.19–7.28 (m, 2H). <sup>19</sup>FNMR (376 MHz, CDCl<sub>3</sub>): δ −114.86. <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>): δ 24.14, 26.79, 26.80, 35.28, 38.66, 115.33 (d, <i>J</i><sub>C-F</sub> = 23 Hz), 123.64 (d, <i>J</i><sub>C–F</sub> = 4 Hz), 125.25 (d, <i>J</i><sub>C–F</sub> = 15 Hz), 128.22 (d, <i>J</i><sub>C–F</sub> = 8 Hz), 132.44 (d, <i>J</i><sub>C–F</sub> = 5 Hz), 161.43 (d, <i>J</i><sub>C–F</sub> = 244 Hz).</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Ethyl 2,2-Dimethyl-2,3-dihydro-1<i>H</i>-indene-4-carboxylate (<b>10</b>)<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a></h4><div class="NLM_p">Method 1: Compound <b>9</b> (4.5 g, 15.5 mmol) was first dissolved in 155 mL of anhydrous <i>n</i>-pentane-diethyl ether solution (4:1 by volume). The solution was cooled to −78 °C, after which <i>t</i>-BuLi (1.9 M solution in pentane, 26.1 mL, 49.5 mmol) was added dropwise. The solution was stirred at the same temperature for 15 min, and then, dry THF (7.8 mL) was added, turning the blue solution to a yellow, heterogeneous mixture. Next, the reaction mixture was warmed to room temperature (rt), stirred for 30 min, and cooled back to −78 °C. Ethyl chloroformate (15.3 mL, 154.7 mmol) was added dropwise, and the mixture was stirred for 15 min before warming up to rt and stirring for another 15 min. The mixture was quenched with water and extracted with diethyl ether (3 × 100 mL). The organic layer pool was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated under reduced pressure, producing a brown, viscous liquid which was used in the next step without purification and characterization.</div><div class="NLM_p last">Method 2: A mixture of TMS-esters <b>17</b> and <b>18</b> (20.3 mg, 0.07 mmol), KI (58.0 mg, 0.35 mmol), H<sub>2</sub>O (6 μL, 0.35 mmol), and acetonitrile (0.7 mL) was mixed in a vial. Trimethylsilyl chloride (44 μL, 0.35 mmol) was then added dropwise, and the mixture was stirred at 60 °C. After 12 h, the mixture was quenched with saturated NaHCO<sub>3</sub> and extracted with ethyl acetate. The organic layer pool was washed brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The crude product was purified by automatic flash column chromatography on silica gel (isocratic elution: 5% EtOAc-hexanes) to afford <b>10</b> as a colorless, viscous liquid (10.4 mg, 68% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.15 (s, 6H), 1.39 (t, 3H), 2.74 (s, 2H), 3.10 (s, 2H), 4.35 (q, 2H), 7.19 (t, 1H), 7.33 (d, 1H), 7.81 (d, 1H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>): δ 14.38, 28.85, 39.52, 47.27, 48.79, 60.56, 126.08, 127.04, 127.86, 128.86, 145.10, 145.95, 167.25. HRMS (ESI, <i>m</i>/<i>z</i>): for C<sub>14</sub>H<sub>19</sub>O<sub>2</sub> [M + H]<sup>+</sup> calcd, 219.1375; found, 219.1380.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 2,2-Dimethyl-2,3-dihydro-1<i>H</i>-indene-4-carboxylic acid (<b>11</b>)</h4><div class="NLM_p last">Ester <b>10</b> (crude from method 1 or purified from method 2) was first dissolved in ethanol (0.2 M). KOH (2.0 M solution in H<sub>2</sub>O, 3.0 eq) was then added, and the mixture was stirred overnight at ambient temperature. The mixture was then cooled in an ice bath and acidified with concentrated HCl until pH 1. The solids were filtered and washed with cold water. The resulting white powder (Method 1: 17% over two steps, Method 2: 95%) was used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.16 (s, 6H), 2.76 (s, 2H), 3.16 (s, 2H), 7.23 (t, 1H), 7.39 (d, 1H), 7.90 (d, 1H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>): δ 28.95, 39.69, 47.34, 49.04, 125.90, 126.36, 128.81, 129.99, 145.42, 147.17, 172.84. HRMS (ESI, <i>m</i>/<i>z</i>): for C<sub>12</sub>H<sub>13</sub>O<sub>2</sub> [M – H]<sup>−</sup> calcd, 189.0921; found, 189.0914. mp decomposes at 277 °C.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> (2,2-dimethyl-2,3-dihydro-1<i>H</i>-inden-4-yl) (1-pentyl-1<i>H</i>-indol-3-yl)methanone (<b>GBD-002, 3</b>).<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></h4><div class="NLM_p last">A mixture containing <b>11</b> (164.8 mg, 0.87 mmol) and dichloromethane (5.1 mL) was cooled to 0 °C. Thionyl chloride (0.16 mL, 2.2 mmol) was added dropwise, followed by a catalytic amount of DMF (7 μL, 0.09 mmol). After stirring at ambient temperature for 8 h, the mixture was concentrated under reduced pressure and redissolved in 0.6 mL of 1,1,1,3,3,3-hexafluoroisopropanol (HFIP). The solution was added dropwise to a mixture of <i>N</i>-pentylindole (486.6 mg, 2.6 mmol) and 0.6 mL of HFIP. The mixture was stirred at ambient temperature for 24 h and concentrated under reduced pressure. Purification by automatic flash column chromatography on silica gel (gradient elution from 5 to 40% EtOAc-hexanes) afforded a colorless oil (68% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 0.88 (t, 3H), 1.13 (s, 6H), 1.26–1.40 (m, 4H), 1.86 (quint, 2H), 2.78 (s, 2H), 2.91 (s, 2H), 4.12 (t, 2H), 7.19–7.24 (m, 1H), 7.29–7.35 (m, 3H), 7.36–7.42 (m, 2H), 7.46 (s, 1H), 8.39–8.44 ppm (m, 1H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>): δ 13.91, 22.21, 28.69, 28.97, 29.56, 40.03, 47.05, 47.14, 47.53, 109.83, 116.34, 122.60, 122.79, 123.41, 125.68, 126.09, 126.56, 127.05, 136.86, 137.32, 137.61, 142.78, 144.92, 191.88. HRMS (ESI, <i>m</i>/<i>z</i>): for C<sub>25</sub>H<sub>30</sub>NO [M + H]<sup>+</sup> calcd, 360.2322; found, 360.2317. Purity (qNMR), 100.4%.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 5,5-Dimethyl-3-oxocyclohex-1-en-1-yl trifluoromethanesulfonate, VAT (<b>13</b>)<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></h4><div class="NLM_p last">Pyridine (11.9 mL, 146.8 mmol) was added to a suspension of dimedone (10.3 g, 73.4 mmol) in dry dichloromethane (367 mL) at ambient temperature. The mixture was cooled to −78 °C and stirred for 10 min. Triflic anhydride (13.6 mL, 80.7 mmol) was then added slowly. After 20 min, the mixture was removed from the bath and warmed to ambient temperature. The mixture was quenched with 1 M HCl after complete consumption of the starting material and extracted with diethyl ether (3 × 50 mL). The organic layer pool was washed with saturated Na<sub>2</sub>CO<sub>3</sub> and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The crude product was purified by automatic flash column chromatography on silica gel (gradient elution from 2% to 20% EtOAc-hexanes) to afford VAT as a colorless, viscous liquid (19.3 g, 97% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.14 (s, 6H), 2.32 (s, 2H), 2.55 (s, 2H), 6.08 (s, 1H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>): δ 28.03, 33.42, 42.37, 50.58, 116.84, 118.38, 166.09, 197.55.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Ethyl 5,5-Dimethyl-3-oxooct-7-ynoate (<b>14</b>)</h4><div class="NLM_p last">LHMDS (1.0 M solution in THF, 9.1 mL, 9.1 mmol) was first cooled to −78 °C for 10 min. Ethyl acetate (0.9 mL, 9.1 mmol) was then added, and the mixture was stirred for 15 min. In a separate flask, a mixture of <b>13</b> (2.1 g, 7.6 mmol) in THF (30 mL) was also cooled to −78 °C. To this mixture, the ethyl lithioacetate solution was added slowly. After 20 min, the mixture was warmed to 0 °C, and then, LHMDS (1.0 M solution in THF, 22.7 mL, 22.7 mmol) was added dropwise over a period of 20 min. The resulting red solution was warmed to ambient temperature and stirred for 1 h. Saturated NH<sub>4</sub>Cl was added, and the mixture was extracted with ether (3 × 20 mL). The organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The crude product was purified by automatic flash column chromatography on silica gel (isocratic elution: 5% EtOAc-hexanes) to afford the β-ketoester as a yellow, viscous liquid (1.0 g, 63% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.08 (s, 6H), 1.26 (t, 3H), 1.99 (t, 1H), 2.26 (d, 2H), 2.57 (s, 2H), 3.41 (s, 2H), 4.17 (q, 2H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>): δ 14.09, 26.93, 31.14, 33.42, 50.95, 51.55, 61.32, 70.54, 81.90, 167.12, 201.92.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Ethyl (<i>Z</i>)-5,5-Dimethyl-3-(((trifluoromethyl)sulfonyl)oxy)oct-2-en-7-ynoate (<b>15</b>)</h4><div class="NLM_p last">A mixture of <b>14</b> (0.97 g, 4.6 mmol) and hexanes (23 mL) was cooled in an ice bath. Saturated aqueous LiOH (1.5 mL/mmol β-ketoester) was added, and the resulting suspension was stirred for 5 min. Triflic anhydride (1.9 mL, 11.5 mmol) was then added slowly. The mixture was removed from the bath and stirred for 30 min. After the reaction, the mixture was diluted with water and extracted with ether (3 × 10 mL). The organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The crude product was purified by automatic flash column chromatography on silica gel (isocratic elution: 5% EtOAc-hexanes) to afford the triflate as a light-yellow, viscous liquid (1.39 g, 88% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.09 (s, 6H), 1.32 (t, 3H), 2.09 (t, 1H), 2.16 (d, 2H), 2.40 (s, 2H), 4.26 (q, 2H), 5.84 (s, 1H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>): δ 14.00, 26.72, 31.61, 34.82, 45.00, 61.33, 71.51, 80.85, 115.01, 116.70, 119.88, 156.43, 162.40.</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Ethyl 5,5-Dimethylocta-2,7-diynoate (<b>16</b>)</h4><div class="NLM_p last">To a mixture of <b>15</b> (1.2 g, 3.5 mmol) in THF (17 mL) cooled at 0 °C, LHMDS (1.0 M solution in THF, 3.8 mL, 3.8 mmol) was added. The solution was warmed to ambient temperature and stirred for 1 h. After the reaction, saturated NH<sub>4</sub>Cl was added, and the mixture was extracted with ether (3 × 10 mL). The organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The crude product was purified by automatic flash column chromatography on silica gel (gradient elution from 2 to 20% EtOAc-hexanes) to afford the diyne as a light-yellow oil (0.42 g, 63% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.11 (s, 6H), 1.31 (t, 3H), 2.03 (t, 1H), 2.22 (s, 2H), 2.37 (s, 2H), 4.22 (q, 2H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>): δ 14.04, 26.39, 30.87, 31.13, 34.09, 61.83, 70.76, 75.14, 81.29, 86.70, 153.72.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Ethyl 2,2-Dimethyl-5-(trimethylsilyl)-2,3-dihydro-1<i>H</i>-indene-4-carboxylate (<b>17/18</b>)</h4><div class="NLM_p last">In a vial, [Rh(COD)<sub>2</sub>]BF<sub>4</sub> (16.2 mg, 0.04 mmol), (±)-BINAP (24.6 mg, 0.04 mmol), and CH<sub>2</sub>Cl<sub>2</sub> (7.9 mL) were stirred for 1 h at ambient temperature under a H<sub>2</sub> atmosphere. The mixture was concentrated and redissolved in CH<sub>2</sub>Cl<sub>2</sub> (2.0 mL). TMS-acetylene (0.25 mL, 1.7 mmol) was added, followed by a solution of diyne <b>16</b> (152.0 mg, 0.79 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (7.9 mL). After stirring for 1 h at ambient temperature, the mixture was concentrated and purified by automatic flash column chromatography on silica gel (isocratic elution: 2% EtOAc-hexanes) to afford a mixture of TMS-esters as a colorless, viscous liquid (206 mg, 90% yield). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>CO): ortho isomer: δ 0.29 (s, 9H), 1.14 (s, 6H), 1.40 (t, 3H), 2.73 (s, 2H), 2.91 (s, 2H), 4.36 (q, 2H), 7.25 (d, 1H), 7.42 (d, 1H). Meta isomer: δ 0.28 (s, 9H), 1.15 (s, 6H), 1.40 (t, 3H), 2.74 (s, 2H), 3.09 (s, 2H), 4.36 (q, 2H), 7.47 (d, 1H), 7.95 (d, 1H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>): δ 1.38, 15.37, 15.45, 29.90, 29.96, 40.42, 40.43, 48.28, 48.49, 49.30, 49.99, 61.58, 61.90, 127.60, 127.67, 133.91, 134.32, 134.65, 135.22, 138.57, 139.19, 144.47, 145.51, 146.68, 147.62, 168.62, 170.96. HRMS (ESI, <i>m</i>/<i>z</i>): for C<sub>17</sub>H<sub>27</sub>O<sub>2</sub>Si [M + H]<sup>+</sup> calcd, 291.1768; found, 291.1775.</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 3-Hydroxy-5,5-dimethyl-cyclohex-1-en-1-yl Trifluoromethane Sulfonate, VHAT (<b>19</b>)<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></h4><div class="NLM_p last">A mixture of <b>13</b> (19.3 g, 70.9 mmol) and dry THF (322 mL) was cooled to −78 °C. DIBAL-H (1.0 M solution in toluene, 92.2 mL, 92.2 mmol) was added slowly, and the resulting mixture was stirred for 10 min. The mixture was warmed to ambient temperature until complete consumption of the starting material and then diluted with ether (∼160 mL) before cooling in an ice bath. Water (3.7 mL) was added slowly, followed by 15% aqueous NaOH (3.7 mL) and water (9.2 mL). The mixture was removed from the bath and dried over MgSO<sub>4</sub>. After 15 min of stirring, the mixture was filtered. The filtrate was concentrated under reduced pressure and finally purified by automatic flash column chromatography on silica gel (gradient elution from 5% to 40% EtOAc-hexanes) to afford VHAT as a colorless, viscous liquid (14.5 g, 75% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 0.99 (s, 3H), 1.09 (s, 3H), 1.33 (dd, 1H), 1.83 (dd, 1H), 1.96 (broad, s, 1H), 2.01 (d, 1H), 2.27 (d, 1H), 4.43–4.46 (m, 1H), 5.80 (s, 1H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>): δ 25.95, 30.55, 32.30, 41.08, 44.17, 65.57, 116.91, 120.35, 149.82.</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Ethyl-<i>E</i>-4-(diethoxyphosphoryl)but-2-enoate<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a></h4><div class="NLM_p last">Triethyl phosphite (10.0 g, 38.8 mmol) and ethyl 4-bromocrotonate (7.9 g, 46.6 mmol) were combined in a pressure flask and heated to 140 °C overnight. The mixture was cooled to ambient temperature, transferred to a flask, and distilled until complete removal of ethyl bromide. The crude product was a brown, viscous liquid and used in the next step without purification. The <sup>1</sup>H NMR is consistent with the literature report.</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Ethyl (2<i>E</i>, 4<i>E</i>)-7,7-Dimethyldeca-2,4-dien-9-ynoate (<b>20</b>)<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></h4><div class="NLM_p last">A mixture of <b>19</b> (5.3 g, 19.5 mmol), ethyl-<i>E</i>-4-(diethoxyphosphoryl)but-2-enoate (7.3 g, 29.2 mmol), and dry THF (97 mL) was cooled to −78 °C. LHMDS (1.0 M solution in THF, 42.8 mL, 42.8 mmol) was added slowly, and the resulting mixture was stirred for 15 min. The mixture was warmed to ambient temperature and then at 60 °C for 1 h or until complete consumption of the starting material. After cooling to ambient temperature, 1 M HCl (∼97 mL) was added, and the mixture was extracted with ethyl acetate (3 × 25 mL). The organic layer was washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The crude product was purified by automatic flash column chromatography on silica gel (gradient elution from 2 to 20% EtOAc-hexanes) to afford dienyne as a light-yellow, viscous liquid (3.2 g, 75% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 0.10 (s, 6H), 1.30 (t, 3H), 2.03 (t, 1H), 2.08 (d, 2H), 2.19 (d, 2H), 4.21 (q, 2H), 5.82 (d, 1H) 6.10–6.16 (m, 1H), 6.22 (dd, 1H), 7.28 (dd, 1H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>): δ 14.30, 26.66, 31.51, 34.31, 44.43, 60.19, 70.32, 81.99, 119.83, 131.13, 140.44, 144.57, 167.19.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Ethyl 2,2-Dimethyl-2,3-dihydro-1<i>H</i>-indene-5-carboxylate (<b>21</b>)<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></h4><div class="NLM_p last">To a mixture of <b>20</b> (3.2 g, 14.6 mmol) in dry dichloromethane (291 mL), di-μ-chlorobis(norbornadiene)dirhodium [Rh(nbd)Cl]<sub>2</sub> (0.14 g, 0.29 mmol) was added, followed by silver hexafluoroantimonate (AgSbF<sub>6</sub>, 0.43 g, 1.24 mmol). The resulting mixture was stirred at ambient temperature for 1 h. DDQ (4.1 g, 17.5 mmol) was added, and stirring was continued until complete oxidation (1–2 h). After the reaction, the brown mixture was filtered in basic alumina. The filtrate was concentrated under reduced pressure and purified by automatic flash column chromatography on silica gel (gradient elution from 1 to 10% EtOAc-hexanes) to afford the ester as a colorless, viscous liquid (2.7 g, 85% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.15 (s, 6H), 1.38 (t, 3H), 2.75 (s, 4H), 4.35 (q, 2H), 7.21 (d, 1H), 7.81–7.86 (m, 2H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>): δ 14.38, 28.60, 40.51, 47.31, 47.74, 60.70, 124.53, 125.79, 127.88, 128.52, 143.84, 149.27, 167.09.</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 2,2-Dimethyl-2,3-dihydro-1<i>H</i>-indene-5-carboxylic acid (<b>22</b>)</h4><div class="NLM_p last">Compound <b>21</b> (3.7 g, 17.1 mmol) was first dissolved in ethanol (82 mL). Aqueous KOH (9.1 mL) was then added, and the mixture was stirred overnight at ambient temperature. After the reaction, the mixture was neutralized with 3 M HCl. The solids were filtered and washed with cold water. The crude product was white, fluffy crystals (2.8 g, 85%) and used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.16 (s, 6H), 2.77 (s, 4H), 7.25 (d, 1H), 7.89–7.93 (m, 2H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>): δ 28.69, 40.65, 47.36, 47.93, 124.80, 126.56, 127.40, 128.73, 144.16, 150.62, 172.73. HRMS (ESI, <i>m</i>/<i>z</i>): for C<sub>12</sub>H<sub>13</sub>O<sub>2</sub> [M – H]<sup>−</sup> calcd, 189.0921; found, 189.0915. mp 158–160 °C.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> General Procedure for the Synthesis of Indoles <b>23</b> and <b>24</b><a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></h3><div class="NLM_p">A mixture containing <b>22</b> (500.0 mg, 2.6 mmol) and dichloromethane (15.5 mL) was cooled to 0 °C. Thionyl chloride (0.4 mL, 5.3 mmol) was added dropwise, followed by a catalytic amount of DMF (0.02 mL, 0.3 mmol). After stirring at ambient temperature for 24 h, the mixture was concentrated under reduced pressure and redissolved in 1.5 mL of 1,1,1,3,3,3-HFIP. The acid chloride solution was added dropwise to a mixture of indole (2.8 mmol) and 2.0 mL of HFIP. The mixture was stirred at ambient temperature for 24 h, diluted with DCM, concentrated under reduced pressure, and purified by automatic flash column chromatography on silica gel (gradient elution from 1 to 10% MeOH–CH<sub>2</sub>Cl<sub>2</sub>).</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> (2,2-Dimethyl-2,3-dihydro-1<i>H</i>-inden-5-yl) (1<i>H</i>-indol-3-yl)methanone (<b>GBD-001, 23</b>)</h4><div class="NLM_p last">Obtained as white, powdery crystals (58% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.15 (s, 6H), 2.77 (overlapping s, 4H), 7.19–7.27 (m, 2H), 7.31 (d, 1H), 7.50–7.53 (m, 1H), 7.55–7.58 (m, 1H), 7.59 (d, 1H), 7.93 (s, 1H), 8.22–8.25 (m, 1H), 12.00 ppm (s, 1H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 28.45, 40.12, 46.94, 47.10, 112.20, 115.13, 121.50, 121.75, 123.01, 124.40, 124.72, 126.36, 126.99, 135.40, 136.66, 138.84, 143.34, 146.69, 190.08. HRMS (ESI, <i>m</i>/<i>z</i>): for C<sub>20</sub>H<sub>18</sub>NO [M – H]<sup>−</sup> calcd, 288.1394; found, 288.1394. mp 224–225 °C. Purity (qNMR), 100.1%.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> (2,2-Dimethyl-2,3-dihydro-1<i>H</i>-inden-5-yl) (2-methyl-1<i>H</i>-indol-3-yl)methanone (<b>GBD-019, 24</b>)</h4><div class="NLM_p last">Obtained as white, powdery crystals (53% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.13 (s, 6H), 2.72 (s, 2H), 2.76 (s, 2H), 7.00 (t, 1H), 7.10 (t, 1H), 7.27 (d, 1H), 7.24 (d, 1H), 7.36 (d, 1H), 7.38 (d, 1H), 7.43 (s, 1H), 11.87 (s, 1H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 14.13, 28.30, 40.21, 46.83, 47.07, 111.18, 112.75, 120.01, 120.74, 121.67, 124.35, 124.51, 126.77, 127.35, 134.92, 139.72, 143.27, 143.80, 146.77, 191.84. HRMS (ESI, <i>m</i>/<i>z</i>): for C<sub>21</sub>H<sub>22</sub>NO [M + H]<sup>+</sup> calcd, 304.1696; found, 304.1636. mp 239–241 °C.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> General Procedure for the Synthesis of <b>4</b>, <b>26–34</b>, <b>36</b>, <b>37</b>, and <b>39</b></h3><div class="NLM_p">NaH (27.6 mg, 0.69 mmol) and DMSO (1.0 mL) were mixed thoroughly in a round-bottom flask. In a separate pear-shaped flask, <b>23</b> (100 mg, 0.35 mmol) and DMSO (1.5 mL) were heated to ∼40 °C to form a solution and then added slowly to the NaH suspension. After stirring at ambient temperature for 30 min, the alkyl halide (0.42 mmol) was added. The resulting mixture was stirred overnight at ambient temperature. The reaction mixture was quenched with water and extracted with ethyl acetate (2 × 10 mL). The organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, concentrated under reduced pressure, and purified by automatic flash column chromatography on silica gel (gradient elution from 5 to 40% EtOAc-hexanes).</div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> (2,2-Dimethyl-2,3-dihydro-1<i>H</i>-inden-5-yl) (1-pentyl-1<i>H</i>-indol-3-yl)methanone (<b>GBD-003, 4</b>)</h4><div class="NLM_p last">Obtained as white crystals (88% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.89 (t, 3H), 1.19 (s, 6H), 1.26–140 (m, 4H), 1.87 (quintet, 2H), 2.79 (s, 4H), 4.15 (t, 2H), 7.22–7.27 (m, 1H), 7.28–7.35 (m, 2H), 7.36–7.41 (m, 1H), 7.57–7.62 (m, 2H), 7.64 (s, 1H), 8.39–8.45 (m, 1H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>) δ 13.93, 22.22, 28.72, 28.98, 29.57, 40.48, 47.10, 47.52, 47.73, 109.77, 115.67, 122.40, 122.80, 123.31, 124.27, 125.15, 127.30, 127.45, 136.68, 136.75, 139.21, 143.88, 147.37, 191.20. HRMS (ESI, <i>m</i>/<i>z</i>) for C<sub>25</sub>H<sub>30</sub>NO [M + H]<sup>+</sup> calcd, 360.2322, found 360.2318. mp 62–64 °C. Purity (qNMR), 99.9%.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> (2,2-dimethyl-2,3-dihydro-1<i>H</i>-inden-5-yl) (1-propyl-1<i>H</i>-indol-3-yl)methanone (<b>GBD-005, 26</b>)</h4><div class="NLM_p last">Obtained as white, powdery crystals (83% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 0.95 (t, 3H), 1.19 (s, 6H), 1.91 (sextet, 2H), 2.79 (s, 4H), 4.13 (t, 2H), 7.23–7.27 (m, 1H), 7.29–7.35 (m, 2H), 7.36–7.42 (m, 1H), 7.58–7.62 (m, 2H), 7.64 (s, 1H), 8.39–8.45 (m, 1H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>): δ 11.42, 23.21, 28.73, 40.48, 47.52, 47.73, 48.74, 109.79, 115.67, 122.42, 122.82, 123.32, 124.26, 125.13, 127.28, 127.46, 136.76, 136.78, 139.21, 143.90, 147.36, 191.22. HRMS (ESI, <i>m</i>/<i>z</i>): for C<sub>23</sub>H<sub>26</sub>NO [M + H]<sup>+</sup> calcd, 332.2009; found, 332.2006. mp 91–93 °C. Purity (qNMR), 99.2%.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> (2,2-Dimethyl-2,3-dihydro-1<i>H</i>-inden-5-yl) (1-butyl-1<i>H</i>-indol-3-yl)methanone (<b>GBD-006, 27</b>)</h4><div class="NLM_p last">Obtained as white, powdery crystals (85% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 0.93 (t, 3H), 1.19 (s, 6H), 1.36 (sextet, 2H), 1.86 (quintet, 2H), 2.80 (s, 4H), 4.17 (t, 2H), 7.23–7.27 (m, 1H), 7.29–7.35 (m, 2H), 7.36–7.41 (m, 1H), 7.58–7.62 (m, 2H), 7.64 (s, 1H), 8.39–8.44 ppm (m, 1H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>) δ 13.63, 20.09, 28.73, 31.92, 40.48, 46.86, 47.52, 47.73, 109.77, 15.69, 122.41, 122.82, 123.31, 124.27, 125.14, 127.28, 127.45, 136.68, 136.76, 139.21, 143.90, 147.37, 191.20. HRMS (ESI, <i>m</i>/<i>z</i>): for C<sub>24</sub>H<sub>28</sub>NO [M + H]<sup>+</sup> calcd, 346.2165; found, 346.2163. mp 70–72 °C. Purity (qNMR), 100.1%.</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> (2,2-Dimethyl-2,3-dihydro-1<i>H</i>-inden-5-yl) (1-hexyl-1<i>H</i>-indol-3-yl)methanone (<b>GBD-007, 28</b>)</h4><div class="NLM_p last">Obtained as white, powdery crystals (82% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 0.87 (t, 3H), 1.19 (s, 6H), 1.31 (m, 6H), 1.87 (quintet, 2H), 2.80 (s, 2H), 4.15 (t, 2H), 7.23–7.27 (m, 1H), 7.29–7.36 (m, 2H), 7.37–7.41 (m, 1H), 7.57–7.62 (m, 2H), 7.64 (s, 1H), 8.39–8.44 ppm (m, 1H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>): δ 13.97, 22.50, 26.54, 28.73, 29.83, 31.28, 40.48, 47.12, 47.53, 47.74, 109.77, 115.68, 122.41, 122.82, 123.31, 124.27, 125.15, 127.30, 127.47, 136.67, 136.75, 139.23, 143.88, 147.36, 191.20. HRMS (ESI, <i>m</i>/<i>z</i>): for C<sub>26</sub>H<sub>32</sub>NO [M + H]<sup>+</sup> calcd, 374.2478; found, 374.2477. mp 61–63 °C. Purity (qNMR), 99.7%.</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> (2,2-Dimethyl-2,3-dihydro-1<i>H</i>-inden-5-yl) (1-isobutyl-1<i>H</i>-indol-3-yl)methanone (<b>GBD-008, 29</b>)</h4><div class="NLM_p last">Obtained as yellowish oil (53% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 0.94 (d, 6H), 1.18 (s, 6H), 2.23 (m, 1H), 2.79 (s, 4H), 3.94 (d, 2H), 7.22–7.26 (m, 1H), 7.28–7.33 (m, 2H), 7.34–7.39 (m, 1H), 7.54–7.61 (m, 2H), 7.64 (s, 1H), 8.39–8.44 ppm (m, 1H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>): δ 20.19, 28.72, 29.15, 40.46, 47.51, 47.71, 54.68, 109.97, 115.54, 122.37, 122.76, 123.29, 124.25, 125.16, 127.29, 127.40, 137.00, 137.16, 139.18, 143.89, 147.38, 191.23. HRMS (ESI, <i>m</i>/<i>z</i>): for C<sub>24</sub>H<sub>28</sub>NO [M + H]<sup>+</sup> calcd, 346.2165; found, 346.2161. Purity (qNMR), 98.5%.</div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> (1-Benzyl-1<i>H</i>-indol-3-yl) (2,2-dimethyl-2,3-dihydro-1<i>H</i>-inden-5-yl)methanone (<b>GBD-009, 30</b>)</h4><div class="NLM_p last">Obtained as white, powdery crystals (86% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.17 (s, 6H), 2.78 (s, 4H), 5.37 (s, 2H), 7.11–7.15 (m, 2H), 7.21–7.35 (m, 7H), 7.58–7.62 (app. d, 1H), 7.64 (s, 2H), 8.42–8.46 ppm (m, 1H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>): δ 28.71, 40.47, 47.50, 47.71, 50.74, 110.14, 116.25, 122.64, 122.82, 123.63, 124.31, 125.16, 126.78, 127.31, 127.52, 128.10, 128.98, 135.92, 136.96, 137.02, 139.01, 143.91, 147.52, 191.24. HRMS (ESI, <i>m</i>/<i>z</i>): for C<sub>27</sub>H<sub>26</sub>NO [M + H]<sup>+</sup> calcd, 380.2009; found, 380.2005. mp 111–114 °C. Purity (qNMR), 99.6%.</div></div><div id="sec4_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> (2,2-Dimethyl-2,3-dihydro-1<i>H</i>-inden-5-yl) (1-(4-fluorobenzyl)-1<i>H</i>-indol-3-yl)methanone (<b>GBD-010, 31</b>)</h4><div class="NLM_p last">Obtained as white, powdery crystals (90% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.18 (s, 6H), 2.78 (s, 4H), 5.34 (s, 2H), 6.98–7.04 (m, 2H), 7.09–7.14 (m, 2H), 7.24 (m, 1H), 7.28–7.35 (m, 3H), 7.58–7.65 (m, 3H), 8.40–8.43 ppm (m, 1H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>): δ 28.70, 40.49, 47.50, 47.71, 50.09, 110.02, 115.86, 116.06, 116.40, 122.72, 122.90, 123.72, 124.33, 125.15, 127.31, 127.55, 131.64, 128.50, 128.58, 136.68, 136.87, 138.95, 143.96, 147.62, 163.65, 191.20. <sup>19</sup>FNMR (376 MHz, CDCl<sub>3</sub>): δ −113.65. HRMS (ESI, <i>m</i>/<i>z</i>): for C<sub>27</sub>H<sub>25</sub>FNO [M + H]<sup>+</sup> calcd, 398.1915; found, 398.1911. mp 124–126 °C. Purity (qNMR), 100.5%.</div></div><div id="sec4_3_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> (<i>E</i>)-(2,2-Dimethyl-2,3-dihydro-1<i>H</i>-inden-5-yl) (1-(pent-2-en-1-yl)-1<i>H</i>-indol-3-yl)methanone (<b>GBD-011, 32</b>)</h4><div class="NLM_p last">Obtained as white, powdery crystals (88% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 0.98 (t, 3H), 1.18 (s, 6H), 2.06 (quint, 2H), 2.79 (s, 4H), 4.69–4.74 (app. d, 2H), 5.56–5.65 (m, 1H, <i>J</i> = 15.3 Hz, 6.0 Hz, 1.4 Hz), 5.71–5.80 (m, 1H, <i>J</i> = 15.4 Hz, 6.2 Hz, 1.4 Hz), 7.22–7.27 (m, 1H), 7.29–7.35 (m, 2H), 7.36–7.42 (m, 1H), 7.58–7.62 (m, 2H), 7.65 (s, 1H), 8.39–8.44 (m, 1H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>): δ 13.21, 25.18, 28.72, 40.48, 47.52, 47.72, 48.94, 110.05, 115.86, 122.46, 122.70, 122.77, 123.33, 124.28, 125.14, 127.30, 127.52, 136.47, 136.85, 137.27, 139.17, 143.87, 147.38, 191.20. HRMS (ESI, <i>m</i>/<i>z</i>): for C<sub>25</sub>H<sub>28</sub>NO [M + H]<sup>+</sup> calcd, 358.2165; found, 358.2163. mp 80–82 °C. Purity (qNMR), 99.1%.</div></div><div id="sec4_3_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> (<i>Z</i>)-(2,2-Dimethyl-2,3-dihydro-1<i>H</i>-inden-5-yl) (1-(pent-2-en-1-yl)-1<i>H</i>-indol-3-yl)methanone (<b>GBD-012, 33</b>)</h4><div class="NLM_p last">Obtained as white, powdery crystals (68% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.07 (t, 3H), 1.17 (s, 6H), 2.24 (quint, 2H), 2.78 (s, 4H), 4.78 (app. d, 2H), 5.51–5.59 (m, 1H, <i>J</i> = 10.8 Hz, 6.8 Hz, 0.8 Hz), 5.68–5.76 (m, 1H, <i>J</i> = 10.7 Hz, 7.4 Hz, 0.8 Hz), 7.22–7.26 (m, 1H), 7.29–7.34 (m, 2H), 7.35–7.40 (m, 1H), 7.56–7.62 (m, 2H), 7.63 (s, 1H), 8.37–8.43 (m, 1H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>): δ 14.00, 20.96, 28.72, 40.48, 43.79, 47.52, 47.73, 109.83, 115.91, 122.54, 122.58, 122.82, 123.36, 124.28, 125.14, 127.29, 127.60, 136.18, 136.83, 136.85, 139.17, 143.87, 147.38, 191.18. HRMS (ESI, <i>m</i>/<i>z</i>): for C<sub>25</sub>H<sub>28</sub>NO [M + H]<sup>+</sup> calcd, 358.2165; found, 358.2162. mp 70–71 °C. Purity (qNMR), 99.5%.</div></div><div id="sec4_3_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> (2,2-Dimethyl-2,3-dihydro-1<i>H</i>-inden-5-yl) (1-(pent-4-en-1-yl)-1<i>H</i>-indol-3-yl)methanone (<b>GBD-013, 34</b>)</h4><div class="NLM_p last">Obtained as light-yellow, powdery crystals (74% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.18 (s, 6H), 1.97 (quint, 2H), 2.09 (q, 2H), 2.79 (s, 4H), 4.16 (t, 2H), 5.01–5.04 (m 1H), 5.05–5.09 (m, 1H), 5.72–5.84 (ddt, 1H), 7.22–7.26 (m, 1H), 7.29–7.34 (m, 2H), 7.35–7.40 (m, 1H), 7.56–7.61 (m, 2H), 7.63 (s, 1H), 8.39–8.44 ppm (m, 1H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>): δ 28.72, 28.77, 30.67, 40.48, 46.24, 47.53, 47.73, 109.75, 115.80, 116.17, 122.46, 122.86, 123.37, 124.28, 125.12, 127.26, 127.48, 136.69, 136.71, 136.79, 139.18, 143.88, 147.39, 191.18. HRMS (ESI, <i>m</i>/<i>z</i>): for C<sub>25</sub>H<sub>28</sub>NO [M + H]<sup>+</sup> calcd, 358.2165; found, 358.2162. mp 78–79 °C. Purity (qNMR), 99.3%.</div></div><div id="sec4_3_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> (2,2-Dimethyl-2,3-dihydro-1<i>H</i>-inden-5-yl) (1-(pent-2-yn-1-yl)-1<i>H</i>-indol-3-yl)methanone (<b>GBD-015, 36</b>)</h4><div class="NLM_p last">Obtained as light-yellow, powdery crystals (55% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.13 (t, 3H), 1.19 (s, 6H), 2.18–2.25 (qt, 2H), 2.79 (s, 4H), 4.88 (t, 2H), 7.23–7.27 (m, 1H), 7.31–7.38 (m, 2H), 7.42–7.48 (m, 1H), 7.60–7.68 (m, 2H), 7.77 (s, 1H), 8.39–8.45 (m, 1H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>): δ 12.37, 13.58, 28.71, 37.02, 40.49, 47.53, 47.73, 71.93, 88.93, 109.79, 116.00, 122.70, 122.88, 123.53, 124.31, 125.15, 127.33, 127.63, 136.07, 136.48, 139.05, 143.85, 147.47, 191.18. HRMS (ESI, <i>m</i>/<i>z</i>): for C<sub>25</sub>H<sub>26</sub>NO [M + H]<sup>+</sup> calcd, 356.2009; found, 332.2007. mp 98–99 °C. Purity (qNMR), 96.8%.</div></div><div id="sec4_3_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> (1-Allyl-1<i>H</i>-indol-3-yl) (2,2-dimethyl-2,3-dihydro-1<i>H</i>-inden-5-yl)methanone (<b>GBD-016, 37</b>)</h4><div class="NLM_p last">Obtained as yellowish oil (81% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.18 (s, 6H), 2.79 (s, 4H), 4.76 (m, 2H), 5.10–5.17 (m, 1H), 5.23–5.28 (m, 1H), 5.94–6.04 (m, 1H), 7.22–7.26 (m, 1H), 7.29–7.38 (m, 3H), 7.57–7.61 (m, 2H), 7.64 (s, 1H), 8.41–8.45 ppm (m, 1H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>): δ 28.67, 40.43, 47.46, 47.66, 49.33, 109.97, 116.01, 118.39, 122.50, 122.74, 123.42, 124.25, 125.04, 127.23, 127.39, 132.07, 136.60, 136.80, 139.04, 143.87, 147.40, 191.17. HRMS (ESI, <i>m</i>/<i>z</i>): for C<sub>23</sub>H<sub>24</sub>NO [M + H]<sup>+</sup> calcd, 330.1852; found, 330.1848. Purity (qNMR), 98.3%.</div></div><div id="sec4_3_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> Ethyl 2-(3-(2,2-Dimethyl-2,3-dihydro-1<i>H</i>-indene-5-carbonyl)-1<i>H</i>-indol-1-yl)acetate (<b>GBD-018, 39</b>)</h4><div class="NLM_p last">Obtained as yellowish oil (28% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.18 (s, 6H), 1.26 (t, 3H), 2.78 (s, 4H), 4.22 (q, 2H), 4.86 (s, 2H), 7.22–7.36 (m, 4H), 7.59–7.63 (m, 2H), 7.65 (s, 1H), 8.40–8.45 ppm (m, 1H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>): δ 14.10, 28.69, 40.47, 47.48, 47.70, 48.15, 62.11, 109.20, 116.80, 122.76, 122.91, 123.85, 124.32, 125.11, 127.21, 127.34, 137.10, 137.32, 138.89, 143.90, 147.60, 167.49, 191.28. HRMS (ESI, <i>m</i>/<i>z</i>): for C<sub>24</sub>H<sub>26</sub>NO<sub>3</sub> [M + H]<sup>+</sup> calcd, 376.1907; found, 376.1904. Purity (qNMR), 96.5%.</div></div><div id="sec4_3_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> (2,2-dimethyl-2,3-dihydro-1<i>H</i>-inden-5-yl) (1-methyl-1<i>H</i>-indol-3-yl)methanone (<b>GBD-004, 25</b>)</h4><div class="NLM_p last">NaH (14.2 mg, 0.36 mmol) and DMSO (1.0 mL) were mixed thoroughly in a round-bottom flask. In a separate pear-shaped flask, <b>23</b> (51.4 mg, 0.18 mmol) and DMSO (1.5 mL) were heated to ∼40 °C to form a solution and then added slowly to the NaH suspension. After stirring at ambient temperature for 30 min, (chloromethyl)trimethylsilane (0.03 mL, 0.21 mmol) was added. The resulting mixture was stirred overnight at ambient temperature. The reaction was quenched with water and extracted with ethyl acetate (2 × 5 mL). The organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. Purification by automatic flash column chromatography on silica gel (gradient elution from 5 to 40% EtOAc-hexanes) afforded white, powdery crystals (64% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.18 (s, 6H), 2.79 (s, 4H), 3.85 (s, 3H), 7.22–7.26 (m, 1H), 7.31–7.39 (m, 3H), 7.56 (s, 1H), 7.57–7.62 (app. d, 1H), 7.63 (s, 1H), 8.40–8.44 ppm (m, 1H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>) δ 28.71, 33.53, 40.48, 47.51, 47.71, 109.53, 115.75, 122.51, 122.74, 123.47, 124.28, 125.06, 127.03, 127.28, 137.46, 137.61, 139.15, 143.86, 147.36, 191.18. HRMS (ESI, <i>m</i>/<i>z</i>): for C<sub>21</sub>H<sub>22</sub>NO [M + H]<sup>+</sup> calcd, 304.1696; found, 304.1693. mp 92–95 °C. Purity (qNMR), 99.9%.</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> General Procedure for the Synthesis of <b>35</b> and <b>38</b></h3><div class="NLM_p">To a mixture of <b>23</b> (100 mg, 0.35 mmol) and DMSO (2.0 mL) was added KOH (38.8 mg, 0.69 mmol). After stirring at ambient temperature for 1 h, the alkyl halide (0.52 mmol) was added. The resulting mixture was stirred for 2 h at ambient temperature. The reaction was quenched with water and extracted with ethyl acetate (2 × 10 mL). The organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, concentrated under reduced pressure, and purified by automatic flash column chromatography on silica gel (gradient elution from 5 to 40% EtOAc-hexanes).</div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> (2,2-Dimethyl-2,3-dihydro-1<i>H</i>-inden-5-yl) (1-(pent-4-yn-1-yl)-1<i>H</i>-indol-3-yl)methanone (<b>GBD-014, 35</b>)</h4><div class="NLM_p last">Obtained as light-yellow, powdery crystals (79% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.18 (s, 6H), 2.03–2.12 (m, 3H), 2.17–2.22 (td, 2H, <i>J</i> = 6.4 Hz, 2.5 Hz), 2.79 (s, 4H), 4.34 (t, 2H), 7.22–7.28 (m, 1H), 7.29–7.36 (m, 2H), 7.39–7.45 (m, 1H), 7.58–7.63 (d, 1H), 7.65 (m, 2H), 8.39–8.46 ppm (m, 1H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>): δ 15.64, 28.06, 28.71, 40.49, 45.29, 47.53, 47.73, 70.21, 82.30, 109.68, 115.84, 122.55, 122.91, 123.48, 124.32, 125.20, 127.33, 127.53, 136.59, 136.97, 139.06, 143.88, 147.47, 191.15. HRMS (ESI, <i>m</i>/<i>z</i>): for C<sub>25</sub>H<sub>26</sub>NO [M + H]<sup>+</sup> calcd, 356.2009; found, 356.2006. mp 84–85 °C. Purity (qNMR), 100.4%.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> (2,2-Dimethyl-2,3-dihydro-1<i>H</i>-inden-5-yl) (1-(prop-2-yn-1-yl)-1<i>H</i>-indol-3-yl)methanone (<b>GBD-017, 38</b>)</h4><div class="NLM_p last">Obtained as light-yellow oil (66% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.19 (s, 6H), 2.49 (t, 1H), 2.80 (s, 4H), 4.93 (d, 2H), 7.23–7.28 (m, 1H), 7.32–7.41 (m, 2H), 7.43–7.49 (m, 1H), 7.59–7.67 (m, 2H), 7.74 (s, 1H), 8.39–8.45 ppm (m, 1H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>): δ 28.71, 36.53, 40.50, 47.50, 47.73, 75.02, 76.29, 109.64, 116.47, 122.87, 122.97, 123.76, 124.34, 125.14, 127.33, 127.56, 135.81, 136.41, 138.89, 143.96, 147.63, 191.21. HRMS (ESI, <i>m</i>/<i>z</i>): for C<sub>23</sub>H<sub>22</sub>NO [M + H]<sup>+</sup> calcd, 328.1696; found, 328.1695. Purity (qNMR), 100.0%.</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> General Procedure for the Synthesis of <b>40–48</b> and <b>50</b></h3><div class="NLM_p">NaH (26.4 mg, 0.66 mmol) and DMSO (1.0 mL) were mixed thoroughly in a round-bottom flask. In a separate pear-shaped flask, <b>24</b> (100 mg, 0.33 mmol) and DMSO (1.5 mL) were heated to ∼40 °C to form a solution and then added slowly to the NaH suspension. After stirring at ambient temperature for 30 min, the alkyl halide (0.40 mmol) was added. The resulting mixture was stirred overnight at ambient temperature. The reaction mixture was quenched with water and extracted with ethyl acetate (2 × 10 mL). The organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, concentrated under reduced pressure, and purified by automatic flash column chromatography on silica gel (gradient elution from 5 to 40% EtOAc-hexanes).</div><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> (2,2-Dimethyl-2,3-dihydro-1<i>H</i>-inden-5-yl) (2-methyl-1-propyl-1<i>H</i>-indol-3-yl)methanone (<b>GBD-020, 40</b>)</h4><div class="NLM_p last">Obtained as yellowish oil (72% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.01 (t, 3H), 1.17 (s, 6H), 1.85 (sextet, 2H), 2.59 (s, 3H), 2.75 (s, 2H), 2.78 (s, 2H), 4.11 (t, 2H), 7.05 (app. t, 1H), 7.15–7.21 (m, 2H), 7.33 (app. t, 2H), 7.53 (app. d, 1H), 7.60 (s, 1H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>): δ 11.48, 12.43, 22.99, 28.64, 40.50, 44.84, 47.40, 47.74, 109.36, 113.92, 121.02, 121.06, 121.70, 124.24, 125.41, 127.28, 127.86, 135.83, 139.56, 143.70, 143.79, 147.83, 193.28. HRMS (ESI, <i>m</i>/<i>z</i>): for C<sub>24</sub>H<sub>28</sub>NO [M + H]<sup>+</sup> calcd, 346.2165; found, 346.2162. Purity (qNMR), 98.8%.</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> (2,2-Dimethyl-2,3-dihydro-1<i>H</i>-inden-5-yl) (1-butyl-2-methyl-1<i>H</i>-indol-3-yl)methanone (<b>GBD-021, 41</b>)</h4><div class="NLM_p last">Obtained as yellowish oil (71% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 0.98 (t, 3H), 1.16 (s, 6H), 1.43 (sextet, 2H), 1.78 (quintet, 2H), 2.59 (s, 3H), 2.74 (s, 2H), 2.78 (s, 2H), 4.13 (t, 2H), 7.04 (app. t, 1H), 7.15–7.21 (m, 2H), 7.32 (dd, 2H), 7.52 (app. d, 1H), 7.59 (s, 1H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>): δ 12.42, 13.83, 20.31, 28.65, 31.81, 40.52, 43.15, 47.41, 47.76, 109.33, 113.94, 121.02, 121.09, 121.70, 124.25, 125.42, 127.31, 127.88, 135.79, 139.58, 143.72, 143.77, 147.84, 193.28. HRMS (ESI, <i>m</i>/<i>z</i>): for C<sub>25</sub>H<sub>30</sub>NO [M + H]<sup>+</sup> calcd, 360.2322; found, 360.2318. Purity (qNMR), 97.3%.</div></div><div id="sec4_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> (2,2-Dimethyl-2,3-dihydro-1<i>H</i>-inden-5-yl) (2-methyl-1-pentyl-1<i>H</i>-indol-3-yl)methanone (<b>GBD-022, 42</b>)</h4><div class="NLM_p last">Obtained as yellowish oil (74% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 0.92 (t, 3H), 1.17 (s, 6H), 1.34–1.43 (m, 4H), 1.80 (quintet, 2H), 2.59 (s, 3H), 2.75 (s, 2H), 2.78 (s, 2H), 4.12 (t, 2H), 7.05 (m, 1H), 7.15–7.21 (m, 2H), 7.33 (app. t, 2H), 7.53 (app. d, 1H), 7.61 (s, 1H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>): δ 12.42, 13.95, 22.41, 28.65, 29.13, 29.43, 40.51, 43.34, 47.41, 47.75, 109.33, 113.92, 121.02, 121.08, 121.71, 124.24, 125.41, 127.31, 127.86, 135.78, 139.59, 143.70, 143.75, 147.82, 193.26. HRMS (ESI, <i>m</i>/<i>z</i>): for C<sub>26</sub>H<sub>32</sub>NO [M + H]<sup>+</sup> calcd, 374.2478; found, 374.2477. Purity (qNMR), 96.2%.</div></div><div id="sec4_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> (2,2-Dimethyl-2,3-dihydro-1<i>H</i>-inden-5-yl) (1-hexyl-2-methyl-1<i>H</i>-indol-3-yl)methanone (<b>GBD-023, 43</b>)</h4><div class="NLM_p last">Obtained as yellowish oil (62% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 0.89 (t, 3H), 1.17 (s, 6H), 1.28–1.44 (m, 6H), 1.79 (quintet, 2H), 2.59 (s, 3H), 2.74 (s, 2H), 2.78 (s, 2H), 4.12 (t, 2H), 7.04 (m, 1H), 7.15–7.21 (m, 2H), 7.32 (app. t, 2H), 7.52 (app. d, 1H), 7.59 (s, 1H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>): δ 12.44, 14.00, 22.55, 26.72, 28.65, 29.70, 31.47, 40.52, 43.39, 47.42, 47.76, 109.32, 113.93, 121.02, 121.09, 121.71, 124.25, 125.43, 127.32, 127.87, 135.78, 139.60, 143.71, 143.75, 147.83, 193.28. HRMS (ESI, <i>m</i>/<i>z</i>): for C<sub>27</sub>H<sub>34</sub>NO [M + H]<sup>+</sup> calcd, 388.2635; found, 388.2632. Purity (qNMR), 98.1%.</div></div><div id="sec4_5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> (2,2-Dimethyl-2,3-dihydro-1<i>H</i>-inden-5-yl) (1-benzyl-2-methyl-1<i>H</i>-indol-3-yl)methanone (<b>GBD-024, 44</b>)</h4><div class="NLM_p last">Obtained as yellowish oil (56% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.18 (s, 6H), 2.54 (s, 3H), 2.76 (s, 2H), 2.79 (s, 2H), 5.40 (s, 2H), 7.01–7.11 (m, 3H), 7.13–7.23 (m, 2H), 7.24–7.33 (m, 4H), 7.39–7.43 (app. d, 1H), 7.54–7.58 (app. d, 1H), 7.63 (br s, 1H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>): δ 12.48, 28.65, 40.53, 46.62, 47.42, 47.77, 109.54, 114.45, 121.16, 121.36, 122.14, 124.30, 125.47, 125.99, 127.31, 127.69, 127.96, 128.97, 136.28, 136.31, 139.39, 143.79, 143.95, 148.06, 193.34. HRMS (ESI, <i>m</i>/<i>z</i>): for C<sub>28</sub>H<sub>28</sub>NO [M + H]<sup>+</sup> calcd, 394.2165; found, 394.2162. Purity (qNMR), 97.4%.</div></div><div id="sec4_5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> (2,2-Dimethyl-2,3-dihydro-1<i>H</i>-inden-5-yl) (1-(4-fluorobenzyl)-2-methyl-1<i>H</i>-indol-3-yl)methanone (<b>GBD-025, 45</b>)</h4><div class="NLM_p last">Obtained as yellowish oil (52% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.18 (s, 6H), 2.53 (s, 3H), 2.76 (s, 2H), 2.79 (s, 2H), 5.36 (s, 2H), 6.98–7.02 (m, 4H), 7.06–7.11 (m, 1H), 7.14–7.27 (m, 3H), 7.39–7.43 (app. d, 1H), 7.54–7.57 (app. d, 1H), 7.63 (br s, 1H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>): δ 12.44, 28.64, 40.54, 45.98, 47.41, 47.77, 109.40, 114.59, 115.83, 116.04, 121.23, 121.45, 122.24, 124.32, 125.47, 127.32, 127.96, 127.72, 127.64, 132.01, 136.14, 139.29, 143.86, 143.83, 148.16, 163.41, 193.29. <sup>19</sup>FNMR (376 MHz, CDCl<sub>3</sub>): δ −114.40. HRMS (ESI, <i>m</i>/<i>z</i>): for C<sub>28</sub>H<sub>27</sub>FNO [M + H]<sup>+</sup> calcd, 412.2071; found, 412.2068. Purity (qNMR), 96.8%.</div></div><div id="sec4_5_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> (<i>E</i>)-(2,2-dimethyl-2,3-dihydro-1<i>H</i>-inden-5-yl) (2-methyl-1-(pent-2-en-1-yl)-1<i>H</i>-indol-3-yl)methanone (<b>GBD-026, 46</b>)</h4><div class="NLM_p last">Obtained as yellowish oil (78% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 0.94 (t, 3H), 1.17 (s, 6H), 2.02 (quint, 2H), 2.56 (s, 3H), 2.75 (s, 2H), 2.78 (s, 2H), 4.69–4.73 (m, 2H), 5.48–5.58 (m, 2H), 7.03–7.09 (m, 1H), 7.15–7.22 (m, 2H), 7.31 (dd, 1H), 7.37 (dd, 1H), 7.54 (d, 1H), 7.61 (s, 1H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>): δ 12.32, 13.19, 25.07, 28.62, 40.49, 44.92, 47.38, 47.73, 109.41, 114.02, 121.02, 121.09, 121.79, 122.51, 124.23, 125.41, 127.24, 127.87, 135.38, 135.84, 139.51, 143.69, 143.88, 147.85, 193.27. HRMS (ESI, <i>m</i>/<i>z</i>): for C<sub>26</sub>H<sub>30</sub>NO [M + H]<sup>+</sup> calcd, 372.2322; found, 372.2318. Purity (qNMR), 95.9%.</div></div><div id="sec4_5_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> (<i>Z</i>)-(2,2-dimethyl-2,3-dihydro-1<i>H</i>-inden-5-yl) (2-methyl-1-(pent-2-en-1-yl)-1<i>H</i>-indol-3-yl)methanone (<b>GBD-027, 47</b>)</h4><div class="NLM_p last">Obtained as white, powdery crystals (73% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.11 (t, 3H), 1.17 (s, 6H), 2.29 (quint, 2H), 2.58 (s, 3H), 2.75 (s, 2H), 2.78 (s, 2H), 4.78–4.83 (m, 2H), 5.32–5.40 (m, 1H), 5.57–5.65 (m, 1H), 7.04–7.09 (m, 1H), 7.16–7.22 (m, 2H), 7.30 (dd, 1H), 7.36 (dd, 1H), 7.53 (d, 1H), 7.61 (s, 1H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>): δ 12.39, 14.03, 21.07, 28.65, 40.52, 40.63, 47.41, 47.76, 109.24, 114.15, 121.12, 121.16, 121.81, 123.38, 124.26, 125.44, 127.37, 127.91, 134.90, 135.76, 139.50, 143.67, 143.73, 147.91, 193.26. HRMS (ESI, <i>m</i>/<i>z</i>) for C<sub>26</sub>H<sub>30</sub>NO [M + H]<sup>+</sup>: calcd, 372.2322; found, 372.2322. mp 65–66 °C. Purity (qNMR), 100.5%.</div></div><div id="sec4_5_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> (2,2-Dimethyl-2,3-dihydro-1<i>H</i>-inden-5-yl) (2-methyl-1-(pent-4-en-1-yl)-1<i>H</i>-indol-3-yl)methanone (<b>GBD-028, 48</b>)</h4><div class="NLM_p last">Obtained as yellowish oil (48% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.17 (s, 6H), 1.90 (quintet, 2H), 2.18 (q, 2H), 2.58 (s, 3H), 2.74 (s, 2H), 2.78 (s, 2H), 4.14 (t, 2H), 5.03–5.14 (m, 2H), 5.78–5.90 (ddt, 1H), 7.02–7.08 (m, 1H), 7.15–7.21 (m, 2H), 7.29–7.36 (app. t, 2H), 7.53 (app. d, 1H), 7.60 (s, 1H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>): δ 12.41, 28.58, 28.64, 30.90, 40.50, 42.68, 47.41, 47.75, 109.27, 114.04, 115.95, 121.08, 121.11, 121.76, 124.25, 125.41, 127.31, 127.87, 135.75, 136.94, 139.52, 143.64, 143.72, 147.87, 193.25. HRMS (ESI, <i>m</i>/<i>z</i>): for C<sub>26</sub>H<sub>30</sub>NO [M + H]<sup>+</sup> calcd, 372.2322; found, 372.2319. Purity (qNMR), 99.7%.</div></div><div id="sec4_5_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> (2,2-Dimethyl-2,3-dihydro-1<i>H</i>-inden-5-yl) (2-methyl-1-(pent-2-yn-1-yl)-1<i>H</i>-indol-3-yl)methanone (<b>GBD-030, 50</b>)</h4><div class="NLM_p last">Obtained as yellowish oil (22% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.09 (t, 3H), 1.17 (s, 6H), 2.15 (qt, 2H), 2.62 (s, 3H), 2.75 (s, 2H), 2.78 (s, 2H), 4.84 (t, 2H), 7.05–7.11 (m, 1H), 7.17–7.25 (m, 2H), 7.36–7.42 (m, 2H), 7.54 (app. d, 1H), 7.62 (s, 1H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>): δ 12.29, 12.33, 13.59, 28.64, 33.04, 40.51, 47.39, 47.75, 72.65, 86.73, 109.33, 114.42, 121.08, 121.31, 122.02, 124.27, 125.46, 127.26, 127.94, 135.57, 139.36, 143.38, 143.74, 148.01, 193.23. HRMS (ESI, <i>m</i>/<i>z</i>): for C<sub>26</sub>H<sub>28</sub>NO [M + H]<sup>+</sup> calcd, 370.2165; found, 370.2163. Purity (qNMR), 99.4%.</div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> General Procedure for the Synthesis of <b>49</b> and <b>51</b></h3><div class="NLM_p">To a mixture of <b>24</b> (100 mg, 0.33 mmol) and DMSO (2.0 mL) was added KOH (37.0 mg, 0.66 mmol). After stirring at ambient temperature for 1 h, the alkyl halide (0.49 mmol) was added. The resulting mixture was stirred for 2 h at ambient temperature. The reaction mixture was quenched with water and extracted with ethyl acetate (2 × 10 mL). The organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, concentrated under reduced pressure, and purified by automatic flash column chromatography on silica gel (gradient elution from 5 to 40% EtOAc-hexanes).</div><div id="sec4_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> (2,2-Dimethyl-2,3-dihydro-1<i>H</i>-inden-5-yl) (2-methyl-1-(pent-4-yn-1-yl)-1<i>H</i>-indol-3-yl)methanone (<b>GBD-029, 49</b>)</h4><div class="NLM_p last">Obtained as yellowish oil (63% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.17 (s, 6H), 2.02 (quintet, 2H), 2.10 (t, 1H), 2.26–2.32 (td, 2H), 2.61 (s, 3H), 2.75 (s, 2H), 2.78 (s, 2H), 4.29 (t, 2H), 7.03–7.09 (m, 1H), 7.16–7.22 (m, 2H), 7.33–7.40 (m, 2H), 7.53 (app. d, 1H), 7.60 (s, 1H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>): δ 12.37, 15.95, 28.17, 28.62, 40.49, 41.83, 47.38, 47.73, 69.89, 82.75, 109.23, 114.16, 121.10, 121.17, 121.88, 124.25, 125.41, 127.29, 127.87, 135.79, 139.42, 143.65, 143.73, 147.94, 193.23. HRMS (ESI, <i>m</i>/<i>z</i>): for C<sub>26</sub>H<sub>28</sub>NO [M + H]<sup>+</sup> calcd, 370.2165; found, 370.2163. Purity (qNMR), 100.5%.</div></div><div id="sec4_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> (2,2-Dimethyl-2,3-dihydro-1<i>H</i>-inden-5-yl) (2-methyl-1-(prop-2-yn-1-yl)-1<i>H</i>-indol-3-yl)methanone (<b>GBD-031, 51</b>)</h4><div class="NLM_p last">Obtained as colorless oil (32% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.17 (s, 6H), 2.33 (t, 1H), 2.63 (s, 3H), 2.75 (s, 2H), 2.79 (s, 2H), 4.89 (d, 2H), 7.07–7.11 (m, 1H), 7.18–7.25 (m, 2H), 7.36–7.43 (m, 2H), 7.54 (app. d, 1H), 7.62 (s, 1H). <sup>13</sup>C{<sup>1</sup>H}NMR (100 MHz, CDCl<sub>3</sub>): δ 12.25, 28.65, 32.61, 40.53, 47.40, 47.77, 73.17, 77.22, 109.12, 114.80, 121.23, 121.55, 122.27, 124.32, 125.50, 127.30, 127.99, 135.50, 139.17, 143.01, 143.81, 148.21, 193.22. HRMS (ESI, <i>m</i>/<i>z</i>): for C<sub>24</sub>H<sub>24</sub>NO [M + H]<sup>+</sup> calcd, 342.1852; found, 342.1849. Purity (qNMR), 97.2%.</div></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> Pharmacology</h3><div class="NLM_p last">CP-55,940, rimonabant, and AM-630 were obtained from Tocris Bioscience (Bristol, UK). All drugs were prepared as a stock solution in 100% DMSO at a concentration of 100 mM, divided into aliquots, and maintained at −4 °C until use. [<sup>3</sup>H]CP-55,950 (168 Ci/mmol) and [<sup>35</sup>S]GTPγS (1250 Ci/mmol) were purchased from Perkin Elmer (Boston, MA). All other reagents were obtained from Fisher Scientific Inc. (Pittsburgh, PA).</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> Competition Receptor Binding</h3><div class="NLM_p last">Increasing concentrations of the GBD compounds were incubated with 0.2 nM of the nonselective CB<sub>1</sub>/CB<sub>2</sub> agonist [<sup>3</sup>H]CP-55,940 in a final volume of 1 mL of the binding buffer (50 mM Tris, 0.05% bovine serum albumin, 5 mM of MgCl<sub>2</sub>, pH 7.4) as described previously.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Each binding assay contained 100 or 50 μg of membrane protein prepared from CHO-<i>h</i>CB1 or CHO-<i>h</i>CB<sub>2</sub> cells, respectively. Reactions were incubated for 90 min at rt. Nonspecific binding was defined as binding observed in the presence of 10 μM of the nonselective CB<sub>1</sub>/CB<sub>2</sub> ligand WIN-55,212-2. Reactions were terminated by rapid vacuum filtration through Whatman GF/B glass fiber filters, followed by three washes with the ice-cold binding buffer. Filters were then immediately placed into scintillation vials with 4 mL of the scintiverse<sup>TM</sup> BD cocktail scintillation fluid (Fisher Scientific, Fair Lawn, NJ). Samples were incubated overnight in the scintillation fluid, and vortexed and bound reactivity was determined by employing a liquid scintillation spectrophotometer (Tri Carb 2100 TR Liquid Scintillation Analyzer, Packard Instrument Company, Meriden, CT).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> [<sup>35</sup>S]GTPγS Binding</h3><div class="NLM_p last">All [<sup>35</sup>S]GTPγS assays were conducted as described previously<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> in a buffer containing 20 mM <i>N</i>-(2-hydroxyethyl)piperazine-<i>N</i>′-ethanesulfonic acid (HEPES), 100 mM NaCl, 10 mM MgCl<sub>2</sub>, 0.05% BSA, and 20 units/L of adenosine deaminase. Assays were performed in triplicate in a final volume of 1 mL with all reactions containing 0.1 nM [<sup>35</sup>S]GTPγS and an experimental drug or drug vehicle and 50 or 25 μg of membrane protein prepared from CHO-<i>h</i>CB<sub>2</sub> cells, respectively. Nonspecific binding was defined by inclusion of 10 μM of nonradiolabeled GTPγS. Reactions were incubated at 30 °C for 30 min and terminated by rapid vacuum filtration through Whatman GF/B glass fiber filters and followed by four 1 mL washes with the ice-cold filtration buffer (20 mM HEPES, pH 7.4, 0.05% BSA). Filters were then immediately placed into scintillation vials with 4 mL of the scintiverse<sup>TM</sup> BD cocktail scintillation fluid (Fisher Scientific, Fair Lawn, NJ). Samples were incubated overnight in the scintillation fluid, and vortexed and bound reactivity was determined by employing a liquid scintillation spectrophotometer (Tri Carb 2100 TR Liquid Scintillation Analyzer, Packard Instrument Company, Meriden, CT).</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> Data Analysis</h3><div class="NLM_p last">Curve fitting was conducted utilizing GraphPad Prism v6.0b (GraphPad Software, Inc.; San Diego, CA). Nonlinear regression for one-site competition was used to determine the IC<sub>50</sub> for competition receptor binding. The Cheng-Prusoff equation was employed to convert the experimental IC<sub>50</sub> values obtained from competition receptor binding experiments to <i>K</i><sub>i</sub> values (a quantitative measure of receptor affinity). Statistical significance of values from 100% (basal) in the [<sup>35</sup>S]GTPγS assay was assessed by the one-sample <i>t</i>-test (*<i>P</i> < 0.05 and **<i>P</i> < 0.01).</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> Molecular Modeling</h3><div class="NLM_p last">To elucidate the binding modes of the GBD series of compounds, a hybrid docking/MD simulation approach was utilized. This methodology has been previously used accurately and precisely to estimate the binding affinity and selectivity of compounds toward the cannabinoid receptors.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> In summary, the selected ligands (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) GBD-002 and GBD-003 had their lowest energy conformation estimated using OpenEye OMEGA.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> These ligands were then prepared with Autodock Tools to the PDBQT format for use with Autodock Vina.<a onclick="showRef(event, 'ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref69 ref70">(69,70)</a> CB<sub>1</sub> and CB<sub>2</sub> receptor structures (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5XR8">5XR8</a> for CB<sub>1</sub>R and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZTY">5ZTY</a> for CB<sub>2</sub>R) were used for the initial docking, and the grid center was placed upon the original crystal structure ligand.<a onclick="showRef(event, 'ref71 ref72'); return false;" href="javascript:void(0);" class="ref ref71 ref72">(71,72)</a> The resulting binding poses (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A1,A2,B1,B2) then had their atomic charges calculated using the AM1-BCC method in the Antechamber module of AMBER16<a onclick="showRef(event, 'ref73 ref74'); return false;" href="javascript:void(0);" class="ref ref73 ref74">(73,74)</a> and were subsequently energy-minimized using the SANDER module of AMBER16.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> The energy-minimized binding structures then had their binding free energy estimated using the MMPBSA.py<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> module of AMBER16.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> The rest of the GBD series of compounds were then modeled using PyMol<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> to revise the structure of GBD-003 within either CB<sub>1</sub>R or CB<sub>2</sub>R as the initial binding structure. The initial binding structures of these compounds were similarly energy-minimized and had their binding free energy estimated by using the same MMPBSA.py module.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i77"><a href="/doi/suppl/10.1021/acs.jmedchem.1c00442" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50428" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50428" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.1c00442?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00442</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00442/suppl_file/jm1c00442_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Graphs correlating experimental and calculated binding energies, copies of <sup>1</sup>H and <sup>13</sup>C NMR spectra and qNMR analysis, and PDB files for docking models (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00442/suppl_file/jm1c00442_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00442/suppl_file/jm1c00442_si_001.csv">jm1c00442_si_001.csv (2.67 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00442/suppl_file/jm1c00442_si_002.pdf">jm1c00442_si_002.pdf (18.2 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.1c00442" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20861" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20861" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gregory B. Dudley</span> - <span class="hlFld-Affiliation affiliation">C.
Eugene Bennett Department of Chemistry, West Virginia University, Morgantown, West Virginia 26506, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6133-3747" title="Orcid link">http://orcid.org/0000-0001-6133-3747</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#dabda8bfbdb5a8a3f4beafbeb6bfa39ab7bbb3b6f4adacaff4bfbeaf"><span class="__cf_email__" data-cfemail="70170215171f02095e1405141c1509301d11191c5e0706055e151405">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Harvey F. Fulo</span> - <span class="hlFld-Affiliation affiliation">C.
Eugene Bennett Department of Chemistry, West Virginia University, Morgantown, West Virginia 26506, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amal Shoeib</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Toxicology, University
of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christian V. Cabanlong</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Toxicology, University
of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexander H. Williams</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Sciences, University of
Kentucky, Lexington, Kentucky 40536, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chang-Guo Zhan</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Sciences, University of
Kentucky, Lexington, Kentucky 40536, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul L. Prather</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology and Toxicology, University
of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>All authors have given approval to the final version of the manuscript.</p></li><li><span class="author-information-subsection-header">Funding</span><p>This work was supported in part by the funding from the National Institutes of Health (R01 DA039143) for PLP, with additional support from West Virginia University and the Eberly Family Foundation. Molecular modeling studies were supported by the National Institutes of Health (P20 GM130456 and T32 DA016176).</p></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i79">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11286" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11286" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Prof Steven Kinsey (University of Connecticut) is gratefully acknowledged for helpful discussions and assistance with early development of this project.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">ECS</td><td class="NLM_def"><p class="first last">endocannabinoid system</p></td></tr><tr><td class="NLM_term">HFIP</td><td class="NLM_def"><p class="first last">1,1,1,3,3,3-hexafluoroisopropanol</p></td></tr><tr><td class="NLM_term">BINAP</td><td class="NLM_def"><p class="first last">(2,2′-bis(diphenylphosphino)-1,1′-binaphthyl)</p></td></tr><tr><td class="NLM_term">SI</td><td class="NLM_def"><p class="first last">selectivity index</p></td></tr><tr><td class="NLM_term">nbd</td><td class="NLM_def"><p class="first last">norbornadiene</p></td></tr><tr><td class="NLM_term"><i>n</i>-BuLi</td><td class="NLM_def"><p class="first last"><i>n</i>-butyllithium</p></td></tr><tr><td class="NLM_term"><i>t</i>-BuLi</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyllithium</p></td></tr><tr><td class="NLM_term">MsCl</td><td class="NLM_def"><p class="first last">mesyl chloride</p></td></tr><tr><td class="NLM_term">Tf<sub>2</sub>O</td><td class="NLM_def"><p class="first last">triflic anhydride</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i81">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62663" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62663" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 76 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Marzo, V.</span></span> <span> </span><span class="NLM_article-title">Targeting the Endocannabinoid System: To Enhance or Reduce?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">438</span>– <span class="NLM_lpage">455</span>, <span class="refDoi"> DOI: 10.1038/nrd2553</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1038%2Fnrd2553" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=18446159" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlt1agtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=438-455&author=V.+Di%0AMarzo&title=Targeting+the+Endocannabinoid+System%3A+To+Enhance+or+Reduce%3F&doi=10.1038%2Fnrd2553"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the endocannabinoid system: to enhance or reduce?</span></div><div class="casAuthors">Di Marzo, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">438-455</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In this Review, the author discusses how prolonging the lifespan of endocannabinoids or toning down their action may be beneficial in a range of conditions such as pain, affective and neurodegenerative disorders, gastrointestinal inflammation, and obesity and metabolic dysfunctions.  As our understanding of the endocannabinoids improves, so does the awareness of their complexity.  During pathol. states, the levels of these mediators in tissues change, and their effects vary from those of protective endogenous compds. to those of dysregulated signals.  These observations led to the discovery of compds. that either prolong the lifespan of endocannabinoids or tone down their action for the potential future treatment of pain, affective and neurodegenerative disorders, gastrointestinal inflammation, obesity and metabolic dysfunctions, cardiovascular conditions and liver diseases.  When moving to the clinic, however, the pleiotropic nature of endocannabinoid functions will require careful judgement in the choice of patients and stage of the disorder for treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpebzNFDRaNEbVg90H21EOLACvtfcHk0ljDDtPLxm_F8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlt1agtbk%253D&md5=f0af1a666a7c51a594d94661bfb5a7d9</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd2553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2553%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26atitle%3DTargeting%2520the%2520Endocannabinoid%2520System%253A%2520To%2520Enhance%2520or%2520Reduce%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D438%26epage%3D455%26doi%3D10.1038%2Fnrd2553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Finn, D. P.</span></span> <span> </span><span class="NLM_article-title">Endocannabinoid-mediated Modulation of Stress Responses: Physiological and Pathophysiological Significance</span>. <i>Immunobiology</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>215</i></span>,  <span class="NLM_fpage">629</span>– <span class="NLM_lpage">646</span>, <span class="refDoi"> DOI: 10.1016/j.imbio.2009.05.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1016%2Fj.imbio.2009.05.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=19616342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsVCks7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=215&publication_year=2010&pages=629-646&author=D.+P.+Finn&title=Endocannabinoid-mediated+Modulation+of+Stress+Responses%3A+Physiological+and+Pathophysiological+Significance&doi=10.1016%2Fj.imbio.2009.05.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Endocannabinoid-mediated modulation of stress responses: Physiological and pathophysiological significance</span></div><div class="casAuthors">Finn, David P.</div><div class="citationInfo"><span class="NLM_cas:title">Immunobiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">215</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">629-646</span>CODEN:
                <span class="NLM_cas:coden">IMMND4</span>;
        ISSN:<span class="NLM_cas:issn">0171-2985</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">A review.  The stress response is assocd. with a broad spectrum of physiol. and behavioral effects including hypothalamo-pituitary-adrenal (HPA) axis activation, altered central nervous system activity, neuroimmune alterations, anxiety- and depressive-like behavior and analgesia.  While the acute stress response has essential survival value, chronic stress and dysfunction of the stress response can be maladaptive, contributing to the development and severity of psychiatric and pain disorders.  The endogenous cannabinoid (endocannabinoid) system has emerged as an important lipid signalling system playing a key role in mediating and/or modulating behavioral, neurochem., neuroendocrine, neuroimmune and mol. responses to stress.  The wt. of evidence, reviewed here, points largely to a system which serves to constrain HPA axis activity, facilitate adaptation or habituation of HPA axis and behavioral responses to stress, reduce anxiety- and depressive-like behavior and mediate analgesic responses to unconditioned or conditioned stress.  Possible involvement of the immune system and assocd. signalling mols. (e.g. cytokines) in endocannabinoid-mediated modulation of neuroendocrine and behavioral responses to stress is considered.  The goal now should be to exploit our understanding of the role of the endocannabinoid system in fundamental stress physiol. and pathophysiol. processes to better understand and treat a range of stress-related disorders including anxiety, depression and pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQRqOvTRnLvbVg90H21EOLACvtfcHk0ljPWfZeGTV1jQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsVCks7k%253D&md5=2ba724255538778ce634858e5da7ce5f</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.imbio.2009.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.imbio.2009.05.011%26sid%3Dliteratum%253Aachs%26aulast%3DFinn%26aufirst%3DD.%2BP.%26atitle%3DEndocannabinoid-mediated%2520Modulation%2520of%2520Stress%2520Responses%253A%2520Physiological%2520and%2520Pathophysiological%2520Significance%26jtitle%3DImmunobiology%26date%3D2010%26volume%3D215%26spage%3D629%26epage%3D646%26doi%3D10.1016%2Fj.imbio.2009.05.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bab, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmer, A.</span></span> <span> </span><span class="NLM_article-title">Cannabinoid Receptors and the Regulation of Bone Mass</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>153</i></span>,  <span class="NLM_fpage">182</span>– <span class="NLM_lpage">188</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0707593</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1038%2Fsj.bjp.0707593" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=18071301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovFClsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2008&pages=182-188&author=I.+Babauthor=A.+Zimmer&title=Cannabinoid+Receptors+and+the+Regulation+of+Bone+Mass&doi=10.1038%2Fsj.bjp.0707593"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid receptors and the regulation of bone mass</span></div><div class="casAuthors">Bab, I.; Zimmer, A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">182-188</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  A functional endocannabinoid system is present in several mammalian organs and tissues.  Recently, endocannabinoids and their receptors have been reported in the skeleton.  Osteoblasts, the bone forming cells, and osteoclasts, the bone resorbing cells, produce the endocannabinoids anandamide and 2-arachidonoylglycerol and express CB2 cannabinoid receptors.  Although CB2 has been implicated in pathol. processes in the central nervous system and peripheral tissues, the skeleton appears as the main system physiol. regulated by CB2.  CB2-deficient mice show a markedly accelerated age-related bone loss and the CNR2 gene (encoding CB2) in women is assocd. with low bone mineral d.  The activation of CB2 attenuates ovariectomy-induced bone loss in mice by restraining bone resorption and enhancing bone formation.  Hence synthetic CB2 ligands, which are stable and orally available, provide a basis for developing novel anti-osteoporotic therapies.  Activation of CB1 in sympathetic nerve terminals in bone inhibits norepinephrine release, thus balancing the tonic sympathetic restrain of bone formation.  Low levels of CB1 were also reported in osteoclasts.  CB1-null mice display a skeletal phenotype that is dependent on the mouse strain, gender and specific mutation of the CB1 encoding gene, CNR1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe0y7uhkrEE7Vg90H21EOLACvtfcHk0ljPWfZeGTV1jQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovFClsA%253D%253D&md5=c461a34365f7c258bbb9b422f8e0bd48</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707593%26sid%3Dliteratum%253Aachs%26aulast%3DBab%26aufirst%3DI.%26aulast%3DZimmer%26aufirst%3DA.%26atitle%3DCannabinoid%2520Receptors%2520and%2520the%2520Regulation%2520of%2520Bone%2520Mass%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D153%26spage%3D182%26epage%3D188%26doi%3D10.1038%2Fsj.bjp.0707593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oesch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gertsch, J.</span></span> <span> </span><span class="NLM_article-title">Cannabinoid Receptor Ligands as Potential Anticancer Agents—High Hopes for New Therapies?</span>. <i>J. Pharm. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">839</span>– <span class="NLM_lpage">853</span>, <span class="refDoi"> DOI: 10.1211/jpp/61.07.0002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1211%2Fjpp%2F61.07.0002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=19589225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1Wrt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2009&pages=839-853&author=S.+Oeschauthor=J.+Gertsch&title=Cannabinoid+Receptor+Ligands+as+Potential+Anticancer+Agents%E2%80%94High+Hopes+for+New+Therapies%3F&doi=10.1211%2Fjpp%2F61.07.0002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid receptor ligands as potential anticancer agents - high hopes for new therapies?</span></div><div class="casAuthors">Oesch, Susanne; Gertsch, Jurg</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">839-853</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Press</span>)
        </div><div class="casAbstract">A review.  Objectives: The endocannabinoid system is an endogenous lipid signaling network comprising arachidonic-acid-derived ligands, cannabinoid (CB) receptors, transporters and endocannabinoid degrading enzymes.  The CB1 receptor is predominantly expressed in neurons but is also co-expressed with the CB2 receptor in peripheral tissues.  In recent years, CB receptor ligands, including Δ9-tetrahydrocannabinol, have been proposed as potential anticancer agents.  Key findings: This review critically discusses the pharmacol. of CB receptor activation as a novel therapeutic anticancer strategy in terms of ligand selectivity, tissue specificity and potency.  Intriguingly, antitumor effects mediated by cannabinoids are not confined to inhibition of cancer cell proliferation; cannabinoids also reduce angiogenesis, cell migration and metastasis, inhibit carcinogenesis and attenuate inflammatory processes.  In the last decade several new selective CB1 and CB2 receptor agents have been described, but most studies in the area of cancer research have used non-selective CB ligands.  Moreover, many of these ligands exert prominent CB receptor-independent pharmacol. effects, such as activation of the G-protein-coupled receptor GPR55, peroxisome proliferator-activated receptor gamma and the transient receptor potential vanilloid channels.  Summary: The role of the endocannabinoid system in tumorigenesis is still poorly understood and the mol. mechanisms of cannabinoid anticancer action need to be elucidated.  The development of CB2-selective anticancer agents could be advantageous in light of the unwanted central effects exerted by CB1 receptor ligands.  Probably the most interesting question is whether cannabinoids could be useful in chemoprevention or in combination with established chemotherapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqscGZonAECY7Vg90H21EOLACvtfcHk0ljPWfZeGTV1jQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1Wrt74%253D&md5=d9a2239211393bfb12501b3cfe789397</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1211%2Fjpp%2F61.07.0002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1211%252Fjpp%252F61.07.0002%26sid%3Dliteratum%253Aachs%26aulast%3DOesch%26aufirst%3DS.%26aulast%3DGertsch%26aufirst%3DJ.%26atitle%3DCannabinoid%2520Receptor%2520Ligands%2520as%2520Potential%2520Anticancer%2520Agents%25E2%2580%2594High%2520Hopes%2520for%2520New%2520Therapies%253F%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2009%26volume%3D61%26spage%3D839%26epage%3D853%26doi%3D10.1211%2Fjpp%2F61.07.0002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karsak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaffal, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Date, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang-Eckhardt, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehnelt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrosino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starowicz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steuder, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlicker, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mechoulam, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buettner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuting, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmer, A.</span></span> <span> </span><span class="NLM_article-title">Attenuation of Allergic Contact Dermatitis Through the Endocannabinoid System</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>316</i></span>,  <span class="NLM_fpage">1494</span>– <span class="NLM_lpage">1497</span>, <span class="refDoi"> DOI: 10.1126/science.1142265</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1126%2Fscience.1142265" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=17556587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtFSjtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2007&pages=1494-1497&author=M.+Karsakauthor=E.+Gaffalauthor=R.+Dateauthor=L.+Wang-Eckhardtauthor=J.+Rehneltauthor=S.+Petrosinoauthor=K.+Starowiczauthor=R.+Steuderauthor=E.+Schlickerauthor=B.+Cravattauthor=R.+Mechoulamauthor=R.+Buettnerauthor=S.+Wernerauthor=V.+Di+Marzoauthor=T.+Tutingauthor=A.+Zimmer&title=Attenuation+of+Allergic+Contact+Dermatitis+Through+the+Endocannabinoid+System&doi=10.1126%2Fscience.1142265"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Attenuation of Allergic Contact Dermatitis Through the Endocannabinoid System</span></div><div class="casAuthors">Karsak, Meliha; Gaffal, Evelyn; Date, Rahul; Wang-Eckhardt, Lihua; Rehnelt, Jennifer; Petrosino, Stefania; Starowicz, Katarzyna; Steuder, Regina; Schlicker, Eberhard; Cravatt, Benjamin; Mechoulam, Raphael; Buettner, Reinhard; Werner, Sabine; Di Marzo, Vincenzo; Tueting, Thomas; Zimmer, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">5830</span>),
    <span class="NLM_cas:pages">1494-1497</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Allergic contact dermatitis affects about 5% of men and 11% of women in industrialized countries and is one of the leading causes for occupational diseases.  In an animal model for cutaneous contact hypersensitivity, we show that mice lacking both known cannabinoid receptors display exacerbated allergic inflammation.  In contrast, fatty acid amide hydrolase-deficient mice, which have increased levels of the endocannabinoid anandamide, displayed reduced allergic responses in the skin.  Cannabinoid receptor antagonists exacerbated allergic inflammation, whereas receptor agonists attenuated inflammation.  These results demonstrate a protective role of the endocannabinoid system in contact allergy in the skin and suggest a target for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1tpJ3yv_vibVg90H21EOLACvtfcHk0lgeTtURMfkH8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtFSjtrs%253D&md5=e0e96eaa16eedaec7bd642255546be3a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.1142265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1142265%26sid%3Dliteratum%253Aachs%26aulast%3DKarsak%26aufirst%3DM.%26aulast%3DGaffal%26aufirst%3DE.%26aulast%3DDate%26aufirst%3DR.%26aulast%3DWang-Eckhardt%26aufirst%3DL.%26aulast%3DRehnelt%26aufirst%3DJ.%26aulast%3DPetrosino%26aufirst%3DS.%26aulast%3DStarowicz%26aufirst%3DK.%26aulast%3DSteuder%26aufirst%3DR.%26aulast%3DSchlicker%26aufirst%3DE.%26aulast%3DCravatt%26aufirst%3DB.%26aulast%3DMechoulam%26aufirst%3DR.%26aulast%3DBuettner%26aufirst%3DR.%26aulast%3DWerner%26aufirst%3DS.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DTuting%26aufirst%3DT.%26aulast%3DZimmer%26aufirst%3DA.%26atitle%3DAttenuation%2520of%2520Allergic%2520Contact%2520Dermatitis%2520Through%2520the%2520Endocannabinoid%2520System%26jtitle%3DScience%26date%3D2007%26volume%3D316%26spage%3D1494%26epage%3D1497%26doi%3D10.1126%2Fscience.1142265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guindon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hohmann, A. G.</span></span> <span> </span><span class="NLM_article-title">Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>153</i></span>,  <span class="NLM_fpage">319</span>– <span class="NLM_lpage">334</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0707531</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1038%2Fsj.bjp.0707531" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=17994113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovFCluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2008&pages=319-334&author=J.+Guindonauthor=A.+G.+Hohmann&title=Cannabinoid+CB2+receptors%3A+a+therapeutic+target+for+the+treatment+of+inflammatory+and+neuropathic+pain&doi=10.1038%2Fsj.bjp.0707531"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain</span></div><div class="casAuthors">Guindon, J.; Hohmann, A. G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">319-334</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cannabinoids suppress behavioral responses to noxious stimulation and suppress nociceptive transmission through activation of CB1 and CB2 receptor subtypes.  CB1 receptors are expressed at high levels in the central nervous system (CNS), whereas CB2 receptors are found predominantly, but not exclusively, outside the CNS.  CB2 receptors are also upregulated in the CNS and dorsal root ganglia by pathol. pain states.  Here, we review behavioral, neurochem. and electrophysiol. data, which identify cannabinoid CB2 receptors as a therapeutic target for treating pathol. pain states with limited centrally, mediated side effects.  The development of CB2-selective agonists (with minimal affinity for CB1) as well as mutant mice lacking CB2 receptors has provided pharmacol. and genetic tools required to evaluate the effectiveness of CB2 agonists in suppressing persistent pain states.  This review will examine the efficacy of cannabinoid CB2-selective agonists in suppressing acute, inflammatory and neuropathic nociception following systemic and local routes of administration.  Data derived from behavioral, neurochem. and neurophysiol. approaches are discussed to better understand the relationship between antinociceptive effects induced by CB2-selective agonists in behavioral studies and neural mechanisms of pain suppression.  Finally, the therapeutic potential and possible limitations of CB2-based pharmacotherapies for pathol. pain states induced by tissue and nerve injury are discussed.  British Journal of Pharmacol. (2008) 153, 319-334; doi:10.1038/sj.bjp.0707531; published online 12 Nov. 2007.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpi3vVhN_50fbVg90H21EOLACvtfcHk0lgeTtURMfkH8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovFCluw%253D%253D&md5=85e6d615696a73a3538587b564a2fe12</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707531%26sid%3Dliteratum%253Aachs%26aulast%3DGuindon%26aufirst%3DJ.%26aulast%3DHohmann%26aufirst%3DA.%2BG.%26atitle%3DCannabinoid%2520CB2%2520receptors%253A%2520a%2520therapeutic%2520target%2520for%2520the%2520treatment%2520of%2520inflammatory%2520and%2520neuropathic%2520pain%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D153%26spage%3D319%26epage%3D334%26doi%3D10.1038%2Fsj.bjp.0707531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malfitano, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciaglia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gangemi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gazzerro, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laezza, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bifulco, M.</span></span> <span> </span><span class="NLM_article-title">Update on the Endocannabinoid System as an Anticancer Target</span>. <i>Expert Opin. Ther. Targets</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">297</span>– <span class="NLM_lpage">308</span>, <span class="refDoi"> DOI: 10.1517/14728222.2011.553606</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1517%2F14728222.2011.553606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=21244344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ymu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2011&pages=297-308&author=A.+M.+Malfitanoauthor=E.+Ciagliaauthor=G.+Gangemiauthor=P.+Gazzerroauthor=C.+Laezzaauthor=M.+Bifulco&title=Update+on+the+Endocannabinoid+System+as+an+Anticancer+Target&doi=10.1517%2F14728222.2011.553606"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Update on the endocannabinoid system as an anticancer target</span></div><div class="casAuthors">Malfitano, Anna Maria; Ciaglia, Elena; Gangemi, Giuseppina; Gazzerro, Patrizia; Laezza, Chiara; Bifulco, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-308</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Recent studies have shown that the endocannabinoid system (ECS) could offer an attractive antitumor target.  Numerous findings suggest the involvement of this system (constituted mainly by cannabinoid receptors, endogenous compds. and the enzymes for their synthesis and degrdn.) in cancer cell growth in vitro and in vivo.  Areas covered: This review covers literature from the past decade which highlights the potential of targeting the ECS for cancer treatment.  In particular, the levels of endocannabinoids and the expression of their receptors in several types of cancer are discussed, along with the signaling pathways involved in the endocannabinoid antitumor effects.  Furthermore, the beneficial and adverse effects of old and novel compds. in clin. use are discussed.  Expert opinion: One direction that should be pursued in antitumor therapy is to select compds. with reduced psychoactivity.  This is known to be connected to the CB1 receptor; thus, targeting the CB2 receptor is a popular objective.  CB1 receptors could be maintained as a target to design new compds., and mixed CB1--CB2 ligands could be effective if they are able to not cross the BBB.  Furthermore, targeting the ECS with agents that activate cannabinoid receptors or inhibitors of endogenous degrading systems such as fatty acid amide hydrolase inhibitors may have relevant therapeutic impact on tumor growth.  Addnl. studies into the downstream consequences of endocannabinoid treatment are required and may illuminate other potential therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcuutAXHAhSbVg90H21EOLACvtfcHk0lgeTtURMfkH8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ymu7Y%253D&md5=916c99794b810380681457f8aa898183</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1517%2F14728222.2011.553606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.2011.553606%26sid%3Dliteratum%253Aachs%26aulast%3DMalfitano%26aufirst%3DA.%2BM.%26aulast%3DCiaglia%26aufirst%3DE.%26aulast%3DGangemi%26aufirst%3DG.%26aulast%3DGazzerro%26aufirst%3DP.%26aulast%3DLaezza%26aufirst%3DC.%26aulast%3DBifulco%26aufirst%3DM.%26atitle%3DUpdate%2520on%2520the%2520Endocannabinoid%2520System%2520as%2520an%2520Anticancer%2520Target%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2011%26volume%3D15%26spage%3D297%26epage%3D308%26doi%3D10.1517%2F14728222.2011.553606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cianchi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papucci, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiavone, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lulli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinci, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messerini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manera, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronconi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romagnani, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perigli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trallori, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanganelli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capaccioli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masini, E.</span></span> <span> </span><span class="NLM_article-title">Cannabinoid Receptor Activation Induces Apoptosis Through Tumor Necrosis Factor Alpha-mediated Ceramide de novo Synthesis in Colon Cancer Cells</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">7691</span>– <span class="NLM_lpage">7700</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.ccr-08-0799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1158%2F1078-0432.CCR-08-0799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=19047095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVegtrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=7691-7700&author=F.+Cianchiauthor=L.+Papucciauthor=N.+Schiavoneauthor=M.+Lulliauthor=L.+Magnelliauthor=M.+C.+Vinciauthor=L.+Messeriniauthor=C.+Maneraauthor=E.+Ronconiauthor=P.+Romagnaniauthor=M.+Donniniauthor=G.+Perigliauthor=G.+Tralloriauthor=E.+Tanganelliauthor=S.+Capaccioliauthor=E.+Masini&title=Cannabinoid+Receptor+Activation+Induces+Apoptosis+Through+Tumor+Necrosis+Factor+Alpha-mediated+Ceramide+de+novo+Synthesis+in+Colon+Cancer+Cells&doi=10.1158%2F1078-0432.ccr-08-0799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid Receptor Activation Induces Apoptosis through Tumor Necrosis Factor α-Mediated Ceramide De novo Synthesis in Colon Cancer Cells</span></div><div class="casAuthors">Cianchi, Fabio; Papucci, Laura; Schiavone, Nicola; Lulli, Matteo; Magnelli, Lucia; Vinci, Maria Cristina; Messerini, Luca; Manera, Clementina; Ronconi, Elisa; Romagnani, Paola; Donnini, Martino; Perigli, Giuliano; Trallori, Giacomo; Tanganelli, Elisabetta; Capaccioli, Sergio; Masini, Emanuela</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7691-7700</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Cannabinoids have been recently proposed as a new family of potential antitumor agents.  The present study was undertaken to investigate the expression of the two cannabinoid receptors, CB1 and CB2, in colorectal cancer and to provide new insight into the mol. pathways underlying the apoptotic activity induced by their activation.  Exptl. Design: Cannabinoid receptor expression was investigated in both human cancer specimens and in the DLD-1 and HT29 colon cancer cell lines.  The effects of the CB1 agonist arachinodyl-2'-chloroethylamide and the CB2 agonist N-cyclopentyl-7-methyl-1-(2-morpholin-4-ylethyl)-1,8-naphthyridin-4(1H)-on-3-carboxamide (CB13) on tumor cell apoptosis and ceramide and tumor necrosis factor (TNF)-α prodn. were evaluated.  The knockdown of TNF-α mRNA was obtained with the use of selective small interfering RNA.  RESULTS: We show that the CB1 receptor was mainly expressed in human normal colonic epithelium whereas tumor tissue was strongly pos. for the CB2 receptor.  The activation of the CB1 and, more efficiently, of the CB2 receptors induced apoptosis and increased ceramide levels in the DLD-1 and HT29 cells.  Apoptosis was prevented by the pharmacol. inhibition of ceramide de novo synthesis.  The CB2 agonist CB13 also reduced the growth of DLD-1 cells in a mouse model of colon cancer.  The knockdown of TNF-α mRNA abrogated the ceramide increase and, therefore, the apoptotic effect induced by cannabinoid receptor activation.  CONCLUSIONS: The present study shows that either CB1 or CB2 receptor activation induces apoptosis through ceramide de novo synthesis in colon cancer cells.  Our data unveiled, for the first time, that TNF-α acts as a link between cannabinoid receptor activation and ceramide prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqG5XJOnQBRA7Vg90H21EOLACvtfcHk0lgeTtURMfkH8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVegtrbP&md5=351dcff2b2b2a80adc8c14f2c79cb8d7</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-0799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-0799%26sid%3Dliteratum%253Aachs%26aulast%3DCianchi%26aufirst%3DF.%26aulast%3DPapucci%26aufirst%3DL.%26aulast%3DSchiavone%26aufirst%3DN.%26aulast%3DLulli%26aufirst%3DM.%26aulast%3DMagnelli%26aufirst%3DL.%26aulast%3DVinci%26aufirst%3DM.%2BC.%26aulast%3DMesserini%26aufirst%3DL.%26aulast%3DManera%26aufirst%3DC.%26aulast%3DRonconi%26aufirst%3DE.%26aulast%3DRomagnani%26aufirst%3DP.%26aulast%3DDonnini%26aufirst%3DM.%26aulast%3DPerigli%26aufirst%3DG.%26aulast%3DTrallori%26aufirst%3DG.%26aulast%3DTanganelli%26aufirst%3DE.%26aulast%3DCapaccioli%26aufirst%3DS.%26aulast%3DMasini%26aufirst%3DE.%26atitle%3DCannabinoid%2520Receptor%2520Activation%2520Induces%2520Apoptosis%2520Through%2520Tumor%2520Necrosis%2520Factor%2520Alpha-mediated%2520Ceramide%2520de%2520novo%2520Synthesis%2520in%2520Colon%2520Cancer%2520Cells%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D7691%26epage%3D7700%26doi%3D10.1158%2F1078-0432.ccr-08-0799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Velasco, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzmán, M.</span></span> <span> </span><span class="NLM_article-title">Towards the Use of Cannabinoids as Antitumour Agents</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">436</span>– <span class="NLM_lpage">444</span>, <span class="refDoi"> DOI: 10.1038/nrc3247</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1038%2Fnrc3247" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=22555283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsFCgs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=436-444&author=G.+Velascoauthor=C.+S%C3%A1nchezauthor=M.+Guzm%C3%A1n&title=Towards+the+Use+of+Cannabinoids+as+Antitumour+Agents&doi=10.1038%2Fnrc3247"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Towards the use of cannabinoids as antitumour agents</span></div><div class="casAuthors">Velasco, Guillermo; Sanchez, Cristina; Guzman, Manuel</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">436-444</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Various reports have shown that cannabinoids (the active components of marijuana and their derivs.) can reduce tumor growth and progression in animal models of cancer, in addn. to their well-known palliative effects on some cancer-assocd. symptoms.  This Opinion article discusses our current understanding of cannabinoids as antitumor agents, focusing on recent insights into the mol. mechanisms of action, including emerging resistance mechanisms and opportunities for combination therapy approaches.  Such knowledge is required for the optimization of preclin. cannabinoid-based therapies and for the preliminary clin. testing that is currently underway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIsOuHpKgJRLVg90H21EOLACvtfcHk0lgCq0kur-8rOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsFCgs70%253D&md5=4ec6d1bee283a5145c5c83f4c3eb5cfb</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrc3247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3247%26sid%3Dliteratum%253Aachs%26aulast%3DVelasco%26aufirst%3DG.%26aulast%3DS%25C3%25A1nchez%26aufirst%3DC.%26aulast%3DGuzm%25C3%25A1n%26aufirst%3DM.%26atitle%3DTowards%2520the%2520Use%2520of%2520Cannabinoids%2520as%2520Antitumour%2520Agents%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2012%26volume%3D12%26spage%3D436%26epage%3D444%26doi%3D10.1038%2Fnrc3247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pertwee, R. G.</span></span> <span> </span><span class="NLM_article-title">Targeting the Endocannabinoid System with Cannabinoid Receptor Agonists: Pharmacological Strategies and Therapeutic Possibilities</span>. <i>Philos. Trans. R. Soc. Lond. B Biol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>367</i></span>,  <span class="NLM_fpage">3353</span>– <span class="NLM_lpage">3363</span>, <span class="refDoi"> DOI: 10.1098/rstb.2011.0381</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1098%2Frstb.2011.0381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=23108552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A280%3ADC%252BC3s%252FptFWnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2012&pages=3353-3363&author=R.+G.+Pertwee&title=Targeting+the+Endocannabinoid+System+with+Cannabinoid+Receptor+Agonists%3A+Pharmacological+Strategies+and+Therapeutic+Possibilities&doi=10.1098%2Frstb.2011.0381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities</span></div><div class="casAuthors">Pertwee Roger G</div><div class="citationInfo"><span class="NLM_cas:title">Philosophical transactions of the Royal Society of London. Series B, Biological sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">1607</span>),
    <span class="NLM_cas:pages">3353-63</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Human tissues express cannabinoid CB(1) and CB(2) receptors that can be activated by endogenously released 'endocannabinoids' or exogenously administered compounds in a manner that reduces the symptoms or opposes the underlying causes of several disorders in need of effective therapy.  Three medicines that activate cannabinoid CB(1)/CB(2) receptors are now in the clinic: Cesamet (nabilone), Marinol (dronabinol; Δ(9)-tetrahydrocannabinol (Δ(9)-THC)) and Sativex (Δ(9)-THC with cannabidiol).  These can be prescribed for the amelioration of chemotherapy-induced nausea and vomiting (Cesamet and Marinol), stimulation of appetite (Marinol) and symptomatic relief of cancer pain and/or management of neuropathic pain and spasticity in adults with multiple sclerosis (Sativex).  This review mentions several possible additional therapeutic targets for cannabinoid receptor agonists.  These include other kinds of pain, epilepsy, anxiety, depression, Parkinson's and Huntington's diseases, amyotrophic lateral sclerosis, stroke, cancer, drug dependence, glaucoma, autoimmune uveitis, osteoporosis, sepsis, and hepatic, renal, intestinal and cardiovascular disorders.  It also describes potential strategies for improving the efficacy and/or benefit-to-risk ratio of these agonists in the clinic.  These are strategies that involve (i) targeting cannabinoid receptors located outside the blood-brain barrier, (ii) targeting cannabinoid receptors expressed by a particular tissue, (iii) targeting upregulated cannabinoid receptors, (iv) selectively targeting cannabinoid CB(2) receptors, and/or (v) adjunctive 'multi-targeting'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQm6R6_wZP6zNFxYDaSSP8XfW6udTcc2eZiHJhXNpiL_bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s%252FptFWnug%253D%253D&md5=84f9925097df2c99002c1d6ec9b21356</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1098%2Frstb.2011.0381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frstb.2011.0381%26sid%3Dliteratum%253Aachs%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26atitle%3DTargeting%2520the%2520Endocannabinoid%2520System%2520with%2520Cannabinoid%2520Receptor%2520Agonists%253A%2520Pharmacological%2520Strategies%2520and%2520Therapeutic%2520Possibilities%26jtitle%3DPhilos.%2520Trans.%2520R.%2520Soc.%2520Lond.%2520B%2520Biol.%2520Sci.%26date%3D2012%26volume%3D367%26spage%3D3353%26epage%3D3363%26doi%3D10.1098%2Frstb.2011.0381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Munro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abu-Shaar, M.</span></span> <span> </span><span class="NLM_article-title">Molecular Characterization of a Peripheral Receptor for Cannabinoids</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>365</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">65</span>, <span class="refDoi"> DOI: 10.1038/365061a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1038%2F365061a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=7689702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADyaK3sXmsVWiurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=1993&pages=61-65&author=S.+Munroauthor=K.+L.+Thomasauthor=M.+Abu-Shaar&title=Molecular+Characterization+of+a+Peripheral+Receptor+for+Cannabinoids&doi=10.1038%2F365061a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular characterization of a peripheral receptor for cannabinoids</span></div><div class="casAuthors">Munro, Sean; Thomas, Kerrie L.; Abu-Shaar, Muna</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">365</span>
        (<span class="NLM_cas:issue">6441</span>),
    <span class="NLM_cas:pages">61-5</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The major active ingredient of marijuana, Δ9-tetrahydrocannabinol (Δ-THC), has been used as a psychoactive agent for thousands of years.  Marijuana, and Δ9-THC, also exert a wide range of other effects including analgesia, anti-inflammation, immunosuppression, anticonvulsion, alleviation of intraocular pressure in glaucoma, and attenuation of vomiting.  The clin. application of cannabinoids has, however, been limited by their psychoactive effects, and this has led to interest in the biochem. bases of their action.  Progress stemmed initially from the synthesis of potent derivs. of Δ9-THC4,5, and more recently from the cloning of a gene encoding a G-protein-coupled receptor for cannabinoids.  This receptor is expressed in the brain but not in the periphery, except for a low level in testes.  It has been proposed that the nonpsychoactive effects of cannabinoids are either mediated centrally or through direct interaction with other, non-receptor proteins.  Here the authors report the cloning of a receptor for cannabinoids that is not expressed in the brain but rather in macrophages in the marginal zone of spleen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHsq4vy1XH17Vg90H21EOLACvtfcHk0lgCq0kur-8rOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXmsVWiurk%253D&md5=476435b57bd0f24483e2f24b813cc32f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2F365061a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F365061a0%26sid%3Dliteratum%253Aachs%26aulast%3DMunro%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DK.%2BL.%26aulast%3DAbu-Shaar%26aufirst%3DM.%26atitle%3DMolecular%2520Characterization%2520of%2520a%2520Peripheral%2520Receptor%2520for%2520Cannabinoids%26jtitle%3DNature%26date%3D1993%26volume%3D365%26spage%3D61%26epage%3D65%26doi%3D10.1038%2F365061a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reggio, P.</span></span> <span> </span><span class="NLM_article-title">Endocannabinoid Binding to the Cannabinoid Receptors: What is Known and What Remains Unknown</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1468</span>– <span class="NLM_lpage">1486</span>, <span class="refDoi"> DOI: 10.2174/092986710790980005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.2174%2F092986710790980005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=20166921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtFehtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=1468-1486&author=P.+Reggio&title=Endocannabinoid+Binding+to+the+Cannabinoid+Receptors%3A+What+is+Known+and+What+Remains+Unknown&doi=10.2174%2F092986710790980005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Endocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown</span></div><div class="casAuthors">Reggio, Patricia H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1468-1486</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The cannabinoid CB1 and CB2 receptors are Class A G protein-coupled receptors (GPCRs).  While many Class A GPCRs have endogenous ligands that are hydrophilic cations (e.g., the serotonin and dopamine receptors), the cannabinoid receptors have neutral, highly lipophilic ligands derived from the fatty acid, arachidonic acid.  The most well-studied of these are N-arachidonoylethanolamide (anandamide, AEA) and sn-2-arachidonoylglycerol (2-AG).  This review focuses on the exptl. and computational studies that have been used to probe the nature of endocannabinoid interaction with the cannabinoid receptors.  These studies include mutation, SAR and NMR studies, as well as, QSAR, docking and mol. dynamics simulations.  Gaps in our knowledge are identified.  The review begins more generally, however, by discussing the entire endocannabinoid system, of which the cannabinoid receptors are part.  For in order to understand endocannabinoid action, one needs an appreciation for the environments for which these ligands have been designed and the conformational changes these ligands must undergo in order to act on the cannabinoid receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozOUaPE1hD3rVg90H21EOLACvtfcHk0lir_QyOYe_fRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtFehtb8%253D&md5=7b71c9f8ed680b3165c7e63409203278</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F092986710790980005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986710790980005%26sid%3Dliteratum%253Aachs%26aulast%3DReggio%26aufirst%3DP.%26atitle%3DEndocannabinoid%2520Binding%2520to%2520the%2520Cannabinoid%2520Receptors%253A%2520What%2520is%2520Known%2520and%2520What%2520Remains%2520Unknown%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2010%26volume%3D17%26spage%3D1468%26epage%3D1486%26doi%3D10.2174%2F092986710790980005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lolait, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brownstein, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonner, T. I.</span></span> <span> </span><span class="NLM_article-title">Structure of a Cannabinoid Receptor and Functional Expression of the Cloned cDNA</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>346</i></span>,  <span class="NLM_fpage">561</span>– <span class="NLM_lpage">564</span>, <span class="refDoi"> DOI: 10.1038/346561a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1038%2F346561a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=2165569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADyaK3cXls1Ghu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=1990&pages=561-564&author=L.+A.+Matsudaauthor=S.+J.+Lolaitauthor=M.+J.+Brownsteinauthor=A.+C.+Youngauthor=T.+I.+Bonner&title=Structure+of+a+Cannabinoid+Receptor+and+Functional+Expression+of+the+Cloned+cDNA&doi=10.1038%2F346561a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of a cannabinoid receptor and functional expression of the cloned cDNA</span></div><div class="casAuthors">Matsuda, Lisa A.; Lolait, Stephen J.; Brownstein, Michael J.; Young, Alice C.; Bonner, Tom I.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">346</span>
        (<span class="NLM_cas:issue">6284</span>),
    <span class="NLM_cas:pages">561-4</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Marijuana and many of its constituent cannabinoids influence the central nervous system (CNS) in a complex and dose-dependent manner.  CNS depression and analgesia are well documented effects of the cannabinoids, but the mechanisms responsible for the cannabinoid-induced effects are not known.  The hydrophobic nature of these substances has suggested that cannabinoids resemble anesthetic agents in their action and nonspecifically disrupt cellular membranes.  Recent evidence has supported a mechanism involving a G-protein-coupled receptor found in brain and neural cell lines, and which inhibits adenylate cyclase activity in a dose-dependent, stereoselective, and pertussis toxin-sensitive manner.  Also, the receptor is more responsive to psychoactive cannabinoids than to non-psychoactive cannabinoids.  This study reported the cloning and expression of a cDNA that encodes a G-protein-coupled receptor with all of these properties.  Its mRNA is found in cell lines and regions of the brain that have cannabinoid receptors.  This protein may be involved in cannabinoid-induced CNS effects (including alterations in mood and cognition) experienced by users of marijuana.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYrydatT83mLVg90H21EOLACvtfcHk0lir_QyOYe_fRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXls1Ghu7w%253D&md5=a99aeb39544d87392cee18b82a08003d</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2F346561a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F346561a0%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuda%26aufirst%3DL.%2BA.%26aulast%3DLolait%26aufirst%3DS.%2BJ.%26aulast%3DBrownstein%26aufirst%3DM.%2BJ.%26aulast%3DYoung%26aufirst%3DA.%2BC.%26aulast%3DBonner%26aufirst%3DT.%2BI.%26atitle%3DStructure%2520of%2520a%2520Cannabinoid%2520Receptor%2520and%2520Functional%2520Expression%2520of%2520the%2520Cloned%2520cDNA%26jtitle%3DNature%26date%3D1990%26volume%3D346%26spage%3D561%26epage%3D564%26doi%3D10.1038%2F346561a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Svízenska, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubový, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sulcova, A.</span></span> <span> </span><span class="NLM_article-title">Cannabinoid Receptors 1 and 2 (CB<sub>1</sub> and CB<sub>2</sub>), Their Distribution, Ligands and Functional Involvement in Nervous System Structures — A Short Review</span>. <i>Pharmacol. Biochem. Behav.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">501</span>– <span class="NLM_lpage">511</span>, <span class="refDoi"> DOI: 10.1016/j.pbb.2008.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1016%2Fj.pbb.2008.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=18584858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVClurvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2008&pages=501-511&author=I.+Sv%C3%ADzenskaauthor=P.+Dubov%C3%BDauthor=A.+Sulcova&title=Cannabinoid+Receptors+1+and+2+%28CB1+and+CB2%29%2C+Their+Distribution%2C+Ligands+and+Functional+Involvement+in+Nervous+System+Structures+%E2%80%94+A+Short+Review&doi=10.1016%2Fj.pbb.2008.05.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures - a short review</span></div><div class="casAuthors">Svizenska, Ivana; Dubovy, Petr; Sulcova, Alexandra</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology, Biochemistry and Behavior</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">501-511</span>CODEN:
                <span class="NLM_cas:coden">PBBHAU</span>;
        ISSN:<span class="NLM_cas:issn">0091-3057</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  In the last 25 years data has grown exponentially dealing with the discovery of the endocannabinoid system consisting of specific cannabinoid receptors, their endogenous ligands, and enzymic systems of their biosynthesis and degrdn.  Progress is being made in the development of novel agonists and antagonists with receptor subtype selectivity which should help in providing a greater understanding of the physiol. role of the endocannabinoid system and perhaps also in a broad no. of pathologies.  This could lead to advances with important therapeutic potential of drugs modulating activity of endocannabinoid system as hypnotics, analgesics, antiemetics, antiasthmatics, antihypertensives, immunomodulatory drugs, antiphlogistics, neuroprotective agents, antiepileptics, agents influencing glaucoma, spasticity and other "movement disorders", eating disorders, alc. withdrawal, hepatic fibrosis, bone growth, and atherosclerosis.  The aim of this review is to highlight distribution of the CB1 and CB2 receptor subtypes in the nervous system and functional involvement of their specific ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgtx8FThyh1rVg90H21EOLACvtfcHk0lir_QyOYe_fRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVClurvE&md5=cfbf0c84fc1439b6ecef399e7fb075d3</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.pbb.2008.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbb.2008.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DSv%25C3%25ADzenska%26aufirst%3DI.%26aulast%3DDubov%25C3%25BD%26aufirst%3DP.%26aulast%3DSulcova%26aufirst%3DA.%26atitle%3DCannabinoid%2520Receptors%25201%2520and%25202%2520%2528CB1%2520and%2520CB2%2529%252C%2520Their%2520Distribution%252C%2520Ligands%2520and%2520Functional%2520Involvement%2520in%2520Nervous%2520System%2520Structures%2520%25E2%2580%2594%2520A%2520Short%2520Review%26jtitle%3DPharmacol.%2520Biochem.%2520Behav.%26date%3D2008%26volume%3D90%26spage%3D501%26epage%3D511%26doi%3D10.1016%2Fj.pbb.2008.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ameri, A.</span></span> <span> </span><span class="NLM_article-title">The Effects of Cannabinoids on the Brain</span>. <i>Prog. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">315</span>– <span class="NLM_lpage">348</span>, <span class="refDoi"> DOI: 10.1016/s0301-0082(98)00087-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1016%2FS0301-0082%2898%2900087-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10368032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADyaK1MXjs1ejs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1999&pages=315-348&author=A.+Ameri&title=The+Effects+of+Cannabinoids+on+the+Brain&doi=10.1016%2Fs0301-0082%2898%2900087-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of cannabinoids on the brain</span></div><div class="casAuthors">Ameri, Angela</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">315-348</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with many refs.  Cannabinoids have a long history of consumption for recreational and medical reasons.  The primary active constituent of the hemp plant Cannabis sativa is Δ9-tetrahydrocannabinol (Δ9-THC).  In humans, psychoactive cannabinoids produce euphoria, enhancement of sensory perception, tachycardia, antinociception, difficulties in concn. and impairment of memory.  The cognitive deficiencies seem to persist after withdrawal.  The toxicity of marijuana has been underestimated for a long time, since recent findings revealed Δ9-THC-induced cell death with shrinkage of neurons and DNA fragmentation in the hippocampus.  The acute effects of cannabinoids as well as the development of tolerance are mediated by G protein-coupled cannabinoid receptors.  The CB1 receptor and its splice variant CB1A, are found predominantly in the brain with highest densities in the hippocampus, cerebellum and striatum.  The CB2 receptor is found predominantly in the spleen and in hemopoietic cells and has only 44% overall nucleotide sequence identity with the CB1 receptor.  The existence of this receptor provided the mol. basis for the immunosuppressive actions of marijuana.  The CB1 receptor mediates inhibition of adenylate cyclase, inhibition of N- and P/Q-type calcium channels, stimulation of potassium channels, and activation of mitogen-activated protein kinase.  The CB2 receptor mediates inhibition of adenylate cyclase and activation of mitogen-activated protein kinase.  The discovery of endogenous cannabinoid receptor ligands, anandamide (N-arachidonylethanolamine) and 2-arachidonylglycerol made the notion of a central cannabinoid neuromodulatory system plausible.  Anandamide is released from neurons upon depolarization through a mechanism that requires calcium-dependent cleavage from a phospholipid precursor in neuronal membranes.  The release of anandamide is followed by rapid uptake into the plasma and hydrolysis by fatty-acid amidohydrolase.  The psychoactive cannabinoids increase the activity of dopaminergic neurons in the ventral tegmental area-mesolimbic pathway.  Since these dopaminergic circuits are known to play a pivotal role in mediating the reinforcing (rewarding) effects of the most drugs of abuse, the enhanced dopaminergic drive elicited by the cannabinoids is thought to underlie the reinforcing and abuse properties of marijuana.  Thus, cannabinoids share a final common neuronal action with other major drugs of abuse such as morphine, ethanol and nicotine in producing facilitation of the mesolimbic dopamine system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdPcJ7-vQg37Vg90H21EOLACvtfcHk0lgDia4WapXtTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjs1ejs7c%253D&md5=7ffe2ffb3c7604a4795f59aa240d260a</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS0301-0082%2898%2900087-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0301-0082%252898%252900087-2%26sid%3Dliteratum%253Aachs%26aulast%3DAmeri%26aufirst%3DA.%26atitle%3DThe%2520Effects%2520of%2520Cannabinoids%2520on%2520the%2520Brain%26jtitle%3DProg.%2520Neurobiol.%26date%3D1999%26volume%3D58%26spage%3D315%26epage%3D348%26doi%3D10.1016%2Fs0301-0082%2898%2900087-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Das, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paria, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakraborty, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dey, S. K.</span></span> <span> </span><span class="NLM_article-title">Cannabinoid Ligand-Receptor Signaling in the Mouse Uterus</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">4332</span>– <span class="NLM_lpage">4336</span>, <span class="refDoi"> DOI: 10.1073/pnas.92.10.4332</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1073%2Fpnas.92.10.4332" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=7753807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADyaK2MXls1alu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1995&pages=4332-4336&author=S.+K.+Dasauthor=B.+C.+Pariaauthor=I.+Chakrabortyauthor=S.+K.+Dey&title=Cannabinoid+Ligand-Receptor+Signaling+in+the+Mouse+Uterus&doi=10.1073%2Fpnas.92.10.4332"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid ligand-receptor signaling in the mouse uterus</span></div><div class="casAuthors">Das, S. K.; Paria, B. C.; Chakraborty, I.; Dey, S. K.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4332-6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Using RNA (Northern) blot hybridization and reverse transcription-PCR, we demonstrate that the brain-type cannabinoid receptor (CB1-R) mRNA, but not the spleen-type cannabinoid receptor (CB2-R) mRNA, is expressed in the mouse uterus and that this organ has the capacity to synthesize the putative endogenous cannabinoid ligand, anandamide (arachidonylethanolamide).  The psychoactive cannabinoid component of marijuana-Δ9-tetrahydrocannabinol (THC)-or anandamide, but not the inactive and nonpsychoactive cannabidiol (CBD), inhibited forskolin-stimulated cAMP formation in the mouse uterus, which was prevented by pertussis toxin pretreatment.  These results suggest that uterine CB1-R is coupled to inhibitory guanine nucleotide-binding protein and is biol. active.  Autoradiog. studies identified ligand binding sites ([3H]anandamide) in the uterine epithelium and stromal cells, suggesting that these cells are perhaps the targets for cannabinoid action.  Scatchard anal. of the binding of [3H]WIN 55212-2, another cannabinoid receptor ligand, showed a single class of high-affinity binding sites in the endometrium with an apparent Kd of 2.4 nM and Bmax of 5.4 × 109 mols. per mg of protein.  The gene encoding lactoferrin is an estrogen-responsive gene in the mouse uterus that was rapidly and transiently up-regulated by THC, but not by CBD, in ovariectomized mice in the absence of ovarian steroids.  This effect, unlike that of 17β-estradiol (E2), was not influenced by a pure antiestrogen, ICI 182780, suggesting that the THC-induced uterine lactoferrin gene expression does not involve estrogen receptors.  We propose that the uterus is a new target for cannabinoid ligand-receptor signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_NrwuCxkgMbVg90H21EOLACvtfcHk0lgDia4WapXtTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXls1alu74%253D&md5=6e5e438a655262f21be72ca69ba8b7ba</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1073%2Fpnas.92.10.4332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.92.10.4332%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DS.%2BK.%26aulast%3DParia%26aufirst%3DB.%2BC.%26aulast%3DChakraborty%26aufirst%3DI.%26aulast%3DDey%26aufirst%3DS.%2BK.%26atitle%3DCannabinoid%2520Ligand-Receptor%2520Signaling%2520in%2520the%2520Mouse%2520Uterus%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1995%26volume%3D92%26spage%3D4332%26epage%3D4336%26doi%3D10.1073%2Fpnas.92.10.4332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galiegue, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mary, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dussossoy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carriere, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carayon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouaboula, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shire, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fur, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casellas, P.</span></span> <span> </span><span class="NLM_article-title">Expression of Central and Peripheral Cannabinoid Receptors in Human Immune Tissues and Leukocyte Subpopulations</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>232</i></span>,  <span class="NLM_fpage">54</span>– <span class="NLM_lpage">61</span>, <span class="refDoi"> DOI: 10.1111/j.1432-1033.1995.tb20780.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1111%2Fj.1432-1033.1995.tb20780.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=7556170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADyaK2MXnvVKksL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=232&publication_year=1995&pages=54-61&author=S.+Galiegueauthor=S.+Maryauthor=J.+Marchandauthor=D.+Dussossoyauthor=D.+Carriereauthor=P.+Carayonauthor=M.+Bouaboulaauthor=D.+Shireauthor=G.+Furauthor=P.+Casellas&title=Expression+of+Central+and+Peripheral+Cannabinoid+Receptors+in+Human+Immune+Tissues+and+Leukocyte+Subpopulations&doi=10.1111%2Fj.1432-1033.1995.tb20780.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations</span></div><div class="casAuthors">Galiegue, Sylvaine; Mary, Sophie; Marchand, Jean; Dussossoy, Danielle; Carriere, Dominique; Carayon, Pierre; Bouaboula, Monsif; Shire, David; Le Fur, Gerard; Casellas, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">232</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">54-61</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Two proteins with 7 transmembrane-spanning domains typical of guanosine-nucleotide-binding-protein-coupled receptors have been identified as cannabinoid receptors; the central cannabinoid receptor, CB1, and the peripheral cannabinoid receptor, CB2, initially described in rat brain and spleen, resp.  The distribution patterns for both CB1 and CB2 transcripts in human immune cells and in several human tissues are reported, as analyzed by a PCR-based method.  CB1 was mainly expressed in the central nervous system and, to a lower extent, in several peripheral tissues such as adrenal gland, heart, lung, prostate, uterus, ovary, testis, bone marrow, thymus and tonsils.  The CB2 gene, which is not expressed in the brain, was particularly abundant in immune tissues, with an expression level 10-100-fold higher than that of CB1.  Although CB2 mRNA was also detected in some other peripheral tissues, its level remained very low.  In spleen and tonsils, the CB2 mRNA content was equiv. to that of CB1 mRNA in the central nervous system.  Among the main human blood cell subpopulations, the distribution pattern of the CB2 mRNA displayed important variations.  The rank order of CB2 mRNA levels in these cells was B-cells > natural killer cells » monocytes > polymorphonuclear neutrophil cells > T8 cells > T4 cells.  The same rank order was also established in human cell lines belonging to the myeloid, monocytic and lymphoid lineages.  The prevailing expression of the CB2 gene in immune tissues was confirmed by Northern-blot anal.  The expression of the CB2 protein was demonstrated by an immunohistol. anal. performed on tonsil sections by specific anti-(human CB2) IgG; this expt. showed that CB2 expression was restricted to B-lymphocyte-enriched areas of the mantle of secondary lymphoid follicles.  Thus, CB1 and CB2 can be considered as tissue-selective antigens of the central nervous system and immune system, resp., and cannabinoids may exert specific receptor-mediated actions on the immune system through the CB2 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwC6x6XdvbW7Vg90H21EOLACvtfcHk0lgDia4WapXtTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnvVKksL8%253D&md5=ff4c2f420824fdbef66c94ea9d129288</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1995.tb20780.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1995.tb20780.x%26sid%3Dliteratum%253Aachs%26aulast%3DGaliegue%26aufirst%3DS.%26aulast%3DMary%26aufirst%3DS.%26aulast%3DMarchand%26aufirst%3DJ.%26aulast%3DDussossoy%26aufirst%3DD.%26aulast%3DCarriere%26aufirst%3DD.%26aulast%3DCarayon%26aufirst%3DP.%26aulast%3DBouaboula%26aufirst%3DM.%26aulast%3DShire%26aufirst%3DD.%26aulast%3DFur%26aufirst%3DG.%26aulast%3DCasellas%26aufirst%3DP.%26atitle%3DExpression%2520of%2520Central%2520and%2520Peripheral%2520Cannabinoid%2520Receptors%2520in%2520Human%2520Immune%2520Tissues%2520and%2520Leukocyte%2520Subpopulations%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1995%26volume%3D232%26spage%3D54%26epage%3D61%26doi%3D10.1111%2Fj.1432-1033.1995.tb20780.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gerard, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollereau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vassart, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmentier, M.</span></span> <span> </span><span class="NLM_article-title">Molecular Cloning of a Human Cannabinoid Receptor Which is Also Expressed in Testis</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">129</span>– <span class="NLM_lpage">134</span>, <span class="refDoi"> DOI: 10.1042/bj2790129</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1042%2Fbj2790129" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1718258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADyaK38XltVGntLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=1991&pages=129-134&author=C.+M.+Gerardauthor=C.+Mollereauauthor=G.+Vassartauthor=M.+Parmentier&title=Molecular+Cloning+of+a+Human+Cannabinoid+Receptor+Which+is+Also+Expressed+in+Testis&doi=10.1042%2Fbj2790129"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular cloning of a human cannabinoid receptor which is also expressed in testis</span></div><div class="casAuthors">Gerard, Catherine M.; Mollereau, Catherine; Vassart, Gilbert; Parmentier, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">129-34</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    </div><div class="casAbstract">A cDNA clone encoding a receptor protein which presents all the characteristics of a guanine-nucleotide-binding protein (G-protein)-coupled receptor was isolated from a human brain stem cDNA library.  The probe used (HGMP08) was a 600 bp DNA fragment amplified by a low-stringency polymerase chain reaction (PCR), using human genomic DNA as template and degenerate oligonucleotide primers corresponding to conserved sequences amongst the known G-protein-coupled receptors.  The deduced amino acid sequence encodes a protein of 472 residues which shares 97.3% identity with the rat cannabinoid receptor cloned recently [Matsuda, L. A., et al., (1990)].  Abundant transcripts were detected in the brain, as expected, but lower amts. were also found in the testis.  The same probe was used to screen a human testis cDNA library.  The cDNA clones obtained were partially sequenced, demonstrating the identity of the cannabinoid receptors expressed in both tissues.  Specific binding of the synthetic cannabinoid ligand [3H]CP55940 was obsd. on membranes from Cos-7 cells transfected with the recombinant receptor clone.  In stably transfected CHO-K1 cell lines, cannabinoid agonists mediated a dose-dependent and stereoselective inhibition of forskolin-induced cAMP accumulation.  The ability to express the human cannabinoid receptor in mammalian cells should help in developing more selective drugs, and should facilitate the search for the endogenous cannabinoid ligand(s).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXFhq0W367AbVg90H21EOLACvtfcHk0ljlqCV1KmX5dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XltVGntLs%253D&md5=b24a3f84fa796759dcf6a6ced2304125</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1042%2Fbj2790129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj2790129%26sid%3Dliteratum%253Aachs%26aulast%3DGerard%26aufirst%3DC.%2BM.%26aulast%3DMollereau%26aufirst%3DC.%26aulast%3DVassart%26aufirst%3DG.%26aulast%3DParmentier%26aufirst%3DM.%26atitle%3DMolecular%2520Cloning%2520of%2520a%2520Human%2520Cannabinoid%2520Receptor%2520Which%2520is%2520Also%2520Expressed%2520in%2520Testis%26jtitle%3DBiochem.%2520J.%26date%3D1991%26volume%3D279%26spage%3D129%26epage%3D134%26doi%3D10.1042%2Fbj2790129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wenger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ledent, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Csernus, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerendai, I.</span></span> <span> </span><span class="NLM_article-title">The Central Cannabinoid Receptor Inactivation Suppresses Endocrine Reproductive Functions</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">363</span>– <span class="NLM_lpage">368</span>, <span class="refDoi"> DOI: 10.1006/bbrc.2001.4977</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1006%2Fbbrc.2001.4977" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=11394887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktFWhtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2001&pages=363-368&author=T.+Wengerauthor=C.+Ledentauthor=V.+Csernusauthor=I.+Gerendai&title=The+Central+Cannabinoid+Receptor+Inactivation+Suppresses+Endocrine+Reproductive+Functions&doi=10.1006%2Fbbrc.2001.4977"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The Central Cannabinoid Receptor Inactivation Suppresses Endocrine Reproductive Functions</span></div><div class="casAuthors">Wenger, Tibor; Ledent, Catherine; Csernus, Valer; Gerendai, Ida</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">363-368</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">The function of central cannabinoid (CB1) receptor was investigated in the regulation of the pituitary-gonad axis in CB1 receptor knockout male mouse.  Serum LH and testosterone (T) levels and basal T secretion in vitro of testes were significantly decreased in mutant (CB1-/-) mice.  The receptor agonist, anandamide (ANA), suppressed LH and T secretion in wild type (CB1+/+) mice but had no effect in receptor-inactivated animals.  The results are the first descriptions indicating the direct action of CB1 receptors on LH and T secretion and the immunohistol. demonstration of CB1 receptors in the Leydig cells.  The results also indicate that CB1 receptors are responsible for the effects of exogenous cannabinoids on reproductive functions.  (c) 2001 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdVEFRoel2GrVg90H21EOLACvtfcHk0ljlqCV1KmX5dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktFWhtrg%253D&md5=c1edceb2bae9f8cded0faf58a5a6284e</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.2001.4977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.2001.4977%26sid%3Dliteratum%253Aachs%26aulast%3DWenger%26aufirst%3DT.%26aulast%3DLedent%26aufirst%3DC.%26aulast%3DCsernus%26aufirst%3DV.%26aulast%3DGerendai%26aufirst%3DI.%26atitle%3DThe%2520Central%2520Cannabinoid%2520Receptor%2520Inactivation%2520Suppresses%2520Endocrine%2520Reproductive%2520Functions%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2001%26volume%3D284%26spage%3D363%26epage%3D368%26doi%3D10.1006%2Fbbrc.2001.4977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benito, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolón, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pazos, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Núñez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castillo, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, J.</span></span> <span> </span><span class="NLM_article-title">Cannabinoid CB<sub>2</sub> Receptors in Human Brain Inflammation</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>153</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">285</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0707505</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1038%2Fsj.bjp.0707505" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=17934510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovFCktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2008&pages=277-285&author=C.+Benitoauthor=R.+M.+Tol%C3%B3nauthor=M.+R.+Pazosauthor=E.+N%C3%BA%C3%B1ezauthor=A.+I.+Castilloauthor=J.+Romero&title=Cannabinoid+CB2+Receptors+in+Human+Brain+Inflammation&doi=10.1038%2Fsj.bjp.0707505"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid CB2 receptors in human brain inflammation</span></div><div class="casAuthors">Benito, C.; Tolon, R. M.; Pazos, M. R.; Nunez, E.; Castillo, A. I.; Romero, J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">277-285</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The presence of functional cannabinoid CB2 receptors in the CNS has provoked considerable controversy over the past few years.  Formerly considered as an exclusively peripheral receptor, it is now accepted that it is also present in limited amts. and distinct locations in the brain of several animal species, including humans.  Furthermore, the inducible nature of these receptors under neuroinflammatory conditions, in contrast to CB1, makes them attractive targets for the development of novel therapeutic approaches.  In fact, the undesired psychoactive effects caused by CB1 activation have largely limited the clin. use of cannabinoid-related compds. that act on these receptors.  In this review some recent findings on the antiinflammatory properties of CB2 receptors are presented, as well as new perspectives that have been obtained based on studies of human postmortem brain samples.  In addn., various working hypotheses are also proposed and discussed.  British Journal of Pharmacol. (2008) 153, 277-285; doi:10.1038/sj.bjp.0707505; published online 15 Oct. 2007.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy1sC3kUak-7Vg90H21EOLACvtfcHk0ljlqCV1KmX5dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovFCktg%253D%253D&md5=acc7f2244e1db16d66e5953eadecb381</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707505%26sid%3Dliteratum%253Aachs%26aulast%3DBenito%26aufirst%3DC.%26aulast%3DTol%25C3%25B3n%26aufirst%3DR.%2BM.%26aulast%3DPazos%26aufirst%3DM.%2BR.%26aulast%3DN%25C3%25BA%25C3%25B1ez%26aufirst%3DE.%26aulast%3DCastillo%26aufirst%3DA.%2BI.%26aulast%3DRomero%26aufirst%3DJ.%26atitle%3DCannabinoid%2520CB2%2520Receptors%2520in%2520Human%2520Brain%2520Inflammation%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D153%26spage%3D277%26epage%3D285%26doi%3D10.1038%2Fsj.bjp.0707505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Onaivi, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishiguro, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perchuk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meozzi, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mora, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tagliaferro, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brusco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akinshola, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hope, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwasaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arinami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teasenfitz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uhl, G. R.</span></span> <span> </span><span class="NLM_article-title">Discovery of the Presence and Functional Expression of Cannabinoid CB<sub>2</sub> Receptors in Brain</span>. <i>Ann. N.Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1074</i></span>,  <span class="NLM_fpage">514</span>– <span class="NLM_lpage">536</span>, <span class="refDoi"> DOI: 10.1196/annals.1369.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1196%2Fannals.1369.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=17105950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFGgs7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1074&publication_year=2006&pages=514-536&author=E.+S.+Onaiviauthor=H.+Ishiguroauthor=J.-P.+Gongauthor=S.+Patelauthor=A.+Perchukauthor=P.+A.+Meozziauthor=L.+Myersauthor=Z.+Moraauthor=P.+Tagliaferroauthor=E.+Gardnerauthor=A.+Bruscoauthor=B.+E.+Akinsholaauthor=Q.-R.+Liuauthor=B.+Hopeauthor=S.+Iwasakiauthor=T.+Arinamiauthor=L.+Teasenfitzauthor=G.+R.+Uhl&title=Discovery+of+the+Presence+and+Functional+Expression+of+Cannabinoid+CB2+Receptors+in+Brain&doi=10.1196%2Fannals.1369.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain</span></div><div class="casAuthors">Onaivi, Emmanuel S.; Ishiguro, Hiroki; Gong, Jian-Ping; Patel, Sejal; Perchuk, Alex; Meozzi, Paul A.; Myers, Lester; Mora, Zoila; Tagliaferro, Patricia; Gardner, Eileen; Brusco, Alicia; Akinshola, Babatunde E.; Liu, Qing-Rong; Hope, Bruce; Iwasaki, Shinya; Arinami, Tadao; Teasenfitz, Lindsey; Uhl, George R.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1074</span>
        (<span class="NLM_cas:issue">Cellular and Molecular Mechanisms of Drugs of Abuse and Neurotoxicity</span>),
    <span class="NLM_cas:pages">514-536</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">A review.  Two well-characterized cannabinoid receptors (CBrs), CB1 and CB2, mediate the effects of cannabinoids and marijuana use, with functional evidence for other CBrs.  CB1 receptors are expressed primarily in brain and peripheral tissues.  For over a decade several labs. were unable to detect CB2 receptors in brain and were known to be intensely expressed in peripheral and immune tissues and have traditionally been referred to as peripheral CB2 CBrs.  We have reported the discovery and functional presence of CB2 cannabinoid receptors in mammalian brain that may be involved in depression and drug abuse and this was supported by reports of identification of neuronal CB2 receptors that are involved in emesis.  We used RT-PCR, immunoblotting, hippocampal cultures, immunohistochem., transmission electron microscopy, and stereotaxic techniques with behavioral assays to det. the functional expression of CB2 CBrs in rat brain and mice brain exposed to chronic mild stress (CMS) or those treated with abused drugs.  RT-PCR analyses supported the expression of brain CB2 receptor transcripts at levels much lower than those of CB1 receptors.  In situ hybridization revealed CB2 mRNA in cerebellar neurons of wild-type but not of CB2 knockout mice.  Abundant CB2 receptor immunoreactivity (iCB2) in neuronal and glial processes was detected in brain and CB2 expression was detected in neuron-specific enolase (NSE) pos. hippocampal cell cultures.  The effect of direct CB2 antisense oligonucleotide injection into the brain and treatment with JWH015 in motor function and plus-maze tests also demonstrated the functional presence of CB2 cannabinoid receptors in the central nervous system (CNS).  Thus, contrary to the prevailing view that CB2 CBrs are restricted to peripheral tissues and predominantly in immune cells, we demonstrated that CB2 CBrs and their gene transcripts are widely distributed in the brain.  This multifocal expression of CB2 immunoreactivity in brain suggests that CB2 receptors may play broader roles in the brain than previously anticipated and may be exploited as new targets in the treatment of depression and substance abuse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUIPPJ2UOp67Vg90H21EOLACvtfcHk0liV4YJIyIk_KA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFGgs7vJ&md5=42b319306c27fbb91389d4134648ac82</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1196%2Fannals.1369.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1196%252Fannals.1369.052%26sid%3Dliteratum%253Aachs%26aulast%3DOnaivi%26aufirst%3DE.%2BS.%26aulast%3DIshiguro%26aufirst%3DH.%26aulast%3DGong%26aufirst%3DJ.-P.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DPerchuk%26aufirst%3DA.%26aulast%3DMeozzi%26aufirst%3DP.%2BA.%26aulast%3DMyers%26aufirst%3DL.%26aulast%3DMora%26aufirst%3DZ.%26aulast%3DTagliaferro%26aufirst%3DP.%26aulast%3DGardner%26aufirst%3DE.%26aulast%3DBrusco%26aufirst%3DA.%26aulast%3DAkinshola%26aufirst%3DB.%2BE.%26aulast%3DLiu%26aufirst%3DQ.-R.%26aulast%3DHope%26aufirst%3DB.%26aulast%3DIwasaki%26aufirst%3DS.%26aulast%3DArinami%26aufirst%3DT.%26aulast%3DTeasenfitz%26aufirst%3DL.%26aulast%3DUhl%26aufirst%3DG.%2BR.%26atitle%3DDiscovery%2520of%2520the%2520Presence%2520and%2520Functional%2520Expression%2520of%2520Cannabinoid%2520CB2%2520Receptors%2520in%2520Brain%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2006%26volume%3D1074%26spage%3D514%26epage%3D536%26doi%3D10.1196%2Fannals.1369.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maccarrone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bab, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bíró, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabral, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dey, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konje, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mechoulam, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacher, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharkey, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmer, A.</span></span> <span> </span><span class="NLM_article-title">Endocannabinoid Signaling at the Periphery: 50 years After THC</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">296</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2015.02.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1016%2Fj.tips.2015.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=25796370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC2MXktFehur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=277-296&author=M.+Maccarroneauthor=I.+Babauthor=T.+B%C3%ADr%C3%B3author=G.+A.+Cabralauthor=S.+K.+Deyauthor=V.+Di+Marzoauthor=J.+C.+Konjeauthor=G.+Kunosauthor=R.+Mechoulamauthor=P.+Pacherauthor=K.+A.+Sharkeyauthor=A.+Zimmer&title=Endocannabinoid+Signaling+at+the+Periphery%3A+50+years+After+THC&doi=10.1016%2Fj.tips.2015.02.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Endocannabinoid signaling at the periphery: 50 years after THC</span></div><div class="casAuthors">Maccarrone, Mauro; Bab, Itai; Biro, Tamas; Cabral, Guy A.; Dey, Sudhansu K.; Di Marzo, Vincenzo; Konje, Justin C.; Kunos, George; Mechoulam, Raphael; Pacher, Pal; Sharkey, Keith A.; Zimmer, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">277-296</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  In 1964, the psychoactive ingredient of Cannabis sativa, Δ9-tetrahydrocannabinol (THC), was isolated.  Nearly 30 years later the endogenous counterparts of THC, collectively termed endocannabinoids (eCBs), were discovered: N-arachidonoylethanolamine (anandamide) (AEA) in 1992 and 2-arachidonoylglycerol (2-AG) in 1995.  Since then, considerable research has shed light on the impact of eCBs on human health and disease, identifying an ensemble of proteins that bind, synthesize, and degrade them and that together form the eCB system (ECS). eCBs control basic biol. processes including cell choice between survival and death and progenitor/stem cell proliferation and differentiation.  Unsurprisingly, in the past two decades eCBs have been recognized as key mediators of several aspects of human pathophysiol. and thus have emerged to be among the most widespread and versatile signaling mols. ever discovered.  Here some of the pioneers of this research field review the state of the art of crit. eCB functions in peripheral organs.  Our community effort is aimed at establishing consensus views on the relevance of the peripheral ECS for human health and disease pathogenesis, as well as highlighting emerging challenges and therapeutic hopes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqliBLJSeUEKLVg90H21EOLACvtfcHk0liV4YJIyIk_KA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXktFehur4%253D&md5=a06cc2d98beb8bd8e42336b5c9c7a278</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2015.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2015.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DMaccarrone%26aufirst%3DM.%26aulast%3DBab%26aufirst%3DI.%26aulast%3DB%25C3%25ADr%25C3%25B3%26aufirst%3DT.%26aulast%3DCabral%26aufirst%3DG.%2BA.%26aulast%3DDey%26aufirst%3DS.%2BK.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DKonje%26aufirst%3DJ.%2BC.%26aulast%3DKunos%26aufirst%3DG.%26aulast%3DMechoulam%26aufirst%3DR.%26aulast%3DPacher%26aufirst%3DP.%26aulast%3DSharkey%26aufirst%3DK.%2BA.%26aulast%3DZimmer%26aufirst%3DA.%26atitle%3DEndocannabinoid%2520Signaling%2520at%2520the%2520Periphery%253A%252050%2520years%2520After%2520THC%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2015%26volume%3D36%26spage%3D277%26epage%3D296%26doi%3D10.1016%2Fj.tips.2015.02.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, J. C.</span></span> <span> </span><span class="NLM_article-title">Psychoactive Substances — Some New, Some Old: A Scan of the Situation in the U.S.</span>. <i>Drug Alcohol Depend.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1016/j.drugalcdep.2013.09.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1016%2Fj.drugalcdep.2013.09.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=24140401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A280%3ADC%252BC2c%252FotF2mtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2014&pages=71-77&author=J.+C.+Maxwell&title=Psychoactive+Substances+%E2%80%94+Some+New%2C+Some+Old%3A+A+Scan+of+the+Situation+in+the+U.S.&doi=10.1016%2Fj.drugalcdep.2013.09.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Psychoactive substances--some new, some old: a scan of the situation in the U.S</span></div><div class="casAuthors">Maxwell Jane Carlisle</div><div class="citationInfo"><span class="NLM_cas:title">Drug and alcohol dependence</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">71-77</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">INTRODUCTION:  New synthetic drugs are appearing as old hallucinogen psychedelic drugs are reappearing.  This article combines the findings from a variety of datasets to characterize the users in terms of gender, age, drug use patterns, and adverse results, as well as provide an overview of the changes in formulations of these drugs and the impact of legal controls.  Methods.  Data from Monitoring the Future and the National Survey on Drug Use and Health are analyzed, along with the national DAWN emergency room admissions, Texas poison control center cases, and Texas treatment data, along with national forensic laboratory results.  Results.  Users of the synthetic cannabinoids, synthetic cathinones, phenethylamines, tryptamines, LSD, MDMA, and mushrooms tended to be young and male.  They differed in terms of race and ethnicity.  The effects of the drugs differed in terms of emergency room outcomes and poison center reports, and the treatment data showed they were similar in terms of education level, employment, and legal problems.  Conclusion.  Combining the different data sources provided a first picture of the characteristics of these users and their needs.  Creditable descriptions on the risks of these drugs should be disseminated.  Intervention programs should be targeted to these young users and new neuropsychobiological deficits from some of these drugs should be monitored.  Because of the ever-changing chemical combinations to stay legal and the need for information on content and dosage, a more effective approach may be needed basing control on the effects of the substances rather than their changing chemical composition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTyK9-qm75EbjC850By6mxpfW6udTcc2eZOt9OWxOTx2Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c%252FotF2mtQ%253D%253D&md5=c98da2772d936fbf9bdcf734c7f4d0b1</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.drugalcdep.2013.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drugalcdep.2013.09.011%26sid%3Dliteratum%253Aachs%26aulast%3DMaxwell%26aufirst%3DJ.%2BC.%26atitle%3DPsychoactive%2520Substances%2520%25E2%2580%2594%2520Some%2520New%252C%2520Some%2520Old%253A%2520A%2520Scan%2520of%2520the%2520Situation%2520in%2520the%2520U.S.%26jtitle%3DDrug%2520Alcohol%2520Depend.%26date%3D2014%26volume%3D134%26spage%3D71%26epage%3D77%26doi%3D10.1016%2Fj.drugalcdep.2013.09.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ford, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fantegrossi, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prather, P. L.</span></span> <span> </span><span class="NLM_article-title">Synthetic Pot: Not Your Grandfather’s Marijuana</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">257</span>– <span class="NLM_lpage">276</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2016.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1016%2Fj.tips.2016.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=28162792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitFeht7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2017&pages=257-276&author=B.+M.+Fordauthor=S.+Taiauthor=W.+E.+Fantegrossiauthor=P.+L.+Prather&title=Synthetic+Pot%3A+Not+Your+Grandfather%E2%80%99s+Marijuana&doi=10.1016%2Fj.tips.2016.12.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic Pot: Not Your Grandfather's Marijuana</span></div><div class="casAuthors">Ford, Benjamin M.; Tai, Sherrica; Fantegrossi, William E.; Prather, Paul L.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">257-276</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">In the early 2000s in Europe and shortly thereafter in the USA, it was reported that 'legal' forms of marijuana were being sold under the name K2 and/or Spice.  Active ingredients in K2/Spice products were detd. to be synthetic cannabinoids (SCBs), producing psychotropic actions via CB1 cannabinoid receptors, similar to those of Δ9-tetrahydrocannabinol (Δ9-THC), the primary active constituent in marijuana.  Often abused by adolescents and military personnel to elude detection in drug tests due to their lack of structural similarity to Δ9-THC, SCBs are falsely marketed as safe marijuana substitutes.  Instead, SCBs are a highly structural diverse group of compds., easily synthesized, which produce very dangerous adverse effects occurring by, as of yet, unknown mechanisms.  Therefore, available evidence indicates that K2/Spice products are clearly not safe marijuana alternatives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq__z5CUgbGPbVg90H21EOLACvtfcHk0lgQSOczBxxgjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitFeht7w%253D&md5=ca3afa2ea70b14d8f2c74d569d5e1174</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2016.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2016.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DFord%26aufirst%3DB.%2BM.%26aulast%3DTai%26aufirst%3DS.%26aulast%3DFantegrossi%26aufirst%3DW.%2BE.%26aulast%3DPrather%26aufirst%3DP.%2BL.%26atitle%3DSynthetic%2520Pot%253A%2520Not%2520Your%2520Grandfather%25E2%2580%2599s%2520Marijuana%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2017%26volume%3D38%26spage%3D257%26epage%3D276%26doi%3D10.1016%2Fj.tips.2016.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banister, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longworth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuart, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apetz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">English, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooker, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goebel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hibbs, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glass, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGregor, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassiou, M.</span></span> <span> </span><span class="NLM_article-title">The Synthesis and Pharmacological Evaluation of Adamantane-Derived Indoles: Cannabimimetic Drugs of Abuse</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1081</span>– <span class="NLM_lpage">1092</span>, and the references cited therein <span class="refDoi"> DOI: 10.1021/cn400035r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn400035r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltV2nu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1081-1092&author=S.+D.+Banisterauthor=S.+M.+Wilkinsonauthor=M.+Longworthauthor=J.+Stuartauthor=N.+Apetzauthor=K.+Englishauthor=L.+Brookerauthor=C.+Goebelauthor=D.+E.+Hibbsauthor=M.+Glassauthor=M.+Connorauthor=I.+S.+McGregorauthor=M.+Kassiou&title=The+Synthesis+and+Pharmacological+Evaluation+of+Adamantane-Derived+Indoles%3A+Cannabimimetic+Drugs+of+Abuse&doi=10.1021%2Fcn400035r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The Synthesis and Pharmacological Evaluation of Adamantane-Derived Indoles: Cannabimimetic Drugs of Abuse</span></div><div class="casAuthors">Banister, Samuel D.; Wilkinson, Shane M.; Longworth, Mitchell; Stuart, Jordyn; Apetz, Nadine; English, Katrina; Brooker, Lance; Goebel, Catrin; Hibbs, David E.; Glass, Michelle; Connor, Mark; McGregor, Iain S.; Kassiou, Michael</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1081-1092</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two novel adamantane derivs., adamantan-1-yl(1-pentyl-1H-indol-3-yl)methanone (AB-001) and N-(adamtan-1-yl)-1-pentyl-1H-indole-3-carboxamide (SDB-001), were recently identified as cannabimimetic indoles of abuse.  Conflicting anecdotal reports of the psychoactivity of AB-001 in humans, and a complete dearth of information about the bioactivity of SDB-001, prompted the prepn. of AB-001, SDB-001, and several analogs intended to explore preliminary structure-activity relationships within this class.  This study sought to elucidate which structural features of AB-001, SDB-001, and their analogs govern the cannabimimetic potency of these chemotypes in vitro and in vivo.  All compds. showed similar full agonist profiles at CB1 (EC50 = 16-43 nM) and CB2 (EC50 = 29-216 nM) receptors in vitro using a FLIPR membrane potential assay, with the exception of SDB-002, which demonstrated partial agonist activity at CB2 receptors.  The activity of AB-001, AB-002, and SDB-001 in rats was compared to that of Δ9-tetrahydrocannabinol (Δ9-THC) and cannabimimetic indole JWH-018 using biotelemetry.  SDB-001 dose-dependently induced hypothermia and reduced heart rate (maximal dose 10 mg/kg) with potency comparable to that of Δ9-tetrahydrocannabinol (Δ9-THC, maximal dose 10 mg/kg), and lower than that of JWH-018 (maximal dose 3 mg/kg).  Addnl., the changes in body temp. and heart rate affected by SDB-001 are of longer duration than those of Δ9-THC or JWH-018, suggesting a different pharmacokinetic profile.  In contrast, AB-001, and its homolog, AB-002, did not produce significant hypothermic and bradycardic effects, even at relatively higher doses (up to 30 mg/kg), indicating greatly reduced potency compared to Δ9-THC, JWH-018, and SDB-001.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoo-YnN-QuYjLVg90H21EOLACvtfcHk0lgQSOczBxxgjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltV2nu7c%253D&md5=859bff2f95ad6a0931b013ac532b3407</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fcn400035r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn400035r%26sid%3Dliteratum%253Aachs%26aulast%3DBanister%26aufirst%3DS.%2BD.%26aulast%3DWilkinson%26aufirst%3DS.%2BM.%26aulast%3DLongworth%26aufirst%3DM.%26aulast%3DStuart%26aufirst%3DJ.%26aulast%3DApetz%26aufirst%3DN.%26aulast%3DEnglish%26aufirst%3DK.%26aulast%3DBrooker%26aufirst%3DL.%26aulast%3DGoebel%26aufirst%3DC.%26aulast%3DHibbs%26aufirst%3DD.%2BE.%26aulast%3DGlass%26aufirst%3DM.%26aulast%3DConnor%26aufirst%3DM.%26aulast%3DMcGregor%26aufirst%3DI.%2BS.%26aulast%3DKassiou%26aufirst%3DM.%26atitle%3DThe%2520Synthesis%2520and%2520Pharmacological%2520Evaluation%2520of%2520Adamantane-Derived%2520Indoles%253A%2520Cannabimimetic%2520Drugs%2520of%2520Abuse%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2013%26volume%3D4%26spage%3D1081%26epage%3D1092%26doi%3D10.1021%2Fcn400035r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wiley, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marusich, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefever, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabenauer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, B. F.</span></span> <span> </span><span class="NLM_article-title">Cannabinoids in Disguise: Δ<sup>9</sup>-Tetrahydrocannabinol-like Effects of Tetramethylcyclopropyl Ketone Indoles</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">145</span>– <span class="NLM_lpage">154</span>, and the references cited therein <span class="refDoi"> DOI: 10.1016/j.neuropharm.2013.07.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1016%2Fj.neuropharm.2013.07.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=23916483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFyltbrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2013&pages=145-154&author=J.+L.+Wileyauthor=J.+A.+Marusichauthor=T.+W.+Lefeverauthor=M.+Grabenauerauthor=K.+N.+Mooreauthor=B.+F.+Thomas&title=Cannabinoids+in+Disguise%3A+%CE%949-Tetrahydrocannabinol-like+Effects+of+Tetramethylcyclopropyl+Ketone+Indoles&doi=10.1016%2Fj.neuropharm.2013.07.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoids in disguise: Δ9-Tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles</span></div><div class="casAuthors">Wiley, Jenny L.; Marusich, Julie A.; Lefever, Timothy W.; Grabenauer, Megan; Moore, Katherine N.; Thomas, Brian F.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">145-154</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Synthetic indole-derived cannabinoids have become commonly used recreational drugs and continue to be abused despite their adverse consequences.  As compds. that were identified early in the epidemic (e.g., naphthoylindoles) have become legally banned, new compds. have appeared on the drug market.  Two tetramethylcyclopropyl ketone indoles, UR-144 [(1-pentyl-1H-indol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone] and XLR-11 [(1-(5-fluoropentyl)-1H-indol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone], recently have been identified in confiscated products.  These compds. are structurally related to a series of CB2-selective compds. explored by Abbott Labs.  The purpose of the present study was to evaluate the extent to which UR-144 and XLR-11 shared cannabinoid effects with Δ9-tetrahydrocannabinol (Δ9-THC).  Indexes of in vitro and in vivo activity at cannabinoid receptors were assessed.  Similar to other psychoactive cannabinoid agonists, XLR-11 and UR-144 showed low nanomolar (<30) affinity for CB1 and CB2 receptors, activated these receptors as full agonists, and produced dose-dependent effects that were blocked by rimonabant in mice, including antinociception, hypothermia, catalepsy and suppression of locomotor activity.  The potency of both compds. was several-fold greater than Δ9-THC.  XLR-11 and UR-144 also substituted for Δ9-THC in a Δ9-THC discrimination procedure in mice, effects that were attenuated by rimonabant.  Anal. of urine from mice treated with the compds. revealed that both were extensively metabolized, with predominant urinary excretion as glucuronide conjugates.  Together, these results demonstrate that UR-144 and XLR-11 share a pharmacol. profile of in vitro and in vivo effects with Δ9-THC and other abused indole-derived cannabinoids and would be predicted to produce Δ9-THC-like subjective effects in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUvHF0gRQzR7Vg90H21EOLACvtfcHk0lgQSOczBxxgjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFyltbrP&md5=26ab6006c2b9c2b161845ef3beeaf8fa</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2013.07.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2013.07.022%26sid%3Dliteratum%253Aachs%26aulast%3DWiley%26aufirst%3DJ.%2BL.%26aulast%3DMarusich%26aufirst%3DJ.%2BA.%26aulast%3DLefever%26aufirst%3DT.%2BW.%26aulast%3DGrabenauer%26aufirst%3DM.%26aulast%3DMoore%26aufirst%3DK.%2BN.%26aulast%3DThomas%26aufirst%3DB.%2BF.%26atitle%3DCannabinoids%2520in%2520Disguise%253A%2520%25CE%25949-Tetrahydrocannabinol-like%2520Effects%2520of%2520Tetramethylcyclopropyl%2520Ketone%2520Indoles%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D75%26spage%3D145%26epage%3D154%26doi%3D10.1016%2Fj.neuropharm.2013.07.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nutt, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, D. E.</span></span> <span> </span><span class="NLM_article-title">Effects of Schedule I Drug Laws on Neuroscience Research and Treatment Innovation</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">577</span>– <span class="NLM_lpage">585</span>, <span class="refDoi"> DOI: 10.1038/nrn3530</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1038%2Fnrn3530" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=23756634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpt1Cmtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=577-585&author=D.+J.+Nuttauthor=L.+A.+Kingauthor=D.+E.+Nichols&title=Effects+of+Schedule+I+Drug+Laws+on+Neuroscience+Research+and+Treatment+Innovation&doi=10.1038%2Fnrn3530"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of Schedule I drug laws on neuroscience research and treatment innovation</span></div><div class="casAuthors">Nutt, David J.; King, Leslie A.; Nichols, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">577-585</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Many psychoactive drugs are used recreationally, particularly by young people.  This use and its perceived dangers have led to many different classes of drugs being banned under national laws and international conventions.  Indeed, the possession of cannabis, 3,4-methylenedioxy-N-methylamphetamine (MDMA; also known as ecstasy) and psychedelics is stringently regulated.  An important and unfortunate outcome of the controls placed on these and other psychoactive drugs is that they make research into their mechanisms of action and potential therapeutic uses - for example, in depression and post-traumatic stress disorder - difficult and in many cases almost impossible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_s93GyCYsNrVg90H21EOLACvtfcHk0liTVJlCw2nW1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpt1Cmtbs%253D&md5=446f16a994fe9582f78434b26eff4fc4</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnrn3530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn3530%26sid%3Dliteratum%253Aachs%26aulast%3DNutt%26aufirst%3DD.%2BJ.%26aulast%3DKing%26aufirst%3DL.%2BA.%26aulast%3DNichols%26aufirst%3DD.%2BE.%26atitle%3DEffects%2520of%2520Schedule%2520I%2520Drug%2520Laws%2520on%2520Neuroscience%2520Research%2520and%2520Treatment%2520Innovation%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2013%26volume%3D14%26spage%3D577%26epage%3D585%26doi%3D10.1038%2Fnrn3530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huffman, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zengin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hynd, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bushell, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bushell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tartal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurst, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reggio, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selley, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassidy, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiley, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, B. R.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB1 and CB2 receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB2 receptor agonists</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2004.09.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1016%2Fj.bmc.2004.09.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=15582455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A280%3ADC%252BD2cngvVaisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=89-112&author=J.+W.+Huffmanauthor=G.+Zenginauthor=M.-J.+Wuauthor=J.+Luauthor=G.+Hyndauthor=K.+Bushellauthor=A.+L.+S.+Thompsonauthor=S.+Bushellauthor=C.+Tartalauthor=D.+P.+Hurstauthor=P.+H.+Reggioauthor=D.+E.+Selleyauthor=M.+P.+Cassidyauthor=J.+L.+Wileyauthor=B.+R.+Martin&title=Structure-activity+relationships+for+1-alkyl-3-%281-naphthoyl%29indoles+at+the+cannabinoid+CB1+and+CB2+receptors%3A+steric+and+electronic+effects+of+naphthoyl+substituents.+New+highly+selective+CB2+receptor+agonists&doi=10.1016%2Fj.bmc.2004.09.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB(1) and CB(2) receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB(2) receptor agonists</span></div><div class="casAuthors">Huffman John W; Zengin Gulay; Wu Ming-Jung; Lu Jianzhong; Hynd George; Bushell Kristen; Thompson Alicia L S; Bushell Simon; Tartal Cindy; Hurst Dow P; Reggio Patricia H; Selley Dana E; Cassidy Michael P; Wiley Jenny L; Martin Billy R</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & medicinal chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-112</span>
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    </div><div class="casAbstract">In an effort to improve indole-based CB(2) cannabinoid receptor ligands and also to develop SAR for both the CB(1) and CB(2) receptors, 47 indole derivatives were prepared and their CB(1) and CB(2) receptor affinities were determined.  The indole derivatives include 1-propyl- and 1-pentyl-3-(1-naphthoyl)indoles both with and without a 2-methyl substituent.  Naphthoyl substituents include 4- and 7-alkyl groups as well as 2-, 4-, 6-, 7-methoxy and 4-ethoxy groups.  The effects of these substituents on receptor affinities are discussed and structure-activity relationships are presented.  In the course of this work three new highly selective CB(2) receptor agonists were identified, 1-propyl-3-(4-methyl-1-naphthoylindole (JWH-120), 1-propyl-2-methyl-3-(6-methoxy-1-naphthoylindole (JWH-151), and 1-pentyl-3-(2-methoxy-1-naphthoylindole (JWH-267).  GTPgammaS assays indicated that JWH-151 is a full agonist at CB(2), while JWH-120 and JWH-267 are partial agonists.  Molecular modeling and receptor docking studies were carried out on a set of 3-(4-propyl-1-naphthoyl)indoles, a set of 3-(6-methoxy-1-naphthoyl)indoles and the pair of N-pentyl-3-(2-methoxy-1-naphthoyl)indoles.  Docking studies indicated that the CB(1) receptor affinities of these compounds were consistent with their aromatic stacking interactions in the aromatic microdomain of the CB(1) receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQAeapzNd70yENHe_gFldTbfW6udTcc2eajEphk7C3DH7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2cngvVaisQ%253D%253D&md5=e21fe8969660b1180f6bc851cc02db91</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2004.09.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2004.09.050%26sid%3Dliteratum%253Aachs%26aulast%3DHuffman%26aufirst%3DJ.%2BW.%26aulast%3DZengin%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DM.-J.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DHynd%26aufirst%3DG.%26aulast%3DBushell%26aufirst%3DK.%26aulast%3DThompson%26aufirst%3DA.%2BL.%2BS.%26aulast%3DBushell%26aufirst%3DS.%26aulast%3DTartal%26aufirst%3DC.%26aulast%3DHurst%26aufirst%3DD.%2BP.%26aulast%3DReggio%26aufirst%3DP.%2BH.%26aulast%3DSelley%26aufirst%3DD.%2BE.%26aulast%3DCassidy%26aufirst%3DM.%2BP.%26aulast%3DWiley%26aufirst%3DJ.%2BL.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3DStructure-activity%2520relationships%2520for%25201-alkyl-3-%25281-naphthoyl%2529indoles%2520at%2520the%2520cannabinoid%2520CB1%2520and%2520CB2%2520receptors%253A%2520steric%2520and%2520electronic%2520effects%2520of%2520naphthoyl%2520substituents.%2520New%2520highly%2520selective%2520CB2%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D89%26epage%3D112%26doi%3D10.1016%2Fj.bmc.2004.09.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Drug
Enforcement Administration</span> <span> </span><span class="NLM_article-title">Schedules of Controlled Substances: Temporary Placement of Five Synthetic
Cannabinoids into Schedule I</span>. <i>Fed. Regist.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">11075</span>– <span class="NLM_lpage">11078</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2011&pages=11075-11078&author=Drug%0AEnforcement+Administration&title=Schedules+of+Controlled+Substances%3A+Temporary+Placement+of+Five+Synthetic%0ACannabinoids+into+Schedule+I"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DSchedules%2520of%2520Controlled%2520Substances%253A%2520Temporary%2520Placement%2520of%2520Five%2520Synthetic%250ACannabinoids%2520into%2520Schedule%2520I%26jtitle%3DFed.%2520Regist.%26date%3D2011%26volume%3D76%26spage%3D11075%26epage%3D11078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frost, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dart, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tietje, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrison, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grayson, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daza, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Kouhen, O. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandran, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, M. D.</span></span> <span> </span><span class="NLM_article-title">Indol-3-ylcycloalkyl Ketones: Effects of N1 Substituted Indole Side Chain Variations on CB2Cannabinoid Receptor Activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">295</span>– <span class="NLM_lpage">315</span>, <span class="refDoi"> DOI: 10.1021/jm901214q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901214q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsValtbfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=295-315&author=J.+M.+Frostauthor=M.+J.+Dartauthor=K.+R.+Tietjeauthor=T.+R.+Garrisonauthor=G.+K.+Graysonauthor=A.+V.+Dazaauthor=O.+F.+El-Kouhenauthor=B.+B.+Yaoauthor=G.+C.+Hsiehauthor=M.+Paiauthor=C.+Z.+Zhuauthor=P.+Chandranauthor=M.+D.+Meyer&title=Indol-3-ylcycloalkyl+Ketones%3A+Effects+of+N1+Substituted+Indole+Side+Chain+Variations+on+CB2Cannabinoid+Receptor+Activity&doi=10.1021%2Fjm901214q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Indol-3-ylcycloalkyl Ketones: Effects of N1 Substituted Indole Side Chain Variations on CB2 Cannabinoid Receptor Activity</span></div><div class="casAuthors">Frost, Jennifer M.; Dart, Michael J.; Tietje, Karin R.; Garrison, Tiffany R.; Grayson, George K.; Daza, Anthony V.; El-Kouhen, Odile F.; Yao, Betty B.; Hsieh, Gin C.; Pai, Madhavi; Zhu, Chang Z.; Chandran, Prasant; Meyer, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">295-315</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Several 3-acylindoles with high affinity for the CB2 cannabinoid receptor and selectivity over the CB1 receptor have been prepd.  A variety of 3-acyl substituents were investigated, and the tetramethylcyclopropyl group was found to lead to high affinity CB2 agonists.  Substitution at the N1-indole position was then examd.  A series of aminoalkylindoles was prepd. and several substituted aminoethyl derivs. were active at the CB2 receptor.  A study of N1 nonarom. side chain variants provided potent agonists at the CB2 receptor.  Several polar side chains (alcs., oxazolidinone) were well tolerated for CB2 receptor activity, while others (amide, acid) led to weaker or inactive compds..  N1 arom. side chains also afforded several high affinity CB2 receptor agonists, but were generally less potent in an in vitro CB2 functional assay than were nonarom. side chain analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBqUcQi4rUorVg90H21EOLACvtfcHk0lgQjEuODU4inQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsValtbfP&md5=5bdd69db011d3abc7924a9093209e84b</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm901214q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901214q%26sid%3Dliteratum%253Aachs%26aulast%3DFrost%26aufirst%3DJ.%2BM.%26aulast%3DDart%26aufirst%3DM.%2BJ.%26aulast%3DTietje%26aufirst%3DK.%2BR.%26aulast%3DGarrison%26aufirst%3DT.%2BR.%26aulast%3DGrayson%26aufirst%3DG.%2BK.%26aulast%3DDaza%26aufirst%3DA.%2BV.%26aulast%3DEl-Kouhen%26aufirst%3DO.%2BF.%26aulast%3DYao%26aufirst%3DB.%2BB.%26aulast%3DHsieh%26aufirst%3DG.%2BC.%26aulast%3DPai%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DC.%2BZ.%26aulast%3DChandran%26aufirst%3DP.%26aulast%3DMeyer%26aufirst%3DM.%2BD.%26atitle%3DIndol-3-ylcycloalkyl%2520Ketones%253A%2520Effects%2520of%2520N1%2520Substituted%2520Indole%2520Side%2520Chain%2520Variations%2520on%2520CB2Cannabinoid%2520Receptor%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D295%26epage%3D315%26doi%3D10.1021%2Fjm901214q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malan, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibrahim, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanderah, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porreca, F.</span></span> <span> </span><span class="NLM_article-title">CB2 cannabinoid receptor agonists: pain relief without psychoactive effects?</span>. <i>Curr. Opin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">62</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1016/s1471-4892(02)00004-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1016%2FS1471-4892%2802%2900004-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=12550743" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsVaqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=62-67&author=T.+P.+Malanauthor=M.+M.+Ibrahimauthor=J.+Laiauthor=T.+W.+Vanderahauthor=A.+Makriyannisauthor=F.+Porreca&title=CB2+cannabinoid+receptor+agonists%3A+pain+relief+without+psychoactive+effects%3F&doi=10.1016%2Fs1471-4892%2802%2900004-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">CB2 cannabinoid receptor agonists: pain relief without psychoactive effects?</span></div><div class="casAuthors">Malan, T. Philip, Jr.; Ibrahim, Mohab M.; Lai, Josephine; Vanderah, Todd W.; Makriyannis, Alexandros; Porreca, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">62-67</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Cannabinoid receptor agonists significantly diminish pain responses in animal models; however, they exhibit only modest analgesic effects in humans.  The relative lack of efficacy in man may be because of the dose limitations imposed by psychoactive side effects.  Cannabinoid agonists that selectively target CB2 (peripheral) cannabinoid receptors should be free of psychoactive effects, perhaps allowing for more effective dosing.  CB2 receptor activation inhibits acute, inflammatory and neuropathic pain responses in animal models.  In preclin. studies, CB2 receptor agonists do not produce central nervous system effects.  Therefore, they show promise for the treatment of acute and chronic pain without psychoactive effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMDosKe7bNVrVg90H21EOLACvtfcHk0lgQjEuODU4inQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsVaqsA%253D%253D&md5=a3d17be42f9850114483ad51f2b33fa7</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2FS1471-4892%2802%2900004-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1471-4892%252802%252900004-8%26sid%3Dliteratum%253Aachs%26aulast%3DMalan%26aufirst%3DT.%2BP.%26aulast%3DIbrahim%26aufirst%3DM.%2BM.%26aulast%3DLai%26aufirst%3DJ.%26aulast%3DVanderah%26aufirst%3DT.%2BW.%26aulast%3DMakriyannis%26aufirst%3DA.%26aulast%3DPorreca%26aufirst%3DF.%26atitle%3DCB2%2520cannabinoid%2520receptor%2520agonists%253A%2520pain%2520relief%2520without%2520psychoactive%2520effects%253F%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2003%26volume%3D3%26spage%3D62%26epage%3D67%26doi%3D10.1016%2Fs1471-4892%2802%2900004-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manera, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuccinardi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinelli, A.</span></span> <span> </span><span class="NLM_article-title">Indoles and Related Compounds as Cannabinoid Ligands</span>. <i>Mini Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">370</span>– <span class="NLM_lpage">387</span>, <span class="refDoi"> DOI: 10.2174/138955708783955935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.2174%2F138955708783955935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=18473928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkt1alsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=370-387&author=C.+Maneraauthor=T.+Tuccinardiauthor=A.+Martinelli&title=Indoles+and+Related+Compounds+as+Cannabinoid+Ligands&doi=10.2174%2F138955708783955935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Indoles and related compounds as cannabinoid ligands</span></div><div class="casAuthors">Manera, Clementina; Tuccinardi, Tiziano; Martinelli, Adriano</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">370-387</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The discovery of the endocannabinoid system has lead to great strides in research development.  At present, two cannabinoid receptors, CB1R and CB2R, are known.  They belong to Class A rhodopsin-like GPCRs, and possess a different tissue distribution.  Many synthetic compds. have been synthesized and tested for their cannabinoid activity.  A particular class among them, the aminoalkylindole derivs. (typified by WIN55212-2) are hypothesized to interact in a binding site different from the main cannabinoid agonists.  In this review we report the main aminoalkylindole derivs., and other compds. which are hypothesized to interact in the same binding site.  Furthermore we analyze the pharmacol. profiles, the mutagenesis data and the computational models that describe their interaction in the cannabinoid receptors, evaluating the most important aspects for their activity and selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8tBHv9wnw37Vg90H21EOLACvtfcHk0lgQjEuODU4inQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkt1alsrY%253D&md5=efab4b24bb66450a58176d6684c57a20</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.2174%2F138955708783955935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138955708783955935%26sid%3Dliteratum%253Aachs%26aulast%3DManera%26aufirst%3DC.%26aulast%3DTuccinardi%26aufirst%3DT.%26aulast%3DMartinelli%26aufirst%3DA.%26atitle%3DIndoles%2520and%2520Related%2520Compounds%2520as%2520Cannabinoid%2520Ligands%26jtitle%3DMini%2520Rev.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D370%26epage%3D387%26doi%3D10.2174%2F138955708783955935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adler, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abood, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganea, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jallo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuma, R. F.</span></span> <span> </span><span class="NLM_article-title">CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injury</span>. <i>Microvasc. Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">86</span>– <span class="NLM_lpage">94</span>, <span class="refDoi"> DOI: 10.1016/j.mvr.2009.03.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1016%2Fj.mvr.2009.03.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=19332079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1Ggs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=86-94&author=M.+Zhangauthor=M.+W.+Adlerauthor=M.+E.+Aboodauthor=D.+Ganeaauthor=J.+Jalloauthor=R.+F.+Tuma&title=CB2+receptor+activation+attenuates+microcirculatory+dysfunction+during+cerebral+ischemic%2Freperfusion+injury&doi=10.1016%2Fj.mvr.2009.03.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injury</span></div><div class="casAuthors">Zhang, Ming; Adler, Martin W.; Abood, Mary E.; Ganea, Doina; Jallo, Jack; Tuma, Ronald F.</div><div class="citationInfo"><span class="NLM_cas:title">Microvascular Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">86-94</span>CODEN:
                <span class="NLM_cas:coden">MIVRA6</span>;
        ISSN:<span class="NLM_cas:issn">0026-2862</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Previous studies from our lab. indicated that selective cannabinoid CB2 agonists were able to attenuate cerebral ischemia/reperfusion (I/R) injury.  The goal of current study is to further test whether this attenuation involves cerebral microcirculatory function during I/R injury.  Middle cerebral artery occlusion with reperfusion (MCAO/R) was performed in male mice.  A selective CB2 agonist was administered at different dosages and different times.  Cerebral infarction vol., neurol. function and cerebral microcirculatory function (leukocyte/endothelial interactions, cell adhesion mol. expression and blood-brain barrier disruption) were examd. in vivo and in vitro.  CB2 knockout mice were subjected to MCAO/R following same procedures.  Administration of the CB2 agonist at middle dosage exerted optimal effects in reducing cerebral infarction and improving neurol. function compared with other dosage groups and control group.  Treatment with the CB2 agonist at the optimal dose was still effective when given 3 h after MCAO.  Transient ischemia significantly increased leukocyte/endothelial interactions, adhesion mols. expression and blood-brain barrier disruption which were all attenuated by pre-treatment with a CB2 agonist.  CB2 knockout mice showed larger cerebral infarction and worse neurol. function compared to wide type.  In conclusion, CB2 activation contributed to protecting the brain through the attenuation of cerebral microcirculatory dysfunction during cerebral I/R injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroq2E3HleP5rVg90H21EOLACvtfcHk0lgZ0IlJQ8mNkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1Ggs78%253D&md5=96dc7214c65d0e945e2663715042467d</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.mvr.2009.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mvr.2009.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DAdler%26aufirst%3DM.%2BW.%26aulast%3DAbood%26aufirst%3DM.%2BE.%26aulast%3DGanea%26aufirst%3DD.%26aulast%3DJallo%26aufirst%3DJ.%26aulast%3DTuma%26aufirst%3DR.%2BF.%26atitle%3DCB2%2520receptor%2520activation%2520attenuates%2520microcirculatory%2520dysfunction%2520during%2520cerebral%2520ischemic%252Freperfusion%2520injury%26jtitle%3DMicrovasc.%2520Res.%26date%3D2009%26volume%3D78%26spage%3D86%26epage%3D94%26doi%3D10.1016%2Fj.mvr.2009.03.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shoemaker, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seely, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crow, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prather, P. L.</span></span> <span> </span><span class="NLM_article-title">The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">98</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2006.04346.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1111%2Fj.1471-4159.2006.04346.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=17241118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksFSqsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2007&pages=87-98&author=J.+L.+Shoemakerauthor=K.+A.+Seelyauthor=R.+L.+Reedauthor=J.+P.+Crowauthor=P.+L.+Prather&title=The+CB2+cannabinoid+agonist+AM-1241+prolongs+survival+in+a+transgenic+mouse+model+of+amyotrophic+lateral+sclerosis+when+initiated+at+symptom+onset&doi=10.1111%2Fj.1471-4159.2006.04346.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset</span></div><div class="casAuthors">Shoemaker, Jennifer L.; Seely, Kathryn A.; Reed, Ronald L.; Crow, John P.; Prather, Paul L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-98</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive motor neuron loss, paralysis and death within 2-5 years of diagnosis.  Currently, no effective pharmacol. agents exist for the treatment of this devastating disease.  Neuroinflammation may accelerate the progression of ALS.  Cannabinoids produce anti-inflammatory actions via cannabinoid receptor 1 (CB1) and cannabinoid receptor 2 (CB2), and delay the progression of neuroinflammatory diseases.  Addnl., CB2 receptors, which normally exist primarily in the periphery, are dramatically up-regulated in inflamed neural tissues assocd. with CNS disorders.  In G93A-SOD1 mutant mice, the most well-characterized animal model of ALS, endogenous cannabinoids are elevated in spinal cords of symptomatic mice.  Furthermore, treatment with non-selective cannabinoid partial agonists prior to, or upon, symptom appearance minimally delays disease onset and prolongs survival through undefined mechanisms.  We demonstrate that mRNA, receptor binding and function of CB2, but not CB1, receptors are dramatically and selectively up-regulated in spinal cords of G93A-SOD1 mice in a temporal pattern paralleling disease progression.  More importantly, daily injections of the selective CB2 agonist AM-1241, initiated at symptom onset, increase the survival interval after disease onset by 56%.  Therefore, CB2 agonists may slow motor neuron degeneration and preserve motor function, and represent a novel therapeutic modality for treatment of ALS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0tTHgAMzBILVg90H21EOLACvtfcHk0lgZ0IlJQ8mNkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksFSqsb4%253D&md5=3d05001d4f2eb1ae8e10e1986b1d153c</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.04346.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.04346.x%26sid%3Dliteratum%253Aachs%26aulast%3DShoemaker%26aufirst%3DJ.%2BL.%26aulast%3DSeely%26aufirst%3DK.%2BA.%26aulast%3DReed%26aufirst%3DR.%2BL.%26aulast%3DCrow%26aufirst%3DJ.%2BP.%26aulast%3DPrather%26aufirst%3DP.%2BL.%26atitle%3DThe%2520CB2%2520cannabinoid%2520agonist%2520AM-1241%2520prolongs%2520survival%2520in%2520a%2520transgenic%2520mouse%2520model%2520of%2520amyotrophic%2520lateral%2520sclerosis%2520when%2520initiated%2520at%2520symptom%2520onset%26jtitle%3DJ.%2520Neurochem.%26date%3D2007%26volume%3D101%26spage%3D87%26epage%3D98%26doi%3D10.1111%2Fj.1471-4159.2006.04346.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Croxford, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S. D.</span></span> <span> </span><span class="NLM_article-title">Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R(+)WIN55,212</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">1231</span>– <span class="NLM_lpage">1240</span>, <span class="refDoi"> DOI: 10.1172/jci200317652</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1172%2FJCI200317652" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=12697742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtFCrs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2003&pages=1231-1240&author=J.+L.+Croxfordauthor=S.+D.+Miller&title=Immunoregulation+of+a+viral+model+of+multiple+sclerosis+using+the+synthetic+cannabinoid+R%28%2B%29WIN55%2C212&doi=10.1172%2Fjci200317652"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R(+)WIN55212</span></div><div class="casAuthors">Croxford, J. Ludovic; Miller, Stephen D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1231-1240</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Theiler murine encephalomyelitis virus-induced demyelinating disease (TMEV-IDD) is a mouse model of chronic-progressive multiple sclerosis (MS) characterized by Th1-mediated CNS demyelination and spastic hindlimb paralysis.  Existing MS therapies reduce relapse rates in 30% of relapsing-remitting MS patients, but are ineffective in chronic-progressive disease, and their effects on disability progression are unclear.  Exptl. studies demonstrate cannabinoids are useful for symptomatic treatment of spasticity and tremor in chronic-relapsing exptl. autoimmune encephalomyelitis.  Cannabinoids, however, have reported immunosuppressive properties.  We show that the cannabinoid receptor agonist, R(+)WIN55212, ameliorates progression of clin. disease symptoms in mice with preexisting TMEV-IDD.  Amelioration of clin. disease is assocd. with downregulation of both virus and myelin epitope-specific Th1 effector functions (delayed-type hypersensitivity and IFN-γ prodn.) and the inhibition of CNS mRNA expression coding for the proinflammatory cytokines, TNF-α, IL1-β, and IL-6.  Clin. trials investigating the therapeutic potential of cannabinoids for the symptomatic treatment of MS are ongoing, and this study demonstrates that they may also have potent immunoregulatory properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8Np2y1qW4k7Vg90H21EOLACvtfcHk0lhbGy7TMQ1lmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtFCrs7k%253D&md5=e55dd55db2ca18122a2eb65e71972a03</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1172%2FJCI200317652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI200317652%26sid%3Dliteratum%253Aachs%26aulast%3DCroxford%26aufirst%3DJ.%2BL.%26aulast%3DMiller%26aufirst%3DS.%2BD.%26atitle%3DImmunoregulation%2520of%2520a%2520viral%2520model%2520of%2520multiple%2520sclerosis%2520using%2520the%2520synthetic%2520cannabinoid%2520R%2528%252B%2529WIN55%252C212%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2003%26volume%3D111%26spage%3D1231%26epage%3D1240%26doi%3D10.1172%2Fjci200317652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-Ruiz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velasco, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolón, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzmán, M.</span></span> <span> </span><span class="NLM_article-title">Cannabinoid CB2 receptor: a new target for controlling neural cell survival?</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">39</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2006.11.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1016%2Fj.tips.2006.11.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=17141334" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitlOmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=39-45&author=J.+Fern%C3%A1ndez-Ruizauthor=J.+Romeroauthor=G.+Velascoauthor=R.+M.+Tol%C3%B3nauthor=J.+A.+Ramosauthor=M.+Guzm%C3%A1n&title=Cannabinoid+CB2+receptor%3A+a+new+target+for+controlling+neural+cell+survival%3F&doi=10.1016%2Fj.tips.2006.11.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid CB2 receptor: a new target for controlling neural cell survival?</span></div><div class="casAuthors">Fernandez-Ruiz, Javier; Romero, Julian; Velasco, Guillermo; Tolon, Rosa M.; Ramos, Jose A.; Guzman, Manuel</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-45</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Two types of cannabinoid receptor have been cloned and characterized.  Whereas CB1 receptors are ubiquitously expressed in neurons of the CNS, CB2 receptors have been thought to be absent from the CNS.  Recent data now question this notion and support the expression of CB2 receptors in microglial cells, astrocytes and even some neuron subpopulations.  This discrete distribution makes CB2 receptors interesting targets for treating neurol. disorders because CB2-selective agonists lack psychoactivity.  Here, we review evidence supporting the idea that CB2 receptors are implicated in the control of fundamental neural cell processes, such as proliferation and survival, and that their pharmacol. manipulation might be useful for both delaying the progression of neurodegenerative disorders and inhibiting the growth of glial tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpNrWrT5XU9bVg90H21EOLACvtfcHk0lhbGy7TMQ1lmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitlOmsw%253D%253D&md5=8f809e0332df14885c66df7e891294f2</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2006.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2006.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez-Ruiz%26aufirst%3DJ.%26aulast%3DRomero%26aufirst%3DJ.%26aulast%3DVelasco%26aufirst%3DG.%26aulast%3DTol%25C3%25B3n%26aufirst%3DR.%2BM.%26aulast%3DRamos%26aufirst%3DJ.%2BA.%26aulast%3DGuzm%25C3%25A1n%26aufirst%3DM.%26atitle%3DCannabinoid%2520CB2%2520receptor%253A%2520a%2520new%2520target%2520for%2520controlling%2520neural%2520cell%2520survival%253F%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2007%26volume%3D28%26spage%3D39%26epage%3D45%26doi%3D10.1016%2Fj.tips.2006.11.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benito, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Núñez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolón, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrier, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rábano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillard, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, J.</span></span> <span> </span><span class="NLM_article-title">Cannabinoid CB2Receptors and Fatty Acid Amide Hydrolase Are Selectively Overexpressed in Neuritic Plaque-Associated Glia in Alzheimer’s Disease Brains</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">11136</span>– <span class="NLM_lpage">11141</span>, <span class="refDoi"> DOI: 10.1523/jneurosci.23-35-11136.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1523%2FJNEUROSCI.23-35-11136.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=14657172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvV2gtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=11136-11141&author=C.+Benitoauthor=E.+N%C3%BA%C3%B1ezauthor=R.+M.+Tol%C3%B3nauthor=E.+J.+Carrierauthor=A.+R%C3%A1banoauthor=C.+J.+Hillardauthor=J.+Romero&title=Cannabinoid+CB2Receptors+and+Fatty+Acid+Amide+Hydrolase+Are+Selectively+Overexpressed+in+Neuritic+Plaque-Associated+Glia+in+Alzheimer%E2%80%99s+Disease+Brains&doi=10.1523%2Fjneurosci.23-35-11136.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains</span></div><div class="casAuthors">Benito, Cristina; Nunez, Estefania; Tolon, Rosa M.; Carrier, Erica J.; Rabano, Alberto; Hillard, Cecilia J.; Romero, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">11136-11141</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The endocannabinoid system is still poorly understood.  Recently, the basic elements that constitute it, i.e., membrane receptors, endogenous ligands, and mechanisms for termination of the signaling process, have been partially characterized.  There is a considerable lack of information, however, concerning the distribution, concn., and function of those components in the human body, particularly during pathol. events.  We have studied the status of some of the components of the endocannabinoid system, fatty acid amide hydrolase and cannabinoid CB1 and CB2 receptors, in postmortem brains from patients with Alzheimer's disease.  Using specific polyclonal antibodies, we have performed immunohistochem. anal. in hippocampus and entorhinal cortex sections from brains of Alzheimer's disease patients.  Our results show that both fatty acid amide hydrolase and cannabinoid CB2 receptors are abundantly and selectively expressed in neuritic plaque-assocd. astrocytes and microglia, resp., whereas the expression of CB1 receptors remains unchanged.  In addn., the hydrolase activity seems to be elevated in the plaques and surrounding areas.  Thus, some elements of the endocannabinoid system may be postulated as possible modulators of the inflammatory response assocd. with this neurodegenerative process and as possible targets for new therapeutic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ8Gm8V3n8jrVg90H21EOLACvtfcHk0lhbGy7TMQ1lmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvV2gtbw%253D&md5=c324980efac10a672fc425ef376694f1</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.23-35-11136.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.23-35-11136.2003%26sid%3Dliteratum%253Aachs%26aulast%3DBenito%26aufirst%3DC.%26aulast%3DN%25C3%25BA%25C3%25B1ez%26aufirst%3DE.%26aulast%3DTol%25C3%25B3n%26aufirst%3DR.%2BM.%26aulast%3DCarrier%26aufirst%3DE.%2BJ.%26aulast%3DR%25C3%25A1bano%26aufirst%3DA.%26aulast%3DHillard%26aufirst%3DC.%2BJ.%26aulast%3DRomero%26aufirst%3DJ.%26atitle%3DCannabinoid%2520CB2Receptors%2520and%2520Fatty%2520Acid%2520Amide%2520Hydrolase%2520Are%2520Selectively%2520Overexpressed%2520in%2520Neuritic%2520Plaque-Associated%2520Glia%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%2520Brains%26jtitle%3DJ.%2520Neurosci.%26date%3D2003%26volume%3D23%26spage%3D11136%26epage%3D11141%26doi%3D10.1523%2Fjneurosci.23-35-11136.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pacher, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bátkai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunos, G.</span></span> <span> </span><span class="NLM_article-title">The Endocannabinoid System as an Emerging Target of Pharmacotherapy</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">389</span>– <span class="NLM_lpage">462</span>, <span class="refDoi"> DOI: 10.1124/pr.58.3.2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1124%2Fpr.58.3.2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=16968947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVOhtLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2006&pages=389-462&author=P.+Pacherauthor=S.+B%C3%A1tkaiauthor=G.+Kunos&title=The+Endocannabinoid+System+as+an+Emerging+Target+of+Pharmacotherapy&doi=10.1124%2Fpr.58.3.2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The endocannabinoid system as an emerging target of pharmacotherapy</span></div><div class="casAuthors">Pacher, Pal; Batkai, Sandor; Kunos, George</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">389-462</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The recent identification of cannabinoid receptors and their endogenous lipid ligands has triggered an exponential growth of studies exploring the endocannabinoid system and its regulatory functions in health and disease.  Such studies have been greatly facilitated by the introduction of selective cannabinoid receptor antagonists and inhibitors of endocannabinoid metab. and transport, as well as mice deficient in cannabinoid receptors or the endocannabinoid-degrading enzyme fatty acid amidohydrolase.  In the past decade, the endocannabinoid system has been implicated in a growing no. of physiol. functions, both in the central and peripheral nervous systems and in peripheral organs.  More importantly, modulating the activity of the endocannabinoid system turned out to hold therapeutic promise in a wide range of disparate diseases and pathol. conditions, ranging from mood and anxiety disorders, movement disorders such as Parkinson's and Huntington's disease, neuropathic pain, multiple sclerosis and spinal cord injury, to cancer, atherosclerosis, myocardial infarction, stroke, hypertension, glaucoma, obesity/metabolic syndrome, and osteoporosis, to name just a few.  An impediment to the development of cannabinoid medications has been the socially unacceptable psychoactive properties of plant-derived or synthetic agonists, mediated by CB1 receptors.  However, this problem does not arise when the therapeutic aim is achieved by treatment with a CB1 receptor antagonist, such as in obesity, and may also be absent when the action of endocannabinoids is enhanced indirectly through blocking their metab. or transport.  The use of selective CB2 receptor agonists, which lack psychoactive properties, could represent another promising avenue for certain conditions.  The abuse potential of plant-derived cannabinoids may also be limited through the use of prepns. with controlled compn. and the careful selection of does and route of administration.  The growing no. of preclin. studies and clin. trials with compds. that modulate the endocannabinoid system will probably result in novel therapeutic approaches in a no. of diseases for which current treatments do not fully address the patients' need.  Here, we provide a comprehensive overview on the current state of knowledge of the endocannabinoid system as a target of pharmacotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN_yobbKbuLbVg90H21EOLACvtfcHk0lgP6HozrnyBLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVOhtLfO&md5=f54e6d1303645a1c63809879ef2813f3</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1124%2Fpr.58.3.2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.58.3.2%26sid%3Dliteratum%253Aachs%26aulast%3DPacher%26aufirst%3DP.%26aulast%3DB%25C3%25A1tkai%26aufirst%3DS.%26aulast%3DKunos%26aufirst%3DG.%26atitle%3DThe%2520Endocannabinoid%2520System%2520as%2520an%2520Emerging%2520Target%2520of%2520Pharmacotherapy%26jtitle%3DPharmacol.%2520Rev.%26date%3D2006%26volume%3D58%26spage%3D389%26epage%3D462%26doi%3D10.1124%2Fpr.58.3.2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sagredo, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Arencibia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Lago, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finetti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-Ruiz, J.</span></span> <span> </span><span class="NLM_article-title">Cannabinoids and Neuroprotection in Basal Ganglia Disorders</span>. <i>Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">82</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1007/s12035-007-0004-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1007%2Fs12035-007-0004-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=17952653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12js7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2007&pages=82-91&author=O.+Sagredoauthor=M.+Garc%C3%ADa-Arencibiaauthor=E.+de+Lagoauthor=S.+Finettiauthor=A.+Decioauthor=J.+Fern%C3%A1ndez-Ruiz&title=Cannabinoids+and+Neuroprotection+in+Basal+Ganglia+Disorders&doi=10.1007%2Fs12035-007-0004-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoids and neuroprotection in basal ganglia disorders</span></div><div class="casAuthors">Sagredo, Onintza; Garcia-Arencibia, Moises; de Lago, Eva; Finetti, Simone; Decio, Alessandra; Fernandez-Ruiz, Javier</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">82-91</span>CODEN:
                <span class="NLM_cas:coden">MONBEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-7648</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  Cannabinoids have been proposed as clin. promising neuroprotective mols., as they are capable to reduce excitotoxicity, calcium influx, and oxidative injury.  They are also able to decrease inflammation by acting on glial processes that regulate neuronal survival and to restore blood supply to the injured area by reducing the vasoconstriction produced by several endothelium-derived factors.  Through one or more of these processes, cannabinoids may provide neuroprotection in different neurodegenerative disorders including Parkinson's disease and Huntington's chorea, 2 chronic diseases that are originated as a consequence of the degeneration of specific nuclei of the basal ganglia, resulting in a deterioration of the control of movement.  Both diseases have been still scarcely explored at the clin. level for a possible application of cannabinoids to delay the progressive degeneration of the basal ganglia.  However, the preclin. evidence seems to be solid and promising.  There are 2 key mechanisms involved in the neuroprotection by cannabinoids in exptl. models of these 2 disorders: first, a cannabinoid receptor-independent mechanism aimed at producing a decrease in the oxidative injury and second, an induction/upregulation of cannabinoid CB2 receptors, mainly in reactive microglia, that is capable to regulate the influence of these glial cells on neuronal homeostasis.  Considering the relevance of these preclin. data and the lack of efficient neuroprotective strategies in both disorders, the authors urge the development of further studies that allow that the promising exectatives generated for these mols. progress from the present preclin. evidence till a real clin. application.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCy7cQFwE6IrVg90H21EOLACvtfcHk0lgP6HozrnyBLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12js7fL&md5=d161705497d7db6234697127f28c776a</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1007%2Fs12035-007-0004-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12035-007-0004-3%26sid%3Dliteratum%253Aachs%26aulast%3DSagredo%26aufirst%3DO.%26aulast%3DGarc%25C3%25ADa-Arencibia%26aufirst%3DM.%26aulast%3Dde%2BLago%26aufirst%3DE.%26aulast%3DFinetti%26aufirst%3DS.%26aulast%3DDecio%26aufirst%3DA.%26aulast%3DFern%25C3%25A1ndez-Ruiz%26aufirst%3DJ.%26atitle%3DCannabinoids%2520and%2520Neuroprotection%2520in%2520Basal%2520Ganglia%2520Disorders%26jtitle%3DMol.%2520Neurobiol.%26date%3D2007%26volume%3D36%26spage%3D82%26epage%3D91%26doi%3D10.1007%2Fs12035-007-0004-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Whiteside, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenzano, K.</span></span> <span> </span><span class="NLM_article-title">The Role of the Cannabinoid CB2 Receptor in Pain Transmission and Therapeutic Potential of Small Molecule CB2 Receptor Agonists</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">917</span>– <span class="NLM_lpage">936</span>, <span class="refDoi"> DOI: 10.2174/092986707780363023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.2174%2F092986707780363023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=17430144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsF2qt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=917-936&author=G.+Whitesideauthor=G.+Leeauthor=K.+Valenzano&title=The+Role+of+the+Cannabinoid+CB2+Receptor+in+Pain+Transmission+and+Therapeutic+Potential+of+Small+Molecule+CB2+Receptor+Agonists&doi=10.2174%2F092986707780363023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">The role of the cannabinoid CB2 receptor in pain transmission and therapeutic potential of small molecule CB2 receptor agonists</span></div><div class="casAuthors">Whiteside, G. T.; Lee, G. P.; Valenzano, K. J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">917-936</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  This review gives a brief overview of the expression patterns, mol. pharmacol. and physiol. role of the cannabinoid 2 receptor (CB2) in pain.  Particular emphasis is given to the therapeutic utility of CB2 receptor agonists.  Through studies utilizing selective CB2 receptor agonists, non-selective cannabinoid agonists in conjunction with selective CB1 and CB2 receptor antagonists, or CB2 receptor knockout mice, it is now clear that this receptor plays a crit. role in nociception.  To this end, CB2 receptors have been shown to modulate acute pain, chronic inflammatory pain, post-surgical pain, cancer pain and pain assocd. with nerve injury.  Here we review these studies and the compds. that were utilized.  We hypothesize the mechanism of action by which the CB2 receptor could be involved in these processes.  Finally we summarize the most recent novel chem. scaffolds that are being investigated towards advancing selective CB2 receptor agonists into the clinic.  Many new pharmacol. agents have been identified by high throughput screening and small mol. lead discovery and optimization in the past 10 years.  It is anticipated that at least some of these agents may ultimately constitute effective new pain therapeutics that lack the side effects assocd. with traditional cannabinoid ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMlVzQowHYO7Vg90H21EOLACvtfcHk0lgP6HozrnyBLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsF2qt7o%253D&md5=17305ca634113f7c129e15b8d693ba4e</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.2174%2F092986707780363023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986707780363023%26sid%3Dliteratum%253Aachs%26aulast%3DWhiteside%26aufirst%3DG.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DValenzano%26aufirst%3DK.%26atitle%3DThe%2520Role%2520of%2520the%2520Cannabinoid%2520CB2%2520Receptor%2520in%2520Pain%2520Transmission%2520and%2520Therapeutic%2520Potential%2520of%2520Small%2520Molecule%2520CB2%2520Receptor%2520Agonists%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2007%26volume%3D14%26spage%3D917%26epage%3D936%26doi%3D10.2174%2F092986707780363023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitchcock, S. A.</span></span> <span> </span><span class="NLM_article-title">Targeting Cannabinoid Agonists for Inflammatory and Neuropathic Pain</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">951</span>– <span class="NLM_lpage">965</span>, <span class="refDoi"> DOI: 10.1517/13543784.16.7.951</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1517%2F13543784.16.7.951" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=17594182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmvVOmsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2007&pages=951-965&author=Y.+Chengauthor=S.+A.+Hitchcock&title=Targeting+Cannabinoid+Agonists+for+Inflammatory+and+Neuropathic+Pain&doi=10.1517%2F13543784.16.7.951"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cannabinoid agonists for inflammatory and neuropathic pain</span></div><div class="casAuthors">Cheng, Yuan; Hitchcock, Stephen A.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">951-965</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The cannabinoid receptors CB1 and CB2 are class A G-protein-coupled receptors.  It is well known that cannabinoid receptor agonists produce relief of pain in a variety of animal models by interacting with cannabinoid receptors.  CB1 receptors are located centrally and peripherally, whereas CB2 receptors are expressed primarily on immune cells and tissues.  A large body of preclin. data supports the hypothesis that either CB2-selective agonists or CB1 agonists acting at peripheral sites, or with limited CNS exposure, will inhibit pain and neuroinflammation without side effects within the CNS.  There has been a growing interest in developing cannabinoid agonists.  Many new cannabinoid ligands have been synthesized and studied covering a wide variety of novel structural scaffolds.  This review focuses on the present development of cannabinoid agonists with an emphasis on selective CB2 agonists and peripherally restricted CB1 or CB1/CB2 dual agonists for treatment of inflammatory and neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprxE9ZXlueyrVg90H21EOLACvtfcHk0ljPUz5-orAyTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmvVOmsbY%253D&md5=0728e81e6981449c3ec1551703caba03</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1517%2F13543784.16.7.951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.16.7.951%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26atitle%3DTargeting%2520Cannabinoid%2520Agonists%2520for%2520Inflammatory%2520and%2520Neuropathic%2520Pain%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2007%26volume%3D16%26spage%3D951%26epage%3D965%26doi%3D10.1517%2F13543784.16.7.951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yao, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frost, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrison, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daza, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grayson, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandran, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salyers, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wensink, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honore, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dart, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, M. D.</span></span> <span> </span><span class="NLM_article-title">In Vitro and In Vivo Characterization of A-796260: A Selective Cannabinoid CB<sub>2</sub> Receptor Agonist Exhibiting Analgesic Activity in Rodent Pain Models</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>153</i></span>,  <span class="NLM_fpage">390</span>– <span class="NLM_lpage">401</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0707568</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1038%2Fsj.bjp.0707568" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=17994110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlajsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2008&pages=390-401&author=B.+B.+Yaoauthor=G.+C.+Hsiehauthor=J.+M.+Frostauthor=Y.+Fanauthor=T.+R.+Garrisonauthor=A.+V.+Dazaauthor=G.+K.+Graysonauthor=C.+Z.+Zhuauthor=M.+Paiauthor=P.+Chandranauthor=A.+K.+Salyersauthor=E.+J.+Wensinkauthor=P.+Honoreauthor=J.+P.+Sullivanauthor=M.+J.+Dartauthor=M.+D.+Meyer&title=In+Vitro+and+In+Vivo+Characterization+of+A-796260%3A+A+Selective+Cannabinoid+CB2+Receptor+Agonist+Exhibiting+Analgesic+Activity+in+Rodent+Pain+Models&doi=10.1038%2Fsj.bjp.0707568"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo characterization of A-796260: a selective cannabinoid CB2 receptor agonist exhibiting analgesic activity in rodent pain models</span></div><div class="casAuthors">Yao, B. B.; Hsieh, G. C.; Frost, J. M.; Fan, Y.; Garrison, T. R.; Daza, A. V.; Grayson, G. K.; Zhu, C. Z.; Pai, M.; Chandran, P.; Salyers, A. K.; Wensink, E. J.; Honore, P.; Sullivan, J. P.; Dart, M. J.; Meyer, M. D.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">390-401</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Selective cannabinoid CB2 receptor agonists have demonstrated analgesic activity across multiple preclin. pain models.  AM1241 is an indole deriv. that exhibits high affinity and selectivity for the CB2 binding site and broad spectrum analgesic activity in rodent models, but is not an antagonist of CB2 in vitro functional assays.  Addnl., its analgesic effects are -opioid receptor-dependent.  Herein, we describe the in vitro and in vivo pharmacol. properties of A-796260, a novel CB2 agonist.  Exptl. approach: A-796260 was characterized in radioligand binding and in vitro functional assays at rat and human CB1 and CB2 receptors.  The behavioral profile of A-796260 was assessed in models of inflammatory, post-operative, neuropathic, and osteoarthritic (OA) pain, as well as its effects on motor activity.  The receptor specificity was confirmed using selective CB1, CB2, and -opioid receptor antagonists.  A-796260 exhibited high affinity and agonist efficacy at human and rat CB2 receptors, and was selective for the CB2 vs CB1 subtype.  Efficacy in models of inflammatory, post-operative, neuropathic and OA pain was demonstrated, and these activities were selectively blocked by CB2, but not CB1, or -opioid receptor-selective antagonists.  Efficacy was achieved at doses that had no significant effects on motor activity.  These results further confirm the therapeutic potential of CB2 receptor-selective agonists for the treatment of pain.  In addn., they demonstrate that A-796260 may be a useful new pharmacol. compd. for further studying CB2 receptor pharmacol. and for evaluating its role in the modulation of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRpbBOoGZg27Vg90H21EOLACvtfcHk0ljPUz5-orAyTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlajsbs%253D&md5=c4d06d34da40f688a17aa15fffe03c64</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707568%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DB.%2BB.%26aulast%3DHsieh%26aufirst%3DG.%2BC.%26aulast%3DFrost%26aufirst%3DJ.%2BM.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DGarrison%26aufirst%3DT.%2BR.%26aulast%3DDaza%26aufirst%3DA.%2BV.%26aulast%3DGrayson%26aufirst%3DG.%2BK.%26aulast%3DZhu%26aufirst%3DC.%2BZ.%26aulast%3DPai%26aufirst%3DM.%26aulast%3DChandran%26aufirst%3DP.%26aulast%3DSalyers%26aufirst%3DA.%2BK.%26aulast%3DWensink%26aufirst%3DE.%2BJ.%26aulast%3DHonore%26aufirst%3DP.%26aulast%3DSullivan%26aufirst%3DJ.%2BP.%26aulast%3DDart%26aufirst%3DM.%2BJ.%26aulast%3DMeyer%26aufirst%3DM.%2BD.%26atitle%3DIn%2520Vitro%2520and%2520In%2520Vivo%2520Characterization%2520of%2520A-796260%253A%2520A%2520Selective%2520Cannabinoid%2520CB2%2520Receptor%2520Agonist%2520Exhibiting%2520Analgesic%2520Activity%2520in%2520Rodent%2520Pain%2520Models%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D153%26spage%3D390%26epage%3D401%26doi%3D10.1038%2Fsj.bjp.0707568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramirez, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blazquez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez del Pulgar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Ceballos, M. L.</span></span> <span> </span><span class="NLM_article-title">Prevention of Alzheimer’s Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade of Microglial Activation</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1904</span>– <span class="NLM_lpage">1913</span>, <span class="refDoi"> DOI: 10.1523/jneurosci.4540-04.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1523%2FJNEUROSCI.4540-04.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=15728830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVSnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=1904-1913&author=B.+G.+Ramirezauthor=C.+Blazquezauthor=T.+Gomez+del+Pulgarauthor=M.+Guzmanauthor=M.+L.+de+Ceballos&title=Prevention+of+Alzheimer%E2%80%99s+Disease+Pathology+by+Cannabinoids%3A+Neuroprotection+Mediated+by+Blockade+of+Microglial+Activation&doi=10.1523%2Fjneurosci.4540-04.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation</span></div><div class="casAuthors">Ramirez, Belen G.; Blazquez, Cristina; Del Pulgar, Teresa Gomez; Guzman, Manuel; De Ceballos, Maria L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1904-1913</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is characterized by enhanced β-amyloid peptide (βA) deposition along with glial activation in senile plaques, selective neuronal loss, and cognitive deficits.  Cannabinoids are neuroprotective agents against excitotoxicity in vitro and acute brain damage in vivo.  This background prompted us to study the localization, expression, and function of cannabinoid receptors in AD and the possible protective role of cannabinoids after βA treatment, both in vivo and in vitro.  Here, the authors show that senile plaques in AD patients express cannabinoid receptors CB1 and CB2, together with markers of microglial activation, and that CB1-pos. neurons, present in high nos. in control cases, are greatly reduced in areas of microglial activation.  In pharmacol. expts., the authors found that G-protein coupling and CB1 receptor protein expression are markedly decreased in AD brains.  Addnl., in AD brains, protein nitration is increased, and, more specifically, CB1 and CB2 proteins show enhanced nitration.  Intracerebroventricular administration of the synthetic cannabinoid WIN55,212-2 to rats prevent βA-induced microglial activation, cognitive impairment, and loss of neuronal markers.  Cannabinoids (HU-210, WIN55,212-2, and JWH-133) block βA-induced activation of cultured microglial cells, as judged by mitochondrial activity, cell morphol., and tumor necrosis factor-α release; these effects are independent of the antioxidant action of cannabinoid compds. and are also exerted by a CB2-selective agonist.  Moreover, cannabinoids abrogate microglia-mediated neurotoxicity after βA addn. to rat cortical cocultures.  The authors' results indicate that cannabinoid receptors are important in the pathol. of AD and that cannabinoids succeed in preventing the neurodegenerative process occurring in the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyXcy-bOWtp7Vg90H21EOLACvtfcHk0lg6-OegFPbYNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVSnu7o%253D&md5=76c4a036fea6afc3b8484dc411ece070</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4540-04.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4540-04.2005%26sid%3Dliteratum%253Aachs%26aulast%3DRamirez%26aufirst%3DB.%2BG.%26aulast%3DBlazquez%26aufirst%3DC.%26aulast%3DGomez%2Bdel%2BPulgar%26aufirst%3DT.%26aulast%3DGuzman%26aufirst%3DM.%26aulast%3Dde%2BCeballos%26aufirst%3DM.%2BL.%26atitle%3DPrevention%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%2520Pathology%2520by%2520Cannabinoids%253A%2520Neuroprotection%2520Mediated%2520by%2520Blockade%2520of%2520Microglial%2520Activation%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D1904%26epage%3D1913%26doi%3D10.1523%2Fjneurosci.4540-04.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Body-Malapel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Bakali, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mérour, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desreumaux, P.</span></span> <span> </span><span class="NLM_article-title">741 4-Oxo-1,4-Dihydroquinoline-3-Carboxamides Derivatives As New Potent and Selective Cb2 Agonists with Anti-Inflammatory and Analgesic Properties in the Gut</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">A–107</span>, <span class="refDoi"> DOI: 10.1016/s0016-5085(08)60500-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1016%2FS0016-5085%2808%2960500-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2008&pages=A%E2%80%93107&author=M.+Body-Malapelauthor=J.+El-Bakaliauthor=E.+M%C3%A9rourauthor=E.+Sternauthor=R.+Milletauthor=P.+Desreumaux&title=741+4-Oxo-1%2C4-Dihydroquinoline-3-Carboxamides+Derivatives+As+New+Potent+and+Selective+Cb2+Agonists+with+Anti-Inflammatory+and+Analgesic+Properties+in+the+Gut&doi=10.1016%2Fs0016-5085%2808%2960500-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2FS0016-5085%2808%2960500-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0016-5085%252808%252960500-4%26sid%3Dliteratum%253Aachs%26aulast%3DBody-Malapel%26aufirst%3DM.%26aulast%3DEl-Bakali%26aufirst%3DJ.%26aulast%3DM%25C3%25A9rour%26aufirst%3DE.%26aulast%3DStern%26aufirst%3DE.%26aulast%3DMillet%26aufirst%3DR.%26aulast%3DDesreumaux%26aufirst%3DP.%26atitle%3D741%25204-Oxo-1%252C4-Dihydroquinoline-3-Carboxamides%2520Derivatives%2520As%2520New%2520Potent%2520and%2520Selective%2520Cb2%2520Agonists%2520with%2520Anti-Inflammatory%2520and%2520Analgesic%2520Properties%2520in%2520the%2520Gut%26jtitle%3DGastroenterology%26date%3D2008%26volume%3D134%26spage%3DA%25E2%2580%2593107%26doi%3D10.1016%2Fs0016-5085%2808%2960500-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benito, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolón, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clemente, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Docagne, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillard, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guaza, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, J.</span></span> <span> </span><span class="NLM_article-title">Cannabinoid CB<sub>1</sub> and CB<sub>2</sub> Receptors and Fatty Acid Amide Hydrolase are Specific Markers of Plaque Cell Subtypes in Human Multiple Sclerosis</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2396</span>– <span class="NLM_lpage">2402</span>, <span class="refDoi"> DOI: 10.1523/jneurosci.4814-06.2007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1523%2FJNEUROSCI.4814-06.2007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=17329437" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsVymsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=2396-2402&author=C.+Benitoauthor=J.+P.+Romeroauthor=R.+M.+Tol%C3%B3nauthor=D.+Clementeauthor=F.+Docagneauthor=C.+J.+Hillardauthor=C.+Guazaauthor=J.+Romero&title=Cannabinoid+CB1+and+CB2+Receptors+and+Fatty+Acid+Amide+Hydrolase+are+Specific+Markers+of+Plaque+Cell+Subtypes+in+Human+Multiple+Sclerosis&doi=10.1523%2Fjneurosci.4814-06.2007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis</span></div><div class="casAuthors">Benito, Cristina; Romero, Juan Pablo; Tolon, Rosa Maria; Clemente, Diego; Docagne, Fabian; Hillard, Cecilia J.; Guaza, Camen; Romero, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2396-2402</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Increasing evidence supports the idea of a beneficial effect of cannabinoid compds. for the treatment of multiple sclerosis (MS).  However, most exptl. data come from animal models of MS.  We investigated the status of cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase (FAAH) enzyme in brain tissue samples obtained from MS patients.  Areas of demyelination were identified and classified as active, chronic, and inactive plaques.  CB1 and CB2 receptors and FAAH densities and cellular sites of expression were examd. using immunohistochem. and immunofluorescence.  In MS samples, cannabinoid CB1 receptors were expressed by cortical neurons, oligodendrocytes, and also oligodendrocyte precursor cells, demonstrated using double immunofluorescence with antibodies against the CB1 receptor with antibodies against type 2 microtubule-assocd. protein, myelin basic protein, and the platelet-derived growth factor receptor-α, resp.  CB1 receptors were also present in macrophages and infiltrated T-lymphocytes.  Conversely, CB2 receptors were present in T-lymphocytes, astrocytes, and perivascular and reactive microglia (major histocompatibility complex class-II pos.) in MS plaques.  Specifically, CB2-pos. microglial cells were evenly distributed within active plaques but were located in the periphery of chronic active plaques.  FAAH expression was restricted to neurons and hypertrophic astrocytes.  As seen for other neuroinflammatory conditions, selective glial expression of cannabinoid CB1 and CB2 receptors and FAAH enzyme is induced in MS, thus supporting a role for the endocannabinoid system in the pathogenesis and/or evolution of this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohbJVv49pGA7Vg90H21EOLACvtfcHk0lg6-OegFPbYNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsVymsLY%253D&md5=597beaa5d37154540dd56bd58b2034bc</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4814-06.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4814-06.2007%26sid%3Dliteratum%253Aachs%26aulast%3DBenito%26aufirst%3DC.%26aulast%3DRomero%26aufirst%3DJ.%2BP.%26aulast%3DTol%25C3%25B3n%26aufirst%3DR.%2BM.%26aulast%3DClemente%26aufirst%3DD.%26aulast%3DDocagne%26aufirst%3DF.%26aulast%3DHillard%26aufirst%3DC.%2BJ.%26aulast%3DGuaza%26aufirst%3DC.%26aulast%3DRomero%26aufirst%3DJ.%26atitle%3DCannabinoid%2520CB1%2520and%2520CB2%2520Receptors%2520and%2520Fatty%2520Acid%2520Amide%2520Hydrolase%2520are%2520Specific%2520Markers%2520of%2520Plaque%2520Cell%2520Subtypes%2520in%2520Human%2520Multiple%2520Sclerosis%26jtitle%3DJ.%2520Neurosci.%26date%3D2007%26volume%3D27%26spage%3D2396%26epage%3D2402%26doi%3D10.1523%2Fjneurosci.4814-06.2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pasquini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligresti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mugnaini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semeraro, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cicione, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rosa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guida, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luongo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Chiaro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cascio, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pertwee, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maione, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzo, V. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corelli, F.</span></span> <span> </span><span class="NLM_article-title">Investigations on the 4-Quinolone-3-carboxylic acid Motif. 3. Synthesis, Structure-affinity Relationships, and Pharmacological Characterization of 6-Substituted 4-quinolone-3-carboxamides as Highly Selective Cannabinoid-2 Receptor Ligands</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">5915</span>– <span class="NLM_lpage">5928</span>, and the references cited therein <span class="refDoi"> DOI: 10.1021/jm100123x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100123x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsVCht78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5915-5928&author=S.+Pasquiniauthor=A.+Ligrestiauthor=C.+Mugnainiauthor=T.+Semeraroauthor=L.+Cicioneauthor=M.+De+Rosaauthor=F.+Guidaauthor=L.+Luongoauthor=M.+De+Chiaroauthor=M.+G.+Cascioauthor=D.+Bologniniauthor=P.+Mariniauthor=R.+Pertweeauthor=S.+Maioneauthor=V.+D.+Marzoauthor=F.+Corelli&title=Investigations+on+the+4-Quinolone-3-carboxylic+acid+Motif.+3.+Synthesis%2C+Structure-affinity+Relationships%2C+and+Pharmacological+Characterization+of+6-Substituted+4-quinolone-3-carboxamides+as+Highly+Selective+Cannabinoid-2+Receptor+Ligands&doi=10.1021%2Fjm100123x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 3. Synthesis, Structure-Affinity Relationships, and Pharmacological Characterization of 6-Substituted 4-Quinolone-3-carboxamides as Highly Selective Cannabinoid-2 Receptor Ligands</span></div><div class="casAuthors">Pasquini, Serena; Ligresti, Alessia; Mugnaini, Claudia; Semeraro, Teresa; Cicione, Lavinia; De Rosa, Maria; Guida, Francesca; Luongo, Livio; De Chiaro, Maria; Cascio, Maria Grazia; Bolognini, Daniele; Marini, Pietro; Pertwee, Roger; Maione, Sabatino; Di Marzo, Vincenzo; Corelli, Federico</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5915-5928</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A set of quinolone-3-carboxamides I [R1 = (un)substituted Ph, 2-furyl, 1-cyclohexenyl, 1-isobutylpyrazol-4-yl, etc.; R2 = 1-adamantyl, 1-fenchyl, hexyl, 1-piperidinyl; R3 = pentyl, 1-buten-4-yl, allyl] bearing diverse substituents at position 1, 3, and 6 of the bicyclic nucleus was prepd.  Except for six compds. exhibiting Ki > 100 nM, all the quinolone-3-carboxamides I proved to be high affinity CB2 ligands, with Ki values ranging from 73.2 to 0.7 nM and selectivity [SI = Ki(CB1)/Ki(CB2)] varying from >14285 to 1.9, with only one compd. exhibiting a reverse selectivity (SI < 1).  In the formalin test of peripheral acute and inflammatory pain in mice, I [R1 = CH2CH2Ph, R2 = 1-adamantyl, R3 = pentyl] showed analgesic activity that was antagonized by a selective CB2 antagonist.  By contrast, I [R1 = 2-furyl, R2 = 1-adamantyl, R3 = pentyl] was inactive per se and antagonized the effect of a selective CB2 agonist.  Also, two of these compds. exhibited CB2 inverse agonist-like behavior in this in vivo test.  However, two different functional assays carried out in vitro indicated for both compds. an overall inverse agonist activity at CB2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWqQVRHQABn7Vg90H21EOLACvtfcHk0lhAjWpqNcbdxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsVCht78%253D&md5=642a103b93312fd2f1e124173143b656</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm100123x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100123x%26sid%3Dliteratum%253Aachs%26aulast%3DPasquini%26aufirst%3DS.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DMugnaini%26aufirst%3DC.%26aulast%3DSemeraro%26aufirst%3DT.%26aulast%3DCicione%26aufirst%3DL.%26aulast%3DDe%2BRosa%26aufirst%3DM.%26aulast%3DGuida%26aufirst%3DF.%26aulast%3DLuongo%26aufirst%3DL.%26aulast%3DDe%2BChiaro%26aufirst%3DM.%26aulast%3DCascio%26aufirst%3DM.%2BG.%26aulast%3DBolognini%26aufirst%3DD.%26aulast%3DMarini%26aufirst%3DP.%26aulast%3DPertwee%26aufirst%3DR.%26aulast%3DMaione%26aufirst%3DS.%26aulast%3DMarzo%26aufirst%3DV.%2BD.%26aulast%3DCorelli%26aufirst%3DF.%26atitle%3DInvestigations%2520on%2520the%25204-Quinolone-3-carboxylic%2520acid%2520Motif.%25203.%2520Synthesis%252C%2520Structure-affinity%2520Relationships%252C%2520and%2520Pharmacological%2520Characterization%2520of%25206-Substituted%25204-quinolone-3-carboxamides%2520as%2520Highly%2520Selective%2520Cannabinoid-2%2520Receptor%2520Ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5915%26epage%3D5928%26doi%3D10.1021%2Fjm100123x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lunn, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fine, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas-Triana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonsiorek, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavey, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlowski, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narula, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundell, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hipkin, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bober, L. A.</span></span> <span> </span><span class="NLM_article-title">A Novel Cannabinoid Peripheral Cannabinoid Receptor-Selective Inverse Agonist Blocks Leukocyte Recruitment in Vivo</span>. <i>J. Pharmacol. Exp. Therapeut.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>316</i></span>,  <span class="NLM_fpage">780</span>– <span class="NLM_lpage">788</span>, <span class="refDoi"> DOI: 10.1124/jpet.105.093500</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1124%2Fjpet.105.093500" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=16258021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlWqtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2006&pages=780-788&author=C.+A.+Lunnauthor=J.+S.+Fineauthor=A.+Rojas-Trianaauthor=J.+V.+Jacksonauthor=X.+Fanauthor=T.+T.+Kungauthor=W.+Gonsiorekauthor=M.+A.+Schwarzauthor=B.+Laveyauthor=J.+A.+Kozlowskiauthor=S.+K.+Narulaauthor=D.+J.+Lundellauthor=R.+W.+Hipkinauthor=L.+A.+Bober&title=A+Novel+Cannabinoid+Peripheral+Cannabinoid+Receptor-Selective+Inverse+Agonist+Blocks+Leukocyte+Recruitment+in+Vivo&doi=10.1124%2Fjpet.105.093500"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">A novel cannabinoid peripheral cannabinoid receptor-selective inverse agonist blocks leukocyte recruitment in vivo</span></div><div class="casAuthors">Lunn, Charles A.; Fine, Jay S.; Rojas-Triana, Alberto; Jackson, James V.; Fan, Xuedong; Kung, Ted T.; Gonsiorek, Waldemar; Schwarz, Martin A.; Lavey, Brian; Kozlowski, Joseph A.; Narula, Satwant K.; Lundell, Daniel J.; Hipkin, R. William; Bober, Loretta A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">780-788</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The expression of the cannabinoid peripheral cannabinoid receptor (CB2) receptor on peripheral immune cells suggests that compds. specific for CB2 might be effective anti-inflammatory agents.  In this report, we present the initial biol. profiling of a novel triaryl bis-sulfone, Sch.336 (N-[1(S)-[4-[[4-methoxy-2-[(4-methoxyphenyl)sulfonyl]phenyl]-sulfonyl]phenyl]ethyl]methanesulfonamide), which is selective for the human cannabinoid CB2 receptor (hCB2).  Sch.336 is an inverse agonist at hCB2, as shown by its ability to decrease guanosine 5'-3-O-(thio)triphosphate (GTPγS) binding to membranes contg. hCB2, by the ability of GTPγS to left-shift Sch.336 binding to hCB2 in these membranes, and by the compd.'s ability to increase forskolin-stimulated cAMP levels in CHO cells expressing hCB2.  In these systems, Sch.336 displays a greater potency than that reported for the CB2-selective dihydropyrazole, SR144528 (N-[(1S)-endo-1,3,3-trimethylbicyclo [2.2.1]heptan2-yl]-5-(4-chloro-3-methylphenyl)-1-[(4-methylphenyl)methyl]-1H-pyrazole-3-carboxamide).  In vitro, Sch.336 impairs the migration of CB2-expressing recombinant cell lines to the cannabinoid agonist 2-arachidonylglycerol.  In vivo, the compd. impairs migration of cells to cannabinoid agonist HU210 [(6aR)-trans-3-(1,1-dimethylheptyl)-6a,7,10,10a-tetrahydro-1-hydroxy-6,6-dimethyl-6H-dibenzo[b,d]pyran-9-methanol].  Oral administration of the Sch.336 significantly inhibited leukocyte trafficking in several rodent in vivo models, induced either by specific chemokines or by antigen challenge.  Finally, oral administration of Sch.336 blocked ovalbumin-induced lung eosinophilia in mice, a disease model for allergic asthma.  We conclude that selective cannabinoid CB2 inverse agonists may serve as novel immunomodulatory agents in the treatment of a broad range of acute and chronic inflammatory disorders in which leukocyte recruitment is a hallmark of disease pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1l5AWSaKtfbVg90H21EOLACvtfcHk0lhAjWpqNcbdxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlWqtrY%253D&md5=542a1bcf6463ed23ac200fc5ed332162</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.093500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.093500%26sid%3Dliteratum%253Aachs%26aulast%3DLunn%26aufirst%3DC.%2BA.%26aulast%3DFine%26aufirst%3DJ.%2BS.%26aulast%3DRojas-Triana%26aufirst%3DA.%26aulast%3DJackson%26aufirst%3DJ.%2BV.%26aulast%3DFan%26aufirst%3DX.%26aulast%3DKung%26aufirst%3DT.%2BT.%26aulast%3DGonsiorek%26aufirst%3DW.%26aulast%3DSchwarz%26aufirst%3DM.%2BA.%26aulast%3DLavey%26aufirst%3DB.%26aulast%3DKozlowski%26aufirst%3DJ.%2BA.%26aulast%3DNarula%26aufirst%3DS.%2BK.%26aulast%3DLundell%26aufirst%3DD.%2BJ.%26aulast%3DHipkin%26aufirst%3DR.%2BW.%26aulast%3DBober%26aufirst%3DL.%2BA.%26atitle%3DA%2520Novel%2520Cannabinoid%2520Peripheral%2520Cannabinoid%2520Receptor-Selective%2520Inverse%2520Agonist%2520Blocks%2520Leukocyte%2520Recruitment%2520in%2520Vivo%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Therapeut.%26date%3D2006%26volume%3D316%26spage%3D780%26epage%3D788%26doi%3D10.1124%2Fjpet.105.093500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Savinainen, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kokkola, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salo, O. M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Järvinen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laitinen, J. T.</span></span> <span> </span><span class="NLM_article-title">Identification of WIN55212-3 as a competitive neutral antagonist of the human cannabinoid CB2 receptor</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>145</i></span>,  <span class="NLM_fpage">636</span>– <span class="NLM_lpage">645</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0706230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1038%2Fsj.bjp.0706230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=15852035" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlslWhsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2005&pages=636-645&author=J.+R.+Savinainenauthor=T.+Kokkolaauthor=O.+M.+H.+Saloauthor=A.+Posoauthor=T.+J%C3%A4rvinenauthor=J.+T.+Laitinen&title=Identification+of+WIN55212-3+as+a+competitive+neutral+antagonist+of+the+human+cannabinoid+CB2+receptor&doi=10.1038%2Fsj.bjp.0706230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of WIN55212-3 as a competitive neutral antagonist of the human cannabinoid CB2 receptor</span></div><div class="casAuthors">Savinainen, Juha R.; Kokkola, Tarja; Salo, Outi M. H.; Poso, Antti; Jaervinen, Tomi; Laitinen, Jarmo T.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">636-645</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Several G protein-coupled receptors (GPCRs), including cannabinoid CB1 and CB2 receptors, show constitutive activity under heterologous expression.  Such a tonic response is generated in the absence of an activating ligand, and can be inhibited by inverse agonists.  Neutral antagonists, however, are silent at such receptors, but can reverse both agonist and inverse agonist responses.  To date, no neutral antagonist for the CB2 receptor has been reported.  Here, by monitoring receptor-dependent G protein activation, we demonstrate that WIN55212-3 acts as a neutral antagonist at the human CB2 (hCB2) receptor.  WIN55212-3 alone, at concns. ≤10-4 M, behaved as a silent ligand exhibiting no agonist or inverse agonist activity.  However, WIN55212-3 competitively antagonized cannabinoid agonist CP-55,940-stimulated responses (pA2 6.1).  Importantly, the inverse agonism evoked by SR144528 in hCB2 was dose-dependently reversed by WIN55212-3 (pEC50 5.3±0.2), indicating true neutral antagonist behavior.  Furthermore, WIN55212-3 also antagonized CB1 receptor signaling in a competitive manner (pA2 5.6), but behaved as a partial inverse agonist (pIC50 5.5±0.1) at the constitutively active human CB1.  Addnl., WIN55212-3 antagonized signaling of the human melatonin MT1 receptor, with modest activity at the human muscarinic M4 receptor, but it was inactive towards several other GPCRs.  These data identify WIN55212-3 as a true neutral hCB2 receptor antagonist.  WIN55212-3 offers a valuable tool for further characterization of ligand activities at the CB2 receptor and may serve as a lead compd. in further efforts to develop more potent and selective neutral CB2 receptor antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdgQCRQkCZvrVg90H21EOLACvtfcHk0lhAjWpqNcbdxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlslWhsb8%253D&md5=2ed7ee5b52613a9274ce0ee3aff4bd74</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706230%26sid%3Dliteratum%253Aachs%26aulast%3DSavinainen%26aufirst%3DJ.%2BR.%26aulast%3DKokkola%26aufirst%3DT.%26aulast%3DSalo%26aufirst%3DO.%2BM.%2BH.%26aulast%3DPoso%26aufirst%3DA.%26aulast%3DJ%25C3%25A4rvinen%26aufirst%3DT.%26aulast%3DLaitinen%26aufirst%3DJ.%2BT.%26atitle%3DIdentification%2520of%2520WIN55212-3%2520as%2520a%2520competitive%2520neutral%2520antagonist%2520of%2520the%2520human%2520cannabinoid%2520CB2%2520receptor%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2005%26volume%3D145%26spage%3D636%26epage%3D645%26doi%3D10.1038%2Fsj.bjp.0706230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deveaux, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadoudal, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichigotani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teixeira-Clerc, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louvet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nhieu, J. T.-V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belot, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Even, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cani, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knauf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burcelin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertola, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Marchand-Brustel, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gual, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lotersztajn, S.</span></span> <span> </span><span class="NLM_article-title">Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis</span>. <i>PloS One</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">e5844</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0005844</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1371%2Fjournal.pone.0005844" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=19513120" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&author=V.+Deveauxauthor=T.+Cadoudalauthor=Y.+Ichigotaniauthor=F.+Teixeira-Clercauthor=A.+Louvetauthor=S.+Maninauthor=J.+T.-V.+Nhieuauthor=M.+P.+Belotauthor=A.+Zimmerauthor=P.+Evenauthor=P.+D.+Caniauthor=C.+Knaufauthor=R.+Burcelinauthor=A.+Bertolaauthor=Y.+Le+Marchand-Brustelauthor=P.+Gualauthor=A.+Mallatauthor=S.+Lotersztajn&title=Cannabinoid+CB2+Receptor+Potentiates+Obesity-Associated+Inflammation%2C+Insulin+Resistance+and+Hepatic+Steatosis&doi=10.1371%2Fjournal.pone.0005844"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0005844&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0005844%26sid%3Dliteratum%253Aachs%26aulast%3DDeveaux%26aufirst%3DV.%26aulast%3DCadoudal%26aufirst%3DT.%26aulast%3DIchigotani%26aufirst%3DY.%26aulast%3DTeixeira-Clerc%26aufirst%3DF.%26aulast%3DLouvet%26aufirst%3DA.%26aulast%3DManin%26aufirst%3DS.%26aulast%3DNhieu%26aufirst%3DJ.%2BT.-V.%26aulast%3DBelot%26aufirst%3DM.%2BP.%26aulast%3DZimmer%26aufirst%3DA.%26aulast%3DEven%26aufirst%3DP.%26aulast%3DCani%26aufirst%3DP.%2BD.%26aulast%3DKnauf%26aufirst%3DC.%26aulast%3DBurcelin%26aufirst%3DR.%26aulast%3DBertola%26aufirst%3DA.%26aulast%3DLe%2BMarchand-Brustel%26aufirst%3DY.%26aulast%3DGual%26aufirst%3DP.%26aulast%3DMallat%26aufirst%3DA.%26aulast%3DLotersztajn%26aufirst%3DS.%26atitle%3DCannabinoid%2520CB2%2520Receptor%2520Potentiates%2520Obesity-Associated%2520Inflammation%252C%2520Insulin%2520Resistance%2520and%2520Hepatic%2520Steatosis%26jtitle%3DPloS%2520One%26date%3D2009%26volume%3D4%26doi%3D10.1371%2Fjournal.pone.0005844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frost, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dart, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tietje, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrison, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grayson, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daza, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Kouhen, O. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandran, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, M. D.</span></span> <span> </span><span class="NLM_article-title">Indol-3-yl-tetramethylcyclopropyl Ketones: Effects of Indole Ring Substitution on CB2Cannabinoid Receptor Activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1904</span>– <span class="NLM_lpage">1912</span>, <span class="refDoi"> DOI: 10.1021/jm7011613</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm7011613" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVCnsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1904-1912&author=J.+M.+Frostauthor=M.+J.+Dartauthor=K.+R.+Tietjeauthor=T.+R.+Garrisonauthor=G.+K.+Graysonauthor=A.+V.+Dazaauthor=O.+F.+El-Kouhenauthor=L.+N.+Millerauthor=L.+Liauthor=B.+B.+Yaoauthor=G.+C.+Hsiehauthor=M.+Paiauthor=C.+Z.+Zhuauthor=P.+Chandranauthor=M.+D.+Meyer&title=Indol-3-yl-tetramethylcyclopropyl+Ketones%3A+Effects+of+Indole+Ring+Substitution+on+CB2Cannabinoid+Receptor+Activity&doi=10.1021%2Fjm7011613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Indol-3-yl-tetramethylcyclopropyl Ketones: Effects of Indole Ring Substitution on CB2 Cannabinoid Receptor Activity</span></div><div class="casAuthors">Frost, Jennifer M.; Dart, Michael J.; Tietje, Karin R.; Garrison, Tiffany R.; Grayson, George K.; Daza, Anthony V.; El-Kouhen, Odile F.; Miller, Loan N.; Li, Lanlan; Yao, Betty B.; Hsieh, Gin C.; Pai, Madhavi; Zhu, Chang Z.; Chandran, Prasant; Meyer, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1904-1912</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of potent indol-3-yltetramethylcyclopropyl ketones have been prepd. as CB2 cannabinoid receptor ligands.  Two unsubstituted indoles (I, II) were the starting points for an investigation of the effect of indole ring substitutions on CB2 and CB1 binding affinities and activity in a CB2 in vitro functional assay.  Indole ring substitutions had varying effects on CB2 and CB1 binding, but were generally detrimental to agonist activity.  Substitution on the indole ring did lead to improved CB2/CB1 binding selectivity in some cases.  All indoles with the morpholinoethyl side chain exhibited weaker binding affinity and less agonist activity relative to that of their tetrahydropyranylmethyl analogs.  Several agonists were active in the complete Freund's adjuvant model of chronic inflammatory thermal hyperalgesia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLc34sGUL95rVg90H21EOLACvtfcHk0lijIy2f2QJeQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVCnsro%253D&md5=2fab721dcf172df11636476e207e62d9</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm7011613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7011613%26sid%3Dliteratum%253Aachs%26aulast%3DFrost%26aufirst%3DJ.%2BM.%26aulast%3DDart%26aufirst%3DM.%2BJ.%26aulast%3DTietje%26aufirst%3DK.%2BR.%26aulast%3DGarrison%26aufirst%3DT.%2BR.%26aulast%3DGrayson%26aufirst%3DG.%2BK.%26aulast%3DDaza%26aufirst%3DA.%2BV.%26aulast%3DEl-Kouhen%26aufirst%3DO.%2BF.%26aulast%3DMiller%26aufirst%3DL.%2BN.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DYao%26aufirst%3DB.%2BB.%26aulast%3DHsieh%26aufirst%3DG.%2BC.%26aulast%3DPai%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DC.%2BZ.%26aulast%3DChandran%26aufirst%3DP.%26aulast%3DMeyer%26aufirst%3DM.%2BD.%26atitle%3DIndol-3-yl-tetramethylcyclopropyl%2520Ketones%253A%2520Effects%2520of%2520Indole%2520Ring%2520Substitution%2520on%2520CB2Cannabinoid%2520Receptor%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1904%26epage%3D1912%26doi%3D10.1021%2Fjm7011613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Drug
Enforcement Administration</span> <span> </span><span class="NLM_article-title">Schedules of Controlled Substances: Placement of UR-144, XLR11, and
AKB48 into Schedule I</span>. <i>Fed. Regist.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">29142</span>– <span class="NLM_lpage">29145</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=27192731" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2016&pages=29142-29145&author=Drug%0AEnforcement+Administration&title=Schedules+of+Controlled+Substances%3A+Placement+of+UR-144%2C+XLR11%2C+and%0AAKB48+into+Schedule+I"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DSchedules%2520of%2520Controlled%2520Substances%253A%2520Placement%2520of%2520UR-144%252C%2520XLR11%252C%2520and%250AAKB48%2520into%2520Schedule%2520I%26jtitle%3DFed.%2520Regist.%26date%3D2016%26volume%3D81%26spage%3D29142%26epage%3D29145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Regulatory
agencies including
the US Drug Enforcement Agency consider “history and current
pattern of abuse”</span>. <span> </span><span class="NLM_article-title">“evidence
that individuals are taking the drug or other substance in amounts
sufficient to create a hazard”; and “significant diversion
of the drug or other substance from legitimate drug channels”
as key “indicators that a drug or other substance has a potential
for abuse”; see: Drugs of Abuse: A DEA Resource Guide, 2020
Edition, April 13, 2020</span>. see <a href="https://www.dea.gov/documents/2020/04/13/drugs-abuse" class="extLink">https://www.dea.gov/documents/2020/04/13/drugs-abuse</a> (accessed Apr 4 2021).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Regulatory%0Aagencies+including%0Athe+US+Drug+Enforcement+Agency+consider+%E2%80%9Chistory+and+current%0Apattern+of+abuse%E2%80%9D.+%E2%80%9Cevidence%0Athat+individuals+are+taking+the+drug+or+other+substance+in+amounts%0Asufficient+to+create+a+hazard%E2%80%9D%3B+and+%E2%80%9Csignificant+diversion%0Aof+the+drug+or+other+substance+from+legitimate+drug+channels%E2%80%9D%0Aas+key+%E2%80%9Cindicators+that+a+drug+or+other+substance+has+a+potential%0Afor+abuse%E2%80%9D%3B+see%3A+Drugs+of+Abuse%3A+A+DEA+Resource+Guide%2C+2020%0AEdition%2C+April+13%2C+2020.+see+https%3A%2F%2Fwww.dea.gov%2Fdocuments%2F2020%2F04%2F13%2Fdrugs-abuse+%28accessed+Apr+4+2021%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3D%25E2%2580%259Cevidence%250Athat%2520individuals%2520are%2520taking%2520the%2520drug%2520or%2520other%2520substance%2520in%2520amounts%250Asufficient%2520to%2520create%2520a%2520hazard%25E2%2580%259D%253B%2520and%2520%25E2%2580%259Csignificant%2520diversion%250Aof%2520the%2520drug%2520or%2520other%2520substance%2520from%2520legitimate%2520drug%2520channels%25E2%2580%259D%250Aas%2520key%2520%25E2%2580%259Cindicators%2520that%2520a%2520drug%2520or%2520other%2520substance%2520has%2520a%2520potential%250Afor%2520abuse%25E2%2580%259D%253B%2520see%253A%2520Drugs%2520of%2520Abuse%253A%2520A%2520DEA%2520Resource%2520Guide%252C%25202020%250AEdition%252C%2520April%252013%252C%25202020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wiley, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marusich, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huffman, J. W.</span></span> <span> </span><span class="NLM_article-title">Moving Around the Molecule: Relationship Between Chemical Structure and in vivo Activity of Synthetic Cannabinoids</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2013.09.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1016%2Fj.lfs.2013.09.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=24071522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Srs7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2014&pages=55-63&author=J.+L.+Wileyauthor=J.+A.+Marusichauthor=J.+W.+Huffman&title=Moving+Around+the+Molecule%3A+Relationship+Between+Chemical+Structure+and+in+vivo+Activity+of+Synthetic+Cannabinoids&doi=10.1016%2Fj.lfs.2013.09.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Moving around the molecule: Relationship between chemical structure and in vivo activity of synthetic cannabinoids</span></div><div class="casAuthors">Wiley, Jenny L.; Marusich, Julie A.; Huffman, John W.</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-63</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Originally synthesized for research purposes, indole- and pyrrole-derived synthetic cannabinoids are the most common psychoactive compds. contained in abused products marketed as "spice" or "herbal incense." While CB1 and CB2 receptor affinities are available for most of these research chems., in vivo pharmacol. data are sparse.  In mice, cannabinoids produce a characteristic profile of dose-dependent effects: antinociception, hypothermia, catalepsy and suppression of locomotion.  In combination with receptor binding data, this tetrad battery has been useful in evaluation of the relationship between the structural features of synthetic cannabinoids and their in vivo cannabimimetic activity.  Here, published tetrad studies are reviewed and addnl. in vivo data on synthetic cannabinoids are presented.  Overall, the best predictor of likely cannabimimetic effects in the tetrad tests was good CB1 receptor affinity.  Further, retention of good CB1 affinity and in vivo activity was obsd. across a wide array of structural manipulations of substituents of the prototypic aminoalkylindole mol. WIN55,212-2, including substitution of an alkyl for the morpholino group, replacement of an indole core with a pyrrole or phenylpyrrole, substitution of a phenylacetyl or tetramethylcyclopropyl group for JWH-018's naphthoyl, and halogenation of the naphthoyl group.  This flexibility of cannabinoid ligand-receptor interactions has been a particular challenge for forensic scientists who have struggled to identify and regulate each new compd. as it has appeared on the drug market.  One of the most pressing future research needs is detn. of the extent to which the pharmacol. of these synthetic cannabinoids may differ from those of classical cannabinoids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9o7LiXmgZc7Vg90H21EOLACvtfcHk0ljj54EVH0RdmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Srs7vP&md5=b6e3a3c52b834af7d8d7d4e9aa9447a9</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2013.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2013.09.011%26sid%3Dliteratum%253Aachs%26aulast%3DWiley%26aufirst%3DJ.%2BL.%26aulast%3DMarusich%26aufirst%3DJ.%2BA.%26aulast%3DHuffman%26aufirst%3DJ.%2BW.%26atitle%3DMoving%2520Around%2520the%2520Molecule%253A%2520Relationship%2520Between%2520Chemical%2520Structure%2520and%2520in%2520vivo%2520Activity%2520of%2520Synthetic%2520Cannabinoids%26jtitle%3DLife%2520Sci.%26date%3D2014%26volume%3D97%26spage%3D55%26epage%3D63%26doi%3D10.1016%2Fj.lfs.2013.09.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pasquini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mugnaini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligresti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tafi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brogi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falciani, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedani, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pesco, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guida, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luongo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borea, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maione, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corelli, F.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis, and Pharmacological Characterizationof Indol-3- ylacetamides, Indol-3-yloxoacetamides, and Indol-3-ylcarboxamides: Potent and Selective CB2 Cannabinoid Receptor Inverse Agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">5391</span>– <span class="NLM_lpage">5402</span>, <span class="refDoi"> DOI: 10.1021/jm3003334</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3003334" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtlSmsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5391-5402&author=S.+Pasquiniauthor=C.+Mugnainiauthor=A.+Ligrestiauthor=A.+Tafiauthor=S.+Brogiauthor=C.+Falcianiauthor=V.+Pedaniauthor=N.+Pescoauthor=F.+Guidaauthor=L.+Luongoauthor=K.+Varaniauthor=P.+A.+Boreaauthor=S.+Maioneauthor=V.+Di+Marzoauthor=F.+Corelli&title=Design%2C+Synthesis%2C+and+Pharmacological+Characterizationof+Indol-3-+ylacetamides%2C+Indol-3-yloxoacetamides%2C+and+Indol-3-ylcarboxamides%3A+Potent+and+Selective+CB2+Cannabinoid+Receptor+Inverse+Agonists&doi=10.1021%2Fjm3003334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Pharmacological Characterization of Indol-3-ylacetamides, Indol-3-yloxoacetamides, and Indol-3-ylcarboxamides: Potent and Selective CB2 Cannabinoid Receptor Inverse Agonists</span></div><div class="casAuthors">Pasquini, Serena; Mugnaini, Claudia; Ligresti, Alessia; Tafi, Andrea; Brogi, Simone; Falciani, Chiara; Pedani, Valentina; Pesco, Nicolo; Guida, Francesca; Luongo, Livio; Varani, Katia; Borea, Pier Andrea; Maione, Sabatino; Di Marzo, Vincenzo; Corelli, Federico</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5391-5402</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aryl-substituted indole carboxamides I (R = Ph, 4-HOC6H4, 2-furanyl, 2-thienyl, H; R1 = H, Ph; R2 = 1-adamantyl, cycloheptyl, cyclohexyl; R3 = allyl, BuCH2, Me, Et, EtCH2, Bu, H2C:CHCH2CH2, PhCH2; X = bond, CH2, CO) were prepd. as CB2-selective cannabinoid receptor inverse agonists and tested for their selectivities for inverse agonism at CB1 and CB2 cannabinoid receptors and, in some cases, for their ability to reverse the effects of a CB2 selective agonist in an antiinflammatory/analgesic model in mice.  Most of the indole carboxamides bound to CB2 receptors with affinities in the nanomolar range (Ki values between 0.37 nM and 377 nM) and with moderate to good selectivities for CB2 cannabinoid receptors over CB1 receptors [Ki(CB2)/Ki(CB1) = 0.6 and 5 - >487].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0DEYHepc9qrVg90H21EOLACvtfcHk0ljnRU5NyPelOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtlSmsbw%253D&md5=910785cca9e1637b5f7e2f61e0473bfd</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm3003334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3003334%26sid%3Dliteratum%253Aachs%26aulast%3DPasquini%26aufirst%3DS.%26aulast%3DMugnaini%26aufirst%3DC.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DTafi%26aufirst%3DA.%26aulast%3DBrogi%26aufirst%3DS.%26aulast%3DFalciani%26aufirst%3DC.%26aulast%3DPedani%26aufirst%3DV.%26aulast%3DPesco%26aufirst%3DN.%26aulast%3DGuida%26aufirst%3DF.%26aulast%3DLuongo%26aufirst%3DL.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DMaione%26aufirst%3DS.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DCorelli%26aufirst%3DF.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Pharmacological%2520Characterizationof%2520Indol-3-%2520ylacetamides%252C%2520Indol-3-yloxoacetamides%252C%2520and%2520Indol-3-ylcarboxamides%253A%2520Potent%2520and%2520Selective%2520CB2%2520Cannabinoid%2520Receptor%2520Inverse%2520Agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5391%26epage%3D5402%26doi%3D10.1021%2Fjm3003334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tavakoli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudley, G. B.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 4,4-Dimethyl-1,6-heptadiyne and Alcyopterosin O</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">8947</span>– <span class="NLM_lpage">8951</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.0c03356</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.0c03356" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BB3cXit1eqtrvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2020&pages=8947-8951&author=A.+Tavakoliauthor=G.+B.+Dudley&title=Synthesis+of+4%2C4-Dimethyl-1%2C6-heptadiyne+and+Alcyopterosin+O&doi=10.1021%2Facs.orglett.0c03356"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 4,4-Dimethyl-1,6-heptadiyne and Alcyopterosin O</span></div><div class="casAuthors">Tavakoli, Amir; Dudley, Gregory B.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8947-8951</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A four-step synthesis of 4,4-dimethyl-1,6-heptadiyne and an assocd. five-step synthesis of alcyopterosin O, an illudalane sesquiterpene natural product, are described starting from com. available dimedone.  The process features C-C bond-cleaving fragmentation and elimination methods for making alkynes, and it proceeds by way of nonsym. diynes that are themselves valuable synthetic building blocks, as exemplified by the synthesis of alcyopterosin O.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZguLkv1sjx7Vg90H21EOLACvtfcHk0ljnRU5NyPelOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXit1eqtrvI&md5=67ba234eaf552d0cea780d03224793ac</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.0c03356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.0c03356%26sid%3Dliteratum%253Aachs%26aulast%3DTavakoli%26aufirst%3DA.%26aulast%3DDudley%26aufirst%3DG.%2BB.%26atitle%3DSynthesis%2520of%25204%252C4-Dimethyl-1%252C6-heptadiyne%2520and%2520Alcyopterosin%2520O%26jtitle%3DOrg.%2520Lett.%26date%3D2020%26volume%3D22%26spage%3D8947%26epage%3D8951%26doi%3D10.1021%2Facs.orglett.0c03356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoang, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudley, G. B.</span></span> <span> </span><span class="NLM_article-title">Reaction Discovery Using Neopentylene-Tethered Coupling Partners: Cycloisomerization/Oxidation of Electron-Deficient Dienynes</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">4636</span>– <span class="NLM_lpage">4639</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.7b02261</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.7b02261" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlKmtb3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2017&pages=4636-4639&author=N.+J.+Kramerauthor=T.+T.+Hoangauthor=G.+B.+Dudley&title=Reaction+Discovery+Using+Neopentylene-Tethered+Coupling+Partners%3A+Cycloisomerization%2FOxidation+of+Electron-Deficient+Dienynes&doi=10.1021%2Facs.orglett.7b02261"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Reaction Discovery Using Neopentylene-Tethered Coupling Partners: Cycloisomerization/Oxidation of Electron-Deficient Dienynes</span></div><div class="casAuthors">Kramer, Nicholas J.; Hoang, Tung T.; Dudley, Gregory B.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4636-4639</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A rhodium-catalyzed cycloisomerization and oxidn. of tethered dienynes for the synthesis of indans, e.g. I, is described.  An auxiliary fragmentation/olefination method (also described herein) provides novel access to tethered alkyne-dienoate substrates.  The reported method circumvents current limitations in and expands the scope of inverse-demand Diels-Alder-type cycloaddns.  Traditional discovery substrates involving malonate-, ether- and sulfonamide-based tethers are problematic in the current methodol., underscoring the unique virtue of neopentylene-tethered substrates for reaction discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvlvTTHkhfL7Vg90H21EOLACvtfcHk0ljnRU5NyPelOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlKmtb3L&md5=27b7507969c4a2216d6e6fb7238fe7f5</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.7b02261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.7b02261%26sid%3Dliteratum%253Aachs%26aulast%3DKramer%26aufirst%3DN.%2BJ.%26aulast%3DHoang%26aufirst%3DT.%2BT.%26aulast%3DDudley%26aufirst%3DG.%2BB.%26atitle%3DReaction%2520Discovery%2520Using%2520Neopentylene-Tethered%2520Coupling%2520Partners%253A%2520Cycloisomerization%252FOxidation%2520of%2520Electron-Deficient%2520Dienynes%26jtitle%3DOrg.%2520Lett.%26date%3D2017%26volume%3D19%26spage%3D4636%26epage%3D4639%26doi%3D10.1021%2Facs.orglett.7b02261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longstaff, S. C.</span></span> <span> </span><span class="NLM_article-title">Generation and Cyclization of a Benzyne-Tethered Alkyllithium: Preparation of 4-Substituted Indans</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">432</span>– <span class="NLM_lpage">433</span>, <span class="refDoi"> DOI: 10.1021/jo972065z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo972065z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADyaK1cXksFCrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1998&pages=432-433&author=W.+F.+Baileyauthor=S.+C.+Longstaff&title=Generation+and+Cyclization+of+a+Benzyne-Tethered+Alkyllithium%3A+Preparation+of+4-Substituted+Indans&doi=10.1021%2Fjo972065z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Generation and Cyclization of a Benzyne-Tethered Alkyllithium: Preparation of 4-Substituted Indans</span></div><div class="casAuthors">Bailey, William F.; Longstaff, Sarah C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">432-433</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">2-FC6H4CH2CH2CH2I was treated with Me3CLi in n-pentane-diethyl ether at -78°, followed by addn. of THF to render residual Me3CLi monomeric.  The ortho-lithiation of 2-FC6H4CH2CH2CH2Li was followed by formation of a benzyne-tethered propyllithium intermediate, which was trapped with electrophiles to give 4-substituted indans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_-38nebLCybVg90H21EOLACvtfcHk0lgmA5rgP-ypHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXksFCrtQ%253D%253D&md5=4dc1639146a1fcd44e5a89dc4cfb5c5b</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjo972065z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo972065z%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DW.%2BF.%26aulast%3DLongstaff%26aufirst%3DS.%2BC.%26atitle%3DGeneration%2520and%2520Cyclization%2520of%2520a%2520Benzyne-Tethered%2520Alkyllithium%253A%2520Preparation%2520of%25204-Substituted%2520Indans%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1998%26volume%3D63%26spage%3D432%26epage%3D433%26doi%3D10.1021%2Fjo972065z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoang, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudley, G. B.</span></span> <span> </span><span class="NLM_article-title">Synthesis of High-Value 1,6-Enynes by Tandem Fragmentation/Olefination</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">4026</span>– <span class="NLM_lpage">4029</span>, <span class="refDoi"> DOI: 10.1021/ol401839e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol401839e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFOltr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=4026-4029&author=T.+T.+Hoangauthor=G.+B.+Dudley&title=Synthesis+of+High-Value+1%2C6-Enynes+by+Tandem+Fragmentation%2FOlefination&doi=10.1021%2Fol401839e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of High-Value 1,6-Enynes by Tandem Fragmentation/Olefination</span></div><div class="casAuthors">Hoang, Tung T.; Dudley, Gregory B.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4026-4029</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A tandem process provides high-value 1,6-enynes that are otherwise difficult to prep.  Two base-mediated reactions-fragmentation and olefination-are executed in a coordinated manner that is overall more efficient than either reaction on its own.  The 1,6-enynes can be strategically employed in conjunction with carbocyclization to deliver important targets, as noted for reported syntheses of hirsutene and illudol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKv0dmHf9oirVg90H21EOLACvtfcHk0lgmA5rgP-ypHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFOltr3P&md5=34ce9ac21b9014e31edeb523b64b1904</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fol401839e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol401839e%26sid%3Dliteratum%253Aachs%26aulast%3DHoang%26aufirst%3DT.%2BT.%26aulast%3DDudley%26aufirst%3DG.%2BB.%26atitle%3DSynthesis%2520of%2520High-Value%25201%252C6-Enynes%2520by%2520Tandem%2520Fragmentation%252FOlefination%26jtitle%3DOrg.%2520Lett.%26date%3D2013%26volume%3D15%26spage%3D4026%26epage%3D4029%26doi%3D10.1021%2Fol401839e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aung, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huffman, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Showalter, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abood, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, B. R.</span></span> <span> </span><span class="NLM_article-title">Influence of the N-1 Alkyl Chain Length of Cannabimimetic Indoles upon CB<sub>1</sub> and CB<sub>2</sub> Receptor Binding</span>. <i>Drug Alcohol Depend.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">133</span>– <span class="NLM_lpage">140</span>, <span class="refDoi"> DOI: 10.1016/s0376-8716(99)00152-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1016%2FS0376-8716%2899%2900152-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10940540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlsFCis7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=133-140&author=M.+M.+Aungauthor=G.+Griffinauthor=J.+W.+Huffmanauthor=M.-J.+Wuauthor=C.+Keelauthor=B.+Yangauthor=V.+M.+Showalterauthor=M.+E.+Aboodauthor=B.+R.+Martin&title=Influence+of+the+N-1+Alkyl+Chain+Length+of+Cannabimimetic+Indoles+upon+CB1+and+CB2+Receptor+Binding&doi=10.1016%2Fs0376-8716%2899%2900152-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB1 and CB2 receptor binding</span></div><div class="casAuthors">Aung, M. M.; Griffin, G.; Huffman, J. W.; Wu, M.-J.; Keel, C.; Yang, B.; Showalter, V. M.; Abood, M. E.; Martin, B. R.</div><div class="citationInfo"><span class="NLM_cas:title">Drug and Alcohol Dependence</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">133-140</span>CODEN:
                <span class="NLM_cas:coden">DADEDV</span>;
        ISSN:<span class="NLM_cas:issn">0376-8716</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">The N-1 alkyl side chain of the aminoalkylindole analogs (AAI) has been implicated as one of a three-point interaction with the cannabinoid CB1 receptor.  In this study, the morpholinoethyl of WIN 55,212-2 was replaced with carbon chains of varying lengths ranging from a Me to heptyl group.  Addnl. groups were added to the naphthoyl and the C2 positions of the mol.  These structural changes revealed that high affinity binding to the CB1 and CB2 receptors requires an alkyl chain length of at least three carbons with optimum binding to both receptors occurring with a five carbon side chain.  An alkyl chain of 3-6 carbons is sufficient for high affinity binding; however, extension of the chain to a heptyl group results in a dramatic decrease in binding at both receptors.  The unique structure of the cannabimimetic indoles provides a useful tool to define the ligand-receptor interaction at both cannabinoid receptors and to refine proposed pharmacophore models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7xJ1zTV8U47Vg90H21EOLACvtfcHk0ljWqm7ynvlYVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsFCis7o%253D&md5=e37f0944f8d1e476015b1f987803cf7c</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2FS0376-8716%2899%2900152-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0376-8716%252899%252900152-0%26sid%3Dliteratum%253Aachs%26aulast%3DAung%26aufirst%3DM.%2BM.%26aulast%3DGriffin%26aufirst%3DG.%26aulast%3DHuffman%26aufirst%3DJ.%2BW.%26aulast%3DWu%26aufirst%3DM.-J.%26aulast%3DKeel%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DB.%26aulast%3DShowalter%26aufirst%3DV.%2BM.%26aulast%3DAbood%26aufirst%3DM.%2BE.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3DInfluence%2520of%2520the%2520N-1%2520Alkyl%2520Chain%2520Length%2520of%2520Cannabimimetic%2520Indoles%2520upon%2520CB1%2520and%2520CB2%2520Receptor%2520Binding%26jtitle%3DDrug%2520Alcohol%2520Depend.%26date%3D2000%26volume%3D60%26spage%3D133%26epage%3D140%26doi%3D10.1016%2Fs0376-8716%2899%2900152-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hynes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leftheris, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandit, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norris, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiener, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patil-Koota, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillooly, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuster, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntyre, K. W.</span></span> <span> </span><span class="NLM_article-title">C-3 Amido-Indole Cannabinoid Receptor Modulators</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">2399</span>– <span class="NLM_lpage">2402</span>, <span class="refDoi"> DOI: 10.1016/s0960-894x(02)00466-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1016%2FS0960-894X%2802%2900466-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=12161142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvVGisr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=2399-2402&author=J.+Hynesauthor=K.+Leftherisauthor=H.+Wuauthor=C.+Panditauthor=P.+Chenauthor=D.+J.+Norrisauthor=B.-C.+Chenauthor=R.+Zhaoauthor=P.+A.+Kienerauthor=X.+Chenauthor=L.+A.+Turkauthor=V.+Patil-Kootaauthor=K.+M.+Gilloolyauthor=D.+J.+Shusterauthor=K.+W.+McIntyre&title=C-3+Amido-Indole+Cannabinoid+Receptor+Modulators&doi=10.1016%2Fs0960-894x%2802%2900466-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">C-3 Amido-Indole cannabinoid receptor modulators</span></div><div class="casAuthors">Hynes, John; Leftheris, Katerina; Wu, Hong; Pandit, Chennagiri; Chen, Ping; Norris, Derek J.; Chen, Bang-Chi; Zhao, Rulin; Kiener, Peter A.; Chen, Xiaorong; Turk, Lori A.; Patil-Koota, Vina; Gillooly, Kathleen M.; Shuster, David J.; McIntyre, Kim W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2399-2402</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">C-3 Amido-indoles were found to selectively bind to the CB2 receptor.  Structure-activity structure-activity relationship (SAR) studies led to optimized compds. with excellent in vivo potency against LPS induced TNF-α release in murine models of cytokine prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo_97Txjl_ULVg90H21EOLACvtfcHk0ljWqm7ynvlYVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvVGisr4%253D&md5=df16d9075561053ab84ac371351b0160</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2900466-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252900466-3%26sid%3Dliteratum%253Aachs%26aulast%3DHynes%26aufirst%3DJ.%26aulast%3DLeftheris%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DPandit%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DNorris%26aufirst%3DD.%2BJ.%26aulast%3DChen%26aufirst%3DB.-C.%26aulast%3DZhao%26aufirst%3DR.%26aulast%3DKiener%26aufirst%3DP.%2BA.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DTurk%26aufirst%3DL.%2BA.%26aulast%3DPatil-Koota%26aufirst%3DV.%26aulast%3DGillooly%26aufirst%3DK.%2BM.%26aulast%3DShuster%26aufirst%3DD.%2BJ.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26atitle%3DC-3%2520Amido-Indole%2520Cannabinoid%2520Receptor%2520Modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D2399%26epage%3D2402%26doi%3D10.1016%2Fs0960-894x%2802%2900466-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Longworth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banister, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassiou, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Pharmacological Profiling of the Metabolites of Synthetic Cannabinoid Drugs APICA, STS-135, ADB-PINACA, and 5FADB-PINACA</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1673</span>– <span class="NLM_lpage">1680</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.7b00116</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.7b00116" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC2sXptFels7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1673-1680&author=M.+Longworthauthor=M.+Connorauthor=S.+D.+Banisterauthor=M.+Kassiou&title=Synthesis+and+Pharmacological+Profiling+of+the+Metabolites+of+Synthetic+Cannabinoid+Drugs+APICA%2C+STS-135%2C+ADB-PINACA%2C+and+5FADB-PINACA&doi=10.1021%2Facschemneuro.7b00116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Pharmacological Profiling of the Metabolites of Synthetic Cannabinoid Drugs APICA, STS-135, ADB-PINACA, and 5F-ADB-PINACA</span></div><div class="casAuthors">Longworth, Mitchell; Connor, Mark; Banister, Samuel D.; Kassiou, Michael</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1673-1680</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Synthetic cannabinoids (SCs) contg. a 1-pentyl-1-H substituted indole or indazole are abused around the world and are assocd. with an array of serious side effects.  These compds. undergo extensive phase 1 metab. after ingestion with little understanding whether these metabolites are contributing to the cannabimimetic activity of the drugs.  This work presents the synthesis and pharmacol. characterization of the major metabolites of two high concern SCs; APICA and ADB-PINACA.  In a fluorometric assay of membrane potential, all metabolites that did not contain a carboxylic acid functionality retained potent activity at both the CB1 (EC50 = 14-787 nM) and CB2 (EC50 = 5.5-291 nM) receptors regardless of heterocyclic core or 3-carboxamide substituent.  Of note were the 5-hydroxypentyl and 4-pentanone metabolites which showed significant increases in CB2 functional selectivity.  These results suggest that the metabolites of SCs potentially contribute to the overall pharmacol. profile of these drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrie35oLSn9KLVg90H21EOLACvtfcHk0lgl8yRzr-Sv5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXptFels7g%253D&md5=f4e6fcd7b71423492b67c5c083a59ed6</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.7b00116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.7b00116%26sid%3Dliteratum%253Aachs%26aulast%3DLongworth%26aufirst%3DM.%26aulast%3DConnor%26aufirst%3DM.%26aulast%3DBanister%26aufirst%3DS.%2BD.%26aulast%3DKassiou%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520Pharmacological%2520Profiling%2520of%2520the%2520Metabolites%2520of%2520Synthetic%2520Cannabinoid%2520Drugs%2520APICA%252C%2520STS-135%252C%2520ADB-PINACA%252C%2520and%25205FADB-PINACA%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2017%26volume%3D8%26spage%3D1673%26epage%3D1680%26doi%3D10.1021%2Facschemneuro.7b00116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brents, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallus-Zawada, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radominska-Pandya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasiljevik, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prisinzano, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fantegrossi, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moran, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prather, P. L.</span></span> <span> </span><span class="NLM_article-title">Mono-hydroxylated Metabolites of the K2 Synthetic Cannabinoid JWH-073 Retain High Cannabinoid 1 Receptor (CB<sub>1</sub>R) Affinity and Exhibit Neutral Antagonist to Partial Agonist Activity</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">952</span>– <span class="NLM_lpage">961</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2012.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1016%2Fj.bcp.2012.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=22266354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Crur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2012&pages=952-961&author=L.+K.+Brentsauthor=A.+Gallus-Zawadaauthor=A.+Radominska-Pandyaauthor=T.+Vasiljevikauthor=T.+E.+Prisinzanoauthor=W.+E.+Fantegrossiauthor=J.+H.+Moranauthor=P.+L.+Prather&title=Mono-hydroxylated+Metabolites+of+the+K2+Synthetic+Cannabinoid+JWH-073+Retain+High+Cannabinoid+1+Receptor+%28CB1R%29+Affinity+and+Exhibit+Neutral+Antagonist+to+Partial+Agonist+Activity&doi=10.1016%2Fj.bcp.2012.01.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity</span></div><div class="casAuthors">Brents, Lisa K.; Gallus-Zawada, Anna; Radominska-Pandya, Anna; Vasiljevik, Tamara; Prisinzano, Thomas E.; Fantegrossi, William E.; Moran, Jeffery H.; Prather, Paul L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">952-961</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">K2 and several similar purported "incense products" spiked with synthetic cannabinoids are abused as cannabis substitutes.  We hypothesized that metab. of JWH-073, a prevalent cannabinoid found in K2, contributes to toxicity assocd. with K2 use.  Competition receptor binding studies and G-protein activation assays, both performed by employing mouse brain homogenates, were used to det. the affinity and intrinsic activity, resp., of potential monohydroxylated (M1, M3-M5) and monocarboxylated (M6) metabolites at cannabinoid 1 receptors (CB1Rs).  Surprisingly, M1, M4 and M5 retain nanomolar affinity for CB1Rs, while M3 displays micromolar affinity and M6 does not bind to CB1Rs.  JWH-073 displays equiv. efficacy to that of the CB1R full agonist CP-55,940, while M1, M3, and M5 act as CB1R partial agonists, and M4 shows little or no intrinsic activity.  Further in vitro investigation by Schild anal. revealed that M4 acts as a competitive neutral CB1R antagonist (Kb ∼ 40 nM).  In agreement with in vitro studies, M4 also demonstrates CB1R antagonism in vivo by blunting cannabinoid-induced hypothermia in mice.  Interestingly, M4 does not block agonist-mediated responses of other measures in the cannabinoid tetrad (e.g., locomotor suppression, catalepsy or analgesia).  Finally, also as predicted by in vitro results, M1 exhibits agonist activity in vivo by inducing significant hypothermia and suppression of locomotor activity in mice.In conclusion, the present study indicates that further work examg. the physiol. effects of synthetic cannabinoid metab. is warranted.  Such a complex mix of metabolically produced CB1R ligands may contribute to the adverse effect profile of JWH-073-contg. products.  Neutral CB1R antagonist properties of metabolite M4 (I) suggest that it might serve as a scaffold for development of a novel class of anti-obesity drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY05-OLnF6LbVg90H21EOLACvtfcHk0lgl8yRzr-Sv5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Crur0%253D&md5=71e598b1c5517d9594395c0c3d82376a</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2012.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2012.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DBrents%26aufirst%3DL.%2BK.%26aulast%3DGallus-Zawada%26aufirst%3DA.%26aulast%3DRadominska-Pandya%26aufirst%3DA.%26aulast%3DVasiljevik%26aufirst%3DT.%26aulast%3DPrisinzano%26aufirst%3DT.%2BE.%26aulast%3DFantegrossi%26aufirst%3DW.%2BE.%26aulast%3DMoran%26aufirst%3DJ.%2BH.%26aulast%3DPrather%26aufirst%3DP.%2BL.%26atitle%3DMono-hydroxylated%2520Metabolites%2520of%2520the%2520K2%2520Synthetic%2520Cannabinoid%2520JWH-073%2520Retain%2520High%2520Cannabinoid%25201%2520Receptor%2520%2528CB1R%2529%2520Affinity%2520and%2520Exhibit%2520Neutral%2520Antagonist%2520to%2520Partial%2520Agonist%2520Activity%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D83%26spage%3D952%26epage%3D961%26doi%3D10.1016%2Fj.bcp.2012.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klamo, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendt, O. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henling, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bercaw, J. E.</span></span> <span> </span><span class="NLM_article-title">Dialkyl and Methyl-Alkyl Zirconocenes: Synthesis and Characterization of Zirconocene-Alkyls That Model the Polymeryl Chain in Alkene Polymerizations</span>. <i>Organometallics</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3018</span>– <span class="NLM_lpage">3030</span>, <span class="refDoi"> DOI: 10.1021/om0601302</span> </span><div class="citationLinks">[<a href="/doi/10.1021/om0601302" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkvFSjsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=3018-3030&author=S.+B.+Klamoauthor=O.+F.+Wendtauthor=L.+M.+Henlingauthor=M.+W.+Dayauthor=J.+E.+Bercaw&title=Dialkyl+and+Methyl-Alkyl+Zirconocenes%3A+Synthesis+and+Characterization+of+Zirconocene-Alkyls+That+Model+the+Polymeryl+Chain+in+Alkene+Polymerizations&doi=10.1021%2Fom0601302"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Dialkyl and Methyl-Alkyl Zirconocenes: Synthesis and Characterization of Zirconocene-Alkyls That Model the Polymeryl Chain in Alkene Polymerizations</span></div><div class="casAuthors">Klamo, Sara B.; Wendt, Ola F.; Henling, Larry M.; Day, Michael W.; Bercaw, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Organometallics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3018-3030</span>CODEN:
                <span class="NLM_cas:coden">ORGND7</span>;
        ISSN:<span class="NLM_cas:issn">0276-7333</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Zirconocene precatalysts with sterically bulky alkyl groups were designed as model systems for the propagating species in zirconocene-catalyzed alkene polymn.  Specialty alkyllithium reagents Li(CH2CEt3) and Li(CH2CMe2CH2Ph) were prepd. and utilized in the synthesis of dialkyl and methyl-alkyl zirconocenes of the form CpCp*ZrR2, Cp2Zr(CH3)(R), and CpCp*Zr(CH3)(R) (Cp = (η5-C5H5); Cp* = (η5-C5Me5); R = CH2CMe3, CH2SiMe3, CH2CEt3, CH2CMe2CH2Ph).  These new zirconocene alkyls were isolated and fully characterized by NMR spectroscopy and in some cases by x-ray diffraction.  The mol. structures detd. display the bent-sandwich coordination mode common for zirconocenes.  The steric influence of the alkyl group on the obsd. structural parameters is reflected in slightly expanded C-Zr-C or C-Zr-Cl angles in the equatorial plane and long zirconium-alkyl bond distances.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCf5ng3F6-VrVg90H21EOLACvtfcHk0lgl8yRzr-Sv5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkvFSjsLc%253D&md5=a5c98aeb534ee2091629b6a06db6c109</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fom0601302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fom0601302%26sid%3Dliteratum%253Aachs%26aulast%3DKlamo%26aufirst%3DS.%2BB.%26aulast%3DWendt%26aufirst%3DO.%2BF.%26aulast%3DHenling%26aufirst%3DL.%2BM.%26aulast%3DDay%26aufirst%3DM.%2BW.%26aulast%3DBercaw%26aufirst%3DJ.%2BE.%26atitle%3DDialkyl%2520and%2520Methyl-Alkyl%2520Zirconocenes%253A%2520Synthesis%2520and%2520Characterization%2520of%2520Zirconocene-Alkyls%2520That%2520Model%2520the%2520Polymeryl%2520Chain%2520in%2520Alkene%2520Polymerizations%26jtitle%3DOrganometallics%26date%3D2007%26volume%3D26%26spage%3D3018%26epage%3D3030%26doi%3D10.1021%2Fom0601302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vekariya, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubé, J.</span></span> <span> </span><span class="NLM_article-title">Hexafluoro-2-propanol-Promoted Intermolecular Friedel–Crafts Acylation Reaction</span>. <i>J. Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">3534</span>– <span class="NLM_lpage">3537</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.6b01460</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.6b01460" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=3534-3537&author=R.+H.+Vekariyaauthor=J.+Aub%C3%A9&title=Hexafluoro-2-propanol-Promoted+Intermolecular+Friedel%E2%80%93Crafts+Acylation+Reaction&doi=10.1021%2Facs.orglett.6b01460"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.6b01460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.6b01460%26sid%3Dliteratum%253Aachs%26aulast%3DVekariya%26aufirst%3DR.%2BH.%26aulast%3DAub%25C3%25A9%26aufirst%3DJ.%26atitle%3DHexafluoro-2-propanol-Promoted%2520Intermolecular%2520Friedel%25E2%2580%2593Crafts%2520Acylation%2520Reaction%26jtitle%3DJ.%2520Org.%2520Lett.%26date%3D2016%26volume%3D18%26spage%3D3534%26epage%3D3537%26doi%3D10.1021%2Facs.orglett.6b01460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hudlicky, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frazier, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seoane, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiedje, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seoane, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwart, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beal, C.</span></span> <span> </span><span class="NLM_article-title">Topological selectivity in the intramolecular [4 + 1] pyrroline annulation. Formal total stereospecific synthesis of (.+-.)-supinidine, (.+-.)-isoretronecanol, and (.+-.)-trachelanthamidine</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">3755</span>– <span class="NLM_lpage">3762</span>, <span class="refDoi"> DOI: 10.1021/ja00273a033</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00273a033" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADyaL28XkvFOktLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=1986&pages=3755-3762&author=T.+Hudlickyauthor=J.+O.+Frazierauthor=G.+Seoaneauthor=M.+Tiedjeauthor=A.+Seoaneauthor=L.+D.+Kwartauthor=C.+Beal&title=Topological+selectivity+in+the+intramolecular+%5B4+%2B+1%5D+pyrroline+annulation.+Formal+total+stereospecific+synthesis+of+%28.%2B-.%29-supinidine%2C+%28.%2B-.%29-isoretronecanol%2C+and+%28.%2B-.%29-trachelanthamidine&doi=10.1021%2Fja00273a033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Topological selectivity in the intramolecular [4 + 1] pyrroline annulation. Formal total stereospecific synthesis of (±)-supinidine, (±)-isoretronecanol, and (±)-trachelanthamidine</span></div><div class="casAuthors">Hudlicky, Tomas; Frazier, James O.; Seoane, Gustavo; Tiedje, Mark; Seoane, Ana; Kwart, Lawrence D.; Beal, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3755-62</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">The prepn. and cycloaddns. of azido dienes N3(CH2)3CH:C(CH:CH2)CO2Et and N3(CH2)3CH:CHCH:CHCO2Et are described in detail.  The synthesis of pyrrolines I and II is reported, and the conditions are revealed to achieve max. selectivity in their prepn.  The topog. of the ultimately prepd. pyrrolines depends primarily on the substitution parameters of the starting dienes and on the conditions of rearrangement of their resp. vinylaziridines III and IV.  The former parameter is easily controlled through the vinylogous Reformatsky reaction of Et 4-bromocrotonate with aldehyde precursors.  The latter parameter depends on the choice of thermolytic vs. nucleophilic activation of particular bonds in III and IV.  The flexibility and practicality of this method is exemplified by several convergent approaches to I and II and their conversion to the title pyrrolizidine alkaloids.  Stereospecific prepn. of satd. pyrrolizidines V is also described.  A detailed study of the base-catalyzed elimination of β-acetoxy esters was performed, and the stereochem. consequences are reported for the formation of E- and Z-N3(CH2)3CH:C(CH:CH2)CO2Et.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopTZ3WTERUB7Vg90H21EOLACvtfcHk0ljUfRd9yLbckg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XkvFOktLs%253D&md5=ec1ccd5e33fd2c0dd2998035624ffbe9</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fja00273a033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00273a033%26sid%3Dliteratum%253Aachs%26aulast%3DHudlicky%26aufirst%3DT.%26aulast%3DFrazier%26aufirst%3DJ.%2BO.%26aulast%3DSeoane%26aufirst%3DG.%26aulast%3DTiedje%26aufirst%3DM.%26aulast%3DSeoane%26aufirst%3DA.%26aulast%3DKwart%26aufirst%3DL.%2BD.%26aulast%3DBeal%26aufirst%3DC.%26atitle%3DTopological%2520selectivity%2520in%2520the%2520intramolecular%2520%255B4%2520%252B%25201%255D%2520pyrroline%2520annulation.%2520Formal%2520total%2520stereospecific%2520synthesis%2520of%2520%2528.%252B-.%2529-supinidine%252C%2520%2528.%252B-.%2529-isoretronecanol%252C%2520and%2520%2528.%252B-.%2529-trachelanthamidine%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1986%26volume%3D108%26spage%3D3755%26epage%3D3762%26doi%3D10.1021%2Fja00273a033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brents, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichard, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerman, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moran, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fantegrossi, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prather, P. L.</span></span> <span> </span><span class="NLM_article-title">Phase I Hydroxylated Metabolites of the K2 Synthetic Cannabinoid JWH-018 Retain in vitro and in vivo Cannabinoid 1 Receptor Affinity and Activity</span>. <i>PloS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e21917</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0021917</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1371%2Fjournal.pone.0021917" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=21755008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsFChsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&author=L.+K.+Brentsauthor=E.+E.+Reichardauthor=S.+M.+Zimmermanauthor=J.+H.+Moranauthor=W.+E.+Fantegrossiauthor=P.+L.+Prather&title=Phase+I+Hydroxylated+Metabolites+of+the+K2+Synthetic+Cannabinoid+JWH-018+Retain+in+vitro+and+in+vivo+Cannabinoid+1+Receptor+Affinity+and+Activity&doi=10.1371%2Fjournal.pone.0021917"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity</span></div><div class="casAuthors">Brents, Lisa K.; Reichard, Emily E.; Zimmerman, Sarah M.; Moran, Jeffery H.; Fantegrossi, William E.; Prather, Paul L.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">e21917</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">K2 products are synthetic cannabinoid-laced, marijuana-like drugs of abuse, use of which is often assocd. with clin. symptoms atypical of marijuana use, including hypertension, agitation, hallucinations, psychosis, seizures and panic attacks.  JWH-018, a prevalent K2 synthetic cannabinoid, is structurally distinct from Δ9-THC, the main psychoactive ingredient in marijuana.  Since even subtle structural differences can lead to differential metab., formation of novel, biol. active metabolites may be responsible for the distinct effects assocd. with K2 use.  The present study proposes that K2's high adverse effect occurrence is due, at least in part, to distinct JWH-018 metabolite activity at the cannabinoid 1 receptor (CB1R).  JWH-018, five potential monohydroxylated metabolites (M1-M5), and one carboxy metabolite (M6) were examd. in mouse brain homogenates contg. CB1Rs, first for CB1R affinity using a competition binding assay employing the cannabinoid receptor radioligand [3H]CP-55,940, and then for CB1R intrinsic efficacy using an [35S]GTPγS binding assay.  JWH-018 and M1-M5 bound CB1Rs with high affinity, exhibiting Ki values that were lower than or equiv. to Δ9-THC.  These mols. also stimulated G-proteins with equal or greater efficacy relative to Δ9-THC, a CB1R partial agonist.  Most importantly, JWH-018, M2, M3, and M5 produced full CB1R agonist levels of activation.  CB1R-mediated activation was demonstrated by blockade with O-2050, a CB1R-selective neutral antagonist.  Similar to Δ9-THC, JWH-018 and M1 produced a marked depression of locomotor activity and core body temp. in mice that were both blocked by the CB1R-preferring antagonist/inverse agonist AM251.  Unlike metabolites of most drugs, the studied JWH-018 monohydroxylated compds., but not the carboxy metabolite, retain in vitro and in vivo activity at CB1Rs.  These observations, combined with higher CB1R affinity and activity relative to Δ9-THC, may contribute to the greater prevalence of adverse effects obsd. with JWH-018-contg. products relative to cannabis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHN28ACeRV0LVg90H21EOLACvtfcHk0linbqCvjl4DLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsFChsL0%253D&md5=a40b0f6749f9552fd544fa0f6f2dc2ba</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0021917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0021917%26sid%3Dliteratum%253Aachs%26aulast%3DBrents%26aufirst%3DL.%2BK.%26aulast%3DReichard%26aufirst%3DE.%2BE.%26aulast%3DZimmerman%26aufirst%3DS.%2BM.%26aulast%3DMoran%26aufirst%3DJ.%2BH.%26aulast%3DFantegrossi%26aufirst%3DW.%2BE.%26aulast%3DPrather%26aufirst%3DP.%2BL.%26atitle%3DPhase%2520I%2520Hydroxylated%2520Metabolites%2520of%2520the%2520K2%2520Synthetic%2520Cannabinoid%2520JWH-018%2520Retain%2520in%2520vitro%2520and%2520in%2520vivo%2520Cannabinoid%25201%2520Receptor%2520Affinity%2520and%2520Activity%26jtitle%3DPloS%2520One%26date%3D2011%26volume%3D6%26doi%3D10.1371%2Fjournal.pone.0021917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penthala, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prather, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crooks, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, C.-G.</span></span> <span> </span><span class="NLM_article-title">Binding Modes and Selectivity of Cannabinoid 1 (CB1) and Cannabinoid 2 (CB2) Receptor Ligands</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">3455</span>– <span class="NLM_lpage">3463</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.0c00551</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.0c00551" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvFCnsr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=3455-3463&author=J.-F.+Yangauthor=A.+H.+Williamsauthor=N.+R.+Penthalaauthor=P.+L.+Pratherauthor=P.+A.+Crooksauthor=C.-G.+Zhan&title=Binding+Modes+and+Selectivity+of+Cannabinoid+1+%28CB1%29+and+Cannabinoid+2+%28CB2%29+Receptor+Ligands&doi=10.1021%2Facschemneuro.0c00551"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Binding Modes and Selectivity of Cannabinoid 1 (CB1) and Cannabinoid 2 (CB2) Receptor Ligands</span></div><div class="casAuthors">Yang, Jing-Fang; Williams, Alexander H.; Penthala, Narsimha R.; Prather, Paul L.; Crooks, Peter A.; Zhan, Chang-Guo</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3455-3463</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The cannabinoid (CB) receptors (CB1R and CB2R) represent a promising therapeutic target for several indications such as nociception and obesity.  The ligands with nonselectivity can be traced to the high similarity in the binding sites of both cannabinoid receptors.  Therefore, the need for selectivity, potency, and G-protein coupling bias has further complicated the design of desired compds.  The bias of currently studied cannabinoid agonists is seldom investigated, and agonists that do exhibit bias are typically nonselective.  However, certain long-chain endocannabinoids represent a class of selective and potent CB1R agonists.  The binding mode for this class of compds. has remained elusive, limiting the implementation of its binding features to currently studied agonists.  Hence, in the present study, the binding poses for these long-chain cannabinoids, along with other interesting ligands, with the receptors have been detd., by using a combination of mol. docking and mol. dynamics (MD) simulations along with mol. mechanics-Poisson-Boltzmann surface area (MM-PBSA) binding free energy calcns.  The binding poses for the long-chain cannabinoids implicate that a site surrounded by the transmembrane (TM)2, TM7, and extracellular loop (ECL)2 is vital for providing the long-chain ligands with the selectivity for CB1R, esp. I267 of CB1R (corresponding to L182 of CB2R).  Based on the obtained binding modes, the calcd. relative binding free energies and selectivity are all in good agreement with the corresponding exptl. data, suggesting that the detd. binding poses are reasonable.  The computational strategy used in this study may also prove fruitful in applications with other GPCRs or membrane-bound proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzR01wKkDxYrVg90H21EOLACvtfcHk0lhFvDMAfuev5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvFCnsr3E&md5=193f8e216444351a0c1b297892f7c528</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.0c00551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.0c00551%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.-F.%26aulast%3DWilliams%26aufirst%3DA.%2BH.%26aulast%3DPenthala%26aufirst%3DN.%2BR.%26aulast%3DPrather%26aufirst%3DP.%2BL.%26aulast%3DCrooks%26aufirst%3DP.%2BA.%26aulast%3DZhan%26aufirst%3DC.-G.%26atitle%3DBinding%2520Modes%2520and%2520Selectivity%2520of%2520Cannabinoid%25201%2520%2528CB1%2529%2520and%2520Cannabinoid%25202%2520%2528CB2%2529%2520Receptor%2520Ligands%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2020%26volume%3D11%26spage%3D3455%26epage%3D3463%26doi%3D10.1021%2Facschemneuro.0c00551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, P. C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skillman, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellingson, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M. T.</span></span> <span> </span><span class="NLM_article-title">Conformer generation with OMEGA: algorithm and validation using high quality structures from the Protein Databank and Cambridge Structural Database</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">572</span>– <span class="NLM_lpage">584</span>, <span class="refDoi"> DOI: 10.1021/ci100031x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci100031x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtlaisrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=572-584&author=P.+C.+D.+Hawkinsauthor=A.+G.+Skillmanauthor=G.+L.+Warrenauthor=B.+A.+Ellingsonauthor=M.+T.+Stahl&title=Conformer+generation+with+OMEGA%3A+algorithm+and+validation+using+high+quality+structures+from+the+Protein+Databank+and+Cambridge+Structural+Database&doi=10.1021%2Fci100031x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Conformer Generation with OMEGA: Algorithm and Validation Using High Quality Structures from the Protein Databank and Cambridge Structural Database</span></div><div class="casAuthors">Hawkins, Paul C. D.; Skillman, A. Geoffrey; Warren, Gregory L.; Ellingson, Benjamin A.; Stahl, Matthew T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">572-584</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Here, we present the algorithm and validation for OMEGA, a systematic, knowledge-based conformer generator.  The algorithm consists of three phases: assembly of an initial 3D structure from a library of fragments; exhaustive enumeration of all rotatable torsions using values drawn from a knowledge-based list of angles, thereby generating a large set of conformations; and sampling of this set by geometric and energy criteria.  Validation of conformer generators like OMEGA has often been undertaken by comparing computed conformer sets to exptl. mol. conformations from crystallog., usually from the Protein Databank (PDB).  Such an approach is fraught with difficulty due to the systematic problems with small mol. structures in the PDB.  Methods are presented to identify a diverse set of small mol. structures from cocomplexes in the PDB that has maximal reliability.  A challenging set of 197 high quality, carefully selected ligand structures from well-solved models was obtained using these methods.  This set will provide a sound basis for comparison and validation of conformer generators in the future.  Validation results from this set are compared to the results using structures of a set of druglike mols. extd. from the Cambridge Structural Database (CSD).  OMEGA is found to perform very well in reproducing the crystallog. conformations from both these data sets using two complementary metrics of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqq1SOwPH1NzrVg90H21EOLACvtfcHk0ljVkkLxAaGHfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtlaisrY%253D&md5=fb87ecc9c51eddef63b41fffcd9babee</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fci100031x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci100031x%26sid%3Dliteratum%253Aachs%26aulast%3DHawkins%26aufirst%3DP.%2BC.%2BD.%26aulast%3DSkillman%26aufirst%3DA.%2BG.%26aulast%3DWarren%26aufirst%3DG.%2BL.%26aulast%3DEllingson%26aufirst%3DB.%2BA.%26aulast%3DStahl%26aufirst%3DM.%2BT.%26atitle%3DConformer%2520generation%2520with%2520OMEGA%253A%2520algorithm%2520and%2520validation%2520using%2520high%2520quality%2520structures%2520from%2520the%2520Protein%2520Databank%2520and%2520Cambridge%2520Structural%2520Database%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D572%26epage%3D584%26doi%3D10.1021%2Fci100031x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanner, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belew, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodsell, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. J.</span></span> <span> </span><span class="NLM_article-title">AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">2785</span>– <span class="NLM_lpage">2791</span>, <span class="refDoi"> DOI: 10.1002/jcc.21256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1002%2Fjcc.21256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=19399780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=2785-2791&author=G.+M.+Morrisauthor=R.+Hueyauthor=W.+Lindstromauthor=M.+F.+Sannerauthor=R.+K.+Belewauthor=D.+S.+Goodsellauthor=A.+J.+Olson&title=AutoDock4+and+AutoDockTools4%3A+Automated+docking+with+selective+receptor+flexibility&doi=10.1002%2Fjcc.21256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock and AutoDockTools: Automated docking with selective receptor flexibility</span></div><div class="casAuthors">Morris, Garrett M.; Huey, Ruth; Lindstrom, William; Sanner, Michel F.; Belew, Richard K.; Goodsell, David S.; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2785-2791</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">We describe the testing and release of AutoDock4 and the accompanying graphical user interface AutoDockTools.  AutoDock4 incorporates limited flexibility in the receptor.  Several tests are reported here, including a redocking expt. with 188 diverse ligand-protein complexes and a cross-docking expt. using flexible sidechains in 87 HIV protease complexes.  We also report its utility in anal. of covalently bound ligands, using both a grid-based docking method and a modification of the flexible sidechain technique. © 2009 Wiley Periodicals, Inc.  J Comput Chem, 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqktE6WAo4GEbVg90H21EOLACvtfcHk0ljVkkLxAaGHfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK&md5=679ce22fc50e9291c9aa16e7a1855845</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21256%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DG.%2BM.%26aulast%3DHuey%26aufirst%3DR.%26aulast%3DLindstrom%26aufirst%3DW.%26aulast%3DSanner%26aufirst%3DM.%2BF.%26aulast%3DBelew%26aufirst%3DR.%2BK.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock4%2520and%2520AutoDockTools4%253A%2520Automated%2520docking%2520with%2520selective%2520receptor%2520flexibility%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2009%26volume%3D30%26spage%3D2785%26epage%3D2791%26doi%3D10.1002%2Fjcc.21256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trott, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. J.</span></span> <span> </span><span class="NLM_article-title">AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">455</span>– <span class="NLM_lpage">461</span>, <span class="refDoi"> DOI: 10.1002/jcc.21334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1002%2Fjcc.21334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=19499576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=455-461&author=O.+Trottauthor=A.+J.+Olson&title=AutoDock+Vina%3A+improving+the+speed+and+accuracy+of+docking+with+a+new+scoring+function%2C+efficient+optimization%2C+and+multithreading&doi=10.1002%2Fjcc.21334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span></div><div class="casAuthors">Trott, Oleg; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">455-461</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">AutoDock Vina, a new program for mol. docking and virtual screening, is presented.  AutoDock Vina achieves an approx. 2 orders of magnitude speed-up compared with the mol. docking software previously developed in the authors' lab (AutoDock 4), while also significantly improving the accuracy of the binding mode predictions, judging by the authors' tests on the training set used in AutoDock 4 development.  Further speed-up is achieved from parallelism, by using multithreading on multicore machines.  AutoDock Vina automatically calcs. the grid maps and clusters the results in a way transparent to the user.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLecOIkUxIlrVg90H21EOLACvtfcHk0ljVkkLxAaGHfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O&md5=c6974af8a1235f7aa09918d3e6f70dc4</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21334%26sid%3Dliteratum%253Aachs%26aulast%3DTrott%26aufirst%3DO.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock%2520Vina%253A%2520improving%2520the%2520speed%2520and%2520accuracy%2520of%2520docking%2520with%2520a%2520new%2520scoring%2520function%252C%2520efficient%2520optimization%252C%2520and%2520multithreading%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2010%26volume%3D31%26spage%3D455%26epage%3D461%26doi%3D10.1002%2Fjcc.21334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hua, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vemuri, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shui, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laprairie, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zvonok, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kufareva, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohn, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.-J.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of the human cannabinoid receptor CB1</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>167</i></span>,  <span class="NLM_fpage">750</span>– <span class="NLM_lpage">762.e714</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2016.10.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1016%2Fj.cell.2016.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=27768894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslCrsrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2016&pages=750-762.e714&author=T.+Huaauthor=K.+Vemuriauthor=M.+Puauthor=L.+Quauthor=G.+W.+Hanauthor=Y.+Wuauthor=S.+Zhaoauthor=W.+Shuiauthor=S.+Liauthor=A.+Kordeauthor=R.+B.+Laprairieauthor=E.+L.+Stahlauthor=J.-H.+Hoauthor=N.+Zvonokauthor=H.+Zhouauthor=I.+Kufarevaauthor=B.+Wuauthor=Q.+Zhaoauthor=M.+A.+Hansonauthor=L.+M.+Bohnauthor=A.+Makriyannisauthor=R.+C.+Stevensauthor=Z.-J.+Liu&title=Crystal+structure+of+the+human+cannabinoid+receptor+CB1&doi=10.1016%2Fj.cell.2016.10.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of the Human Cannabinoid Receptor CB1</span></div><div class="casAuthors">Hua, Tian; Vemuri, Kiran; Pu, Mengchen; Qu, Lu; Han, Gye Won; Wu, Yiran; Zhao, Suwen; Shui, Wenqing; Li, Shanshan; Korde, Anisha; Laprairie, Robert B.; Stahl, Edward L.; Ho, Jo-Hao; Zvonok, Nikolai; Zhou, Han; Kufareva, Irina; Wu, Beili; Zhao, Qiang; Hanson, Michael A.; Bohn, Laura M.; Makriyannis, Alexandros; Stevens, Raymond C.; Liu, Zhi-Jie</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">750-762.e14</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Cannabinoid receptor 1 (CB1) is the principal target of Δ9-tetrahydrocannabinol (THC), a psychoactive chem. from Cannabis sativa with a wide range of therapeutic applications and a long history of recreational use.  CB1 is activated by endocannabinoids and is a promising therapeutic target for pain management, inflammation, obesity, and substance abuse disorders.  Here, the authors present the 2.8 Å crystal structure of human CB1 in complex with AM6538, a stabilizing antagonist, synthesized and characterized for this structural study.  The structure of the CB1-AM6538 complex reveals key features of the receptor and crit. interactions for antagonist binding.  In combination with functional studies and mol. modeling, the structure provides insight into the binding mode of naturally occurring CB1 ligands, such as THC, and synthetic cannabinoids.  This enhances the understanding of the mol. basis for the physiol. functions of CB1 and provides new opportunities for the design of next-generation CB1-targeting pharmaceuticals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAuMgAfmO22bVg90H21EOLACvtfcHk0lgg11VAV0Z_Xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslCrsrbI&md5=f4862c31391550ee2b83ef198c9c7b17</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2016.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2016.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DHua%26aufirst%3DT.%26aulast%3DVemuri%26aufirst%3DK.%26aulast%3DPu%26aufirst%3DM.%26aulast%3DQu%26aufirst%3DL.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DShui%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DKorde%26aufirst%3DA.%26aulast%3DLaprairie%26aufirst%3DR.%2BB.%26aulast%3DStahl%26aufirst%3DE.%2BL.%26aulast%3DHo%26aufirst%3DJ.-H.%26aulast%3DZvonok%26aufirst%3DN.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DWu%26aufirst%3DB.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DBohn%26aufirst%3DL.%2BM.%26aulast%3DMakriyannis%26aufirst%3DA.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DLiu%26aufirst%3DZ.-J.%26atitle%3DCrystal%2520structure%2520of%2520the%2520human%2520cannabinoid%2520receptor%2520CB1%26jtitle%3DCell%26date%3D2016%26volume%3D167%26spage%3D750%26epage%3D762.e714%26doi%3D10.1016%2Fj.cell.2016.10.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vemuri, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popov, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benchama, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zvonok, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locke, K. a.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cinar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffey, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohn, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.-J.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of the human cannabinoid receptor CB2</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>176</i></span>,  <span class="NLM_fpage">459</span>– <span class="NLM_lpage">467</span>, e13 <span class="refDoi"> DOI: 10.1016/j.cell.2018.12.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1016%2Fj.cell.2018.12.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=30639103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC1MXovFKktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2019&pages=459-467&author=X.+Liauthor=T.+Huaauthor=K.+Vemuriauthor=J.-H.+Hoauthor=Y.+Wuauthor=L.+Wuauthor=P.+Popovauthor=O.+Benchamaauthor=N.+Zvonokauthor=K.+a.+Lockeauthor=L.+Quauthor=G.+W.+Hanauthor=M.+R.+Iyerauthor=R.+Cinarauthor=N.+J.+Coffeyauthor=J.+Wangauthor=M.+Wuauthor=V.+Katritchauthor=S.+Zhaoauthor=G.+Kunosauthor=L.+M.+Bohnauthor=A.+Makriyannisauthor=R.+C.+Stevensauthor=Z.-J.+Liu&title=Crystal+structure+of+the+human+cannabinoid+receptor+CB2&doi=10.1016%2Fj.cell.2018.12.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of the Human Cannabinoid Receptor CB2</span></div><div class="casAuthors">Li, Xiaoting; Hua, Tian; Vemuri, Kiran; Ho, Jo-Hao; Wu, Yiran; Wu, Lijie; Popov, Petr; Benchama, Othman; Zvonok, Nikolai; Locke, K'ara; Qu, Lu; Han, Gye Won; Iyer, Malliga R.; Cinar, Resat; Coffey, Nathan J.; Wang, Jingjing; Wu, Meng; Katritch, Vsevolod; Zhao, Suwen; Kunos, George; Bohn, Laura M.; Makriyannis, Alexandros; Stevens, Raymond C.; Liu, Zhi-Jie</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">459-467.e13</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The cannabinoid receptor CB2 is predominately expressed in the immune system, and selective modulation of CB2 without the psychoactivity of CB1 has therapeutic potential in inflammatory, fibrotic, and neurodegenerative diseases.  Here, we report the crystal structure of human CB2 in complex with a rationally designed antagonist, AM10257, at 2.8 Å resoln.  The CB2-AM10257 structure reveals a distinctly different binding pose compared with CB1.  However, the extracellular portion of the antagonist-bound CB2 shares a high degree of conformational similarity with the agonist-bound CB1, which led to the discovery of AM10257's unexpected opposing functional profile of CB2 antagonism vs. CB1 agonism.  Further structural anal. using mutagenesis studies and mol. docking revealed the mol. basis of their function and selectivity for CB2 and CB1.  Addnl. analyses of our designed antagonist and agonist pairs provide important insight into the activation mechanism of CB2.  The present findings should facilitate rational drug design toward precise modulation of the endocannabinoid system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFwNUEO0q03LVg90H21EOLACvtfcHk0lgg11VAV0Z_Xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXovFKktw%253D%253D&md5=90ee72a6dc13b74b84fb6799c3aa0471</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2018.12.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2018.12.011%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DHua%26aufirst%3DT.%26aulast%3DVemuri%26aufirst%3DK.%26aulast%3DHo%26aufirst%3DJ.-H.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DPopov%26aufirst%3DP.%26aulast%3DBenchama%26aufirst%3DO.%26aulast%3DZvonok%26aufirst%3DN.%26aulast%3DLocke%26aufirst%3DK.%2Ba.%26aulast%3DQu%26aufirst%3DL.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DIyer%26aufirst%3DM.%2BR.%26aulast%3DCinar%26aufirst%3DR.%26aulast%3DCoffey%26aufirst%3DN.%2BJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DKunos%26aufirst%3DG.%26aulast%3DBohn%26aufirst%3DL.%2BM.%26aulast%3DMakriyannis%26aufirst%3DA.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DLiu%26aufirst%3DZ.-J.%26atitle%3DCrystal%2520structure%2520of%2520the%2520human%2520cannabinoid%2520receptor%2520CB2%26jtitle%3DCell%26date%3D2019%26volume%3D176%26spage%3D459%26epage%3D467%26doi%3D10.1016%2Fj.cell.2018.12.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollman, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Case, D. A.</span></span> <span> </span><span class="NLM_article-title">Antechamber: an accessory software package for molecular mechanical calculations</span>. <i>J. Am. Chem. Soc</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>222</i></span>,  <span class="NLM_fpage">U403</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=222&publication_year=2001&pages=U403&author=J.+Wangauthor=W.+Wangauthor=P.+A.+Kollmanauthor=D.+A.+Case&title=Antechamber%3A+an+accessory+software+package+for+molecular+mechanical+calculations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26aulast%3DCase%26aufirst%3DD.%2BA.%26atitle%3DAntechamber%253A%2520an%2520accessory%2520software%2520package%2520for%2520molecular%2520mechanical%2520calculations%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc%26date%3D2001%26volume%3D222%26spage%3DU403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pearlman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Case, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheatham, T. E.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeBolt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seibel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollman, P.</span></span> <span> </span><span class="NLM_article-title">AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules</span>. <i>Comput. Phys. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">41</span>, <span class="refDoi"> DOI: 10.1016/0010-4655(95)00041-d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1016%2F0010-4655%2895%2900041-D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADyaK2MXps1Wrtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1995&pages=1-41&author=D.+A.+Pearlmanauthor=D.+A.+Caseauthor=J.+W.+Caldwellauthor=W.+S.+Rossauthor=T.+E.+Cheathamauthor=S.+DeBoltauthor=D.+Fergusonauthor=G.+Seibelauthor=P.+Kollman&title=AMBER%2C+a+package+of+computer+programs+for+applying+molecular+mechanics%2C+normal+mode+analysis%2C+molecular+dynamics+and+free+energy+calculations+to+simulate+the+structural+and+energetic+properties+of+molecules&doi=10.1016%2F0010-4655%2895%2900041-d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">"AMBER", a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to stimulate the structural and energetic properties of molecules</span></div><div class="casAuthors">Pearlman, David A.; Case, David A.; Caldwell, James W.; Ross, Wilson S.; Cheatham, Thomas E. III; DeBolt, Steve; Ferguson, David; Seibel, George; Kollman, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Computer Physics Communications</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">1-42</span>CODEN:
                <span class="NLM_cas:coden">CPHCBZ</span>;
        ISSN:<span class="NLM_cas:issn">0010-4655</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">We describe the development, current features, and some directions for future development of the AMBER package of computer programs.  This package has evolved from a program that was constructed to do Assisted Model Building and Energy Refinement to a group of programs embodying a no. of the powerful tools of modern computational chem.-mol. dynamics and free energy calcns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvhHD9oiNecbVg90H21EOLACvtfcHk0ljMAQmLgh9QzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXps1Wrtrw%253D&md5=8dc71939a46bbc17d5da08782d4e6ec8</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2F0010-4655%2895%2900041-D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0010-4655%252895%252900041-D%26sid%3Dliteratum%253Aachs%26aulast%3DPearlman%26aufirst%3DD.%2BA.%26aulast%3DCase%26aufirst%3DD.%2BA.%26aulast%3DCaldwell%26aufirst%3DJ.%2BW.%26aulast%3DRoss%26aufirst%3DW.%2BS.%26aulast%3DCheatham%26aufirst%3DT.%2BE.%26aulast%3DDeBolt%26aufirst%3DS.%26aulast%3DFerguson%26aufirst%3DD.%26aulast%3DSeibel%26aufirst%3DG.%26aulast%3DKollman%26aufirst%3DP.%26atitle%3DAMBER%252C%2520a%2520package%2520of%2520computer%2520programs%2520for%2520applying%2520molecular%2520mechanics%252C%2520normal%2520mode%2520analysis%252C%2520molecular%2520dynamics%2520and%2520free%2520energy%2520calculations%2520to%2520simulate%2520the%2520structural%2520and%2520energetic%2520properties%2520of%2520molecules%26jtitle%3DComput.%2520Phys.%2520Commun.%26date%3D1995%26volume%3D91%26spage%3D1%26epage%3D41%26doi%3D10.1016%2F0010-4655%2895%2900041-d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, B. R.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGee, T. D.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swails, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Homeyer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gohlke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roitberg, A. E.</span></span> <span> </span><span class="NLM_article-title">MMPBSA py: an efficient program for end-state free energy calculations</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">3314</span>– <span class="NLM_lpage">3321</span>, <span class="refDoi"> DOI: 10.1021/ct300418h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ct300418h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtV2gtrzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=3314-3321&author=B.+R.+Millerauthor=T.+D.+McGeeauthor=J.+M.+Swailsauthor=N.+Homeyerauthor=H.+Gohlkeauthor=A.+E.+Roitberg&title=MMPBSA+py%3A+an+efficient+program+for+end-state+free+energy+calculations&doi=10.1021%2Fct300418h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">MMPBSA.py: An Efficient Program for End-State Free Energy Calculations</span></div><div class="casAuthors">Miller, Bill R., III; McGee, T. Dwight, Jr.; Swails, Jason M.; Homeyer, Nadine; Gohlke, Holger; Roitberg, Adrian E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3314-3321</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">MM-PBSA is a post-processing end-state method to calc. free energies of mols. in soln.  MMPBSA.py is a program written in Python for streamlining end-state free energy calcns. using ensembles derived from mol. dynamics (MD) or Monte Carlo (MC) simulations.  Several implicit solvation models are available with MMPBSA.py, including the Poisson-Boltzmann Model, the Generalized Born Model, and the Ref. Interaction Site Model.  Vibrational frequencies may be calcd. using normal mode or quasi-harmonic anal. to approx. the solute entropy.  Specific interactions can also be dissected using free energy decompn. or alanine scanning.  A parallel implementation significantly speeds up the calcn. by dividing frames evenly across available processors.  MMPBSA.py is an efficient, user-friendly program with the flexibility to accommodate the needs of users performing end-state free energy calcns.  The source code can be downloaded at http://ambermd.org/ with AmberTools, released under the GNU General Public License.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZK3C1jqiSULVg90H21EOLACvtfcHk0ljMAQmLgh9QzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtV2gtrzP&md5=cc4148bd8f70c7cad94fd3ec6f580e52</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fct300418h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct300418h%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DB.%2BR.%26aulast%3DMcGee%26aufirst%3DT.%2BD.%26aulast%3DSwails%26aufirst%3DJ.%2BM.%26aulast%3DHomeyer%26aufirst%3DN.%26aulast%3DGohlke%26aufirst%3DH.%26aulast%3DRoitberg%26aufirst%3DA.%2BE.%26atitle%3DMMPBSA%2520py%253A%2520an%2520efficient%2520program%2520for%2520end-state%2520free%2520energy%2520calculations%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2012%26volume%3D8%26spage%3D3314%26epage%3D3321%26doi%3D10.1021%2Fct300418h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeLano, W. L.</span></span> <span> </span><span class="NLM_article-title">Pymol: An open-source molecular graphics tool</span>. <i>CCP4 Newsl. protein crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">82</span>– <span class="NLM_lpage">92</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2002&pages=82-92&author=W.+L.+DeLano&title=Pymol%3A+An+open-source+molecular+graphics+tool"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeLano%26aufirst%3DW.%2BL.%26atitle%3DPymol%253A%2520An%2520open-source%2520molecular%2520graphics%2520tool%26jtitle%3DCCP4%2520Newsl.%2520protein%2520crystallogr.%26date%3D2002%26volume%3D40%26spage%3D82%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/medium/jm1c00442_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/large/jm1c00442_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00442&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/medium/jm1c00442_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/large/jm1c00442_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of JWH-018<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/large/jm1c00442_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00442&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) MeMgBr, Et<sub>2</sub>O/THF, 0 °C, then 1-naphthoyl Cl, reflux. (b) <i>n</i>-Pentyl Cl, KOH, DMSO, 80 °C.</p></p></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/medium/jm1c00442_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/large/jm1c00442_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Rational design of a novel class of potent cannabinoids.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/large/jm1c00442_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00442&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/medium/jm1c00442_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/large/jm1c00442_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Overview of the Synthetic Approach</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/large/jm1c00442_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00442&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/medium/jm1c00442_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/large/jm1c00442_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Benzoate 10, the Precursor to 3-(Indan-4-oyl)indole GBD-002<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/large/jm1c00442_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00442&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2-fluorobenzyl bromide, LDA, THF, −78 °C to rt, 5 h, 81%. (b) DIBAL-H, THF, −78 °C to rt, 1 h, 88%. (c) MsCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 1 h, 91%. (d) NaI, NMP, 140 °C, 8 h, 89%. (e) (i) <i>t</i>-BuLi, <i>n</i>-pentane-Et<sub>2</sub>O (4:1 by vol), −78 °C, 15 min; (ii) THF, −78 °C; (iii) −78 °C to rt to −78 °C; (iv) ClCO<sub>2</sub>Et, −78 °C (15 min) to rt (15 min).</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/medium/jm1c00442_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/large/jm1c00442_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of the 3-(Indan-4-oyl)indole GBD-002<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/large/jm1c00442_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00442&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Tf<sub>2</sub>O, pyridine, CH<sub>2</sub>Cl<sub>2</sub>, −78 °C to rt, 20 min, 97%. (b) (i) lithio ethyl acetate, THF, −78 °C, 20 min; (ii) LHMDS, 0 °C (10 min) to rt (1 h), 63%. (c) Tf<sub>2</sub>O, aq. LiOH, hexanes, 0 °C to rt, 30 min, 88%. (d) LHMDS, THF, 0 °C to rt, 1 h, 63%. (e) (i) [Rh(cod)<sub>2</sub>]BF<sub>4</sub>, (±)-BINAP, H<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h; (ii) TMS-acetylene, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h, 90%. (f) KI, TMSCl, H<sub>2</sub>O, CH<sub>3</sub>CN, 60 °C, 12 h, 68%. (g) KOH, H<sub>2</sub>O, EtOH, rt, 8 h, 95%. (h) (i) SOCl<sub>2</sub>, DMF, CH<sub>2</sub>Cl<sub>2</sub>, rt, 8 h; (ii) <i>N</i>-pentylindole, HFIP, rt, 24 h, 68%.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/medium/jm1c00442_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/large/jm1c00442_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of 3-(Indan-5-oyl)indoles<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/large/jm1c00442_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00442&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Tf<sub>2</sub>O, pyridine, CH<sub>2</sub>Cl<sub>2</sub>, −78 °C to rt, 20 min, 97%. (b) DIBAL-H, THF, −78 °C, 1–2 h, 90%. (c) Ethyl-<i>E</i>-4-(diethoxyphosphoryl)but-2-enoate, LHMDS, THF, −78 °C (15 min) to rt to 60 °C (1 h), 82%. (d) (i) [Rh(nbd)Cl]<sub>2</sub>, AgSbF<sub>6</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h; (ii) DDQ, rt, 2 h, 85%. (e) KOH, H<sub>2</sub>O, EtOH, rt, 8 h, 96%. (f) (i) SOCl<sub>2</sub>, DMF, CH<sub>2</sub>Cl<sub>2</sub>, rt, 8 h; (ii) indole or 2-methylindole, HFIP, rt, 24 h, 53–58%. (g) Alkyl halide, NaH, DMSO, rt, 8 h.</p></p></figure><figure data-id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/medium/jm1c00442_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/large/jm1c00442_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Affinities (<i>K</i><sub><i>i</i></sub>) of selected derivatives for <i>h</i>CB<sub>1</sub> and <i>h</i>CB<sub>2</sub> receptors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/large/jm1c00442_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00442&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/medium/jm1c00442_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/large/jm1c00442_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Binding modes of selected derivatives in CB<sub>1</sub> (A1–F1) and CB<sub>2</sub> (A2–F2) receptors. (A1) GBD-002 (3), CB<sub>1</sub>; (A2) GBD-002 (3), CB<sub>2</sub>; (B1) GBD-003 (4), CB<sub>1</sub>; (B2) GBD-003 (4), CB<sub>2</sub>; (C1) GBD-005 (26), CB<sub>1</sub>; (C2) GBD-005 (26), CB<sub>2</sub>; (D1) GBD-013 (34), CB<sub>1</sub>; (D2) GBD-013 (34), CB<sub>2</sub>; (E1) GBD-014 (35), CB<sub>1</sub>; (E2) GBD-014 (35), CB<sub>2</sub>; (F1) GBD-029 (49), CB<sub>1</sub>; (F2) GBD-029 (49), CB<sub>2</sub>. Original crystal structures of CB<sub>1</sub>R (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5XR8">5XR8</a>) and CB<sub>2</sub>R (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZTY">5ZTY</a>) were obtained from the Protein Data Bank for modeling. Pivotal to the difference in binding modes of these compounds between CB<sub>1</sub>R and CB<sub>2</sub>R are the residue changes L193/I110 and L481/V261 (in CB<sub>1</sub>R and CB<sub>2</sub>R, respectively). These substitutions allow for the central indole scaffold of the GBD compounds to rotate, allowing for the dimethylindane moiety and its connecting ketone to engage in hydrogen bonding with S285. Modifications to the aliphatic chain such as truncation (C1-2) and dehydrogenation (D1-2, E1-2) reduce hydrophobic interactions with the nearby hydrophobic pockets in CB<sub>1</sub>R and CB<sub>2</sub>R. The resulting indole moiety rotation due to the residue changes between CB<sub>1</sub>R and CB<sub>2</sub>R also allows for substitutions (F1–F2) on the indole moiety with CB2R that are otherwise unavailable in CB<sub>1</sub>R.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/large/jm1c00442_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00442&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/medium/jm1c00442_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/large/jm1c00442_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. GBD-003 acts as an antagonist at CHO-<i>h</i>CB2 receptors, producing concentration-dependent reduction of G-protein activation produced by the <i>h</i>CB2 receptor agonist CP-55,940.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00442/20210506/images/large/jm1c00442_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00442&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i81">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26167" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26167" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 76 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Marzo, V.</span></span> <span> </span><span class="NLM_article-title">Targeting the Endocannabinoid System: To Enhance or Reduce?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">438</span>– <span class="NLM_lpage">455</span>, <span class="refDoi"> DOI: 10.1038/nrd2553</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1038%2Fnrd2553" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=18446159" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlt1agtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=438-455&author=V.+Di%0AMarzo&title=Targeting+the+Endocannabinoid+System%3A+To+Enhance+or+Reduce%3F&doi=10.1038%2Fnrd2553"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the endocannabinoid system: to enhance or reduce?</span></div><div class="casAuthors">Di Marzo, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">438-455</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In this Review, the author discusses how prolonging the lifespan of endocannabinoids or toning down their action may be beneficial in a range of conditions such as pain, affective and neurodegenerative disorders, gastrointestinal inflammation, and obesity and metabolic dysfunctions.  As our understanding of the endocannabinoids improves, so does the awareness of their complexity.  During pathol. states, the levels of these mediators in tissues change, and their effects vary from those of protective endogenous compds. to those of dysregulated signals.  These observations led to the discovery of compds. that either prolong the lifespan of endocannabinoids or tone down their action for the potential future treatment of pain, affective and neurodegenerative disorders, gastrointestinal inflammation, obesity and metabolic dysfunctions, cardiovascular conditions and liver diseases.  When moving to the clinic, however, the pleiotropic nature of endocannabinoid functions will require careful judgement in the choice of patients and stage of the disorder for treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpebzNFDRaNEbVg90H21EOLACvtfcHk0lgvWekd2bQC8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlt1agtbk%253D&md5=f0af1a666a7c51a594d94661bfb5a7d9</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd2553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2553%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26atitle%3DTargeting%2520the%2520Endocannabinoid%2520System%253A%2520To%2520Enhance%2520or%2520Reduce%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D438%26epage%3D455%26doi%3D10.1038%2Fnrd2553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Finn, D. P.</span></span> <span> </span><span class="NLM_article-title">Endocannabinoid-mediated Modulation of Stress Responses: Physiological and Pathophysiological Significance</span>. <i>Immunobiology</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>215</i></span>,  <span class="NLM_fpage">629</span>– <span class="NLM_lpage">646</span>, <span class="refDoi"> DOI: 10.1016/j.imbio.2009.05.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1016%2Fj.imbio.2009.05.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=19616342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsVCks7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=215&publication_year=2010&pages=629-646&author=D.+P.+Finn&title=Endocannabinoid-mediated+Modulation+of+Stress+Responses%3A+Physiological+and+Pathophysiological+Significance&doi=10.1016%2Fj.imbio.2009.05.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Endocannabinoid-mediated modulation of stress responses: Physiological and pathophysiological significance</span></div><div class="casAuthors">Finn, David P.</div><div class="citationInfo"><span class="NLM_cas:title">Immunobiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">215</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">629-646</span>CODEN:
                <span class="NLM_cas:coden">IMMND4</span>;
        ISSN:<span class="NLM_cas:issn">0171-2985</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">A review.  The stress response is assocd. with a broad spectrum of physiol. and behavioral effects including hypothalamo-pituitary-adrenal (HPA) axis activation, altered central nervous system activity, neuroimmune alterations, anxiety- and depressive-like behavior and analgesia.  While the acute stress response has essential survival value, chronic stress and dysfunction of the stress response can be maladaptive, contributing to the development and severity of psychiatric and pain disorders.  The endogenous cannabinoid (endocannabinoid) system has emerged as an important lipid signalling system playing a key role in mediating and/or modulating behavioral, neurochem., neuroendocrine, neuroimmune and mol. responses to stress.  The wt. of evidence, reviewed here, points largely to a system which serves to constrain HPA axis activity, facilitate adaptation or habituation of HPA axis and behavioral responses to stress, reduce anxiety- and depressive-like behavior and mediate analgesic responses to unconditioned or conditioned stress.  Possible involvement of the immune system and assocd. signalling mols. (e.g. cytokines) in endocannabinoid-mediated modulation of neuroendocrine and behavioral responses to stress is considered.  The goal now should be to exploit our understanding of the role of the endocannabinoid system in fundamental stress physiol. and pathophysiol. processes to better understand and treat a range of stress-related disorders including anxiety, depression and pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQRqOvTRnLvbVg90H21EOLACvtfcHk0lh5Q2yYZwtkGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsVCks7k%253D&md5=2ba724255538778ce634858e5da7ce5f</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.imbio.2009.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.imbio.2009.05.011%26sid%3Dliteratum%253Aachs%26aulast%3DFinn%26aufirst%3DD.%2BP.%26atitle%3DEndocannabinoid-mediated%2520Modulation%2520of%2520Stress%2520Responses%253A%2520Physiological%2520and%2520Pathophysiological%2520Significance%26jtitle%3DImmunobiology%26date%3D2010%26volume%3D215%26spage%3D629%26epage%3D646%26doi%3D10.1016%2Fj.imbio.2009.05.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bab, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmer, A.</span></span> <span> </span><span class="NLM_article-title">Cannabinoid Receptors and the Regulation of Bone Mass</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>153</i></span>,  <span class="NLM_fpage">182</span>– <span class="NLM_lpage">188</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0707593</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1038%2Fsj.bjp.0707593" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=18071301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovFClsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2008&pages=182-188&author=I.+Babauthor=A.+Zimmer&title=Cannabinoid+Receptors+and+the+Regulation+of+Bone+Mass&doi=10.1038%2Fsj.bjp.0707593"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid receptors and the regulation of bone mass</span></div><div class="casAuthors">Bab, I.; Zimmer, A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">182-188</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  A functional endocannabinoid system is present in several mammalian organs and tissues.  Recently, endocannabinoids and their receptors have been reported in the skeleton.  Osteoblasts, the bone forming cells, and osteoclasts, the bone resorbing cells, produce the endocannabinoids anandamide and 2-arachidonoylglycerol and express CB2 cannabinoid receptors.  Although CB2 has been implicated in pathol. processes in the central nervous system and peripheral tissues, the skeleton appears as the main system physiol. regulated by CB2.  CB2-deficient mice show a markedly accelerated age-related bone loss and the CNR2 gene (encoding CB2) in women is assocd. with low bone mineral d.  The activation of CB2 attenuates ovariectomy-induced bone loss in mice by restraining bone resorption and enhancing bone formation.  Hence synthetic CB2 ligands, which are stable and orally available, provide a basis for developing novel anti-osteoporotic therapies.  Activation of CB1 in sympathetic nerve terminals in bone inhibits norepinephrine release, thus balancing the tonic sympathetic restrain of bone formation.  Low levels of CB1 were also reported in osteoclasts.  CB1-null mice display a skeletal phenotype that is dependent on the mouse strain, gender and specific mutation of the CB1 encoding gene, CNR1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe0y7uhkrEE7Vg90H21EOLACvtfcHk0lh5Q2yYZwtkGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovFClsA%253D%253D&md5=c461a34365f7c258bbb9b422f8e0bd48</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707593%26sid%3Dliteratum%253Aachs%26aulast%3DBab%26aufirst%3DI.%26aulast%3DZimmer%26aufirst%3DA.%26atitle%3DCannabinoid%2520Receptors%2520and%2520the%2520Regulation%2520of%2520Bone%2520Mass%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D153%26spage%3D182%26epage%3D188%26doi%3D10.1038%2Fsj.bjp.0707593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oesch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gertsch, J.</span></span> <span> </span><span class="NLM_article-title">Cannabinoid Receptor Ligands as Potential Anticancer Agents—High Hopes for New Therapies?</span>. <i>J. Pharm. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">839</span>– <span class="NLM_lpage">853</span>, <span class="refDoi"> DOI: 10.1211/jpp/61.07.0002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1211%2Fjpp%2F61.07.0002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=19589225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1Wrt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2009&pages=839-853&author=S.+Oeschauthor=J.+Gertsch&title=Cannabinoid+Receptor+Ligands+as+Potential+Anticancer+Agents%E2%80%94High+Hopes+for+New+Therapies%3F&doi=10.1211%2Fjpp%2F61.07.0002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid receptor ligands as potential anticancer agents - high hopes for new therapies?</span></div><div class="casAuthors">Oesch, Susanne; Gertsch, Jurg</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">839-853</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Press</span>)
        </div><div class="casAbstract">A review.  Objectives: The endocannabinoid system is an endogenous lipid signaling network comprising arachidonic-acid-derived ligands, cannabinoid (CB) receptors, transporters and endocannabinoid degrading enzymes.  The CB1 receptor is predominantly expressed in neurons but is also co-expressed with the CB2 receptor in peripheral tissues.  In recent years, CB receptor ligands, including Δ9-tetrahydrocannabinol, have been proposed as potential anticancer agents.  Key findings: This review critically discusses the pharmacol. of CB receptor activation as a novel therapeutic anticancer strategy in terms of ligand selectivity, tissue specificity and potency.  Intriguingly, antitumor effects mediated by cannabinoids are not confined to inhibition of cancer cell proliferation; cannabinoids also reduce angiogenesis, cell migration and metastasis, inhibit carcinogenesis and attenuate inflammatory processes.  In the last decade several new selective CB1 and CB2 receptor agents have been described, but most studies in the area of cancer research have used non-selective CB ligands.  Moreover, many of these ligands exert prominent CB receptor-independent pharmacol. effects, such as activation of the G-protein-coupled receptor GPR55, peroxisome proliferator-activated receptor gamma and the transient receptor potential vanilloid channels.  Summary: The role of the endocannabinoid system in tumorigenesis is still poorly understood and the mol. mechanisms of cannabinoid anticancer action need to be elucidated.  The development of CB2-selective anticancer agents could be advantageous in light of the unwanted central effects exerted by CB1 receptor ligands.  Probably the most interesting question is whether cannabinoids could be useful in chemoprevention or in combination with established chemotherapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqscGZonAECY7Vg90H21EOLACvtfcHk0lh5Q2yYZwtkGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1Wrt74%253D&md5=d9a2239211393bfb12501b3cfe789397</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1211%2Fjpp%2F61.07.0002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1211%252Fjpp%252F61.07.0002%26sid%3Dliteratum%253Aachs%26aulast%3DOesch%26aufirst%3DS.%26aulast%3DGertsch%26aufirst%3DJ.%26atitle%3DCannabinoid%2520Receptor%2520Ligands%2520as%2520Potential%2520Anticancer%2520Agents%25E2%2580%2594High%2520Hopes%2520for%2520New%2520Therapies%253F%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2009%26volume%3D61%26spage%3D839%26epage%3D853%26doi%3D10.1211%2Fjpp%2F61.07.0002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karsak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaffal, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Date, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang-Eckhardt, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehnelt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrosino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starowicz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steuder, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlicker, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mechoulam, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buettner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuting, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmer, A.</span></span> <span> </span><span class="NLM_article-title">Attenuation of Allergic Contact Dermatitis Through the Endocannabinoid System</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>316</i></span>,  <span class="NLM_fpage">1494</span>– <span class="NLM_lpage">1497</span>, <span class="refDoi"> DOI: 10.1126/science.1142265</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1126%2Fscience.1142265" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=17556587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtFSjtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2007&pages=1494-1497&author=M.+Karsakauthor=E.+Gaffalauthor=R.+Dateauthor=L.+Wang-Eckhardtauthor=J.+Rehneltauthor=S.+Petrosinoauthor=K.+Starowiczauthor=R.+Steuderauthor=E.+Schlickerauthor=B.+Cravattauthor=R.+Mechoulamauthor=R.+Buettnerauthor=S.+Wernerauthor=V.+Di+Marzoauthor=T.+Tutingauthor=A.+Zimmer&title=Attenuation+of+Allergic+Contact+Dermatitis+Through+the+Endocannabinoid+System&doi=10.1126%2Fscience.1142265"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Attenuation of Allergic Contact Dermatitis Through the Endocannabinoid System</span></div><div class="casAuthors">Karsak, Meliha; Gaffal, Evelyn; Date, Rahul; Wang-Eckhardt, Lihua; Rehnelt, Jennifer; Petrosino, Stefania; Starowicz, Katarzyna; Steuder, Regina; Schlicker, Eberhard; Cravatt, Benjamin; Mechoulam, Raphael; Buettner, Reinhard; Werner, Sabine; Di Marzo, Vincenzo; Tueting, Thomas; Zimmer, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">5830</span>),
    <span class="NLM_cas:pages">1494-1497</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Allergic contact dermatitis affects about 5% of men and 11% of women in industrialized countries and is one of the leading causes for occupational diseases.  In an animal model for cutaneous contact hypersensitivity, we show that mice lacking both known cannabinoid receptors display exacerbated allergic inflammation.  In contrast, fatty acid amide hydrolase-deficient mice, which have increased levels of the endocannabinoid anandamide, displayed reduced allergic responses in the skin.  Cannabinoid receptor antagonists exacerbated allergic inflammation, whereas receptor agonists attenuated inflammation.  These results demonstrate a protective role of the endocannabinoid system in contact allergy in the skin and suggest a target for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1tpJ3yv_vibVg90H21EOLACvtfcHk0liDN5QZ7OYkyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtFSjtrs%253D&md5=e0e96eaa16eedaec7bd642255546be3a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.1142265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1142265%26sid%3Dliteratum%253Aachs%26aulast%3DKarsak%26aufirst%3DM.%26aulast%3DGaffal%26aufirst%3DE.%26aulast%3DDate%26aufirst%3DR.%26aulast%3DWang-Eckhardt%26aufirst%3DL.%26aulast%3DRehnelt%26aufirst%3DJ.%26aulast%3DPetrosino%26aufirst%3DS.%26aulast%3DStarowicz%26aufirst%3DK.%26aulast%3DSteuder%26aufirst%3DR.%26aulast%3DSchlicker%26aufirst%3DE.%26aulast%3DCravatt%26aufirst%3DB.%26aulast%3DMechoulam%26aufirst%3DR.%26aulast%3DBuettner%26aufirst%3DR.%26aulast%3DWerner%26aufirst%3DS.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DTuting%26aufirst%3DT.%26aulast%3DZimmer%26aufirst%3DA.%26atitle%3DAttenuation%2520of%2520Allergic%2520Contact%2520Dermatitis%2520Through%2520the%2520Endocannabinoid%2520System%26jtitle%3DScience%26date%3D2007%26volume%3D316%26spage%3D1494%26epage%3D1497%26doi%3D10.1126%2Fscience.1142265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guindon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hohmann, A. G.</span></span> <span> </span><span class="NLM_article-title">Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>153</i></span>,  <span class="NLM_fpage">319</span>– <span class="NLM_lpage">334</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0707531</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1038%2Fsj.bjp.0707531" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=17994113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovFCluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2008&pages=319-334&author=J.+Guindonauthor=A.+G.+Hohmann&title=Cannabinoid+CB2+receptors%3A+a+therapeutic+target+for+the+treatment+of+inflammatory+and+neuropathic+pain&doi=10.1038%2Fsj.bjp.0707531"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain</span></div><div class="casAuthors">Guindon, J.; Hohmann, A. G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">319-334</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cannabinoids suppress behavioral responses to noxious stimulation and suppress nociceptive transmission through activation of CB1 and CB2 receptor subtypes.  CB1 receptors are expressed at high levels in the central nervous system (CNS), whereas CB2 receptors are found predominantly, but not exclusively, outside the CNS.  CB2 receptors are also upregulated in the CNS and dorsal root ganglia by pathol. pain states.  Here, we review behavioral, neurochem. and electrophysiol. data, which identify cannabinoid CB2 receptors as a therapeutic target for treating pathol. pain states with limited centrally, mediated side effects.  The development of CB2-selective agonists (with minimal affinity for CB1) as well as mutant mice lacking CB2 receptors has provided pharmacol. and genetic tools required to evaluate the effectiveness of CB2 agonists in suppressing persistent pain states.  This review will examine the efficacy of cannabinoid CB2-selective agonists in suppressing acute, inflammatory and neuropathic nociception following systemic and local routes of administration.  Data derived from behavioral, neurochem. and neurophysiol. approaches are discussed to better understand the relationship between antinociceptive effects induced by CB2-selective agonists in behavioral studies and neural mechanisms of pain suppression.  Finally, the therapeutic potential and possible limitations of CB2-based pharmacotherapies for pathol. pain states induced by tissue and nerve injury are discussed.  British Journal of Pharmacol. (2008) 153, 319-334; doi:10.1038/sj.bjp.0707531; published online 12 Nov. 2007.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpi3vVhN_50fbVg90H21EOLACvtfcHk0liDN5QZ7OYkyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovFCluw%253D%253D&md5=85e6d615696a73a3538587b564a2fe12</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707531%26sid%3Dliteratum%253Aachs%26aulast%3DGuindon%26aufirst%3DJ.%26aulast%3DHohmann%26aufirst%3DA.%2BG.%26atitle%3DCannabinoid%2520CB2%2520receptors%253A%2520a%2520therapeutic%2520target%2520for%2520the%2520treatment%2520of%2520inflammatory%2520and%2520neuropathic%2520pain%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D153%26spage%3D319%26epage%3D334%26doi%3D10.1038%2Fsj.bjp.0707531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malfitano, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciaglia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gangemi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gazzerro, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laezza, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bifulco, M.</span></span> <span> </span><span class="NLM_article-title">Update on the Endocannabinoid System as an Anticancer Target</span>. <i>Expert Opin. Ther. Targets</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">297</span>– <span class="NLM_lpage">308</span>, <span class="refDoi"> DOI: 10.1517/14728222.2011.553606</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1517%2F14728222.2011.553606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=21244344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ymu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2011&pages=297-308&author=A.+M.+Malfitanoauthor=E.+Ciagliaauthor=G.+Gangemiauthor=P.+Gazzerroauthor=C.+Laezzaauthor=M.+Bifulco&title=Update+on+the+Endocannabinoid+System+as+an+Anticancer+Target&doi=10.1517%2F14728222.2011.553606"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Update on the endocannabinoid system as an anticancer target</span></div><div class="casAuthors">Malfitano, Anna Maria; Ciaglia, Elena; Gangemi, Giuseppina; Gazzerro, Patrizia; Laezza, Chiara; Bifulco, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-308</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Recent studies have shown that the endocannabinoid system (ECS) could offer an attractive antitumor target.  Numerous findings suggest the involvement of this system (constituted mainly by cannabinoid receptors, endogenous compds. and the enzymes for their synthesis and degrdn.) in cancer cell growth in vitro and in vivo.  Areas covered: This review covers literature from the past decade which highlights the potential of targeting the ECS for cancer treatment.  In particular, the levels of endocannabinoids and the expression of their receptors in several types of cancer are discussed, along with the signaling pathways involved in the endocannabinoid antitumor effects.  Furthermore, the beneficial and adverse effects of old and novel compds. in clin. use are discussed.  Expert opinion: One direction that should be pursued in antitumor therapy is to select compds. with reduced psychoactivity.  This is known to be connected to the CB1 receptor; thus, targeting the CB2 receptor is a popular objective.  CB1 receptors could be maintained as a target to design new compds., and mixed CB1--CB2 ligands could be effective if they are able to not cross the BBB.  Furthermore, targeting the ECS with agents that activate cannabinoid receptors or inhibitors of endogenous degrading systems such as fatty acid amide hydrolase inhibitors may have relevant therapeutic impact on tumor growth.  Addnl. studies into the downstream consequences of endocannabinoid treatment are required and may illuminate other potential therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcuutAXHAhSbVg90H21EOLACvtfcHk0liDN5QZ7OYkyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ymu7Y%253D&md5=916c99794b810380681457f8aa898183</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1517%2F14728222.2011.553606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.2011.553606%26sid%3Dliteratum%253Aachs%26aulast%3DMalfitano%26aufirst%3DA.%2BM.%26aulast%3DCiaglia%26aufirst%3DE.%26aulast%3DGangemi%26aufirst%3DG.%26aulast%3DGazzerro%26aufirst%3DP.%26aulast%3DLaezza%26aufirst%3DC.%26aulast%3DBifulco%26aufirst%3DM.%26atitle%3DUpdate%2520on%2520the%2520Endocannabinoid%2520System%2520as%2520an%2520Anticancer%2520Target%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2011%26volume%3D15%26spage%3D297%26epage%3D308%26doi%3D10.1517%2F14728222.2011.553606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cianchi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papucci, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiavone, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lulli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinci, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messerini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manera, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronconi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romagnani, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perigli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trallori, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanganelli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capaccioli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masini, E.</span></span> <span> </span><span class="NLM_article-title">Cannabinoid Receptor Activation Induces Apoptosis Through Tumor Necrosis Factor Alpha-mediated Ceramide de novo Synthesis in Colon Cancer Cells</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">7691</span>– <span class="NLM_lpage">7700</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.ccr-08-0799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1158%2F1078-0432.CCR-08-0799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=19047095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVegtrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=7691-7700&author=F.+Cianchiauthor=L.+Papucciauthor=N.+Schiavoneauthor=M.+Lulliauthor=L.+Magnelliauthor=M.+C.+Vinciauthor=L.+Messeriniauthor=C.+Maneraauthor=E.+Ronconiauthor=P.+Romagnaniauthor=M.+Donniniauthor=G.+Perigliauthor=G.+Tralloriauthor=E.+Tanganelliauthor=S.+Capaccioliauthor=E.+Masini&title=Cannabinoid+Receptor+Activation+Induces+Apoptosis+Through+Tumor+Necrosis+Factor+Alpha-mediated+Ceramide+de+novo+Synthesis+in+Colon+Cancer+Cells&doi=10.1158%2F1078-0432.ccr-08-0799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid Receptor Activation Induces Apoptosis through Tumor Necrosis Factor α-Mediated Ceramide De novo Synthesis in Colon Cancer Cells</span></div><div class="casAuthors">Cianchi, Fabio; Papucci, Laura; Schiavone, Nicola; Lulli, Matteo; Magnelli, Lucia; Vinci, Maria Cristina; Messerini, Luca; Manera, Clementina; Ronconi, Elisa; Romagnani, Paola; Donnini, Martino; Perigli, Giuliano; Trallori, Giacomo; Tanganelli, Elisabetta; Capaccioli, Sergio; Masini, Emanuela</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7691-7700</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Cannabinoids have been recently proposed as a new family of potential antitumor agents.  The present study was undertaken to investigate the expression of the two cannabinoid receptors, CB1 and CB2, in colorectal cancer and to provide new insight into the mol. pathways underlying the apoptotic activity induced by their activation.  Exptl. Design: Cannabinoid receptor expression was investigated in both human cancer specimens and in the DLD-1 and HT29 colon cancer cell lines.  The effects of the CB1 agonist arachinodyl-2'-chloroethylamide and the CB2 agonist N-cyclopentyl-7-methyl-1-(2-morpholin-4-ylethyl)-1,8-naphthyridin-4(1H)-on-3-carboxamide (CB13) on tumor cell apoptosis and ceramide and tumor necrosis factor (TNF)-α prodn. were evaluated.  The knockdown of TNF-α mRNA was obtained with the use of selective small interfering RNA.  RESULTS: We show that the CB1 receptor was mainly expressed in human normal colonic epithelium whereas tumor tissue was strongly pos. for the CB2 receptor.  The activation of the CB1 and, more efficiently, of the CB2 receptors induced apoptosis and increased ceramide levels in the DLD-1 and HT29 cells.  Apoptosis was prevented by the pharmacol. inhibition of ceramide de novo synthesis.  The CB2 agonist CB13 also reduced the growth of DLD-1 cells in a mouse model of colon cancer.  The knockdown of TNF-α mRNA abrogated the ceramide increase and, therefore, the apoptotic effect induced by cannabinoid receptor activation.  CONCLUSIONS: The present study shows that either CB1 or CB2 receptor activation induces apoptosis through ceramide de novo synthesis in colon cancer cells.  Our data unveiled, for the first time, that TNF-α acts as a link between cannabinoid receptor activation and ceramide prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqG5XJOnQBRA7Vg90H21EOLACvtfcHk0lhEa427qfZ09w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVegtrbP&md5=351dcff2b2b2a80adc8c14f2c79cb8d7</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-0799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-0799%26sid%3Dliteratum%253Aachs%26aulast%3DCianchi%26aufirst%3DF.%26aulast%3DPapucci%26aufirst%3DL.%26aulast%3DSchiavone%26aufirst%3DN.%26aulast%3DLulli%26aufirst%3DM.%26aulast%3DMagnelli%26aufirst%3DL.%26aulast%3DVinci%26aufirst%3DM.%2BC.%26aulast%3DMesserini%26aufirst%3DL.%26aulast%3DManera%26aufirst%3DC.%26aulast%3DRonconi%26aufirst%3DE.%26aulast%3DRomagnani%26aufirst%3DP.%26aulast%3DDonnini%26aufirst%3DM.%26aulast%3DPerigli%26aufirst%3DG.%26aulast%3DTrallori%26aufirst%3DG.%26aulast%3DTanganelli%26aufirst%3DE.%26aulast%3DCapaccioli%26aufirst%3DS.%26aulast%3DMasini%26aufirst%3DE.%26atitle%3DCannabinoid%2520Receptor%2520Activation%2520Induces%2520Apoptosis%2520Through%2520Tumor%2520Necrosis%2520Factor%2520Alpha-mediated%2520Ceramide%2520de%2520novo%2520Synthesis%2520in%2520Colon%2520Cancer%2520Cells%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D7691%26epage%3D7700%26doi%3D10.1158%2F1078-0432.ccr-08-0799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Velasco, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzmán, M.</span></span> <span> </span><span class="NLM_article-title">Towards the Use of Cannabinoids as Antitumour Agents</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">436</span>– <span class="NLM_lpage">444</span>, <span class="refDoi"> DOI: 10.1038/nrc3247</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1038%2Fnrc3247" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=22555283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsFCgs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=436-444&author=G.+Velascoauthor=C.+S%C3%A1nchezauthor=M.+Guzm%C3%A1n&title=Towards+the+Use+of+Cannabinoids+as+Antitumour+Agents&doi=10.1038%2Fnrc3247"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Towards the use of cannabinoids as antitumour agents</span></div><div class="casAuthors">Velasco, Guillermo; Sanchez, Cristina; Guzman, Manuel</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">436-444</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Various reports have shown that cannabinoids (the active components of marijuana and their derivs.) can reduce tumor growth and progression in animal models of cancer, in addn. to their well-known palliative effects on some cancer-assocd. symptoms.  This Opinion article discusses our current understanding of cannabinoids as antitumor agents, focusing on recent insights into the mol. mechanisms of action, including emerging resistance mechanisms and opportunities for combination therapy approaches.  Such knowledge is required for the optimization of preclin. cannabinoid-based therapies and for the preliminary clin. testing that is currently underway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIsOuHpKgJRLVg90H21EOLACvtfcHk0lhEa427qfZ09w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsFCgs70%253D&md5=4ec6d1bee283a5145c5c83f4c3eb5cfb</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrc3247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3247%26sid%3Dliteratum%253Aachs%26aulast%3DVelasco%26aufirst%3DG.%26aulast%3DS%25C3%25A1nchez%26aufirst%3DC.%26aulast%3DGuzm%25C3%25A1n%26aufirst%3DM.%26atitle%3DTowards%2520the%2520Use%2520of%2520Cannabinoids%2520as%2520Antitumour%2520Agents%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2012%26volume%3D12%26spage%3D436%26epage%3D444%26doi%3D10.1038%2Fnrc3247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pertwee, R. G.</span></span> <span> </span><span class="NLM_article-title">Targeting the Endocannabinoid System with Cannabinoid Receptor Agonists: Pharmacological Strategies and Therapeutic Possibilities</span>. <i>Philos. Trans. R. Soc. Lond. B Biol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>367</i></span>,  <span class="NLM_fpage">3353</span>– <span class="NLM_lpage">3363</span>, <span class="refDoi"> DOI: 10.1098/rstb.2011.0381</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1098%2Frstb.2011.0381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=23108552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A280%3ADC%252BC3s%252FptFWnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2012&pages=3353-3363&author=R.+G.+Pertwee&title=Targeting+the+Endocannabinoid+System+with+Cannabinoid+Receptor+Agonists%3A+Pharmacological+Strategies+and+Therapeutic+Possibilities&doi=10.1098%2Frstb.2011.0381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities</span></div><div class="casAuthors">Pertwee Roger G</div><div class="citationInfo"><span class="NLM_cas:title">Philosophical transactions of the Royal Society of London. Series B, Biological sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">1607</span>),
    <span class="NLM_cas:pages">3353-63</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Human tissues express cannabinoid CB(1) and CB(2) receptors that can be activated by endogenously released 'endocannabinoids' or exogenously administered compounds in a manner that reduces the symptoms or opposes the underlying causes of several disorders in need of effective therapy.  Three medicines that activate cannabinoid CB(1)/CB(2) receptors are now in the clinic: Cesamet (nabilone), Marinol (dronabinol; Δ(9)-tetrahydrocannabinol (Δ(9)-THC)) and Sativex (Δ(9)-THC with cannabidiol).  These can be prescribed for the amelioration of chemotherapy-induced nausea and vomiting (Cesamet and Marinol), stimulation of appetite (Marinol) and symptomatic relief of cancer pain and/or management of neuropathic pain and spasticity in adults with multiple sclerosis (Sativex).  This review mentions several possible additional therapeutic targets for cannabinoid receptor agonists.  These include other kinds of pain, epilepsy, anxiety, depression, Parkinson's and Huntington's diseases, amyotrophic lateral sclerosis, stroke, cancer, drug dependence, glaucoma, autoimmune uveitis, osteoporosis, sepsis, and hepatic, renal, intestinal and cardiovascular disorders.  It also describes potential strategies for improving the efficacy and/or benefit-to-risk ratio of these agonists in the clinic.  These are strategies that involve (i) targeting cannabinoid receptors located outside the blood-brain barrier, (ii) targeting cannabinoid receptors expressed by a particular tissue, (iii) targeting upregulated cannabinoid receptors, (iv) selectively targeting cannabinoid CB(2) receptors, and/or (v) adjunctive 'multi-targeting'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQm6R6_wZP6zNFxYDaSSP8XfW6udTcc2eaeTU0m_H50ELntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s%252FptFWnug%253D%253D&md5=84f9925097df2c99002c1d6ec9b21356</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1098%2Frstb.2011.0381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frstb.2011.0381%26sid%3Dliteratum%253Aachs%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26atitle%3DTargeting%2520the%2520Endocannabinoid%2520System%2520with%2520Cannabinoid%2520Receptor%2520Agonists%253A%2520Pharmacological%2520Strategies%2520and%2520Therapeutic%2520Possibilities%26jtitle%3DPhilos.%2520Trans.%2520R.%2520Soc.%2520Lond.%2520B%2520Biol.%2520Sci.%26date%3D2012%26volume%3D367%26spage%3D3353%26epage%3D3363%26doi%3D10.1098%2Frstb.2011.0381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Munro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abu-Shaar, M.</span></span> <span> </span><span class="NLM_article-title">Molecular Characterization of a Peripheral Receptor for Cannabinoids</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>365</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">65</span>, <span class="refDoi"> DOI: 10.1038/365061a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1038%2F365061a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=7689702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADyaK3sXmsVWiurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=1993&pages=61-65&author=S.+Munroauthor=K.+L.+Thomasauthor=M.+Abu-Shaar&title=Molecular+Characterization+of+a+Peripheral+Receptor+for+Cannabinoids&doi=10.1038%2F365061a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular characterization of a peripheral receptor for cannabinoids</span></div><div class="casAuthors">Munro, Sean; Thomas, Kerrie L.; Abu-Shaar, Muna</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">365</span>
        (<span class="NLM_cas:issue">6441</span>),
    <span class="NLM_cas:pages">61-5</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The major active ingredient of marijuana, Δ9-tetrahydrocannabinol (Δ-THC), has been used as a psychoactive agent for thousands of years.  Marijuana, and Δ9-THC, also exert a wide range of other effects including analgesia, anti-inflammation, immunosuppression, anticonvulsion, alleviation of intraocular pressure in glaucoma, and attenuation of vomiting.  The clin. application of cannabinoids has, however, been limited by their psychoactive effects, and this has led to interest in the biochem. bases of their action.  Progress stemmed initially from the synthesis of potent derivs. of Δ9-THC4,5, and more recently from the cloning of a gene encoding a G-protein-coupled receptor for cannabinoids.  This receptor is expressed in the brain but not in the periphery, except for a low level in testes.  It has been proposed that the nonpsychoactive effects of cannabinoids are either mediated centrally or through direct interaction with other, non-receptor proteins.  Here the authors report the cloning of a receptor for cannabinoids that is not expressed in the brain but rather in macrophages in the marginal zone of spleen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHsq4vy1XH17Vg90H21EOLACvtfcHk0li0RHrT_SY-4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXmsVWiurk%253D&md5=476435b57bd0f24483e2f24b813cc32f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2F365061a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F365061a0%26sid%3Dliteratum%253Aachs%26aulast%3DMunro%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DK.%2BL.%26aulast%3DAbu-Shaar%26aufirst%3DM.%26atitle%3DMolecular%2520Characterization%2520of%2520a%2520Peripheral%2520Receptor%2520for%2520Cannabinoids%26jtitle%3DNature%26date%3D1993%26volume%3D365%26spage%3D61%26epage%3D65%26doi%3D10.1038%2F365061a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reggio, P.</span></span> <span> </span><span class="NLM_article-title">Endocannabinoid Binding to the Cannabinoid Receptors: What is Known and What Remains Unknown</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1468</span>– <span class="NLM_lpage">1486</span>, <span class="refDoi"> DOI: 10.2174/092986710790980005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.2174%2F092986710790980005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=20166921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtFehtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=1468-1486&author=P.+Reggio&title=Endocannabinoid+Binding+to+the+Cannabinoid+Receptors%3A+What+is+Known+and+What+Remains+Unknown&doi=10.2174%2F092986710790980005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Endocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown</span></div><div class="casAuthors">Reggio, Patricia H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1468-1486</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The cannabinoid CB1 and CB2 receptors are Class A G protein-coupled receptors (GPCRs).  While many Class A GPCRs have endogenous ligands that are hydrophilic cations (e.g., the serotonin and dopamine receptors), the cannabinoid receptors have neutral, highly lipophilic ligands derived from the fatty acid, arachidonic acid.  The most well-studied of these are N-arachidonoylethanolamide (anandamide, AEA) and sn-2-arachidonoylglycerol (2-AG).  This review focuses on the exptl. and computational studies that have been used to probe the nature of endocannabinoid interaction with the cannabinoid receptors.  These studies include mutation, SAR and NMR studies, as well as, QSAR, docking and mol. dynamics simulations.  Gaps in our knowledge are identified.  The review begins more generally, however, by discussing the entire endocannabinoid system, of which the cannabinoid receptors are part.  For in order to understand endocannabinoid action, one needs an appreciation for the environments for which these ligands have been designed and the conformational changes these ligands must undergo in order to act on the cannabinoid receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozOUaPE1hD3rVg90H21EOLACvtfcHk0li0RHrT_SY-4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtFehtb8%253D&md5=7b71c9f8ed680b3165c7e63409203278</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F092986710790980005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986710790980005%26sid%3Dliteratum%253Aachs%26aulast%3DReggio%26aufirst%3DP.%26atitle%3DEndocannabinoid%2520Binding%2520to%2520the%2520Cannabinoid%2520Receptors%253A%2520What%2520is%2520Known%2520and%2520What%2520Remains%2520Unknown%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2010%26volume%3D17%26spage%3D1468%26epage%3D1486%26doi%3D10.2174%2F092986710790980005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lolait, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brownstein, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonner, T. I.</span></span> <span> </span><span class="NLM_article-title">Structure of a Cannabinoid Receptor and Functional Expression of the Cloned cDNA</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>346</i></span>,  <span class="NLM_fpage">561</span>– <span class="NLM_lpage">564</span>, <span class="refDoi"> DOI: 10.1038/346561a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1038%2F346561a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=2165569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADyaK3cXls1Ghu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=1990&pages=561-564&author=L.+A.+Matsudaauthor=S.+J.+Lolaitauthor=M.+J.+Brownsteinauthor=A.+C.+Youngauthor=T.+I.+Bonner&title=Structure+of+a+Cannabinoid+Receptor+and+Functional+Expression+of+the+Cloned+cDNA&doi=10.1038%2F346561a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of a cannabinoid receptor and functional expression of the cloned cDNA</span></div><div class="casAuthors">Matsuda, Lisa A.; Lolait, Stephen J.; Brownstein, Michael J.; Young, Alice C.; Bonner, Tom I.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">346</span>
        (<span class="NLM_cas:issue">6284</span>),
    <span class="NLM_cas:pages">561-4</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Marijuana and many of its constituent cannabinoids influence the central nervous system (CNS) in a complex and dose-dependent manner.  CNS depression and analgesia are well documented effects of the cannabinoids, but the mechanisms responsible for the cannabinoid-induced effects are not known.  The hydrophobic nature of these substances has suggested that cannabinoids resemble anesthetic agents in their action and nonspecifically disrupt cellular membranes.  Recent evidence has supported a mechanism involving a G-protein-coupled receptor found in brain and neural cell lines, and which inhibits adenylate cyclase activity in a dose-dependent, stereoselective, and pertussis toxin-sensitive manner.  Also, the receptor is more responsive to psychoactive cannabinoids than to non-psychoactive cannabinoids.  This study reported the cloning and expression of a cDNA that encodes a G-protein-coupled receptor with all of these properties.  Its mRNA is found in cell lines and regions of the brain that have cannabinoid receptors.  This protein may be involved in cannabinoid-induced CNS effects (including alterations in mood and cognition) experienced by users of marijuana.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYrydatT83mLVg90H21EOLACvtfcHk0li0RHrT_SY-4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXls1Ghu7w%253D&md5=a99aeb39544d87392cee18b82a08003d</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2F346561a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F346561a0%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuda%26aufirst%3DL.%2BA.%26aulast%3DLolait%26aufirst%3DS.%2BJ.%26aulast%3DBrownstein%26aufirst%3DM.%2BJ.%26aulast%3DYoung%26aufirst%3DA.%2BC.%26aulast%3DBonner%26aufirst%3DT.%2BI.%26atitle%3DStructure%2520of%2520a%2520Cannabinoid%2520Receptor%2520and%2520Functional%2520Expression%2520of%2520the%2520Cloned%2520cDNA%26jtitle%3DNature%26date%3D1990%26volume%3D346%26spage%3D561%26epage%3D564%26doi%3D10.1038%2F346561a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Svízenska, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubový, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sulcova, A.</span></span> <span> </span><span class="NLM_article-title">Cannabinoid Receptors 1 and 2 (CB<sub>1</sub> and CB<sub>2</sub>), Their Distribution, Ligands and Functional Involvement in Nervous System Structures — A Short Review</span>. <i>Pharmacol. Biochem. Behav.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">501</span>– <span class="NLM_lpage">511</span>, <span class="refDoi"> DOI: 10.1016/j.pbb.2008.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1016%2Fj.pbb.2008.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=18584858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVClurvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2008&pages=501-511&author=I.+Sv%C3%ADzenskaauthor=P.+Dubov%C3%BDauthor=A.+Sulcova&title=Cannabinoid+Receptors+1+and+2+%28CB1+and+CB2%29%2C+Their+Distribution%2C+Ligands+and+Functional+Involvement+in+Nervous+System+Structures+%E2%80%94+A+Short+Review&doi=10.1016%2Fj.pbb.2008.05.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures - a short review</span></div><div class="casAuthors">Svizenska, Ivana; Dubovy, Petr; Sulcova, Alexandra</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology, Biochemistry and Behavior</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">501-511</span>CODEN:
                <span class="NLM_cas:coden">PBBHAU</span>;
        ISSN:<span class="NLM_cas:issn">0091-3057</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  In the last 25 years data has grown exponentially dealing with the discovery of the endocannabinoid system consisting of specific cannabinoid receptors, their endogenous ligands, and enzymic systems of their biosynthesis and degrdn.  Progress is being made in the development of novel agonists and antagonists with receptor subtype selectivity which should help in providing a greater understanding of the physiol. role of the endocannabinoid system and perhaps also in a broad no. of pathologies.  This could lead to advances with important therapeutic potential of drugs modulating activity of endocannabinoid system as hypnotics, analgesics, antiemetics, antiasthmatics, antihypertensives, immunomodulatory drugs, antiphlogistics, neuroprotective agents, antiepileptics, agents influencing glaucoma, spasticity and other "movement disorders", eating disorders, alc. withdrawal, hepatic fibrosis, bone growth, and atherosclerosis.  The aim of this review is to highlight distribution of the CB1 and CB2 receptor subtypes in the nervous system and functional involvement of their specific ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgtx8FThyh1rVg90H21EOLACvtfcHk0lg94rQViHPwYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVClurvE&md5=cfbf0c84fc1439b6ecef399e7fb075d3</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.pbb.2008.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbb.2008.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DSv%25C3%25ADzenska%26aufirst%3DI.%26aulast%3DDubov%25C3%25BD%26aufirst%3DP.%26aulast%3DSulcova%26aufirst%3DA.%26atitle%3DCannabinoid%2520Receptors%25201%2520and%25202%2520%2528CB1%2520and%2520CB2%2529%252C%2520Their%2520Distribution%252C%2520Ligands%2520and%2520Functional%2520Involvement%2520in%2520Nervous%2520System%2520Structures%2520%25E2%2580%2594%2520A%2520Short%2520Review%26jtitle%3DPharmacol.%2520Biochem.%2520Behav.%26date%3D2008%26volume%3D90%26spage%3D501%26epage%3D511%26doi%3D10.1016%2Fj.pbb.2008.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ameri, A.</span></span> <span> </span><span class="NLM_article-title">The Effects of Cannabinoids on the Brain</span>. <i>Prog. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">315</span>– <span class="NLM_lpage">348</span>, <span class="refDoi"> DOI: 10.1016/s0301-0082(98)00087-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1016%2FS0301-0082%2898%2900087-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10368032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADyaK1MXjs1ejs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1999&pages=315-348&author=A.+Ameri&title=The+Effects+of+Cannabinoids+on+the+Brain&doi=10.1016%2Fs0301-0082%2898%2900087-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of cannabinoids on the brain</span></div><div class="casAuthors">Ameri, Angela</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">315-348</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with many refs.  Cannabinoids have a long history of consumption for recreational and medical reasons.  The primary active constituent of the hemp plant Cannabis sativa is Δ9-tetrahydrocannabinol (Δ9-THC).  In humans, psychoactive cannabinoids produce euphoria, enhancement of sensory perception, tachycardia, antinociception, difficulties in concn. and impairment of memory.  The cognitive deficiencies seem to persist after withdrawal.  The toxicity of marijuana has been underestimated for a long time, since recent findings revealed Δ9-THC-induced cell death with shrinkage of neurons and DNA fragmentation in the hippocampus.  The acute effects of cannabinoids as well as the development of tolerance are mediated by G protein-coupled cannabinoid receptors.  The CB1 receptor and its splice variant CB1A, are found predominantly in the brain with highest densities in the hippocampus, cerebellum and striatum.  The CB2 receptor is found predominantly in the spleen and in hemopoietic cells and has only 44% overall nucleotide sequence identity with the CB1 receptor.  The existence of this receptor provided the mol. basis for the immunosuppressive actions of marijuana.  The CB1 receptor mediates inhibition of adenylate cyclase, inhibition of N- and P/Q-type calcium channels, stimulation of potassium channels, and activation of mitogen-activated protein kinase.  The CB2 receptor mediates inhibition of adenylate cyclase and activation of mitogen-activated protein kinase.  The discovery of endogenous cannabinoid receptor ligands, anandamide (N-arachidonylethanolamine) and 2-arachidonylglycerol made the notion of a central cannabinoid neuromodulatory system plausible.  Anandamide is released from neurons upon depolarization through a mechanism that requires calcium-dependent cleavage from a phospholipid precursor in neuronal membranes.  The release of anandamide is followed by rapid uptake into the plasma and hydrolysis by fatty-acid amidohydrolase.  The psychoactive cannabinoids increase the activity of dopaminergic neurons in the ventral tegmental area-mesolimbic pathway.  Since these dopaminergic circuits are known to play a pivotal role in mediating the reinforcing (rewarding) effects of the most drugs of abuse, the enhanced dopaminergic drive elicited by the cannabinoids is thought to underlie the reinforcing and abuse properties of marijuana.  Thus, cannabinoids share a final common neuronal action with other major drugs of abuse such as morphine, ethanol and nicotine in producing facilitation of the mesolimbic dopamine system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdPcJ7-vQg37Vg90H21EOLACvtfcHk0lg94rQViHPwYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjs1ejs7c%253D&md5=7ffe2ffb3c7604a4795f59aa240d260a</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS0301-0082%2898%2900087-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0301-0082%252898%252900087-2%26sid%3Dliteratum%253Aachs%26aulast%3DAmeri%26aufirst%3DA.%26atitle%3DThe%2520Effects%2520of%2520Cannabinoids%2520on%2520the%2520Brain%26jtitle%3DProg.%2520Neurobiol.%26date%3D1999%26volume%3D58%26spage%3D315%26epage%3D348%26doi%3D10.1016%2Fs0301-0082%2898%2900087-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Das, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paria, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakraborty, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dey, S. K.</span></span> <span> </span><span class="NLM_article-title">Cannabinoid Ligand-Receptor Signaling in the Mouse Uterus</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">4332</span>– <span class="NLM_lpage">4336</span>, <span class="refDoi"> DOI: 10.1073/pnas.92.10.4332</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1073%2Fpnas.92.10.4332" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=7753807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADyaK2MXls1alu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1995&pages=4332-4336&author=S.+K.+Dasauthor=B.+C.+Pariaauthor=I.+Chakrabortyauthor=S.+K.+Dey&title=Cannabinoid+Ligand-Receptor+Signaling+in+the+Mouse+Uterus&doi=10.1073%2Fpnas.92.10.4332"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid ligand-receptor signaling in the mouse uterus</span></div><div class="casAuthors">Das, S. K.; Paria, B. C.; Chakraborty, I.; Dey, S. K.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4332-6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Using RNA (Northern) blot hybridization and reverse transcription-PCR, we demonstrate that the brain-type cannabinoid receptor (CB1-R) mRNA, but not the spleen-type cannabinoid receptor (CB2-R) mRNA, is expressed in the mouse uterus and that this organ has the capacity to synthesize the putative endogenous cannabinoid ligand, anandamide (arachidonylethanolamide).  The psychoactive cannabinoid component of marijuana-Δ9-tetrahydrocannabinol (THC)-or anandamide, but not the inactive and nonpsychoactive cannabidiol (CBD), inhibited forskolin-stimulated cAMP formation in the mouse uterus, which was prevented by pertussis toxin pretreatment.  These results suggest that uterine CB1-R is coupled to inhibitory guanine nucleotide-binding protein and is biol. active.  Autoradiog. studies identified ligand binding sites ([3H]anandamide) in the uterine epithelium and stromal cells, suggesting that these cells are perhaps the targets for cannabinoid action.  Scatchard anal. of the binding of [3H]WIN 55212-2, another cannabinoid receptor ligand, showed a single class of high-affinity binding sites in the endometrium with an apparent Kd of 2.4 nM and Bmax of 5.4 × 109 mols. per mg of protein.  The gene encoding lactoferrin is an estrogen-responsive gene in the mouse uterus that was rapidly and transiently up-regulated by THC, but not by CBD, in ovariectomized mice in the absence of ovarian steroids.  This effect, unlike that of 17β-estradiol (E2), was not influenced by a pure antiestrogen, ICI 182780, suggesting that the THC-induced uterine lactoferrin gene expression does not involve estrogen receptors.  We propose that the uterus is a new target for cannabinoid ligand-receptor signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_NrwuCxkgMbVg90H21EOLACvtfcHk0lg94rQViHPwYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXls1alu74%253D&md5=6e5e438a655262f21be72ca69ba8b7ba</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1073%2Fpnas.92.10.4332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.92.10.4332%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DS.%2BK.%26aulast%3DParia%26aufirst%3DB.%2BC.%26aulast%3DChakraborty%26aufirst%3DI.%26aulast%3DDey%26aufirst%3DS.%2BK.%26atitle%3DCannabinoid%2520Ligand-Receptor%2520Signaling%2520in%2520the%2520Mouse%2520Uterus%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1995%26volume%3D92%26spage%3D4332%26epage%3D4336%26doi%3D10.1073%2Fpnas.92.10.4332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galiegue, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mary, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dussossoy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carriere, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carayon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouaboula, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shire, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fur, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casellas, P.</span></span> <span> </span><span class="NLM_article-title">Expression of Central and Peripheral Cannabinoid Receptors in Human Immune Tissues and Leukocyte Subpopulations</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>232</i></span>,  <span class="NLM_fpage">54</span>– <span class="NLM_lpage">61</span>, <span class="refDoi"> DOI: 10.1111/j.1432-1033.1995.tb20780.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1111%2Fj.1432-1033.1995.tb20780.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=7556170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADyaK2MXnvVKksL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=232&publication_year=1995&pages=54-61&author=S.+Galiegueauthor=S.+Maryauthor=J.+Marchandauthor=D.+Dussossoyauthor=D.+Carriereauthor=P.+Carayonauthor=M.+Bouaboulaauthor=D.+Shireauthor=G.+Furauthor=P.+Casellas&title=Expression+of+Central+and+Peripheral+Cannabinoid+Receptors+in+Human+Immune+Tissues+and+Leukocyte+Subpopulations&doi=10.1111%2Fj.1432-1033.1995.tb20780.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations</span></div><div class="casAuthors">Galiegue, Sylvaine; Mary, Sophie; Marchand, Jean; Dussossoy, Danielle; Carriere, Dominique; Carayon, Pierre; Bouaboula, Monsif; Shire, David; Le Fur, Gerard; Casellas, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">232</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">54-61</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Two proteins with 7 transmembrane-spanning domains typical of guanosine-nucleotide-binding-protein-coupled receptors have been identified as cannabinoid receptors; the central cannabinoid receptor, CB1, and the peripheral cannabinoid receptor, CB2, initially described in rat brain and spleen, resp.  The distribution patterns for both CB1 and CB2 transcripts in human immune cells and in several human tissues are reported, as analyzed by a PCR-based method.  CB1 was mainly expressed in the central nervous system and, to a lower extent, in several peripheral tissues such as adrenal gland, heart, lung, prostate, uterus, ovary, testis, bone marrow, thymus and tonsils.  The CB2 gene, which is not expressed in the brain, was particularly abundant in immune tissues, with an expression level 10-100-fold higher than that of CB1.  Although CB2 mRNA was also detected in some other peripheral tissues, its level remained very low.  In spleen and tonsils, the CB2 mRNA content was equiv. to that of CB1 mRNA in the central nervous system.  Among the main human blood cell subpopulations, the distribution pattern of the CB2 mRNA displayed important variations.  The rank order of CB2 mRNA levels in these cells was B-cells > natural killer cells » monocytes > polymorphonuclear neutrophil cells > T8 cells > T4 cells.  The same rank order was also established in human cell lines belonging to the myeloid, monocytic and lymphoid lineages.  The prevailing expression of the CB2 gene in immune tissues was confirmed by Northern-blot anal.  The expression of the CB2 protein was demonstrated by an immunohistol. anal. performed on tonsil sections by specific anti-(human CB2) IgG; this expt. showed that CB2 expression was restricted to B-lymphocyte-enriched areas of the mantle of secondary lymphoid follicles.  Thus, CB1 and CB2 can be considered as tissue-selective antigens of the central nervous system and immune system, resp., and cannabinoids may exert specific receptor-mediated actions on the immune system through the CB2 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwC6x6XdvbW7Vg90H21EOLACvtfcHk0lgdoOLyEdFuOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnvVKksL8%253D&md5=ff4c2f420824fdbef66c94ea9d129288</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1995.tb20780.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1995.tb20780.x%26sid%3Dliteratum%253Aachs%26aulast%3DGaliegue%26aufirst%3DS.%26aulast%3DMary%26aufirst%3DS.%26aulast%3DMarchand%26aufirst%3DJ.%26aulast%3DDussossoy%26aufirst%3DD.%26aulast%3DCarriere%26aufirst%3DD.%26aulast%3DCarayon%26aufirst%3DP.%26aulast%3DBouaboula%26aufirst%3DM.%26aulast%3DShire%26aufirst%3DD.%26aulast%3DFur%26aufirst%3DG.%26aulast%3DCasellas%26aufirst%3DP.%26atitle%3DExpression%2520of%2520Central%2520and%2520Peripheral%2520Cannabinoid%2520Receptors%2520in%2520Human%2520Immune%2520Tissues%2520and%2520Leukocyte%2520Subpopulations%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1995%26volume%3D232%26spage%3D54%26epage%3D61%26doi%3D10.1111%2Fj.1432-1033.1995.tb20780.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gerard, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollereau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vassart, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmentier, M.</span></span> <span> </span><span class="NLM_article-title">Molecular Cloning of a Human Cannabinoid Receptor Which is Also Expressed in Testis</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">129</span>– <span class="NLM_lpage">134</span>, <span class="refDoi"> DOI: 10.1042/bj2790129</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1042%2Fbj2790129" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1718258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADyaK38XltVGntLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=1991&pages=129-134&author=C.+M.+Gerardauthor=C.+Mollereauauthor=G.+Vassartauthor=M.+Parmentier&title=Molecular+Cloning+of+a+Human+Cannabinoid+Receptor+Which+is+Also+Expressed+in+Testis&doi=10.1042%2Fbj2790129"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular cloning of a human cannabinoid receptor which is also expressed in testis</span></div><div class="casAuthors">Gerard, Catherine M.; Mollereau, Catherine; Vassart, Gilbert; Parmentier, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">129-34</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    </div><div class="casAbstract">A cDNA clone encoding a receptor protein which presents all the characteristics of a guanine-nucleotide-binding protein (G-protein)-coupled receptor was isolated from a human brain stem cDNA library.  The probe used (HGMP08) was a 600 bp DNA fragment amplified by a low-stringency polymerase chain reaction (PCR), using human genomic DNA as template and degenerate oligonucleotide primers corresponding to conserved sequences amongst the known G-protein-coupled receptors.  The deduced amino acid sequence encodes a protein of 472 residues which shares 97.3% identity with the rat cannabinoid receptor cloned recently [Matsuda, L. A., et al., (1990)].  Abundant transcripts were detected in the brain, as expected, but lower amts. were also found in the testis.  The same probe was used to screen a human testis cDNA library.  The cDNA clones obtained were partially sequenced, demonstrating the identity of the cannabinoid receptors expressed in both tissues.  Specific binding of the synthetic cannabinoid ligand [3H]CP55940 was obsd. on membranes from Cos-7 cells transfected with the recombinant receptor clone.  In stably transfected CHO-K1 cell lines, cannabinoid agonists mediated a dose-dependent and stereoselective inhibition of forskolin-induced cAMP accumulation.  The ability to express the human cannabinoid receptor in mammalian cells should help in developing more selective drugs, and should facilitate the search for the endogenous cannabinoid ligand(s).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXFhq0W367AbVg90H21EOLACvtfcHk0lgdoOLyEdFuOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XltVGntLs%253D&md5=b24a3f84fa796759dcf6a6ced2304125</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1042%2Fbj2790129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj2790129%26sid%3Dliteratum%253Aachs%26aulast%3DGerard%26aufirst%3DC.%2BM.%26aulast%3DMollereau%26aufirst%3DC.%26aulast%3DVassart%26aufirst%3DG.%26aulast%3DParmentier%26aufirst%3DM.%26atitle%3DMolecular%2520Cloning%2520of%2520a%2520Human%2520Cannabinoid%2520Receptor%2520Which%2520is%2520Also%2520Expressed%2520in%2520Testis%26jtitle%3DBiochem.%2520J.%26date%3D1991%26volume%3D279%26spage%3D129%26epage%3D134%26doi%3D10.1042%2Fbj2790129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wenger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ledent, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Csernus, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerendai, I.</span></span> <span> </span><span class="NLM_article-title">The Central Cannabinoid Receptor Inactivation Suppresses Endocrine Reproductive Functions</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">363</span>– <span class="NLM_lpage">368</span>, <span class="refDoi"> DOI: 10.1006/bbrc.2001.4977</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1006%2Fbbrc.2001.4977" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=11394887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktFWhtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2001&pages=363-368&author=T.+Wengerauthor=C.+Ledentauthor=V.+Csernusauthor=I.+Gerendai&title=The+Central+Cannabinoid+Receptor+Inactivation+Suppresses+Endocrine+Reproductive+Functions&doi=10.1006%2Fbbrc.2001.4977"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The Central Cannabinoid Receptor Inactivation Suppresses Endocrine Reproductive Functions</span></div><div class="casAuthors">Wenger, Tibor; Ledent, Catherine; Csernus, Valer; Gerendai, Ida</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">363-368</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">The function of central cannabinoid (CB1) receptor was investigated in the regulation of the pituitary-gonad axis in CB1 receptor knockout male mouse.  Serum LH and testosterone (T) levels and basal T secretion in vitro of testes were significantly decreased in mutant (CB1-/-) mice.  The receptor agonist, anandamide (ANA), suppressed LH and T secretion in wild type (CB1+/+) mice but had no effect in receptor-inactivated animals.  The results are the first descriptions indicating the direct action of CB1 receptors on LH and T secretion and the immunohistol. demonstration of CB1 receptors in the Leydig cells.  The results also indicate that CB1 receptors are responsible for the effects of exogenous cannabinoids on reproductive functions.  (c) 2001 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdVEFRoel2GrVg90H21EOLACvtfcHk0lim8PdcWBb4TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktFWhtrg%253D&md5=c1edceb2bae9f8cded0faf58a5a6284e</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.2001.4977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.2001.4977%26sid%3Dliteratum%253Aachs%26aulast%3DWenger%26aufirst%3DT.%26aulast%3DLedent%26aufirst%3DC.%26aulast%3DCsernus%26aufirst%3DV.%26aulast%3DGerendai%26aufirst%3DI.%26atitle%3DThe%2520Central%2520Cannabinoid%2520Receptor%2520Inactivation%2520Suppresses%2520Endocrine%2520Reproductive%2520Functions%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2001%26volume%3D284%26spage%3D363%26epage%3D368%26doi%3D10.1006%2Fbbrc.2001.4977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benito, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolón, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pazos, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Núñez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castillo, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, J.</span></span> <span> </span><span class="NLM_article-title">Cannabinoid CB<sub>2</sub> Receptors in Human Brain Inflammation</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>153</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">285</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0707505</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1038%2Fsj.bjp.0707505" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=17934510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovFCktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2008&pages=277-285&author=C.+Benitoauthor=R.+M.+Tol%C3%B3nauthor=M.+R.+Pazosauthor=E.+N%C3%BA%C3%B1ezauthor=A.+I.+Castilloauthor=J.+Romero&title=Cannabinoid+CB2+Receptors+in+Human+Brain+Inflammation&doi=10.1038%2Fsj.bjp.0707505"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid CB2 receptors in human brain inflammation</span></div><div class="casAuthors">Benito, C.; Tolon, R. M.; Pazos, M. R.; Nunez, E.; Castillo, A. I.; Romero, J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">277-285</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The presence of functional cannabinoid CB2 receptors in the CNS has provoked considerable controversy over the past few years.  Formerly considered as an exclusively peripheral receptor, it is now accepted that it is also present in limited amts. and distinct locations in the brain of several animal species, including humans.  Furthermore, the inducible nature of these receptors under neuroinflammatory conditions, in contrast to CB1, makes them attractive targets for the development of novel therapeutic approaches.  In fact, the undesired psychoactive effects caused by CB1 activation have largely limited the clin. use of cannabinoid-related compds. that act on these receptors.  In this review some recent findings on the antiinflammatory properties of CB2 receptors are presented, as well as new perspectives that have been obtained based on studies of human postmortem brain samples.  In addn., various working hypotheses are also proposed and discussed.  British Journal of Pharmacol. (2008) 153, 277-285; doi:10.1038/sj.bjp.0707505; published online 15 Oct. 2007.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy1sC3kUak-7Vg90H21EOLACvtfcHk0lim8PdcWBb4TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovFCktg%253D%253D&md5=acc7f2244e1db16d66e5953eadecb381</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707505%26sid%3Dliteratum%253Aachs%26aulast%3DBenito%26aufirst%3DC.%26aulast%3DTol%25C3%25B3n%26aufirst%3DR.%2BM.%26aulast%3DPazos%26aufirst%3DM.%2BR.%26aulast%3DN%25C3%25BA%25C3%25B1ez%26aufirst%3DE.%26aulast%3DCastillo%26aufirst%3DA.%2BI.%26aulast%3DRomero%26aufirst%3DJ.%26atitle%3DCannabinoid%2520CB2%2520Receptors%2520in%2520Human%2520Brain%2520Inflammation%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D153%26spage%3D277%26epage%3D285%26doi%3D10.1038%2Fsj.bjp.0707505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Onaivi, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishiguro, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perchuk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meozzi, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mora, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tagliaferro, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brusco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akinshola, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hope, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwasaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arinami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teasenfitz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uhl, G. R.</span></span> <span> </span><span class="NLM_article-title">Discovery of the Presence and Functional Expression of Cannabinoid CB<sub>2</sub> Receptors in Brain</span>. <i>Ann. N.Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1074</i></span>,  <span class="NLM_fpage">514</span>– <span class="NLM_lpage">536</span>, <span class="refDoi"> DOI: 10.1196/annals.1369.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1196%2Fannals.1369.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=17105950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFGgs7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1074&publication_year=2006&pages=514-536&author=E.+S.+Onaiviauthor=H.+Ishiguroauthor=J.-P.+Gongauthor=S.+Patelauthor=A.+Perchukauthor=P.+A.+Meozziauthor=L.+Myersauthor=Z.+Moraauthor=P.+Tagliaferroauthor=E.+Gardnerauthor=A.+Bruscoauthor=B.+E.+Akinsholaauthor=Q.-R.+Liuauthor=B.+Hopeauthor=S.+Iwasakiauthor=T.+Arinamiauthor=L.+Teasenfitzauthor=G.+R.+Uhl&title=Discovery+of+the+Presence+and+Functional+Expression+of+Cannabinoid+CB2+Receptors+in+Brain&doi=10.1196%2Fannals.1369.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain</span></div><div class="casAuthors">Onaivi, Emmanuel S.; Ishiguro, Hiroki; Gong, Jian-Ping; Patel, Sejal; Perchuk, Alex; Meozzi, Paul A.; Myers, Lester; Mora, Zoila; Tagliaferro, Patricia; Gardner, Eileen; Brusco, Alicia; Akinshola, Babatunde E.; Liu, Qing-Rong; Hope, Bruce; Iwasaki, Shinya; Arinami, Tadao; Teasenfitz, Lindsey; Uhl, George R.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1074</span>
        (<span class="NLM_cas:issue">Cellular and Molecular Mechanisms of Drugs of Abuse and Neurotoxicity</span>),
    <span class="NLM_cas:pages">514-536</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">A review.  Two well-characterized cannabinoid receptors (CBrs), CB1 and CB2, mediate the effects of cannabinoids and marijuana use, with functional evidence for other CBrs.  CB1 receptors are expressed primarily in brain and peripheral tissues.  For over a decade several labs. were unable to detect CB2 receptors in brain and were known to be intensely expressed in peripheral and immune tissues and have traditionally been referred to as peripheral CB2 CBrs.  We have reported the discovery and functional presence of CB2 cannabinoid receptors in mammalian brain that may be involved in depression and drug abuse and this was supported by reports of identification of neuronal CB2 receptors that are involved in emesis.  We used RT-PCR, immunoblotting, hippocampal cultures, immunohistochem., transmission electron microscopy, and stereotaxic techniques with behavioral assays to det. the functional expression of CB2 CBrs in rat brain and mice brain exposed to chronic mild stress (CMS) or those treated with abused drugs.  RT-PCR analyses supported the expression of brain CB2 receptor transcripts at levels much lower than those of CB1 receptors.  In situ hybridization revealed CB2 mRNA in cerebellar neurons of wild-type but not of CB2 knockout mice.  Abundant CB2 receptor immunoreactivity (iCB2) in neuronal and glial processes was detected in brain and CB2 expression was detected in neuron-specific enolase (NSE) pos. hippocampal cell cultures.  The effect of direct CB2 antisense oligonucleotide injection into the brain and treatment with JWH015 in motor function and plus-maze tests also demonstrated the functional presence of CB2 cannabinoid receptors in the central nervous system (CNS).  Thus, contrary to the prevailing view that CB2 CBrs are restricted to peripheral tissues and predominantly in immune cells, we demonstrated that CB2 CBrs and their gene transcripts are widely distributed in the brain.  This multifocal expression of CB2 immunoreactivity in brain suggests that CB2 receptors may play broader roles in the brain than previously anticipated and may be exploited as new targets in the treatment of depression and substance abuse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUIPPJ2UOp67Vg90H21EOLACvtfcHk0lim8PdcWBb4TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFGgs7vJ&md5=42b319306c27fbb91389d4134648ac82</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1196%2Fannals.1369.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1196%252Fannals.1369.052%26sid%3Dliteratum%253Aachs%26aulast%3DOnaivi%26aufirst%3DE.%2BS.%26aulast%3DIshiguro%26aufirst%3DH.%26aulast%3DGong%26aufirst%3DJ.-P.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DPerchuk%26aufirst%3DA.%26aulast%3DMeozzi%26aufirst%3DP.%2BA.%26aulast%3DMyers%26aufirst%3DL.%26aulast%3DMora%26aufirst%3DZ.%26aulast%3DTagliaferro%26aufirst%3DP.%26aulast%3DGardner%26aufirst%3DE.%26aulast%3DBrusco%26aufirst%3DA.%26aulast%3DAkinshola%26aufirst%3DB.%2BE.%26aulast%3DLiu%26aufirst%3DQ.-R.%26aulast%3DHope%26aufirst%3DB.%26aulast%3DIwasaki%26aufirst%3DS.%26aulast%3DArinami%26aufirst%3DT.%26aulast%3DTeasenfitz%26aufirst%3DL.%26aulast%3DUhl%26aufirst%3DG.%2BR.%26atitle%3DDiscovery%2520of%2520the%2520Presence%2520and%2520Functional%2520Expression%2520of%2520Cannabinoid%2520CB2%2520Receptors%2520in%2520Brain%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2006%26volume%3D1074%26spage%3D514%26epage%3D536%26doi%3D10.1196%2Fannals.1369.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maccarrone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bab, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bíró, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabral, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dey, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konje, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mechoulam, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacher, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharkey, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmer, A.</span></span> <span> </span><span class="NLM_article-title">Endocannabinoid Signaling at the Periphery: 50 years After THC</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">296</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2015.02.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1016%2Fj.tips.2015.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=25796370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC2MXktFehur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=277-296&author=M.+Maccarroneauthor=I.+Babauthor=T.+B%C3%ADr%C3%B3author=G.+A.+Cabralauthor=S.+K.+Deyauthor=V.+Di+Marzoauthor=J.+C.+Konjeauthor=G.+Kunosauthor=R.+Mechoulamauthor=P.+Pacherauthor=K.+A.+Sharkeyauthor=A.+Zimmer&title=Endocannabinoid+Signaling+at+the+Periphery%3A+50+years+After+THC&doi=10.1016%2Fj.tips.2015.02.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Endocannabinoid signaling at the periphery: 50 years after THC</span></div><div class="casAuthors">Maccarrone, Mauro; Bab, Itai; Biro, Tamas; Cabral, Guy A.; Dey, Sudhansu K.; Di Marzo, Vincenzo; Konje, Justin C.; Kunos, George; Mechoulam, Raphael; Pacher, Pal; Sharkey, Keith A.; Zimmer, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">277-296</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  In 1964, the psychoactive ingredient of Cannabis sativa, Δ9-tetrahydrocannabinol (THC), was isolated.  Nearly 30 years later the endogenous counterparts of THC, collectively termed endocannabinoids (eCBs), were discovered: N-arachidonoylethanolamine (anandamide) (AEA) in 1992 and 2-arachidonoylglycerol (2-AG) in 1995.  Since then, considerable research has shed light on the impact of eCBs on human health and disease, identifying an ensemble of proteins that bind, synthesize, and degrade them and that together form the eCB system (ECS). eCBs control basic biol. processes including cell choice between survival and death and progenitor/stem cell proliferation and differentiation.  Unsurprisingly, in the past two decades eCBs have been recognized as key mediators of several aspects of human pathophysiol. and thus have emerged to be among the most widespread and versatile signaling mols. ever discovered.  Here some of the pioneers of this research field review the state of the art of crit. eCB functions in peripheral organs.  Our community effort is aimed at establishing consensus views on the relevance of the peripheral ECS for human health and disease pathogenesis, as well as highlighting emerging challenges and therapeutic hopes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqliBLJSeUEKLVg90H21EOLACvtfcHk0linVJougIq3dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXktFehur4%253D&md5=a06cc2d98beb8bd8e42336b5c9c7a278</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2015.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2015.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DMaccarrone%26aufirst%3DM.%26aulast%3DBab%26aufirst%3DI.%26aulast%3DB%25C3%25ADr%25C3%25B3%26aufirst%3DT.%26aulast%3DCabral%26aufirst%3DG.%2BA.%26aulast%3DDey%26aufirst%3DS.%2BK.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DKonje%26aufirst%3DJ.%2BC.%26aulast%3DKunos%26aufirst%3DG.%26aulast%3DMechoulam%26aufirst%3DR.%26aulast%3DPacher%26aufirst%3DP.%26aulast%3DSharkey%26aufirst%3DK.%2BA.%26aulast%3DZimmer%26aufirst%3DA.%26atitle%3DEndocannabinoid%2520Signaling%2520at%2520the%2520Periphery%253A%252050%2520years%2520After%2520THC%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2015%26volume%3D36%26spage%3D277%26epage%3D296%26doi%3D10.1016%2Fj.tips.2015.02.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, J. C.</span></span> <span> </span><span class="NLM_article-title">Psychoactive Substances — Some New, Some Old: A Scan of the Situation in the U.S.</span>. <i>Drug Alcohol Depend.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1016/j.drugalcdep.2013.09.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1016%2Fj.drugalcdep.2013.09.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=24140401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A280%3ADC%252BC2c%252FotF2mtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2014&pages=71-77&author=J.+C.+Maxwell&title=Psychoactive+Substances+%E2%80%94+Some+New%2C+Some+Old%3A+A+Scan+of+the+Situation+in+the+U.S.&doi=10.1016%2Fj.drugalcdep.2013.09.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Psychoactive substances--some new, some old: a scan of the situation in the U.S</span></div><div class="casAuthors">Maxwell Jane Carlisle</div><div class="citationInfo"><span class="NLM_cas:title">Drug and alcohol dependence</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">71-77</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">INTRODUCTION:  New synthetic drugs are appearing as old hallucinogen psychedelic drugs are reappearing.  This article combines the findings from a variety of datasets to characterize the users in terms of gender, age, drug use patterns, and adverse results, as well as provide an overview of the changes in formulations of these drugs and the impact of legal controls.  Methods.  Data from Monitoring the Future and the National Survey on Drug Use and Health are analyzed, along with the national DAWN emergency room admissions, Texas poison control center cases, and Texas treatment data, along with national forensic laboratory results.  Results.  Users of the synthetic cannabinoids, synthetic cathinones, phenethylamines, tryptamines, LSD, MDMA, and mushrooms tended to be young and male.  They differed in terms of race and ethnicity.  The effects of the drugs differed in terms of emergency room outcomes and poison center reports, and the treatment data showed they were similar in terms of education level, employment, and legal problems.  Conclusion.  Combining the different data sources provided a first picture of the characteristics of these users and their needs.  Creditable descriptions on the risks of these drugs should be disseminated.  Intervention programs should be targeted to these young users and new neuropsychobiological deficits from some of these drugs should be monitored.  Because of the ever-changing chemical combinations to stay legal and the need for information on content and dosage, a more effective approach may be needed basing control on the effects of the substances rather than their changing chemical composition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTyK9-qm75EbjC850By6mxpfW6udTcc2eaMNO82P-NusLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c%252FotF2mtQ%253D%253D&md5=c98da2772d936fbf9bdcf734c7f4d0b1</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.drugalcdep.2013.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drugalcdep.2013.09.011%26sid%3Dliteratum%253Aachs%26aulast%3DMaxwell%26aufirst%3DJ.%2BC.%26atitle%3DPsychoactive%2520Substances%2520%25E2%2580%2594%2520Some%2520New%252C%2520Some%2520Old%253A%2520A%2520Scan%2520of%2520the%2520Situation%2520in%2520the%2520U.S.%26jtitle%3DDrug%2520Alcohol%2520Depend.%26date%3D2014%26volume%3D134%26spage%3D71%26epage%3D77%26doi%3D10.1016%2Fj.drugalcdep.2013.09.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ford, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fantegrossi, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prather, P. L.</span></span> <span> </span><span class="NLM_article-title">Synthetic Pot: Not Your Grandfather’s Marijuana</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">257</span>– <span class="NLM_lpage">276</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2016.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1016%2Fj.tips.2016.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=28162792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitFeht7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2017&pages=257-276&author=B.+M.+Fordauthor=S.+Taiauthor=W.+E.+Fantegrossiauthor=P.+L.+Prather&title=Synthetic+Pot%3A+Not+Your+Grandfather%E2%80%99s+Marijuana&doi=10.1016%2Fj.tips.2016.12.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic Pot: Not Your Grandfather's Marijuana</span></div><div class="casAuthors">Ford, Benjamin M.; Tai, Sherrica; Fantegrossi, William E.; Prather, Paul L.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">257-276</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">In the early 2000s in Europe and shortly thereafter in the USA, it was reported that 'legal' forms of marijuana were being sold under the name K2 and/or Spice.  Active ingredients in K2/Spice products were detd. to be synthetic cannabinoids (SCBs), producing psychotropic actions via CB1 cannabinoid receptors, similar to those of Δ9-tetrahydrocannabinol (Δ9-THC), the primary active constituent in marijuana.  Often abused by adolescents and military personnel to elude detection in drug tests due to their lack of structural similarity to Δ9-THC, SCBs are falsely marketed as safe marijuana substitutes.  Instead, SCBs are a highly structural diverse group of compds., easily synthesized, which produce very dangerous adverse effects occurring by, as of yet, unknown mechanisms.  Therefore, available evidence indicates that K2/Spice products are clearly not safe marijuana alternatives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq__z5CUgbGPbVg90H21EOLACvtfcHk0ljdDIH3sw5CZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitFeht7w%253D&md5=ca3afa2ea70b14d8f2c74d569d5e1174</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2016.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2016.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DFord%26aufirst%3DB.%2BM.%26aulast%3DTai%26aufirst%3DS.%26aulast%3DFantegrossi%26aufirst%3DW.%2BE.%26aulast%3DPrather%26aufirst%3DP.%2BL.%26atitle%3DSynthetic%2520Pot%253A%2520Not%2520Your%2520Grandfather%25E2%2580%2599s%2520Marijuana%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2017%26volume%3D38%26spage%3D257%26epage%3D276%26doi%3D10.1016%2Fj.tips.2016.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banister, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longworth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuart, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apetz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">English, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooker, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goebel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hibbs, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glass, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGregor, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassiou, M.</span></span> <span> </span><span class="NLM_article-title">The Synthesis and Pharmacological Evaluation of Adamantane-Derived Indoles: Cannabimimetic Drugs of Abuse</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1081</span>– <span class="NLM_lpage">1092</span>, and the references cited therein <span class="refDoi"> DOI: 10.1021/cn400035r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn400035r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltV2nu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1081-1092&author=S.+D.+Banisterauthor=S.+M.+Wilkinsonauthor=M.+Longworthauthor=J.+Stuartauthor=N.+Apetzauthor=K.+Englishauthor=L.+Brookerauthor=C.+Goebelauthor=D.+E.+Hibbsauthor=M.+Glassauthor=M.+Connorauthor=I.+S.+McGregorauthor=M.+Kassiou&title=The+Synthesis+and+Pharmacological+Evaluation+of+Adamantane-Derived+Indoles%3A+Cannabimimetic+Drugs+of+Abuse&doi=10.1021%2Fcn400035r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The Synthesis and Pharmacological Evaluation of Adamantane-Derived Indoles: Cannabimimetic Drugs of Abuse</span></div><div class="casAuthors">Banister, Samuel D.; Wilkinson, Shane M.; Longworth, Mitchell; Stuart, Jordyn; Apetz, Nadine; English, Katrina; Brooker, Lance; Goebel, Catrin; Hibbs, David E.; Glass, Michelle; Connor, Mark; McGregor, Iain S.; Kassiou, Michael</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1081-1092</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two novel adamantane derivs., adamantan-1-yl(1-pentyl-1H-indol-3-yl)methanone (AB-001) and N-(adamtan-1-yl)-1-pentyl-1H-indole-3-carboxamide (SDB-001), were recently identified as cannabimimetic indoles of abuse.  Conflicting anecdotal reports of the psychoactivity of AB-001 in humans, and a complete dearth of information about the bioactivity of SDB-001, prompted the prepn. of AB-001, SDB-001, and several analogs intended to explore preliminary structure-activity relationships within this class.  This study sought to elucidate which structural features of AB-001, SDB-001, and their analogs govern the cannabimimetic potency of these chemotypes in vitro and in vivo.  All compds. showed similar full agonist profiles at CB1 (EC50 = 16-43 nM) and CB2 (EC50 = 29-216 nM) receptors in vitro using a FLIPR membrane potential assay, with the exception of SDB-002, which demonstrated partial agonist activity at CB2 receptors.  The activity of AB-001, AB-002, and SDB-001 in rats was compared to that of Δ9-tetrahydrocannabinol (Δ9-THC) and cannabimimetic indole JWH-018 using biotelemetry.  SDB-001 dose-dependently induced hypothermia and reduced heart rate (maximal dose 10 mg/kg) with potency comparable to that of Δ9-tetrahydrocannabinol (Δ9-THC, maximal dose 10 mg/kg), and lower than that of JWH-018 (maximal dose 3 mg/kg).  Addnl., the changes in body temp. and heart rate affected by SDB-001 are of longer duration than those of Δ9-THC or JWH-018, suggesting a different pharmacokinetic profile.  In contrast, AB-001, and its homolog, AB-002, did not produce significant hypothermic and bradycardic effects, even at relatively higher doses (up to 30 mg/kg), indicating greatly reduced potency compared to Δ9-THC, JWH-018, and SDB-001.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoo-YnN-QuYjLVg90H21EOLACvtfcHk0ljdDIH3sw5CZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltV2nu7c%253D&md5=859bff2f95ad6a0931b013ac532b3407</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fcn400035r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn400035r%26sid%3Dliteratum%253Aachs%26aulast%3DBanister%26aufirst%3DS.%2BD.%26aulast%3DWilkinson%26aufirst%3DS.%2BM.%26aulast%3DLongworth%26aufirst%3DM.%26aulast%3DStuart%26aufirst%3DJ.%26aulast%3DApetz%26aufirst%3DN.%26aulast%3DEnglish%26aufirst%3DK.%26aulast%3DBrooker%26aufirst%3DL.%26aulast%3DGoebel%26aufirst%3DC.%26aulast%3DHibbs%26aufirst%3DD.%2BE.%26aulast%3DGlass%26aufirst%3DM.%26aulast%3DConnor%26aufirst%3DM.%26aulast%3DMcGregor%26aufirst%3DI.%2BS.%26aulast%3DKassiou%26aufirst%3DM.%26atitle%3DThe%2520Synthesis%2520and%2520Pharmacological%2520Evaluation%2520of%2520Adamantane-Derived%2520Indoles%253A%2520Cannabimimetic%2520Drugs%2520of%2520Abuse%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2013%26volume%3D4%26spage%3D1081%26epage%3D1092%26doi%3D10.1021%2Fcn400035r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wiley, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marusich, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefever, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabenauer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, B. F.</span></span> <span> </span><span class="NLM_article-title">Cannabinoids in Disguise: Δ<sup>9</sup>-Tetrahydrocannabinol-like Effects of Tetramethylcyclopropyl Ketone Indoles</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">145</span>– <span class="NLM_lpage">154</span>, and the references cited therein <span class="refDoi"> DOI: 10.1016/j.neuropharm.2013.07.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1016%2Fj.neuropharm.2013.07.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=23916483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFyltbrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2013&pages=145-154&author=J.+L.+Wileyauthor=J.+A.+Marusichauthor=T.+W.+Lefeverauthor=M.+Grabenauerauthor=K.+N.+Mooreauthor=B.+F.+Thomas&title=Cannabinoids+in+Disguise%3A+%CE%949-Tetrahydrocannabinol-like+Effects+of+Tetramethylcyclopropyl+Ketone+Indoles&doi=10.1016%2Fj.neuropharm.2013.07.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoids in disguise: Δ9-Tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles</span></div><div class="casAuthors">Wiley, Jenny L.; Marusich, Julie A.; Lefever, Timothy W.; Grabenauer, Megan; Moore, Katherine N.; Thomas, Brian F.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">145-154</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Synthetic indole-derived cannabinoids have become commonly used recreational drugs and continue to be abused despite their adverse consequences.  As compds. that were identified early in the epidemic (e.g., naphthoylindoles) have become legally banned, new compds. have appeared on the drug market.  Two tetramethylcyclopropyl ketone indoles, UR-144 [(1-pentyl-1H-indol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone] and XLR-11 [(1-(5-fluoropentyl)-1H-indol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone], recently have been identified in confiscated products.  These compds. are structurally related to a series of CB2-selective compds. explored by Abbott Labs.  The purpose of the present study was to evaluate the extent to which UR-144 and XLR-11 shared cannabinoid effects with Δ9-tetrahydrocannabinol (Δ9-THC).  Indexes of in vitro and in vivo activity at cannabinoid receptors were assessed.  Similar to other psychoactive cannabinoid agonists, XLR-11 and UR-144 showed low nanomolar (<30) affinity for CB1 and CB2 receptors, activated these receptors as full agonists, and produced dose-dependent effects that were blocked by rimonabant in mice, including antinociception, hypothermia, catalepsy and suppression of locomotor activity.  The potency of both compds. was several-fold greater than Δ9-THC.  XLR-11 and UR-144 also substituted for Δ9-THC in a Δ9-THC discrimination procedure in mice, effects that were attenuated by rimonabant.  Anal. of urine from mice treated with the compds. revealed that both were extensively metabolized, with predominant urinary excretion as glucuronide conjugates.  Together, these results demonstrate that UR-144 and XLR-11 share a pharmacol. profile of in vitro and in vivo effects with Δ9-THC and other abused indole-derived cannabinoids and would be predicted to produce Δ9-THC-like subjective effects in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUvHF0gRQzR7Vg90H21EOLACvtfcHk0ljdDIH3sw5CZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFyltbrP&md5=26ab6006c2b9c2b161845ef3beeaf8fa</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2013.07.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2013.07.022%26sid%3Dliteratum%253Aachs%26aulast%3DWiley%26aufirst%3DJ.%2BL.%26aulast%3DMarusich%26aufirst%3DJ.%2BA.%26aulast%3DLefever%26aufirst%3DT.%2BW.%26aulast%3DGrabenauer%26aufirst%3DM.%26aulast%3DMoore%26aufirst%3DK.%2BN.%26aulast%3DThomas%26aufirst%3DB.%2BF.%26atitle%3DCannabinoids%2520in%2520Disguise%253A%2520%25CE%25949-Tetrahydrocannabinol-like%2520Effects%2520of%2520Tetramethylcyclopropyl%2520Ketone%2520Indoles%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D75%26spage%3D145%26epage%3D154%26doi%3D10.1016%2Fj.neuropharm.2013.07.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nutt, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, D. E.</span></span> <span> </span><span class="NLM_article-title">Effects of Schedule I Drug Laws on Neuroscience Research and Treatment Innovation</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">577</span>– <span class="NLM_lpage">585</span>, <span class="refDoi"> DOI: 10.1038/nrn3530</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1038%2Fnrn3530" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=23756634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpt1Cmtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=577-585&author=D.+J.+Nuttauthor=L.+A.+Kingauthor=D.+E.+Nichols&title=Effects+of+Schedule+I+Drug+Laws+on+Neuroscience+Research+and+Treatment+Innovation&doi=10.1038%2Fnrn3530"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of Schedule I drug laws on neuroscience research and treatment innovation</span></div><div class="casAuthors">Nutt, David J.; King, Leslie A.; Nichols, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">577-585</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Many psychoactive drugs are used recreationally, particularly by young people.  This use and its perceived dangers have led to many different classes of drugs being banned under national laws and international conventions.  Indeed, the possession of cannabis, 3,4-methylenedioxy-N-methylamphetamine (MDMA; also known as ecstasy) and psychedelics is stringently regulated.  An important and unfortunate outcome of the controls placed on these and other psychoactive drugs is that they make research into their mechanisms of action and potential therapeutic uses - for example, in depression and post-traumatic stress disorder - difficult and in many cases almost impossible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_s93GyCYsNrVg90H21EOLACvtfcHk0lg4MTwVEr1tIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpt1Cmtbs%253D&md5=446f16a994fe9582f78434b26eff4fc4</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnrn3530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn3530%26sid%3Dliteratum%253Aachs%26aulast%3DNutt%26aufirst%3DD.%2BJ.%26aulast%3DKing%26aufirst%3DL.%2BA.%26aulast%3DNichols%26aufirst%3DD.%2BE.%26atitle%3DEffects%2520of%2520Schedule%2520I%2520Drug%2520Laws%2520on%2520Neuroscience%2520Research%2520and%2520Treatment%2520Innovation%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2013%26volume%3D14%26spage%3D577%26epage%3D585%26doi%3D10.1038%2Fnrn3530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huffman, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zengin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hynd, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bushell, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bushell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tartal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurst, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reggio, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selley, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassidy, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiley, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, B. R.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB1 and CB2 receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB2 receptor agonists</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2004.09.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1016%2Fj.bmc.2004.09.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=15582455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A280%3ADC%252BD2cngvVaisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=89-112&author=J.+W.+Huffmanauthor=G.+Zenginauthor=M.-J.+Wuauthor=J.+Luauthor=G.+Hyndauthor=K.+Bushellauthor=A.+L.+S.+Thompsonauthor=S.+Bushellauthor=C.+Tartalauthor=D.+P.+Hurstauthor=P.+H.+Reggioauthor=D.+E.+Selleyauthor=M.+P.+Cassidyauthor=J.+L.+Wileyauthor=B.+R.+Martin&title=Structure-activity+relationships+for+1-alkyl-3-%281-naphthoyl%29indoles+at+the+cannabinoid+CB1+and+CB2+receptors%3A+steric+and+electronic+effects+of+naphthoyl+substituents.+New+highly+selective+CB2+receptor+agonists&doi=10.1016%2Fj.bmc.2004.09.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB(1) and CB(2) receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB(2) receptor agonists</span></div><div class="casAuthors">Huffman John W; Zengin Gulay; Wu Ming-Jung; Lu Jianzhong; Hynd George; Bushell Kristen; Thompson Alicia L S; Bushell Simon; Tartal Cindy; Hurst Dow P; Reggio Patricia H; Selley Dana E; Cassidy Michael P; Wiley Jenny L; Martin Billy R</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & medicinal chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-112</span>
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    </div><div class="casAbstract">In an effort to improve indole-based CB(2) cannabinoid receptor ligands and also to develop SAR for both the CB(1) and CB(2) receptors, 47 indole derivatives were prepared and their CB(1) and CB(2) receptor affinities were determined.  The indole derivatives include 1-propyl- and 1-pentyl-3-(1-naphthoyl)indoles both with and without a 2-methyl substituent.  Naphthoyl substituents include 4- and 7-alkyl groups as well as 2-, 4-, 6-, 7-methoxy and 4-ethoxy groups.  The effects of these substituents on receptor affinities are discussed and structure-activity relationships are presented.  In the course of this work three new highly selective CB(2) receptor agonists were identified, 1-propyl-3-(4-methyl-1-naphthoylindole (JWH-120), 1-propyl-2-methyl-3-(6-methoxy-1-naphthoylindole (JWH-151), and 1-pentyl-3-(2-methoxy-1-naphthoylindole (JWH-267).  GTPgammaS assays indicated that JWH-151 is a full agonist at CB(2), while JWH-120 and JWH-267 are partial agonists.  Molecular modeling and receptor docking studies were carried out on a set of 3-(4-propyl-1-naphthoyl)indoles, a set of 3-(6-methoxy-1-naphthoyl)indoles and the pair of N-pentyl-3-(2-methoxy-1-naphthoyl)indoles.  Docking studies indicated that the CB(1) receptor affinities of these compounds were consistent with their aromatic stacking interactions in the aromatic microdomain of the CB(1) receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQAeapzNd70yENHe_gFldTbfW6udTcc2eaYY9R4KMjNPLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2cngvVaisQ%253D%253D&md5=e21fe8969660b1180f6bc851cc02db91</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2004.09.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2004.09.050%26sid%3Dliteratum%253Aachs%26aulast%3DHuffman%26aufirst%3DJ.%2BW.%26aulast%3DZengin%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DM.-J.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DHynd%26aufirst%3DG.%26aulast%3DBushell%26aufirst%3DK.%26aulast%3DThompson%26aufirst%3DA.%2BL.%2BS.%26aulast%3DBushell%26aufirst%3DS.%26aulast%3DTartal%26aufirst%3DC.%26aulast%3DHurst%26aufirst%3DD.%2BP.%26aulast%3DReggio%26aufirst%3DP.%2BH.%26aulast%3DSelley%26aufirst%3DD.%2BE.%26aulast%3DCassidy%26aufirst%3DM.%2BP.%26aulast%3DWiley%26aufirst%3DJ.%2BL.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3DStructure-activity%2520relationships%2520for%25201-alkyl-3-%25281-naphthoyl%2529indoles%2520at%2520the%2520cannabinoid%2520CB1%2520and%2520CB2%2520receptors%253A%2520steric%2520and%2520electronic%2520effects%2520of%2520naphthoyl%2520substituents.%2520New%2520highly%2520selective%2520CB2%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D89%26epage%3D112%26doi%3D10.1016%2Fj.bmc.2004.09.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Drug
Enforcement Administration</span> <span> </span><span class="NLM_article-title">Schedules of Controlled Substances: Temporary Placement of Five Synthetic
Cannabinoids into Schedule I</span>. <i>Fed. Regist.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">11075</span>– <span class="NLM_lpage">11078</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2011&pages=11075-11078&author=Drug%0AEnforcement+Administration&title=Schedules+of+Controlled+Substances%3A+Temporary+Placement+of+Five+Synthetic%0ACannabinoids+into+Schedule+I"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DSchedules%2520of%2520Controlled%2520Substances%253A%2520Temporary%2520Placement%2520of%2520Five%2520Synthetic%250ACannabinoids%2520into%2520Schedule%2520I%26jtitle%3DFed.%2520Regist.%26date%3D2011%26volume%3D76%26spage%3D11075%26epage%3D11078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frost, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dart, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tietje, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrison, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grayson, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daza, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Kouhen, O. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandran, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, M. D.</span></span> <span> </span><span class="NLM_article-title">Indol-3-ylcycloalkyl Ketones: Effects of N1 Substituted Indole Side Chain Variations on CB2Cannabinoid Receptor Activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">295</span>– <span class="NLM_lpage">315</span>, <span class="refDoi"> DOI: 10.1021/jm901214q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901214q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsValtbfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=295-315&author=J.+M.+Frostauthor=M.+J.+Dartauthor=K.+R.+Tietjeauthor=T.+R.+Garrisonauthor=G.+K.+Graysonauthor=A.+V.+Dazaauthor=O.+F.+El-Kouhenauthor=B.+B.+Yaoauthor=G.+C.+Hsiehauthor=M.+Paiauthor=C.+Z.+Zhuauthor=P.+Chandranauthor=M.+D.+Meyer&title=Indol-3-ylcycloalkyl+Ketones%3A+Effects+of+N1+Substituted+Indole+Side+Chain+Variations+on+CB2Cannabinoid+Receptor+Activity&doi=10.1021%2Fjm901214q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Indol-3-ylcycloalkyl Ketones: Effects of N1 Substituted Indole Side Chain Variations on CB2 Cannabinoid Receptor Activity</span></div><div class="casAuthors">Frost, Jennifer M.; Dart, Michael J.; Tietje, Karin R.; Garrison, Tiffany R.; Grayson, George K.; Daza, Anthony V.; El-Kouhen, Odile F.; Yao, Betty B.; Hsieh, Gin C.; Pai, Madhavi; Zhu, Chang Z.; Chandran, Prasant; Meyer, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">295-315</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Several 3-acylindoles with high affinity for the CB2 cannabinoid receptor and selectivity over the CB1 receptor have been prepd.  A variety of 3-acyl substituents were investigated, and the tetramethylcyclopropyl group was found to lead to high affinity CB2 agonists.  Substitution at the N1-indole position was then examd.  A series of aminoalkylindoles was prepd. and several substituted aminoethyl derivs. were active at the CB2 receptor.  A study of N1 nonarom. side chain variants provided potent agonists at the CB2 receptor.  Several polar side chains (alcs., oxazolidinone) were well tolerated for CB2 receptor activity, while others (amide, acid) led to weaker or inactive compds..  N1 arom. side chains also afforded several high affinity CB2 receptor agonists, but were generally less potent in an in vitro CB2 functional assay than were nonarom. side chain analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBqUcQi4rUorVg90H21EOLACvtfcHk0ljNocH8EKDJPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsValtbfP&md5=5bdd69db011d3abc7924a9093209e84b</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm901214q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901214q%26sid%3Dliteratum%253Aachs%26aulast%3DFrost%26aufirst%3DJ.%2BM.%26aulast%3DDart%26aufirst%3DM.%2BJ.%26aulast%3DTietje%26aufirst%3DK.%2BR.%26aulast%3DGarrison%26aufirst%3DT.%2BR.%26aulast%3DGrayson%26aufirst%3DG.%2BK.%26aulast%3DDaza%26aufirst%3DA.%2BV.%26aulast%3DEl-Kouhen%26aufirst%3DO.%2BF.%26aulast%3DYao%26aufirst%3DB.%2BB.%26aulast%3DHsieh%26aufirst%3DG.%2BC.%26aulast%3DPai%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DC.%2BZ.%26aulast%3DChandran%26aufirst%3DP.%26aulast%3DMeyer%26aufirst%3DM.%2BD.%26atitle%3DIndol-3-ylcycloalkyl%2520Ketones%253A%2520Effects%2520of%2520N1%2520Substituted%2520Indole%2520Side%2520Chain%2520Variations%2520on%2520CB2Cannabinoid%2520Receptor%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D295%26epage%3D315%26doi%3D10.1021%2Fjm901214q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malan, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibrahim, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanderah, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porreca, F.</span></span> <span> </span><span class="NLM_article-title">CB2 cannabinoid receptor agonists: pain relief without psychoactive effects?</span>. <i>Curr. Opin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">62</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1016/s1471-4892(02)00004-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1016%2FS1471-4892%2802%2900004-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=12550743" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsVaqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=62-67&author=T.+P.+Malanauthor=M.+M.+Ibrahimauthor=J.+Laiauthor=T.+W.+Vanderahauthor=A.+Makriyannisauthor=F.+Porreca&title=CB2+cannabinoid+receptor+agonists%3A+pain+relief+without+psychoactive+effects%3F&doi=10.1016%2Fs1471-4892%2802%2900004-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">CB2 cannabinoid receptor agonists: pain relief without psychoactive effects?</span></div><div class="casAuthors">Malan, T. Philip, Jr.; Ibrahim, Mohab M.; Lai, Josephine; Vanderah, Todd W.; Makriyannis, Alexandros; Porreca, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">62-67</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Cannabinoid receptor agonists significantly diminish pain responses in animal models; however, they exhibit only modest analgesic effects in humans.  The relative lack of efficacy in man may be because of the dose limitations imposed by psychoactive side effects.  Cannabinoid agonists that selectively target CB2 (peripheral) cannabinoid receptors should be free of psychoactive effects, perhaps allowing for more effective dosing.  CB2 receptor activation inhibits acute, inflammatory and neuropathic pain responses in animal models.  In preclin. studies, CB2 receptor agonists do not produce central nervous system effects.  Therefore, they show promise for the treatment of acute and chronic pain without psychoactive effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMDosKe7bNVrVg90H21EOLACvtfcHk0ljNocH8EKDJPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsVaqsA%253D%253D&md5=a3d17be42f9850114483ad51f2b33fa7</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2FS1471-4892%2802%2900004-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1471-4892%252802%252900004-8%26sid%3Dliteratum%253Aachs%26aulast%3DMalan%26aufirst%3DT.%2BP.%26aulast%3DIbrahim%26aufirst%3DM.%2BM.%26aulast%3DLai%26aufirst%3DJ.%26aulast%3DVanderah%26aufirst%3DT.%2BW.%26aulast%3DMakriyannis%26aufirst%3DA.%26aulast%3DPorreca%26aufirst%3DF.%26atitle%3DCB2%2520cannabinoid%2520receptor%2520agonists%253A%2520pain%2520relief%2520without%2520psychoactive%2520effects%253F%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2003%26volume%3D3%26spage%3D62%26epage%3D67%26doi%3D10.1016%2Fs1471-4892%2802%2900004-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manera, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuccinardi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinelli, A.</span></span> <span> </span><span class="NLM_article-title">Indoles and Related Compounds as Cannabinoid Ligands</span>. <i>Mini Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">370</span>– <span class="NLM_lpage">387</span>, <span class="refDoi"> DOI: 10.2174/138955708783955935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.2174%2F138955708783955935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=18473928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkt1alsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=370-387&author=C.+Maneraauthor=T.+Tuccinardiauthor=A.+Martinelli&title=Indoles+and+Related+Compounds+as+Cannabinoid+Ligands&doi=10.2174%2F138955708783955935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Indoles and related compounds as cannabinoid ligands</span></div><div class="casAuthors">Manera, Clementina; Tuccinardi, Tiziano; Martinelli, Adriano</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">370-387</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The discovery of the endocannabinoid system has lead to great strides in research development.  At present, two cannabinoid receptors, CB1R and CB2R, are known.  They belong to Class A rhodopsin-like GPCRs, and possess a different tissue distribution.  Many synthetic compds. have been synthesized and tested for their cannabinoid activity.  A particular class among them, the aminoalkylindole derivs. (typified by WIN55212-2) are hypothesized to interact in a binding site different from the main cannabinoid agonists.  In this review we report the main aminoalkylindole derivs., and other compds. which are hypothesized to interact in the same binding site.  Furthermore we analyze the pharmacol. profiles, the mutagenesis data and the computational models that describe their interaction in the cannabinoid receptors, evaluating the most important aspects for their activity and selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8tBHv9wnw37Vg90H21EOLACvtfcHk0ljNocH8EKDJPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkt1alsrY%253D&md5=efab4b24bb66450a58176d6684c57a20</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.2174%2F138955708783955935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138955708783955935%26sid%3Dliteratum%253Aachs%26aulast%3DManera%26aufirst%3DC.%26aulast%3DTuccinardi%26aufirst%3DT.%26aulast%3DMartinelli%26aufirst%3DA.%26atitle%3DIndoles%2520and%2520Related%2520Compounds%2520as%2520Cannabinoid%2520Ligands%26jtitle%3DMini%2520Rev.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D370%26epage%3D387%26doi%3D10.2174%2F138955708783955935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adler, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abood, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganea, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jallo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuma, R. F.</span></span> <span> </span><span class="NLM_article-title">CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injury</span>. <i>Microvasc. Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">86</span>– <span class="NLM_lpage">94</span>, <span class="refDoi"> DOI: 10.1016/j.mvr.2009.03.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1016%2Fj.mvr.2009.03.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=19332079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1Ggs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=86-94&author=M.+Zhangauthor=M.+W.+Adlerauthor=M.+E.+Aboodauthor=D.+Ganeaauthor=J.+Jalloauthor=R.+F.+Tuma&title=CB2+receptor+activation+attenuates+microcirculatory+dysfunction+during+cerebral+ischemic%2Freperfusion+injury&doi=10.1016%2Fj.mvr.2009.03.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injury</span></div><div class="casAuthors">Zhang, Ming; Adler, Martin W.; Abood, Mary E.; Ganea, Doina; Jallo, Jack; Tuma, Ronald F.</div><div class="citationInfo"><span class="NLM_cas:title">Microvascular Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">86-94</span>CODEN:
                <span class="NLM_cas:coden">MIVRA6</span>;
        ISSN:<span class="NLM_cas:issn">0026-2862</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Previous studies from our lab. indicated that selective cannabinoid CB2 agonists were able to attenuate cerebral ischemia/reperfusion (I/R) injury.  The goal of current study is to further test whether this attenuation involves cerebral microcirculatory function during I/R injury.  Middle cerebral artery occlusion with reperfusion (MCAO/R) was performed in male mice.  A selective CB2 agonist was administered at different dosages and different times.  Cerebral infarction vol., neurol. function and cerebral microcirculatory function (leukocyte/endothelial interactions, cell adhesion mol. expression and blood-brain barrier disruption) were examd. in vivo and in vitro.  CB2 knockout mice were subjected to MCAO/R following same procedures.  Administration of the CB2 agonist at middle dosage exerted optimal effects in reducing cerebral infarction and improving neurol. function compared with other dosage groups and control group.  Treatment with the CB2 agonist at the optimal dose was still effective when given 3 h after MCAO.  Transient ischemia significantly increased leukocyte/endothelial interactions, adhesion mols. expression and blood-brain barrier disruption which were all attenuated by pre-treatment with a CB2 agonist.  CB2 knockout mice showed larger cerebral infarction and worse neurol. function compared to wide type.  In conclusion, CB2 activation contributed to protecting the brain through the attenuation of cerebral microcirculatory dysfunction during cerebral I/R injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroq2E3HleP5rVg90H21EOLACvtfcHk0liCUij8uB4GrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1Ggs78%253D&md5=96dc7214c65d0e945e2663715042467d</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.mvr.2009.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mvr.2009.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DAdler%26aufirst%3DM.%2BW.%26aulast%3DAbood%26aufirst%3DM.%2BE.%26aulast%3DGanea%26aufirst%3DD.%26aulast%3DJallo%26aufirst%3DJ.%26aulast%3DTuma%26aufirst%3DR.%2BF.%26atitle%3DCB2%2520receptor%2520activation%2520attenuates%2520microcirculatory%2520dysfunction%2520during%2520cerebral%2520ischemic%252Freperfusion%2520injury%26jtitle%3DMicrovasc.%2520Res.%26date%3D2009%26volume%3D78%26spage%3D86%26epage%3D94%26doi%3D10.1016%2Fj.mvr.2009.03.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shoemaker, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seely, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crow, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prather, P. L.</span></span> <span> </span><span class="NLM_article-title">The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">98</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2006.04346.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1111%2Fj.1471-4159.2006.04346.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=17241118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksFSqsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2007&pages=87-98&author=J.+L.+Shoemakerauthor=K.+A.+Seelyauthor=R.+L.+Reedauthor=J.+P.+Crowauthor=P.+L.+Prather&title=The+CB2+cannabinoid+agonist+AM-1241+prolongs+survival+in+a+transgenic+mouse+model+of+amyotrophic+lateral+sclerosis+when+initiated+at+symptom+onset&doi=10.1111%2Fj.1471-4159.2006.04346.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset</span></div><div class="casAuthors">Shoemaker, Jennifer L.; Seely, Kathryn A.; Reed, Ronald L.; Crow, John P.; Prather, Paul L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-98</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive motor neuron loss, paralysis and death within 2-5 years of diagnosis.  Currently, no effective pharmacol. agents exist for the treatment of this devastating disease.  Neuroinflammation may accelerate the progression of ALS.  Cannabinoids produce anti-inflammatory actions via cannabinoid receptor 1 (CB1) and cannabinoid receptor 2 (CB2), and delay the progression of neuroinflammatory diseases.  Addnl., CB2 receptors, which normally exist primarily in the periphery, are dramatically up-regulated in inflamed neural tissues assocd. with CNS disorders.  In G93A-SOD1 mutant mice, the most well-characterized animal model of ALS, endogenous cannabinoids are elevated in spinal cords of symptomatic mice.  Furthermore, treatment with non-selective cannabinoid partial agonists prior to, or upon, symptom appearance minimally delays disease onset and prolongs survival through undefined mechanisms.  We demonstrate that mRNA, receptor binding and function of CB2, but not CB1, receptors are dramatically and selectively up-regulated in spinal cords of G93A-SOD1 mice in a temporal pattern paralleling disease progression.  More importantly, daily injections of the selective CB2 agonist AM-1241, initiated at symptom onset, increase the survival interval after disease onset by 56%.  Therefore, CB2 agonists may slow motor neuron degeneration and preserve motor function, and represent a novel therapeutic modality for treatment of ALS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0tTHgAMzBILVg90H21EOLACvtfcHk0liCUij8uB4GrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksFSqsb4%253D&md5=3d05001d4f2eb1ae8e10e1986b1d153c</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.04346.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.04346.x%26sid%3Dliteratum%253Aachs%26aulast%3DShoemaker%26aufirst%3DJ.%2BL.%26aulast%3DSeely%26aufirst%3DK.%2BA.%26aulast%3DReed%26aufirst%3DR.%2BL.%26aulast%3DCrow%26aufirst%3DJ.%2BP.%26aulast%3DPrather%26aufirst%3DP.%2BL.%26atitle%3DThe%2520CB2%2520cannabinoid%2520agonist%2520AM-1241%2520prolongs%2520survival%2520in%2520a%2520transgenic%2520mouse%2520model%2520of%2520amyotrophic%2520lateral%2520sclerosis%2520when%2520initiated%2520at%2520symptom%2520onset%26jtitle%3DJ.%2520Neurochem.%26date%3D2007%26volume%3D101%26spage%3D87%26epage%3D98%26doi%3D10.1111%2Fj.1471-4159.2006.04346.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Croxford, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S. D.</span></span> <span> </span><span class="NLM_article-title">Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R(+)WIN55,212</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">1231</span>– <span class="NLM_lpage">1240</span>, <span class="refDoi"> DOI: 10.1172/jci200317652</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1172%2FJCI200317652" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=12697742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtFCrs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2003&pages=1231-1240&author=J.+L.+Croxfordauthor=S.+D.+Miller&title=Immunoregulation+of+a+viral+model+of+multiple+sclerosis+using+the+synthetic+cannabinoid+R%28%2B%29WIN55%2C212&doi=10.1172%2Fjci200317652"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R(+)WIN55212</span></div><div class="casAuthors">Croxford, J. Ludovic; Miller, Stephen D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1231-1240</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Theiler murine encephalomyelitis virus-induced demyelinating disease (TMEV-IDD) is a mouse model of chronic-progressive multiple sclerosis (MS) characterized by Th1-mediated CNS demyelination and spastic hindlimb paralysis.  Existing MS therapies reduce relapse rates in 30% of relapsing-remitting MS patients, but are ineffective in chronic-progressive disease, and their effects on disability progression are unclear.  Exptl. studies demonstrate cannabinoids are useful for symptomatic treatment of spasticity and tremor in chronic-relapsing exptl. autoimmune encephalomyelitis.  Cannabinoids, however, have reported immunosuppressive properties.  We show that the cannabinoid receptor agonist, R(+)WIN55212, ameliorates progression of clin. disease symptoms in mice with preexisting TMEV-IDD.  Amelioration of clin. disease is assocd. with downregulation of both virus and myelin epitope-specific Th1 effector functions (delayed-type hypersensitivity and IFN-γ prodn.) and the inhibition of CNS mRNA expression coding for the proinflammatory cytokines, TNF-α, IL1-β, and IL-6.  Clin. trials investigating the therapeutic potential of cannabinoids for the symptomatic treatment of MS are ongoing, and this study demonstrates that they may also have potent immunoregulatory properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8Np2y1qW4k7Vg90H21EOLACvtfcHk0liCUij8uB4GrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtFCrs7k%253D&md5=e55dd55db2ca18122a2eb65e71972a03</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1172%2FJCI200317652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI200317652%26sid%3Dliteratum%253Aachs%26aulast%3DCroxford%26aufirst%3DJ.%2BL.%26aulast%3DMiller%26aufirst%3DS.%2BD.%26atitle%3DImmunoregulation%2520of%2520a%2520viral%2520model%2520of%2520multiple%2520sclerosis%2520using%2520the%2520synthetic%2520cannabinoid%2520R%2528%252B%2529WIN55%252C212%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2003%26volume%3D111%26spage%3D1231%26epage%3D1240%26doi%3D10.1172%2Fjci200317652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-Ruiz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velasco, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolón, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzmán, M.</span></span> <span> </span><span class="NLM_article-title">Cannabinoid CB2 receptor: a new target for controlling neural cell survival?</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">39</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2006.11.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1016%2Fj.tips.2006.11.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=17141334" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitlOmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=39-45&author=J.+Fern%C3%A1ndez-Ruizauthor=J.+Romeroauthor=G.+Velascoauthor=R.+M.+Tol%C3%B3nauthor=J.+A.+Ramosauthor=M.+Guzm%C3%A1n&title=Cannabinoid+CB2+receptor%3A+a+new+target+for+controlling+neural+cell+survival%3F&doi=10.1016%2Fj.tips.2006.11.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid CB2 receptor: a new target for controlling neural cell survival?</span></div><div class="casAuthors">Fernandez-Ruiz, Javier; Romero, Julian; Velasco, Guillermo; Tolon, Rosa M.; Ramos, Jose A.; Guzman, Manuel</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-45</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Two types of cannabinoid receptor have been cloned and characterized.  Whereas CB1 receptors are ubiquitously expressed in neurons of the CNS, CB2 receptors have been thought to be absent from the CNS.  Recent data now question this notion and support the expression of CB2 receptors in microglial cells, astrocytes and even some neuron subpopulations.  This discrete distribution makes CB2 receptors interesting targets for treating neurol. disorders because CB2-selective agonists lack psychoactivity.  Here, we review evidence supporting the idea that CB2 receptors are implicated in the control of fundamental neural cell processes, such as proliferation and survival, and that their pharmacol. manipulation might be useful for both delaying the progression of neurodegenerative disorders and inhibiting the growth of glial tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpNrWrT5XU9bVg90H21EOLACvtfcHk0lgB4c1GeTafcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitlOmsw%253D%253D&md5=8f809e0332df14885c66df7e891294f2</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2006.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2006.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez-Ruiz%26aufirst%3DJ.%26aulast%3DRomero%26aufirst%3DJ.%26aulast%3DVelasco%26aufirst%3DG.%26aulast%3DTol%25C3%25B3n%26aufirst%3DR.%2BM.%26aulast%3DRamos%26aufirst%3DJ.%2BA.%26aulast%3DGuzm%25C3%25A1n%26aufirst%3DM.%26atitle%3DCannabinoid%2520CB2%2520receptor%253A%2520a%2520new%2520target%2520for%2520controlling%2520neural%2520cell%2520survival%253F%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2007%26volume%3D28%26spage%3D39%26epage%3D45%26doi%3D10.1016%2Fj.tips.2006.11.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benito, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Núñez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolón, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrier, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rábano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillard, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, J.</span></span> <span> </span><span class="NLM_article-title">Cannabinoid CB2Receptors and Fatty Acid Amide Hydrolase Are Selectively Overexpressed in Neuritic Plaque-Associated Glia in Alzheimer’s Disease Brains</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">11136</span>– <span class="NLM_lpage">11141</span>, <span class="refDoi"> DOI: 10.1523/jneurosci.23-35-11136.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1523%2FJNEUROSCI.23-35-11136.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=14657172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvV2gtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=11136-11141&author=C.+Benitoauthor=E.+N%C3%BA%C3%B1ezauthor=R.+M.+Tol%C3%B3nauthor=E.+J.+Carrierauthor=A.+R%C3%A1banoauthor=C.+J.+Hillardauthor=J.+Romero&title=Cannabinoid+CB2Receptors+and+Fatty+Acid+Amide+Hydrolase+Are+Selectively+Overexpressed+in+Neuritic+Plaque-Associated+Glia+in+Alzheimer%E2%80%99s+Disease+Brains&doi=10.1523%2Fjneurosci.23-35-11136.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains</span></div><div class="casAuthors">Benito, Cristina; Nunez, Estefania; Tolon, Rosa M.; Carrier, Erica J.; Rabano, Alberto; Hillard, Cecilia J.; Romero, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">11136-11141</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The endocannabinoid system is still poorly understood.  Recently, the basic elements that constitute it, i.e., membrane receptors, endogenous ligands, and mechanisms for termination of the signaling process, have been partially characterized.  There is a considerable lack of information, however, concerning the distribution, concn., and function of those components in the human body, particularly during pathol. events.  We have studied the status of some of the components of the endocannabinoid system, fatty acid amide hydrolase and cannabinoid CB1 and CB2 receptors, in postmortem brains from patients with Alzheimer's disease.  Using specific polyclonal antibodies, we have performed immunohistochem. anal. in hippocampus and entorhinal cortex sections from brains of Alzheimer's disease patients.  Our results show that both fatty acid amide hydrolase and cannabinoid CB2 receptors are abundantly and selectively expressed in neuritic plaque-assocd. astrocytes and microglia, resp., whereas the expression of CB1 receptors remains unchanged.  In addn., the hydrolase activity seems to be elevated in the plaques and surrounding areas.  Thus, some elements of the endocannabinoid system may be postulated as possible modulators of the inflammatory response assocd. with this neurodegenerative process and as possible targets for new therapeutic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ8Gm8V3n8jrVg90H21EOLACvtfcHk0lgB4c1GeTafcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvV2gtbw%253D&md5=c324980efac10a672fc425ef376694f1</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.23-35-11136.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.23-35-11136.2003%26sid%3Dliteratum%253Aachs%26aulast%3DBenito%26aufirst%3DC.%26aulast%3DN%25C3%25BA%25C3%25B1ez%26aufirst%3DE.%26aulast%3DTol%25C3%25B3n%26aufirst%3DR.%2BM.%26aulast%3DCarrier%26aufirst%3DE.%2BJ.%26aulast%3DR%25C3%25A1bano%26aufirst%3DA.%26aulast%3DHillard%26aufirst%3DC.%2BJ.%26aulast%3DRomero%26aufirst%3DJ.%26atitle%3DCannabinoid%2520CB2Receptors%2520and%2520Fatty%2520Acid%2520Amide%2520Hydrolase%2520Are%2520Selectively%2520Overexpressed%2520in%2520Neuritic%2520Plaque-Associated%2520Glia%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%2520Brains%26jtitle%3DJ.%2520Neurosci.%26date%3D2003%26volume%3D23%26spage%3D11136%26epage%3D11141%26doi%3D10.1523%2Fjneurosci.23-35-11136.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pacher, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bátkai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunos, G.</span></span> <span> </span><span class="NLM_article-title">The Endocannabinoid System as an Emerging Target of Pharmacotherapy</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">389</span>– <span class="NLM_lpage">462</span>, <span class="refDoi"> DOI: 10.1124/pr.58.3.2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1124%2Fpr.58.3.2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=16968947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVOhtLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2006&pages=389-462&author=P.+Pacherauthor=S.+B%C3%A1tkaiauthor=G.+Kunos&title=The+Endocannabinoid+System+as+an+Emerging+Target+of+Pharmacotherapy&doi=10.1124%2Fpr.58.3.2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The endocannabinoid system as an emerging target of pharmacotherapy</span></div><div class="casAuthors">Pacher, Pal; Batkai, Sandor; Kunos, George</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">389-462</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The recent identification of cannabinoid receptors and their endogenous lipid ligands has triggered an exponential growth of studies exploring the endocannabinoid system and its regulatory functions in health and disease.  Such studies have been greatly facilitated by the introduction of selective cannabinoid receptor antagonists and inhibitors of endocannabinoid metab. and transport, as well as mice deficient in cannabinoid receptors or the endocannabinoid-degrading enzyme fatty acid amidohydrolase.  In the past decade, the endocannabinoid system has been implicated in a growing no. of physiol. functions, both in the central and peripheral nervous systems and in peripheral organs.  More importantly, modulating the activity of the endocannabinoid system turned out to hold therapeutic promise in a wide range of disparate diseases and pathol. conditions, ranging from mood and anxiety disorders, movement disorders such as Parkinson's and Huntington's disease, neuropathic pain, multiple sclerosis and spinal cord injury, to cancer, atherosclerosis, myocardial infarction, stroke, hypertension, glaucoma, obesity/metabolic syndrome, and osteoporosis, to name just a few.  An impediment to the development of cannabinoid medications has been the socially unacceptable psychoactive properties of plant-derived or synthetic agonists, mediated by CB1 receptors.  However, this problem does not arise when the therapeutic aim is achieved by treatment with a CB1 receptor antagonist, such as in obesity, and may also be absent when the action of endocannabinoids is enhanced indirectly through blocking their metab. or transport.  The use of selective CB2 receptor agonists, which lack psychoactive properties, could represent another promising avenue for certain conditions.  The abuse potential of plant-derived cannabinoids may also be limited through the use of prepns. with controlled compn. and the careful selection of does and route of administration.  The growing no. of preclin. studies and clin. trials with compds. that modulate the endocannabinoid system will probably result in novel therapeutic approaches in a no. of diseases for which current treatments do not fully address the patients' need.  Here, we provide a comprehensive overview on the current state of knowledge of the endocannabinoid system as a target of pharmacotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN_yobbKbuLbVg90H21EOLACvtfcHk0lhrRIWtTTroaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVOhtLfO&md5=f54e6d1303645a1c63809879ef2813f3</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1124%2Fpr.58.3.2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.58.3.2%26sid%3Dliteratum%253Aachs%26aulast%3DPacher%26aufirst%3DP.%26aulast%3DB%25C3%25A1tkai%26aufirst%3DS.%26aulast%3DKunos%26aufirst%3DG.%26atitle%3DThe%2520Endocannabinoid%2520System%2520as%2520an%2520Emerging%2520Target%2520of%2520Pharmacotherapy%26jtitle%3DPharmacol.%2520Rev.%26date%3D2006%26volume%3D58%26spage%3D389%26epage%3D462%26doi%3D10.1124%2Fpr.58.3.2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sagredo, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Arencibia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Lago, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finetti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-Ruiz, J.</span></span> <span> </span><span class="NLM_article-title">Cannabinoids and Neuroprotection in Basal Ganglia Disorders</span>. <i>Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">82</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1007/s12035-007-0004-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1007%2Fs12035-007-0004-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=17952653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12js7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2007&pages=82-91&author=O.+Sagredoauthor=M.+Garc%C3%ADa-Arencibiaauthor=E.+de+Lagoauthor=S.+Finettiauthor=A.+Decioauthor=J.+Fern%C3%A1ndez-Ruiz&title=Cannabinoids+and+Neuroprotection+in+Basal+Ganglia+Disorders&doi=10.1007%2Fs12035-007-0004-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoids and neuroprotection in basal ganglia disorders</span></div><div class="casAuthors">Sagredo, Onintza; Garcia-Arencibia, Moises; de Lago, Eva; Finetti, Simone; Decio, Alessandra; Fernandez-Ruiz, Javier</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">82-91</span>CODEN:
                <span class="NLM_cas:coden">MONBEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-7648</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  Cannabinoids have been proposed as clin. promising neuroprotective mols., as they are capable to reduce excitotoxicity, calcium influx, and oxidative injury.  They are also able to decrease inflammation by acting on glial processes that regulate neuronal survival and to restore blood supply to the injured area by reducing the vasoconstriction produced by several endothelium-derived factors.  Through one or more of these processes, cannabinoids may provide neuroprotection in different neurodegenerative disorders including Parkinson's disease and Huntington's chorea, 2 chronic diseases that are originated as a consequence of the degeneration of specific nuclei of the basal ganglia, resulting in a deterioration of the control of movement.  Both diseases have been still scarcely explored at the clin. level for a possible application of cannabinoids to delay the progressive degeneration of the basal ganglia.  However, the preclin. evidence seems to be solid and promising.  There are 2 key mechanisms involved in the neuroprotection by cannabinoids in exptl. models of these 2 disorders: first, a cannabinoid receptor-independent mechanism aimed at producing a decrease in the oxidative injury and second, an induction/upregulation of cannabinoid CB2 receptors, mainly in reactive microglia, that is capable to regulate the influence of these glial cells on neuronal homeostasis.  Considering the relevance of these preclin. data and the lack of efficient neuroprotective strategies in both disorders, the authors urge the development of further studies that allow that the promising exectatives generated for these mols. progress from the present preclin. evidence till a real clin. application.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCy7cQFwE6IrVg90H21EOLACvtfcHk0lhrRIWtTTroaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12js7fL&md5=d161705497d7db6234697127f28c776a</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1007%2Fs12035-007-0004-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12035-007-0004-3%26sid%3Dliteratum%253Aachs%26aulast%3DSagredo%26aufirst%3DO.%26aulast%3DGarc%25C3%25ADa-Arencibia%26aufirst%3DM.%26aulast%3Dde%2BLago%26aufirst%3DE.%26aulast%3DFinetti%26aufirst%3DS.%26aulast%3DDecio%26aufirst%3DA.%26aulast%3DFern%25C3%25A1ndez-Ruiz%26aufirst%3DJ.%26atitle%3DCannabinoids%2520and%2520Neuroprotection%2520in%2520Basal%2520Ganglia%2520Disorders%26jtitle%3DMol.%2520Neurobiol.%26date%3D2007%26volume%3D36%26spage%3D82%26epage%3D91%26doi%3D10.1007%2Fs12035-007-0004-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Whiteside, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenzano, K.</span></span> <span> </span><span class="NLM_article-title">The Role of the Cannabinoid CB2 Receptor in Pain Transmission and Therapeutic Potential of Small Molecule CB2 Receptor Agonists</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">917</span>– <span class="NLM_lpage">936</span>, <span class="refDoi"> DOI: 10.2174/092986707780363023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.2174%2F092986707780363023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=17430144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsF2qt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=917-936&author=G.+Whitesideauthor=G.+Leeauthor=K.+Valenzano&title=The+Role+of+the+Cannabinoid+CB2+Receptor+in+Pain+Transmission+and+Therapeutic+Potential+of+Small+Molecule+CB2+Receptor+Agonists&doi=10.2174%2F092986707780363023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">The role of the cannabinoid CB2 receptor in pain transmission and therapeutic potential of small molecule CB2 receptor agonists</span></div><div class="casAuthors">Whiteside, G. T.; Lee, G. P.; Valenzano, K. J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">917-936</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  This review gives a brief overview of the expression patterns, mol. pharmacol. and physiol. role of the cannabinoid 2 receptor (CB2) in pain.  Particular emphasis is given to the therapeutic utility of CB2 receptor agonists.  Through studies utilizing selective CB2 receptor agonists, non-selective cannabinoid agonists in conjunction with selective CB1 and CB2 receptor antagonists, or CB2 receptor knockout mice, it is now clear that this receptor plays a crit. role in nociception.  To this end, CB2 receptors have been shown to modulate acute pain, chronic inflammatory pain, post-surgical pain, cancer pain and pain assocd. with nerve injury.  Here we review these studies and the compds. that were utilized.  We hypothesize the mechanism of action by which the CB2 receptor could be involved in these processes.  Finally we summarize the most recent novel chem. scaffolds that are being investigated towards advancing selective CB2 receptor agonists into the clinic.  Many new pharmacol. agents have been identified by high throughput screening and small mol. lead discovery and optimization in the past 10 years.  It is anticipated that at least some of these agents may ultimately constitute effective new pain therapeutics that lack the side effects assocd. with traditional cannabinoid ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMlVzQowHYO7Vg90H21EOLACvtfcHk0lhrRIWtTTroaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsF2qt7o%253D&md5=17305ca634113f7c129e15b8d693ba4e</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.2174%2F092986707780363023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986707780363023%26sid%3Dliteratum%253Aachs%26aulast%3DWhiteside%26aufirst%3DG.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DValenzano%26aufirst%3DK.%26atitle%3DThe%2520Role%2520of%2520the%2520Cannabinoid%2520CB2%2520Receptor%2520in%2520Pain%2520Transmission%2520and%2520Therapeutic%2520Potential%2520of%2520Small%2520Molecule%2520CB2%2520Receptor%2520Agonists%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2007%26volume%3D14%26spage%3D917%26epage%3D936%26doi%3D10.2174%2F092986707780363023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitchcock, S. A.</span></span> <span> </span><span class="NLM_article-title">Targeting Cannabinoid Agonists for Inflammatory and Neuropathic Pain</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">951</span>– <span class="NLM_lpage">965</span>, <span class="refDoi"> DOI: 10.1517/13543784.16.7.951</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1517%2F13543784.16.7.951" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=17594182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmvVOmsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2007&pages=951-965&author=Y.+Chengauthor=S.+A.+Hitchcock&title=Targeting+Cannabinoid+Agonists+for+Inflammatory+and+Neuropathic+Pain&doi=10.1517%2F13543784.16.7.951"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cannabinoid agonists for inflammatory and neuropathic pain</span></div><div class="casAuthors">Cheng, Yuan; Hitchcock, Stephen A.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">951-965</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The cannabinoid receptors CB1 and CB2 are class A G-protein-coupled receptors.  It is well known that cannabinoid receptor agonists produce relief of pain in a variety of animal models by interacting with cannabinoid receptors.  CB1 receptors are located centrally and peripherally, whereas CB2 receptors are expressed primarily on immune cells and tissues.  A large body of preclin. data supports the hypothesis that either CB2-selective agonists or CB1 agonists acting at peripheral sites, or with limited CNS exposure, will inhibit pain and neuroinflammation without side effects within the CNS.  There has been a growing interest in developing cannabinoid agonists.  Many new cannabinoid ligands have been synthesized and studied covering a wide variety of novel structural scaffolds.  This review focuses on the present development of cannabinoid agonists with an emphasis on selective CB2 agonists and peripherally restricted CB1 or CB1/CB2 dual agonists for treatment of inflammatory and neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprxE9ZXlueyrVg90H21EOLACvtfcHk0lgcXcavLYTN1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmvVOmsbY%253D&md5=0728e81e6981449c3ec1551703caba03</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1517%2F13543784.16.7.951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.16.7.951%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26atitle%3DTargeting%2520Cannabinoid%2520Agonists%2520for%2520Inflammatory%2520and%2520Neuropathic%2520Pain%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2007%26volume%3D16%26spage%3D951%26epage%3D965%26doi%3D10.1517%2F13543784.16.7.951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yao, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frost, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrison, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daza, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grayson, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandran, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salyers, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wensink, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honore, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dart, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, M. D.</span></span> <span> </span><span class="NLM_article-title">In Vitro and In Vivo Characterization of A-796260: A Selective Cannabinoid CB<sub>2</sub> Receptor Agonist Exhibiting Analgesic Activity in Rodent Pain Models</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>153</i></span>,  <span class="NLM_fpage">390</span>– <span class="NLM_lpage">401</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0707568</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1038%2Fsj.bjp.0707568" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=17994110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlajsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2008&pages=390-401&author=B.+B.+Yaoauthor=G.+C.+Hsiehauthor=J.+M.+Frostauthor=Y.+Fanauthor=T.+R.+Garrisonauthor=A.+V.+Dazaauthor=G.+K.+Graysonauthor=C.+Z.+Zhuauthor=M.+Paiauthor=P.+Chandranauthor=A.+K.+Salyersauthor=E.+J.+Wensinkauthor=P.+Honoreauthor=J.+P.+Sullivanauthor=M.+J.+Dartauthor=M.+D.+Meyer&title=In+Vitro+and+In+Vivo+Characterization+of+A-796260%3A+A+Selective+Cannabinoid+CB2+Receptor+Agonist+Exhibiting+Analgesic+Activity+in+Rodent+Pain+Models&doi=10.1038%2Fsj.bjp.0707568"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo characterization of A-796260: a selective cannabinoid CB2 receptor agonist exhibiting analgesic activity in rodent pain models</span></div><div class="casAuthors">Yao, B. B.; Hsieh, G. C.; Frost, J. M.; Fan, Y.; Garrison, T. R.; Daza, A. V.; Grayson, G. K.; Zhu, C. Z.; Pai, M.; Chandran, P.; Salyers, A. K.; Wensink, E. J.; Honore, P.; Sullivan, J. P.; Dart, M. J.; Meyer, M. D.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">390-401</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Selective cannabinoid CB2 receptor agonists have demonstrated analgesic activity across multiple preclin. pain models.  AM1241 is an indole deriv. that exhibits high affinity and selectivity for the CB2 binding site and broad spectrum analgesic activity in rodent models, but is not an antagonist of CB2 in vitro functional assays.  Addnl., its analgesic effects are -opioid receptor-dependent.  Herein, we describe the in vitro and in vivo pharmacol. properties of A-796260, a novel CB2 agonist.  Exptl. approach: A-796260 was characterized in radioligand binding and in vitro functional assays at rat and human CB1 and CB2 receptors.  The behavioral profile of A-796260 was assessed in models of inflammatory, post-operative, neuropathic, and osteoarthritic (OA) pain, as well as its effects on motor activity.  The receptor specificity was confirmed using selective CB1, CB2, and -opioid receptor antagonists.  A-796260 exhibited high affinity and agonist efficacy at human and rat CB2 receptors, and was selective for the CB2 vs CB1 subtype.  Efficacy in models of inflammatory, post-operative, neuropathic and OA pain was demonstrated, and these activities were selectively blocked by CB2, but not CB1, or -opioid receptor-selective antagonists.  Efficacy was achieved at doses that had no significant effects on motor activity.  These results further confirm the therapeutic potential of CB2 receptor-selective agonists for the treatment of pain.  In addn., they demonstrate that A-796260 may be a useful new pharmacol. compd. for further studying CB2 receptor pharmacol. and for evaluating its role in the modulation of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRpbBOoGZg27Vg90H21EOLACvtfcHk0lgcXcavLYTN1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlajsbs%253D&md5=c4d06d34da40f688a17aa15fffe03c64</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707568%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DB.%2BB.%26aulast%3DHsieh%26aufirst%3DG.%2BC.%26aulast%3DFrost%26aufirst%3DJ.%2BM.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DGarrison%26aufirst%3DT.%2BR.%26aulast%3DDaza%26aufirst%3DA.%2BV.%26aulast%3DGrayson%26aufirst%3DG.%2BK.%26aulast%3DZhu%26aufirst%3DC.%2BZ.%26aulast%3DPai%26aufirst%3DM.%26aulast%3DChandran%26aufirst%3DP.%26aulast%3DSalyers%26aufirst%3DA.%2BK.%26aulast%3DWensink%26aufirst%3DE.%2BJ.%26aulast%3DHonore%26aufirst%3DP.%26aulast%3DSullivan%26aufirst%3DJ.%2BP.%26aulast%3DDart%26aufirst%3DM.%2BJ.%26aulast%3DMeyer%26aufirst%3DM.%2BD.%26atitle%3DIn%2520Vitro%2520and%2520In%2520Vivo%2520Characterization%2520of%2520A-796260%253A%2520A%2520Selective%2520Cannabinoid%2520CB2%2520Receptor%2520Agonist%2520Exhibiting%2520Analgesic%2520Activity%2520in%2520Rodent%2520Pain%2520Models%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D153%26spage%3D390%26epage%3D401%26doi%3D10.1038%2Fsj.bjp.0707568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramirez, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blazquez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez del Pulgar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Ceballos, M. L.</span></span> <span> </span><span class="NLM_article-title">Prevention of Alzheimer’s Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade of Microglial Activation</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1904</span>– <span class="NLM_lpage">1913</span>, <span class="refDoi"> DOI: 10.1523/jneurosci.4540-04.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1523%2FJNEUROSCI.4540-04.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=15728830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVSnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=1904-1913&author=B.+G.+Ramirezauthor=C.+Blazquezauthor=T.+Gomez+del+Pulgarauthor=M.+Guzmanauthor=M.+L.+de+Ceballos&title=Prevention+of+Alzheimer%E2%80%99s+Disease+Pathology+by+Cannabinoids%3A+Neuroprotection+Mediated+by+Blockade+of+Microglial+Activation&doi=10.1523%2Fjneurosci.4540-04.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation</span></div><div class="casAuthors">Ramirez, Belen G.; Blazquez, Cristina; Del Pulgar, Teresa Gomez; Guzman, Manuel; De Ceballos, Maria L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1904-1913</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is characterized by enhanced β-amyloid peptide (βA) deposition along with glial activation in senile plaques, selective neuronal loss, and cognitive deficits.  Cannabinoids are neuroprotective agents against excitotoxicity in vitro and acute brain damage in vivo.  This background prompted us to study the localization, expression, and function of cannabinoid receptors in AD and the possible protective role of cannabinoids after βA treatment, both in vivo and in vitro.  Here, the authors show that senile plaques in AD patients express cannabinoid receptors CB1 and CB2, together with markers of microglial activation, and that CB1-pos. neurons, present in high nos. in control cases, are greatly reduced in areas of microglial activation.  In pharmacol. expts., the authors found that G-protein coupling and CB1 receptor protein expression are markedly decreased in AD brains.  Addnl., in AD brains, protein nitration is increased, and, more specifically, CB1 and CB2 proteins show enhanced nitration.  Intracerebroventricular administration of the synthetic cannabinoid WIN55,212-2 to rats prevent βA-induced microglial activation, cognitive impairment, and loss of neuronal markers.  Cannabinoids (HU-210, WIN55,212-2, and JWH-133) block βA-induced activation of cultured microglial cells, as judged by mitochondrial activity, cell morphol., and tumor necrosis factor-α release; these effects are independent of the antioxidant action of cannabinoid compds. and are also exerted by a CB2-selective agonist.  Moreover, cannabinoids abrogate microglia-mediated neurotoxicity after βA addn. to rat cortical cocultures.  The authors' results indicate that cannabinoid receptors are important in the pathol. of AD and that cannabinoids succeed in preventing the neurodegenerative process occurring in the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyXcy-bOWtp7Vg90H21EOLACvtfcHk0lgcXcavLYTN1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVSnu7o%253D&md5=76c4a036fea6afc3b8484dc411ece070</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4540-04.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4540-04.2005%26sid%3Dliteratum%253Aachs%26aulast%3DRamirez%26aufirst%3DB.%2BG.%26aulast%3DBlazquez%26aufirst%3DC.%26aulast%3DGomez%2Bdel%2BPulgar%26aufirst%3DT.%26aulast%3DGuzman%26aufirst%3DM.%26aulast%3Dde%2BCeballos%26aufirst%3DM.%2BL.%26atitle%3DPrevention%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%2520Pathology%2520by%2520Cannabinoids%253A%2520Neuroprotection%2520Mediated%2520by%2520Blockade%2520of%2520Microglial%2520Activation%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D1904%26epage%3D1913%26doi%3D10.1523%2Fjneurosci.4540-04.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Body-Malapel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Bakali, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mérour, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desreumaux, P.</span></span> <span> </span><span class="NLM_article-title">741 4-Oxo-1,4-Dihydroquinoline-3-Carboxamides Derivatives As New Potent and Selective Cb2 Agonists with Anti-Inflammatory and Analgesic Properties in the Gut</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">A–107</span>, <span class="refDoi"> DOI: 10.1016/s0016-5085(08)60500-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1016%2FS0016-5085%2808%2960500-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2008&pages=A%E2%80%93107&author=M.+Body-Malapelauthor=J.+El-Bakaliauthor=E.+M%C3%A9rourauthor=E.+Sternauthor=R.+Milletauthor=P.+Desreumaux&title=741+4-Oxo-1%2C4-Dihydroquinoline-3-Carboxamides+Derivatives+As+New+Potent+and+Selective+Cb2+Agonists+with+Anti-Inflammatory+and+Analgesic+Properties+in+the+Gut&doi=10.1016%2Fs0016-5085%2808%2960500-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2FS0016-5085%2808%2960500-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0016-5085%252808%252960500-4%26sid%3Dliteratum%253Aachs%26aulast%3DBody-Malapel%26aufirst%3DM.%26aulast%3DEl-Bakali%26aufirst%3DJ.%26aulast%3DM%25C3%25A9rour%26aufirst%3DE.%26aulast%3DStern%26aufirst%3DE.%26aulast%3DMillet%26aufirst%3DR.%26aulast%3DDesreumaux%26aufirst%3DP.%26atitle%3D741%25204-Oxo-1%252C4-Dihydroquinoline-3-Carboxamides%2520Derivatives%2520As%2520New%2520Potent%2520and%2520Selective%2520Cb2%2520Agonists%2520with%2520Anti-Inflammatory%2520and%2520Analgesic%2520Properties%2520in%2520the%2520Gut%26jtitle%3DGastroenterology%26date%3D2008%26volume%3D134%26spage%3DA%25E2%2580%2593107%26doi%3D10.1016%2Fs0016-5085%2808%2960500-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benito, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolón, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clemente, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Docagne, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillard, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guaza, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, J.</span></span> <span> </span><span class="NLM_article-title">Cannabinoid CB<sub>1</sub> and CB<sub>2</sub> Receptors and Fatty Acid Amide Hydrolase are Specific Markers of Plaque Cell Subtypes in Human Multiple Sclerosis</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2396</span>– <span class="NLM_lpage">2402</span>, <span class="refDoi"> DOI: 10.1523/jneurosci.4814-06.2007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1523%2FJNEUROSCI.4814-06.2007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=17329437" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsVymsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=2396-2402&author=C.+Benitoauthor=J.+P.+Romeroauthor=R.+M.+Tol%C3%B3nauthor=D.+Clementeauthor=F.+Docagneauthor=C.+J.+Hillardauthor=C.+Guazaauthor=J.+Romero&title=Cannabinoid+CB1+and+CB2+Receptors+and+Fatty+Acid+Amide+Hydrolase+are+Specific+Markers+of+Plaque+Cell+Subtypes+in+Human+Multiple+Sclerosis&doi=10.1523%2Fjneurosci.4814-06.2007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis</span></div><div class="casAuthors">Benito, Cristina; Romero, Juan Pablo; Tolon, Rosa Maria; Clemente, Diego; Docagne, Fabian; Hillard, Cecilia J.; Guaza, Camen; Romero, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2396-2402</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Increasing evidence supports the idea of a beneficial effect of cannabinoid compds. for the treatment of multiple sclerosis (MS).  However, most exptl. data come from animal models of MS.  We investigated the status of cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase (FAAH) enzyme in brain tissue samples obtained from MS patients.  Areas of demyelination were identified and classified as active, chronic, and inactive plaques.  CB1 and CB2 receptors and FAAH densities and cellular sites of expression were examd. using immunohistochem. and immunofluorescence.  In MS samples, cannabinoid CB1 receptors were expressed by cortical neurons, oligodendrocytes, and also oligodendrocyte precursor cells, demonstrated using double immunofluorescence with antibodies against the CB1 receptor with antibodies against type 2 microtubule-assocd. protein, myelin basic protein, and the platelet-derived growth factor receptor-α, resp.  CB1 receptors were also present in macrophages and infiltrated T-lymphocytes.  Conversely, CB2 receptors were present in T-lymphocytes, astrocytes, and perivascular and reactive microglia (major histocompatibility complex class-II pos.) in MS plaques.  Specifically, CB2-pos. microglial cells were evenly distributed within active plaques but were located in the periphery of chronic active plaques.  FAAH expression was restricted to neurons and hypertrophic astrocytes.  As seen for other neuroinflammatory conditions, selective glial expression of cannabinoid CB1 and CB2 receptors and FAAH enzyme is induced in MS, thus supporting a role for the endocannabinoid system in the pathogenesis and/or evolution of this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohbJVv49pGA7Vg90H21EOLACvtfcHk0lg1Hr_T_9-rSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsVymsLY%253D&md5=597beaa5d37154540dd56bd58b2034bc</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4814-06.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4814-06.2007%26sid%3Dliteratum%253Aachs%26aulast%3DBenito%26aufirst%3DC.%26aulast%3DRomero%26aufirst%3DJ.%2BP.%26aulast%3DTol%25C3%25B3n%26aufirst%3DR.%2BM.%26aulast%3DClemente%26aufirst%3DD.%26aulast%3DDocagne%26aufirst%3DF.%26aulast%3DHillard%26aufirst%3DC.%2BJ.%26aulast%3DGuaza%26aufirst%3DC.%26aulast%3DRomero%26aufirst%3DJ.%26atitle%3DCannabinoid%2520CB1%2520and%2520CB2%2520Receptors%2520and%2520Fatty%2520Acid%2520Amide%2520Hydrolase%2520are%2520Specific%2520Markers%2520of%2520Plaque%2520Cell%2520Subtypes%2520in%2520Human%2520Multiple%2520Sclerosis%26jtitle%3DJ.%2520Neurosci.%26date%3D2007%26volume%3D27%26spage%3D2396%26epage%3D2402%26doi%3D10.1523%2Fjneurosci.4814-06.2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pasquini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligresti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mugnaini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semeraro, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cicione, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rosa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guida, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luongo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Chiaro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cascio, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pertwee, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maione, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzo, V. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corelli, F.</span></span> <span> </span><span class="NLM_article-title">Investigations on the 4-Quinolone-3-carboxylic acid Motif. 3. Synthesis, Structure-affinity Relationships, and Pharmacological Characterization of 6-Substituted 4-quinolone-3-carboxamides as Highly Selective Cannabinoid-2 Receptor Ligands</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">5915</span>– <span class="NLM_lpage">5928</span>, and the references cited therein <span class="refDoi"> DOI: 10.1021/jm100123x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100123x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsVCht78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5915-5928&author=S.+Pasquiniauthor=A.+Ligrestiauthor=C.+Mugnainiauthor=T.+Semeraroauthor=L.+Cicioneauthor=M.+De+Rosaauthor=F.+Guidaauthor=L.+Luongoauthor=M.+De+Chiaroauthor=M.+G.+Cascioauthor=D.+Bologniniauthor=P.+Mariniauthor=R.+Pertweeauthor=S.+Maioneauthor=V.+D.+Marzoauthor=F.+Corelli&title=Investigations+on+the+4-Quinolone-3-carboxylic+acid+Motif.+3.+Synthesis%2C+Structure-affinity+Relationships%2C+and+Pharmacological+Characterization+of+6-Substituted+4-quinolone-3-carboxamides+as+Highly+Selective+Cannabinoid-2+Receptor+Ligands&doi=10.1021%2Fjm100123x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 3. Synthesis, Structure-Affinity Relationships, and Pharmacological Characterization of 6-Substituted 4-Quinolone-3-carboxamides as Highly Selective Cannabinoid-2 Receptor Ligands</span></div><div class="casAuthors">Pasquini, Serena; Ligresti, Alessia; Mugnaini, Claudia; Semeraro, Teresa; Cicione, Lavinia; De Rosa, Maria; Guida, Francesca; Luongo, Livio; De Chiaro, Maria; Cascio, Maria Grazia; Bolognini, Daniele; Marini, Pietro; Pertwee, Roger; Maione, Sabatino; Di Marzo, Vincenzo; Corelli, Federico</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5915-5928</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A set of quinolone-3-carboxamides I [R1 = (un)substituted Ph, 2-furyl, 1-cyclohexenyl, 1-isobutylpyrazol-4-yl, etc.; R2 = 1-adamantyl, 1-fenchyl, hexyl, 1-piperidinyl; R3 = pentyl, 1-buten-4-yl, allyl] bearing diverse substituents at position 1, 3, and 6 of the bicyclic nucleus was prepd.  Except for six compds. exhibiting Ki > 100 nM, all the quinolone-3-carboxamides I proved to be high affinity CB2 ligands, with Ki values ranging from 73.2 to 0.7 nM and selectivity [SI = Ki(CB1)/Ki(CB2)] varying from >14285 to 1.9, with only one compd. exhibiting a reverse selectivity (SI < 1).  In the formalin test of peripheral acute and inflammatory pain in mice, I [R1 = CH2CH2Ph, R2 = 1-adamantyl, R3 = pentyl] showed analgesic activity that was antagonized by a selective CB2 antagonist.  By contrast, I [R1 = 2-furyl, R2 = 1-adamantyl, R3 = pentyl] was inactive per se and antagonized the effect of a selective CB2 agonist.  Also, two of these compds. exhibited CB2 inverse agonist-like behavior in this in vivo test.  However, two different functional assays carried out in vitro indicated for both compds. an overall inverse agonist activity at CB2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWqQVRHQABn7Vg90H21EOLACvtfcHk0liOtXDDI64NHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsVCht78%253D&md5=642a103b93312fd2f1e124173143b656</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm100123x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100123x%26sid%3Dliteratum%253Aachs%26aulast%3DPasquini%26aufirst%3DS.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DMugnaini%26aufirst%3DC.%26aulast%3DSemeraro%26aufirst%3DT.%26aulast%3DCicione%26aufirst%3DL.%26aulast%3DDe%2BRosa%26aufirst%3DM.%26aulast%3DGuida%26aufirst%3DF.%26aulast%3DLuongo%26aufirst%3DL.%26aulast%3DDe%2BChiaro%26aufirst%3DM.%26aulast%3DCascio%26aufirst%3DM.%2BG.%26aulast%3DBolognini%26aufirst%3DD.%26aulast%3DMarini%26aufirst%3DP.%26aulast%3DPertwee%26aufirst%3DR.%26aulast%3DMaione%26aufirst%3DS.%26aulast%3DMarzo%26aufirst%3DV.%2BD.%26aulast%3DCorelli%26aufirst%3DF.%26atitle%3DInvestigations%2520on%2520the%25204-Quinolone-3-carboxylic%2520acid%2520Motif.%25203.%2520Synthesis%252C%2520Structure-affinity%2520Relationships%252C%2520and%2520Pharmacological%2520Characterization%2520of%25206-Substituted%25204-quinolone-3-carboxamides%2520as%2520Highly%2520Selective%2520Cannabinoid-2%2520Receptor%2520Ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5915%26epage%3D5928%26doi%3D10.1021%2Fjm100123x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lunn, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fine, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas-Triana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonsiorek, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavey, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlowski, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narula, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundell, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hipkin, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bober, L. A.</span></span> <span> </span><span class="NLM_article-title">A Novel Cannabinoid Peripheral Cannabinoid Receptor-Selective Inverse Agonist Blocks Leukocyte Recruitment in Vivo</span>. <i>J. Pharmacol. Exp. Therapeut.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>316</i></span>,  <span class="NLM_fpage">780</span>– <span class="NLM_lpage">788</span>, <span class="refDoi"> DOI: 10.1124/jpet.105.093500</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1124%2Fjpet.105.093500" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=16258021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlWqtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2006&pages=780-788&author=C.+A.+Lunnauthor=J.+S.+Fineauthor=A.+Rojas-Trianaauthor=J.+V.+Jacksonauthor=X.+Fanauthor=T.+T.+Kungauthor=W.+Gonsiorekauthor=M.+A.+Schwarzauthor=B.+Laveyauthor=J.+A.+Kozlowskiauthor=S.+K.+Narulaauthor=D.+J.+Lundellauthor=R.+W.+Hipkinauthor=L.+A.+Bober&title=A+Novel+Cannabinoid+Peripheral+Cannabinoid+Receptor-Selective+Inverse+Agonist+Blocks+Leukocyte+Recruitment+in+Vivo&doi=10.1124%2Fjpet.105.093500"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">A novel cannabinoid peripheral cannabinoid receptor-selective inverse agonist blocks leukocyte recruitment in vivo</span></div><div class="casAuthors">Lunn, Charles A.; Fine, Jay S.; Rojas-Triana, Alberto; Jackson, James V.; Fan, Xuedong; Kung, Ted T.; Gonsiorek, Waldemar; Schwarz, Martin A.; Lavey, Brian; Kozlowski, Joseph A.; Narula, Satwant K.; Lundell, Daniel J.; Hipkin, R. William; Bober, Loretta A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">780-788</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The expression of the cannabinoid peripheral cannabinoid receptor (CB2) receptor on peripheral immune cells suggests that compds. specific for CB2 might be effective anti-inflammatory agents.  In this report, we present the initial biol. profiling of a novel triaryl bis-sulfone, Sch.336 (N-[1(S)-[4-[[4-methoxy-2-[(4-methoxyphenyl)sulfonyl]phenyl]-sulfonyl]phenyl]ethyl]methanesulfonamide), which is selective for the human cannabinoid CB2 receptor (hCB2).  Sch.336 is an inverse agonist at hCB2, as shown by its ability to decrease guanosine 5'-3-O-(thio)triphosphate (GTPγS) binding to membranes contg. hCB2, by the ability of GTPγS to left-shift Sch.336 binding to hCB2 in these membranes, and by the compd.'s ability to increase forskolin-stimulated cAMP levels in CHO cells expressing hCB2.  In these systems, Sch.336 displays a greater potency than that reported for the CB2-selective dihydropyrazole, SR144528 (N-[(1S)-endo-1,3,3-trimethylbicyclo [2.2.1]heptan2-yl]-5-(4-chloro-3-methylphenyl)-1-[(4-methylphenyl)methyl]-1H-pyrazole-3-carboxamide).  In vitro, Sch.336 impairs the migration of CB2-expressing recombinant cell lines to the cannabinoid agonist 2-arachidonylglycerol.  In vivo, the compd. impairs migration of cells to cannabinoid agonist HU210 [(6aR)-trans-3-(1,1-dimethylheptyl)-6a,7,10,10a-tetrahydro-1-hydroxy-6,6-dimethyl-6H-dibenzo[b,d]pyran-9-methanol].  Oral administration of the Sch.336 significantly inhibited leukocyte trafficking in several rodent in vivo models, induced either by specific chemokines or by antigen challenge.  Finally, oral administration of Sch.336 blocked ovalbumin-induced lung eosinophilia in mice, a disease model for allergic asthma.  We conclude that selective cannabinoid CB2 inverse agonists may serve as novel immunomodulatory agents in the treatment of a broad range of acute and chronic inflammatory disorders in which leukocyte recruitment is a hallmark of disease pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1l5AWSaKtfbVg90H21EOLACvtfcHk0liOtXDDI64NHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlWqtrY%253D&md5=542a1bcf6463ed23ac200fc5ed332162</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.093500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.093500%26sid%3Dliteratum%253Aachs%26aulast%3DLunn%26aufirst%3DC.%2BA.%26aulast%3DFine%26aufirst%3DJ.%2BS.%26aulast%3DRojas-Triana%26aufirst%3DA.%26aulast%3DJackson%26aufirst%3DJ.%2BV.%26aulast%3DFan%26aufirst%3DX.%26aulast%3DKung%26aufirst%3DT.%2BT.%26aulast%3DGonsiorek%26aufirst%3DW.%26aulast%3DSchwarz%26aufirst%3DM.%2BA.%26aulast%3DLavey%26aufirst%3DB.%26aulast%3DKozlowski%26aufirst%3DJ.%2BA.%26aulast%3DNarula%26aufirst%3DS.%2BK.%26aulast%3DLundell%26aufirst%3DD.%2BJ.%26aulast%3DHipkin%26aufirst%3DR.%2BW.%26aulast%3DBober%26aufirst%3DL.%2BA.%26atitle%3DA%2520Novel%2520Cannabinoid%2520Peripheral%2520Cannabinoid%2520Receptor-Selective%2520Inverse%2520Agonist%2520Blocks%2520Leukocyte%2520Recruitment%2520in%2520Vivo%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Therapeut.%26date%3D2006%26volume%3D316%26spage%3D780%26epage%3D788%26doi%3D10.1124%2Fjpet.105.093500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Savinainen, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kokkola, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salo, O. M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Järvinen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laitinen, J. T.</span></span> <span> </span><span class="NLM_article-title">Identification of WIN55212-3 as a competitive neutral antagonist of the human cannabinoid CB2 receptor</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>145</i></span>,  <span class="NLM_fpage">636</span>– <span class="NLM_lpage">645</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0706230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1038%2Fsj.bjp.0706230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=15852035" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlslWhsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2005&pages=636-645&author=J.+R.+Savinainenauthor=T.+Kokkolaauthor=O.+M.+H.+Saloauthor=A.+Posoauthor=T.+J%C3%A4rvinenauthor=J.+T.+Laitinen&title=Identification+of+WIN55212-3+as+a+competitive+neutral+antagonist+of+the+human+cannabinoid+CB2+receptor&doi=10.1038%2Fsj.bjp.0706230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of WIN55212-3 as a competitive neutral antagonist of the human cannabinoid CB2 receptor</span></div><div class="casAuthors">Savinainen, Juha R.; Kokkola, Tarja; Salo, Outi M. H.; Poso, Antti; Jaervinen, Tomi; Laitinen, Jarmo T.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">636-645</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Several G protein-coupled receptors (GPCRs), including cannabinoid CB1 and CB2 receptors, show constitutive activity under heterologous expression.  Such a tonic response is generated in the absence of an activating ligand, and can be inhibited by inverse agonists.  Neutral antagonists, however, are silent at such receptors, but can reverse both agonist and inverse agonist responses.  To date, no neutral antagonist for the CB2 receptor has been reported.  Here, by monitoring receptor-dependent G protein activation, we demonstrate that WIN55212-3 acts as a neutral antagonist at the human CB2 (hCB2) receptor.  WIN55212-3 alone, at concns. ≤10-4 M, behaved as a silent ligand exhibiting no agonist or inverse agonist activity.  However, WIN55212-3 competitively antagonized cannabinoid agonist CP-55,940-stimulated responses (pA2 6.1).  Importantly, the inverse agonism evoked by SR144528 in hCB2 was dose-dependently reversed by WIN55212-3 (pEC50 5.3±0.2), indicating true neutral antagonist behavior.  Furthermore, WIN55212-3 also antagonized CB1 receptor signaling in a competitive manner (pA2 5.6), but behaved as a partial inverse agonist (pIC50 5.5±0.1) at the constitutively active human CB1.  Addnl., WIN55212-3 antagonized signaling of the human melatonin MT1 receptor, with modest activity at the human muscarinic M4 receptor, but it was inactive towards several other GPCRs.  These data identify WIN55212-3 as a true neutral hCB2 receptor antagonist.  WIN55212-3 offers a valuable tool for further characterization of ligand activities at the CB2 receptor and may serve as a lead compd. in further efforts to develop more potent and selective neutral CB2 receptor antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdgQCRQkCZvrVg90H21EOLACvtfcHk0lhSgjRAAsfl_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlslWhsb8%253D&md5=2ed7ee5b52613a9274ce0ee3aff4bd74</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706230%26sid%3Dliteratum%253Aachs%26aulast%3DSavinainen%26aufirst%3DJ.%2BR.%26aulast%3DKokkola%26aufirst%3DT.%26aulast%3DSalo%26aufirst%3DO.%2BM.%2BH.%26aulast%3DPoso%26aufirst%3DA.%26aulast%3DJ%25C3%25A4rvinen%26aufirst%3DT.%26aulast%3DLaitinen%26aufirst%3DJ.%2BT.%26atitle%3DIdentification%2520of%2520WIN55212-3%2520as%2520a%2520competitive%2520neutral%2520antagonist%2520of%2520the%2520human%2520cannabinoid%2520CB2%2520receptor%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2005%26volume%3D145%26spage%3D636%26epage%3D645%26doi%3D10.1038%2Fsj.bjp.0706230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deveaux, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadoudal, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichigotani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teixeira-Clerc, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louvet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nhieu, J. T.-V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belot, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Even, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cani, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knauf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burcelin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertola, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Marchand-Brustel, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gual, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lotersztajn, S.</span></span> <span> </span><span class="NLM_article-title">Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis</span>. <i>PloS One</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">e5844</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0005844</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1371%2Fjournal.pone.0005844" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=19513120" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&author=V.+Deveauxauthor=T.+Cadoudalauthor=Y.+Ichigotaniauthor=F.+Teixeira-Clercauthor=A.+Louvetauthor=S.+Maninauthor=J.+T.-V.+Nhieuauthor=M.+P.+Belotauthor=A.+Zimmerauthor=P.+Evenauthor=P.+D.+Caniauthor=C.+Knaufauthor=R.+Burcelinauthor=A.+Bertolaauthor=Y.+Le+Marchand-Brustelauthor=P.+Gualauthor=A.+Mallatauthor=S.+Lotersztajn&title=Cannabinoid+CB2+Receptor+Potentiates+Obesity-Associated+Inflammation%2C+Insulin+Resistance+and+Hepatic+Steatosis&doi=10.1371%2Fjournal.pone.0005844"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0005844&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0005844%26sid%3Dliteratum%253Aachs%26aulast%3DDeveaux%26aufirst%3DV.%26aulast%3DCadoudal%26aufirst%3DT.%26aulast%3DIchigotani%26aufirst%3DY.%26aulast%3DTeixeira-Clerc%26aufirst%3DF.%26aulast%3DLouvet%26aufirst%3DA.%26aulast%3DManin%26aufirst%3DS.%26aulast%3DNhieu%26aufirst%3DJ.%2BT.-V.%26aulast%3DBelot%26aufirst%3DM.%2BP.%26aulast%3DZimmer%26aufirst%3DA.%26aulast%3DEven%26aufirst%3DP.%26aulast%3DCani%26aufirst%3DP.%2BD.%26aulast%3DKnauf%26aufirst%3DC.%26aulast%3DBurcelin%26aufirst%3DR.%26aulast%3DBertola%26aufirst%3DA.%26aulast%3DLe%2BMarchand-Brustel%26aufirst%3DY.%26aulast%3DGual%26aufirst%3DP.%26aulast%3DMallat%26aufirst%3DA.%26aulast%3DLotersztajn%26aufirst%3DS.%26atitle%3DCannabinoid%2520CB2%2520Receptor%2520Potentiates%2520Obesity-Associated%2520Inflammation%252C%2520Insulin%2520Resistance%2520and%2520Hepatic%2520Steatosis%26jtitle%3DPloS%2520One%26date%3D2009%26volume%3D4%26doi%3D10.1371%2Fjournal.pone.0005844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frost, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dart, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tietje, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrison, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grayson, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daza, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Kouhen, O. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandran, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, M. D.</span></span> <span> </span><span class="NLM_article-title">Indol-3-yl-tetramethylcyclopropyl Ketones: Effects of Indole Ring Substitution on CB2Cannabinoid Receptor Activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1904</span>– <span class="NLM_lpage">1912</span>, <span class="refDoi"> DOI: 10.1021/jm7011613</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm7011613" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVCnsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1904-1912&author=J.+M.+Frostauthor=M.+J.+Dartauthor=K.+R.+Tietjeauthor=T.+R.+Garrisonauthor=G.+K.+Graysonauthor=A.+V.+Dazaauthor=O.+F.+El-Kouhenauthor=L.+N.+Millerauthor=L.+Liauthor=B.+B.+Yaoauthor=G.+C.+Hsiehauthor=M.+Paiauthor=C.+Z.+Zhuauthor=P.+Chandranauthor=M.+D.+Meyer&title=Indol-3-yl-tetramethylcyclopropyl+Ketones%3A+Effects+of+Indole+Ring+Substitution+on+CB2Cannabinoid+Receptor+Activity&doi=10.1021%2Fjm7011613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Indol-3-yl-tetramethylcyclopropyl Ketones: Effects of Indole Ring Substitution on CB2 Cannabinoid Receptor Activity</span></div><div class="casAuthors">Frost, Jennifer M.; Dart, Michael J.; Tietje, Karin R.; Garrison, Tiffany R.; Grayson, George K.; Daza, Anthony V.; El-Kouhen, Odile F.; Miller, Loan N.; Li, Lanlan; Yao, Betty B.; Hsieh, Gin C.; Pai, Madhavi; Zhu, Chang Z.; Chandran, Prasant; Meyer, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1904-1912</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of potent indol-3-yltetramethylcyclopropyl ketones have been prepd. as CB2 cannabinoid receptor ligands.  Two unsubstituted indoles (I, II) were the starting points for an investigation of the effect of indole ring substitutions on CB2 and CB1 binding affinities and activity in a CB2 in vitro functional assay.  Indole ring substitutions had varying effects on CB2 and CB1 binding, but were generally detrimental to agonist activity.  Substitution on the indole ring did lead to improved CB2/CB1 binding selectivity in some cases.  All indoles with the morpholinoethyl side chain exhibited weaker binding affinity and less agonist activity relative to that of their tetrahydropyranylmethyl analogs.  Several agonists were active in the complete Freund's adjuvant model of chronic inflammatory thermal hyperalgesia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLc34sGUL95rVg90H21EOLACvtfcHk0lhSgjRAAsfl_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVCnsro%253D&md5=2fab721dcf172df11636476e207e62d9</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm7011613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7011613%26sid%3Dliteratum%253Aachs%26aulast%3DFrost%26aufirst%3DJ.%2BM.%26aulast%3DDart%26aufirst%3DM.%2BJ.%26aulast%3DTietje%26aufirst%3DK.%2BR.%26aulast%3DGarrison%26aufirst%3DT.%2BR.%26aulast%3DGrayson%26aufirst%3DG.%2BK.%26aulast%3DDaza%26aufirst%3DA.%2BV.%26aulast%3DEl-Kouhen%26aufirst%3DO.%2BF.%26aulast%3DMiller%26aufirst%3DL.%2BN.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DYao%26aufirst%3DB.%2BB.%26aulast%3DHsieh%26aufirst%3DG.%2BC.%26aulast%3DPai%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DC.%2BZ.%26aulast%3DChandran%26aufirst%3DP.%26aulast%3DMeyer%26aufirst%3DM.%2BD.%26atitle%3DIndol-3-yl-tetramethylcyclopropyl%2520Ketones%253A%2520Effects%2520of%2520Indole%2520Ring%2520Substitution%2520on%2520CB2Cannabinoid%2520Receptor%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1904%26epage%3D1912%26doi%3D10.1021%2Fjm7011613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Drug
Enforcement Administration</span> <span> </span><span class="NLM_article-title">Schedules of Controlled Substances: Placement of UR-144, XLR11, and
AKB48 into Schedule I</span>. <i>Fed. Regist.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">29142</span>– <span class="NLM_lpage">29145</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=27192731" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2016&pages=29142-29145&author=Drug%0AEnforcement+Administration&title=Schedules+of+Controlled+Substances%3A+Placement+of+UR-144%2C+XLR11%2C+and%0AAKB48+into+Schedule+I"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DSchedules%2520of%2520Controlled%2520Substances%253A%2520Placement%2520of%2520UR-144%252C%2520XLR11%252C%2520and%250AAKB48%2520into%2520Schedule%2520I%26jtitle%3DFed.%2520Regist.%26date%3D2016%26volume%3D81%26spage%3D29142%26epage%3D29145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Regulatory
agencies including
the US Drug Enforcement Agency consider “history and current
pattern of abuse”</span>. <span> </span><span class="NLM_article-title">“evidence
that individuals are taking the drug or other substance in amounts
sufficient to create a hazard”; and “significant diversion
of the drug or other substance from legitimate drug channels”
as key “indicators that a drug or other substance has a potential
for abuse”; see: Drugs of Abuse: A DEA Resource Guide, 2020
Edition, April 13, 2020</span>. see <a href="https://www.dea.gov/documents/2020/04/13/drugs-abuse" class="extLink">https://www.dea.gov/documents/2020/04/13/drugs-abuse</a> (accessed Apr 4 2021).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Regulatory%0Aagencies+including%0Athe+US+Drug+Enforcement+Agency+consider+%E2%80%9Chistory+and+current%0Apattern+of+abuse%E2%80%9D.+%E2%80%9Cevidence%0Athat+individuals+are+taking+the+drug+or+other+substance+in+amounts%0Asufficient+to+create+a+hazard%E2%80%9D%3B+and+%E2%80%9Csignificant+diversion%0Aof+the+drug+or+other+substance+from+legitimate+drug+channels%E2%80%9D%0Aas+key+%E2%80%9Cindicators+that+a+drug+or+other+substance+has+a+potential%0Afor+abuse%E2%80%9D%3B+see%3A+Drugs+of+Abuse%3A+A+DEA+Resource+Guide%2C+2020%0AEdition%2C+April+13%2C+2020.+see+https%3A%2F%2Fwww.dea.gov%2Fdocuments%2F2020%2F04%2F13%2Fdrugs-abuse+%28accessed+Apr+4+2021%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3D%25E2%2580%259Cevidence%250Athat%2520individuals%2520are%2520taking%2520the%2520drug%2520or%2520other%2520substance%2520in%2520amounts%250Asufficient%2520to%2520create%2520a%2520hazard%25E2%2580%259D%253B%2520and%2520%25E2%2580%259Csignificant%2520diversion%250Aof%2520the%2520drug%2520or%2520other%2520substance%2520from%2520legitimate%2520drug%2520channels%25E2%2580%259D%250Aas%2520key%2520%25E2%2580%259Cindicators%2520that%2520a%2520drug%2520or%2520other%2520substance%2520has%2520a%2520potential%250Afor%2520abuse%25E2%2580%259D%253B%2520see%253A%2520Drugs%2520of%2520Abuse%253A%2520A%2520DEA%2520Resource%2520Guide%252C%25202020%250AEdition%252C%2520April%252013%252C%25202020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wiley, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marusich, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huffman, J. W.</span></span> <span> </span><span class="NLM_article-title">Moving Around the Molecule: Relationship Between Chemical Structure and in vivo Activity of Synthetic Cannabinoids</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2013.09.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1016%2Fj.lfs.2013.09.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=24071522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Srs7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2014&pages=55-63&author=J.+L.+Wileyauthor=J.+A.+Marusichauthor=J.+W.+Huffman&title=Moving+Around+the+Molecule%3A+Relationship+Between+Chemical+Structure+and+in+vivo+Activity+of+Synthetic+Cannabinoids&doi=10.1016%2Fj.lfs.2013.09.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Moving around the molecule: Relationship between chemical structure and in vivo activity of synthetic cannabinoids</span></div><div class="casAuthors">Wiley, Jenny L.; Marusich, Julie A.; Huffman, John W.</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-63</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Originally synthesized for research purposes, indole- and pyrrole-derived synthetic cannabinoids are the most common psychoactive compds. contained in abused products marketed as "spice" or "herbal incense." While CB1 and CB2 receptor affinities are available for most of these research chems., in vivo pharmacol. data are sparse.  In mice, cannabinoids produce a characteristic profile of dose-dependent effects: antinociception, hypothermia, catalepsy and suppression of locomotion.  In combination with receptor binding data, this tetrad battery has been useful in evaluation of the relationship between the structural features of synthetic cannabinoids and their in vivo cannabimimetic activity.  Here, published tetrad studies are reviewed and addnl. in vivo data on synthetic cannabinoids are presented.  Overall, the best predictor of likely cannabimimetic effects in the tetrad tests was good CB1 receptor affinity.  Further, retention of good CB1 affinity and in vivo activity was obsd. across a wide array of structural manipulations of substituents of the prototypic aminoalkylindole mol. WIN55,212-2, including substitution of an alkyl for the morpholino group, replacement of an indole core with a pyrrole or phenylpyrrole, substitution of a phenylacetyl or tetramethylcyclopropyl group for JWH-018's naphthoyl, and halogenation of the naphthoyl group.  This flexibility of cannabinoid ligand-receptor interactions has been a particular challenge for forensic scientists who have struggled to identify and regulate each new compd. as it has appeared on the drug market.  One of the most pressing future research needs is detn. of the extent to which the pharmacol. of these synthetic cannabinoids may differ from those of classical cannabinoids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9o7LiXmgZc7Vg90H21EOLACvtfcHk0lgGIILsGls65g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Srs7vP&md5=b6e3a3c52b834af7d8d7d4e9aa9447a9</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2013.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2013.09.011%26sid%3Dliteratum%253Aachs%26aulast%3DWiley%26aufirst%3DJ.%2BL.%26aulast%3DMarusich%26aufirst%3DJ.%2BA.%26aulast%3DHuffman%26aufirst%3DJ.%2BW.%26atitle%3DMoving%2520Around%2520the%2520Molecule%253A%2520Relationship%2520Between%2520Chemical%2520Structure%2520and%2520in%2520vivo%2520Activity%2520of%2520Synthetic%2520Cannabinoids%26jtitle%3DLife%2520Sci.%26date%3D2014%26volume%3D97%26spage%3D55%26epage%3D63%26doi%3D10.1016%2Fj.lfs.2013.09.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pasquini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mugnaini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligresti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tafi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brogi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falciani, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedani, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pesco, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guida, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luongo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borea, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maione, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corelli, F.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis, and Pharmacological Characterizationof Indol-3- ylacetamides, Indol-3-yloxoacetamides, and Indol-3-ylcarboxamides: Potent and Selective CB2 Cannabinoid Receptor Inverse Agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">5391</span>– <span class="NLM_lpage">5402</span>, <span class="refDoi"> DOI: 10.1021/jm3003334</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3003334" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtlSmsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5391-5402&author=S.+Pasquiniauthor=C.+Mugnainiauthor=A.+Ligrestiauthor=A.+Tafiauthor=S.+Brogiauthor=C.+Falcianiauthor=V.+Pedaniauthor=N.+Pescoauthor=F.+Guidaauthor=L.+Luongoauthor=K.+Varaniauthor=P.+A.+Boreaauthor=S.+Maioneauthor=V.+Di+Marzoauthor=F.+Corelli&title=Design%2C+Synthesis%2C+and+Pharmacological+Characterizationof+Indol-3-+ylacetamides%2C+Indol-3-yloxoacetamides%2C+and+Indol-3-ylcarboxamides%3A+Potent+and+Selective+CB2+Cannabinoid+Receptor+Inverse+Agonists&doi=10.1021%2Fjm3003334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Pharmacological Characterization of Indol-3-ylacetamides, Indol-3-yloxoacetamides, and Indol-3-ylcarboxamides: Potent and Selective CB2 Cannabinoid Receptor Inverse Agonists</span></div><div class="casAuthors">Pasquini, Serena; Mugnaini, Claudia; Ligresti, Alessia; Tafi, Andrea; Brogi, Simone; Falciani, Chiara; Pedani, Valentina; Pesco, Nicolo; Guida, Francesca; Luongo, Livio; Varani, Katia; Borea, Pier Andrea; Maione, Sabatino; Di Marzo, Vincenzo; Corelli, Federico</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5391-5402</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aryl-substituted indole carboxamides I (R = Ph, 4-HOC6H4, 2-furanyl, 2-thienyl, H; R1 = H, Ph; R2 = 1-adamantyl, cycloheptyl, cyclohexyl; R3 = allyl, BuCH2, Me, Et, EtCH2, Bu, H2C:CHCH2CH2, PhCH2; X = bond, CH2, CO) were prepd. as CB2-selective cannabinoid receptor inverse agonists and tested for their selectivities for inverse agonism at CB1 and CB2 cannabinoid receptors and, in some cases, for their ability to reverse the effects of a CB2 selective agonist in an antiinflammatory/analgesic model in mice.  Most of the indole carboxamides bound to CB2 receptors with affinities in the nanomolar range (Ki values between 0.37 nM and 377 nM) and with moderate to good selectivities for CB2 cannabinoid receptors over CB1 receptors [Ki(CB2)/Ki(CB1) = 0.6 and 5 - >487].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0DEYHepc9qrVg90H21EOLACvtfcHk0lgGIILsGls65g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtlSmsbw%253D&md5=910785cca9e1637b5f7e2f61e0473bfd</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm3003334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3003334%26sid%3Dliteratum%253Aachs%26aulast%3DPasquini%26aufirst%3DS.%26aulast%3DMugnaini%26aufirst%3DC.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DTafi%26aufirst%3DA.%26aulast%3DBrogi%26aufirst%3DS.%26aulast%3DFalciani%26aufirst%3DC.%26aulast%3DPedani%26aufirst%3DV.%26aulast%3DPesco%26aufirst%3DN.%26aulast%3DGuida%26aufirst%3DF.%26aulast%3DLuongo%26aufirst%3DL.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DMaione%26aufirst%3DS.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DCorelli%26aufirst%3DF.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Pharmacological%2520Characterizationof%2520Indol-3-%2520ylacetamides%252C%2520Indol-3-yloxoacetamides%252C%2520and%2520Indol-3-ylcarboxamides%253A%2520Potent%2520and%2520Selective%2520CB2%2520Cannabinoid%2520Receptor%2520Inverse%2520Agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5391%26epage%3D5402%26doi%3D10.1021%2Fjm3003334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tavakoli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudley, G. B.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 4,4-Dimethyl-1,6-heptadiyne and Alcyopterosin O</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">8947</span>– <span class="NLM_lpage">8951</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.0c03356</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.0c03356" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BB3cXit1eqtrvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2020&pages=8947-8951&author=A.+Tavakoliauthor=G.+B.+Dudley&title=Synthesis+of+4%2C4-Dimethyl-1%2C6-heptadiyne+and+Alcyopterosin+O&doi=10.1021%2Facs.orglett.0c03356"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 4,4-Dimethyl-1,6-heptadiyne and Alcyopterosin O</span></div><div class="casAuthors">Tavakoli, Amir; Dudley, Gregory B.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8947-8951</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A four-step synthesis of 4,4-dimethyl-1,6-heptadiyne and an assocd. five-step synthesis of alcyopterosin O, an illudalane sesquiterpene natural product, are described starting from com. available dimedone.  The process features C-C bond-cleaving fragmentation and elimination methods for making alkynes, and it proceeds by way of nonsym. diynes that are themselves valuable synthetic building blocks, as exemplified by the synthesis of alcyopterosin O.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZguLkv1sjx7Vg90H21EOLACvtfcHk0liKmpbGaGLUyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXit1eqtrvI&md5=67ba234eaf552d0cea780d03224793ac</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.0c03356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.0c03356%26sid%3Dliteratum%253Aachs%26aulast%3DTavakoli%26aufirst%3DA.%26aulast%3DDudley%26aufirst%3DG.%2BB.%26atitle%3DSynthesis%2520of%25204%252C4-Dimethyl-1%252C6-heptadiyne%2520and%2520Alcyopterosin%2520O%26jtitle%3DOrg.%2520Lett.%26date%3D2020%26volume%3D22%26spage%3D8947%26epage%3D8951%26doi%3D10.1021%2Facs.orglett.0c03356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoang, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudley, G. B.</span></span> <span> </span><span class="NLM_article-title">Reaction Discovery Using Neopentylene-Tethered Coupling Partners: Cycloisomerization/Oxidation of Electron-Deficient Dienynes</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">4636</span>– <span class="NLM_lpage">4639</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.7b02261</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.7b02261" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlKmtb3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2017&pages=4636-4639&author=N.+J.+Kramerauthor=T.+T.+Hoangauthor=G.+B.+Dudley&title=Reaction+Discovery+Using+Neopentylene-Tethered+Coupling+Partners%3A+Cycloisomerization%2FOxidation+of+Electron-Deficient+Dienynes&doi=10.1021%2Facs.orglett.7b02261"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Reaction Discovery Using Neopentylene-Tethered Coupling Partners: Cycloisomerization/Oxidation of Electron-Deficient Dienynes</span></div><div class="casAuthors">Kramer, Nicholas J.; Hoang, Tung T.; Dudley, Gregory B.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4636-4639</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A rhodium-catalyzed cycloisomerization and oxidn. of tethered dienynes for the synthesis of indans, e.g. I, is described.  An auxiliary fragmentation/olefination method (also described herein) provides novel access to tethered alkyne-dienoate substrates.  The reported method circumvents current limitations in and expands the scope of inverse-demand Diels-Alder-type cycloaddns.  Traditional discovery substrates involving malonate-, ether- and sulfonamide-based tethers are problematic in the current methodol., underscoring the unique virtue of neopentylene-tethered substrates for reaction discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvlvTTHkhfL7Vg90H21EOLACvtfcHk0liKmpbGaGLUyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlKmtb3L&md5=27b7507969c4a2216d6e6fb7238fe7f5</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.7b02261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.7b02261%26sid%3Dliteratum%253Aachs%26aulast%3DKramer%26aufirst%3DN.%2BJ.%26aulast%3DHoang%26aufirst%3DT.%2BT.%26aulast%3DDudley%26aufirst%3DG.%2BB.%26atitle%3DReaction%2520Discovery%2520Using%2520Neopentylene-Tethered%2520Coupling%2520Partners%253A%2520Cycloisomerization%252FOxidation%2520of%2520Electron-Deficient%2520Dienynes%26jtitle%3DOrg.%2520Lett.%26date%3D2017%26volume%3D19%26spage%3D4636%26epage%3D4639%26doi%3D10.1021%2Facs.orglett.7b02261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longstaff, S. C.</span></span> <span> </span><span class="NLM_article-title">Generation and Cyclization of a Benzyne-Tethered Alkyllithium: Preparation of 4-Substituted Indans</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">432</span>– <span class="NLM_lpage">433</span>, <span class="refDoi"> DOI: 10.1021/jo972065z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo972065z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADyaK1cXksFCrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1998&pages=432-433&author=W.+F.+Baileyauthor=S.+C.+Longstaff&title=Generation+and+Cyclization+of+a+Benzyne-Tethered+Alkyllithium%3A+Preparation+of+4-Substituted+Indans&doi=10.1021%2Fjo972065z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Generation and Cyclization of a Benzyne-Tethered Alkyllithium: Preparation of 4-Substituted Indans</span></div><div class="casAuthors">Bailey, William F.; Longstaff, Sarah C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">432-433</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">2-FC6H4CH2CH2CH2I was treated with Me3CLi in n-pentane-diethyl ether at -78°, followed by addn. of THF to render residual Me3CLi monomeric.  The ortho-lithiation of 2-FC6H4CH2CH2CH2Li was followed by formation of a benzyne-tethered propyllithium intermediate, which was trapped with electrophiles to give 4-substituted indans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_-38nebLCybVg90H21EOLACvtfcHk0liKmpbGaGLUyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXksFCrtQ%253D%253D&md5=4dc1639146a1fcd44e5a89dc4cfb5c5b</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjo972065z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo972065z%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DW.%2BF.%26aulast%3DLongstaff%26aufirst%3DS.%2BC.%26atitle%3DGeneration%2520and%2520Cyclization%2520of%2520a%2520Benzyne-Tethered%2520Alkyllithium%253A%2520Preparation%2520of%25204-Substituted%2520Indans%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1998%26volume%3D63%26spage%3D432%26epage%3D433%26doi%3D10.1021%2Fjo972065z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoang, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudley, G. B.</span></span> <span> </span><span class="NLM_article-title">Synthesis of High-Value 1,6-Enynes by Tandem Fragmentation/Olefination</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">4026</span>– <span class="NLM_lpage">4029</span>, <span class="refDoi"> DOI: 10.1021/ol401839e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol401839e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFOltr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=4026-4029&author=T.+T.+Hoangauthor=G.+B.+Dudley&title=Synthesis+of+High-Value+1%2C6-Enynes+by+Tandem+Fragmentation%2FOlefination&doi=10.1021%2Fol401839e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of High-Value 1,6-Enynes by Tandem Fragmentation/Olefination</span></div><div class="casAuthors">Hoang, Tung T.; Dudley, Gregory B.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4026-4029</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A tandem process provides high-value 1,6-enynes that are otherwise difficult to prep.  Two base-mediated reactions-fragmentation and olefination-are executed in a coordinated manner that is overall more efficient than either reaction on its own.  The 1,6-enynes can be strategically employed in conjunction with carbocyclization to deliver important targets, as noted for reported syntheses of hirsutene and illudol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKv0dmHf9oirVg90H21EOLACvtfcHk0liayLSIvge3uA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFOltr3P&md5=34ce9ac21b9014e31edeb523b64b1904</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fol401839e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol401839e%26sid%3Dliteratum%253Aachs%26aulast%3DHoang%26aufirst%3DT.%2BT.%26aulast%3DDudley%26aufirst%3DG.%2BB.%26atitle%3DSynthesis%2520of%2520High-Value%25201%252C6-Enynes%2520by%2520Tandem%2520Fragmentation%252FOlefination%26jtitle%3DOrg.%2520Lett.%26date%3D2013%26volume%3D15%26spage%3D4026%26epage%3D4029%26doi%3D10.1021%2Fol401839e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aung, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huffman, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Showalter, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abood, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, B. R.</span></span> <span> </span><span class="NLM_article-title">Influence of the N-1 Alkyl Chain Length of Cannabimimetic Indoles upon CB<sub>1</sub> and CB<sub>2</sub> Receptor Binding</span>. <i>Drug Alcohol Depend.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">133</span>– <span class="NLM_lpage">140</span>, <span class="refDoi"> DOI: 10.1016/s0376-8716(99)00152-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1016%2FS0376-8716%2899%2900152-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10940540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlsFCis7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=133-140&author=M.+M.+Aungauthor=G.+Griffinauthor=J.+W.+Huffmanauthor=M.-J.+Wuauthor=C.+Keelauthor=B.+Yangauthor=V.+M.+Showalterauthor=M.+E.+Aboodauthor=B.+R.+Martin&title=Influence+of+the+N-1+Alkyl+Chain+Length+of+Cannabimimetic+Indoles+upon+CB1+and+CB2+Receptor+Binding&doi=10.1016%2Fs0376-8716%2899%2900152-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB1 and CB2 receptor binding</span></div><div class="casAuthors">Aung, M. M.; Griffin, G.; Huffman, J. W.; Wu, M.-J.; Keel, C.; Yang, B.; Showalter, V. M.; Abood, M. E.; Martin, B. R.</div><div class="citationInfo"><span class="NLM_cas:title">Drug and Alcohol Dependence</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">133-140</span>CODEN:
                <span class="NLM_cas:coden">DADEDV</span>;
        ISSN:<span class="NLM_cas:issn">0376-8716</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">The N-1 alkyl side chain of the aminoalkylindole analogs (AAI) has been implicated as one of a three-point interaction with the cannabinoid CB1 receptor.  In this study, the morpholinoethyl of WIN 55,212-2 was replaced with carbon chains of varying lengths ranging from a Me to heptyl group.  Addnl. groups were added to the naphthoyl and the C2 positions of the mol.  These structural changes revealed that high affinity binding to the CB1 and CB2 receptors requires an alkyl chain length of at least three carbons with optimum binding to both receptors occurring with a five carbon side chain.  An alkyl chain of 3-6 carbons is sufficient for high affinity binding; however, extension of the chain to a heptyl group results in a dramatic decrease in binding at both receptors.  The unique structure of the cannabimimetic indoles provides a useful tool to define the ligand-receptor interaction at both cannabinoid receptors and to refine proposed pharmacophore models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7xJ1zTV8U47Vg90H21EOLACvtfcHk0liayLSIvge3uA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsFCis7o%253D&md5=e37f0944f8d1e476015b1f987803cf7c</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2FS0376-8716%2899%2900152-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0376-8716%252899%252900152-0%26sid%3Dliteratum%253Aachs%26aulast%3DAung%26aufirst%3DM.%2BM.%26aulast%3DGriffin%26aufirst%3DG.%26aulast%3DHuffman%26aufirst%3DJ.%2BW.%26aulast%3DWu%26aufirst%3DM.-J.%26aulast%3DKeel%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DB.%26aulast%3DShowalter%26aufirst%3DV.%2BM.%26aulast%3DAbood%26aufirst%3DM.%2BE.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3DInfluence%2520of%2520the%2520N-1%2520Alkyl%2520Chain%2520Length%2520of%2520Cannabimimetic%2520Indoles%2520upon%2520CB1%2520and%2520CB2%2520Receptor%2520Binding%26jtitle%3DDrug%2520Alcohol%2520Depend.%26date%3D2000%26volume%3D60%26spage%3D133%26epage%3D140%26doi%3D10.1016%2Fs0376-8716%2899%2900152-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hynes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leftheris, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandit, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norris, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiener, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patil-Koota, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillooly, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuster, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntyre, K. W.</span></span> <span> </span><span class="NLM_article-title">C-3 Amido-Indole Cannabinoid Receptor Modulators</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">2399</span>– <span class="NLM_lpage">2402</span>, <span class="refDoi"> DOI: 10.1016/s0960-894x(02)00466-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1016%2FS0960-894X%2802%2900466-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=12161142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvVGisr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=2399-2402&author=J.+Hynesauthor=K.+Leftherisauthor=H.+Wuauthor=C.+Panditauthor=P.+Chenauthor=D.+J.+Norrisauthor=B.-C.+Chenauthor=R.+Zhaoauthor=P.+A.+Kienerauthor=X.+Chenauthor=L.+A.+Turkauthor=V.+Patil-Kootaauthor=K.+M.+Gilloolyauthor=D.+J.+Shusterauthor=K.+W.+McIntyre&title=C-3+Amido-Indole+Cannabinoid+Receptor+Modulators&doi=10.1016%2Fs0960-894x%2802%2900466-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">C-3 Amido-Indole cannabinoid receptor modulators</span></div><div class="casAuthors">Hynes, John; Leftheris, Katerina; Wu, Hong; Pandit, Chennagiri; Chen, Ping; Norris, Derek J.; Chen, Bang-Chi; Zhao, Rulin; Kiener, Peter A.; Chen, Xiaorong; Turk, Lori A.; Patil-Koota, Vina; Gillooly, Kathleen M.; Shuster, David J.; McIntyre, Kim W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2399-2402</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">C-3 Amido-indoles were found to selectively bind to the CB2 receptor.  Structure-activity structure-activity relationship (SAR) studies led to optimized compds. with excellent in vivo potency against LPS induced TNF-α release in murine models of cytokine prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo_97Txjl_ULVg90H21EOLACvtfcHk0lhMchuF1xl9Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvVGisr4%253D&md5=df16d9075561053ab84ac371351b0160</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2900466-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252900466-3%26sid%3Dliteratum%253Aachs%26aulast%3DHynes%26aufirst%3DJ.%26aulast%3DLeftheris%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DPandit%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DNorris%26aufirst%3DD.%2BJ.%26aulast%3DChen%26aufirst%3DB.-C.%26aulast%3DZhao%26aufirst%3DR.%26aulast%3DKiener%26aufirst%3DP.%2BA.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DTurk%26aufirst%3DL.%2BA.%26aulast%3DPatil-Koota%26aufirst%3DV.%26aulast%3DGillooly%26aufirst%3DK.%2BM.%26aulast%3DShuster%26aufirst%3DD.%2BJ.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26atitle%3DC-3%2520Amido-Indole%2520Cannabinoid%2520Receptor%2520Modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D2399%26epage%3D2402%26doi%3D10.1016%2Fs0960-894x%2802%2900466-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Longworth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banister, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassiou, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Pharmacological Profiling of the Metabolites of Synthetic Cannabinoid Drugs APICA, STS-135, ADB-PINACA, and 5FADB-PINACA</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1673</span>– <span class="NLM_lpage">1680</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.7b00116</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.7b00116" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC2sXptFels7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1673-1680&author=M.+Longworthauthor=M.+Connorauthor=S.+D.+Banisterauthor=M.+Kassiou&title=Synthesis+and+Pharmacological+Profiling+of+the+Metabolites+of+Synthetic+Cannabinoid+Drugs+APICA%2C+STS-135%2C+ADB-PINACA%2C+and+5FADB-PINACA&doi=10.1021%2Facschemneuro.7b00116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Pharmacological Profiling of the Metabolites of Synthetic Cannabinoid Drugs APICA, STS-135, ADB-PINACA, and 5F-ADB-PINACA</span></div><div class="casAuthors">Longworth, Mitchell; Connor, Mark; Banister, Samuel D.; Kassiou, Michael</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1673-1680</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Synthetic cannabinoids (SCs) contg. a 1-pentyl-1-H substituted indole or indazole are abused around the world and are assocd. with an array of serious side effects.  These compds. undergo extensive phase 1 metab. after ingestion with little understanding whether these metabolites are contributing to the cannabimimetic activity of the drugs.  This work presents the synthesis and pharmacol. characterization of the major metabolites of two high concern SCs; APICA and ADB-PINACA.  In a fluorometric assay of membrane potential, all metabolites that did not contain a carboxylic acid functionality retained potent activity at both the CB1 (EC50 = 14-787 nM) and CB2 (EC50 = 5.5-291 nM) receptors regardless of heterocyclic core or 3-carboxamide substituent.  Of note were the 5-hydroxypentyl and 4-pentanone metabolites which showed significant increases in CB2 functional selectivity.  These results suggest that the metabolites of SCs potentially contribute to the overall pharmacol. profile of these drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrie35oLSn9KLVg90H21EOLACvtfcHk0lhMchuF1xl9Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXptFels7g%253D&md5=f4e6fcd7b71423492b67c5c083a59ed6</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.7b00116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.7b00116%26sid%3Dliteratum%253Aachs%26aulast%3DLongworth%26aufirst%3DM.%26aulast%3DConnor%26aufirst%3DM.%26aulast%3DBanister%26aufirst%3DS.%2BD.%26aulast%3DKassiou%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520Pharmacological%2520Profiling%2520of%2520the%2520Metabolites%2520of%2520Synthetic%2520Cannabinoid%2520Drugs%2520APICA%252C%2520STS-135%252C%2520ADB-PINACA%252C%2520and%25205FADB-PINACA%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2017%26volume%3D8%26spage%3D1673%26epage%3D1680%26doi%3D10.1021%2Facschemneuro.7b00116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brents, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallus-Zawada, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radominska-Pandya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasiljevik, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prisinzano, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fantegrossi, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moran, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prather, P. L.</span></span> <span> </span><span class="NLM_article-title">Mono-hydroxylated Metabolites of the K2 Synthetic Cannabinoid JWH-073 Retain High Cannabinoid 1 Receptor (CB<sub>1</sub>R) Affinity and Exhibit Neutral Antagonist to Partial Agonist Activity</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">952</span>– <span class="NLM_lpage">961</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2012.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1016%2Fj.bcp.2012.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=22266354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Crur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2012&pages=952-961&author=L.+K.+Brentsauthor=A.+Gallus-Zawadaauthor=A.+Radominska-Pandyaauthor=T.+Vasiljevikauthor=T.+E.+Prisinzanoauthor=W.+E.+Fantegrossiauthor=J.+H.+Moranauthor=P.+L.+Prather&title=Mono-hydroxylated+Metabolites+of+the+K2+Synthetic+Cannabinoid+JWH-073+Retain+High+Cannabinoid+1+Receptor+%28CB1R%29+Affinity+and+Exhibit+Neutral+Antagonist+to+Partial+Agonist+Activity&doi=10.1016%2Fj.bcp.2012.01.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity</span></div><div class="casAuthors">Brents, Lisa K.; Gallus-Zawada, Anna; Radominska-Pandya, Anna; Vasiljevik, Tamara; Prisinzano, Thomas E.; Fantegrossi, William E.; Moran, Jeffery H.; Prather, Paul L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">952-961</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">K2 and several similar purported "incense products" spiked with synthetic cannabinoids are abused as cannabis substitutes.  We hypothesized that metab. of JWH-073, a prevalent cannabinoid found in K2, contributes to toxicity assocd. with K2 use.  Competition receptor binding studies and G-protein activation assays, both performed by employing mouse brain homogenates, were used to det. the affinity and intrinsic activity, resp., of potential monohydroxylated (M1, M3-M5) and monocarboxylated (M6) metabolites at cannabinoid 1 receptors (CB1Rs).  Surprisingly, M1, M4 and M5 retain nanomolar affinity for CB1Rs, while M3 displays micromolar affinity and M6 does not bind to CB1Rs.  JWH-073 displays equiv. efficacy to that of the CB1R full agonist CP-55,940, while M1, M3, and M5 act as CB1R partial agonists, and M4 shows little or no intrinsic activity.  Further in vitro investigation by Schild anal. revealed that M4 acts as a competitive neutral CB1R antagonist (Kb ∼ 40 nM).  In agreement with in vitro studies, M4 also demonstrates CB1R antagonism in vivo by blunting cannabinoid-induced hypothermia in mice.  Interestingly, M4 does not block agonist-mediated responses of other measures in the cannabinoid tetrad (e.g., locomotor suppression, catalepsy or analgesia).  Finally, also as predicted by in vitro results, M1 exhibits agonist activity in vivo by inducing significant hypothermia and suppression of locomotor activity in mice.In conclusion, the present study indicates that further work examg. the physiol. effects of synthetic cannabinoid metab. is warranted.  Such a complex mix of metabolically produced CB1R ligands may contribute to the adverse effect profile of JWH-073-contg. products.  Neutral CB1R antagonist properties of metabolite M4 (I) suggest that it might serve as a scaffold for development of a novel class of anti-obesity drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY05-OLnF6LbVg90H21EOLACvtfcHk0lhMchuF1xl9Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Crur0%253D&md5=71e598b1c5517d9594395c0c3d82376a</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2012.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2012.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DBrents%26aufirst%3DL.%2BK.%26aulast%3DGallus-Zawada%26aufirst%3DA.%26aulast%3DRadominska-Pandya%26aufirst%3DA.%26aulast%3DVasiljevik%26aufirst%3DT.%26aulast%3DPrisinzano%26aufirst%3DT.%2BE.%26aulast%3DFantegrossi%26aufirst%3DW.%2BE.%26aulast%3DMoran%26aufirst%3DJ.%2BH.%26aulast%3DPrather%26aufirst%3DP.%2BL.%26atitle%3DMono-hydroxylated%2520Metabolites%2520of%2520the%2520K2%2520Synthetic%2520Cannabinoid%2520JWH-073%2520Retain%2520High%2520Cannabinoid%25201%2520Receptor%2520%2528CB1R%2529%2520Affinity%2520and%2520Exhibit%2520Neutral%2520Antagonist%2520to%2520Partial%2520Agonist%2520Activity%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D83%26spage%3D952%26epage%3D961%26doi%3D10.1016%2Fj.bcp.2012.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klamo, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendt, O. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henling, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bercaw, J. E.</span></span> <span> </span><span class="NLM_article-title">Dialkyl and Methyl-Alkyl Zirconocenes: Synthesis and Characterization of Zirconocene-Alkyls That Model the Polymeryl Chain in Alkene Polymerizations</span>. <i>Organometallics</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3018</span>– <span class="NLM_lpage">3030</span>, <span class="refDoi"> DOI: 10.1021/om0601302</span> </span><div class="citationLinks">[<a href="/doi/10.1021/om0601302" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkvFSjsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=3018-3030&author=S.+B.+Klamoauthor=O.+F.+Wendtauthor=L.+M.+Henlingauthor=M.+W.+Dayauthor=J.+E.+Bercaw&title=Dialkyl+and+Methyl-Alkyl+Zirconocenes%3A+Synthesis+and+Characterization+of+Zirconocene-Alkyls+That+Model+the+Polymeryl+Chain+in+Alkene+Polymerizations&doi=10.1021%2Fom0601302"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Dialkyl and Methyl-Alkyl Zirconocenes: Synthesis and Characterization of Zirconocene-Alkyls That Model the Polymeryl Chain in Alkene Polymerizations</span></div><div class="casAuthors">Klamo, Sara B.; Wendt, Ola F.; Henling, Larry M.; Day, Michael W.; Bercaw, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Organometallics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3018-3030</span>CODEN:
                <span class="NLM_cas:coden">ORGND7</span>;
        ISSN:<span class="NLM_cas:issn">0276-7333</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Zirconocene precatalysts with sterically bulky alkyl groups were designed as model systems for the propagating species in zirconocene-catalyzed alkene polymn.  Specialty alkyllithium reagents Li(CH2CEt3) and Li(CH2CMe2CH2Ph) were prepd. and utilized in the synthesis of dialkyl and methyl-alkyl zirconocenes of the form CpCp*ZrR2, Cp2Zr(CH3)(R), and CpCp*Zr(CH3)(R) (Cp = (η5-C5H5); Cp* = (η5-C5Me5); R = CH2CMe3, CH2SiMe3, CH2CEt3, CH2CMe2CH2Ph).  These new zirconocene alkyls were isolated and fully characterized by NMR spectroscopy and in some cases by x-ray diffraction.  The mol. structures detd. display the bent-sandwich coordination mode common for zirconocenes.  The steric influence of the alkyl group on the obsd. structural parameters is reflected in slightly expanded C-Zr-C or C-Zr-Cl angles in the equatorial plane and long zirconium-alkyl bond distances.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCf5ng3F6-VrVg90H21EOLACvtfcHk0ljtyv9HXS7L_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkvFSjsLc%253D&md5=a5c98aeb534ee2091629b6a06db6c109</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fom0601302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fom0601302%26sid%3Dliteratum%253Aachs%26aulast%3DKlamo%26aufirst%3DS.%2BB.%26aulast%3DWendt%26aufirst%3DO.%2BF.%26aulast%3DHenling%26aufirst%3DL.%2BM.%26aulast%3DDay%26aufirst%3DM.%2BW.%26aulast%3DBercaw%26aufirst%3DJ.%2BE.%26atitle%3DDialkyl%2520and%2520Methyl-Alkyl%2520Zirconocenes%253A%2520Synthesis%2520and%2520Characterization%2520of%2520Zirconocene-Alkyls%2520That%2520Model%2520the%2520Polymeryl%2520Chain%2520in%2520Alkene%2520Polymerizations%26jtitle%3DOrganometallics%26date%3D2007%26volume%3D26%26spage%3D3018%26epage%3D3030%26doi%3D10.1021%2Fom0601302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vekariya, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubé, J.</span></span> <span> </span><span class="NLM_article-title">Hexafluoro-2-propanol-Promoted Intermolecular Friedel–Crafts Acylation Reaction</span>. <i>J. Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">3534</span>– <span class="NLM_lpage">3537</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.6b01460</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.6b01460" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=3534-3537&author=R.+H.+Vekariyaauthor=J.+Aub%C3%A9&title=Hexafluoro-2-propanol-Promoted+Intermolecular+Friedel%E2%80%93Crafts+Acylation+Reaction&doi=10.1021%2Facs.orglett.6b01460"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.6b01460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.6b01460%26sid%3Dliteratum%253Aachs%26aulast%3DVekariya%26aufirst%3DR.%2BH.%26aulast%3DAub%25C3%25A9%26aufirst%3DJ.%26atitle%3DHexafluoro-2-propanol-Promoted%2520Intermolecular%2520Friedel%25E2%2580%2593Crafts%2520Acylation%2520Reaction%26jtitle%3DJ.%2520Org.%2520Lett.%26date%3D2016%26volume%3D18%26spage%3D3534%26epage%3D3537%26doi%3D10.1021%2Facs.orglett.6b01460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hudlicky, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frazier, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seoane, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiedje, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seoane, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwart, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beal, C.</span></span> <span> </span><span class="NLM_article-title">Topological selectivity in the intramolecular [4 + 1] pyrroline annulation. Formal total stereospecific synthesis of (.+-.)-supinidine, (.+-.)-isoretronecanol, and (.+-.)-trachelanthamidine</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">3755</span>– <span class="NLM_lpage">3762</span>, <span class="refDoi"> DOI: 10.1021/ja00273a033</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00273a033" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADyaL28XkvFOktLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=1986&pages=3755-3762&author=T.+Hudlickyauthor=J.+O.+Frazierauthor=G.+Seoaneauthor=M.+Tiedjeauthor=A.+Seoaneauthor=L.+D.+Kwartauthor=C.+Beal&title=Topological+selectivity+in+the+intramolecular+%5B4+%2B+1%5D+pyrroline+annulation.+Formal+total+stereospecific+synthesis+of+%28.%2B-.%29-supinidine%2C+%28.%2B-.%29-isoretronecanol%2C+and+%28.%2B-.%29-trachelanthamidine&doi=10.1021%2Fja00273a033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Topological selectivity in the intramolecular [4 + 1] pyrroline annulation. Formal total stereospecific synthesis of (±)-supinidine, (±)-isoretronecanol, and (±)-trachelanthamidine</span></div><div class="casAuthors">Hudlicky, Tomas; Frazier, James O.; Seoane, Gustavo; Tiedje, Mark; Seoane, Ana; Kwart, Lawrence D.; Beal, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3755-62</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">The prepn. and cycloaddns. of azido dienes N3(CH2)3CH:C(CH:CH2)CO2Et and N3(CH2)3CH:CHCH:CHCO2Et are described in detail.  The synthesis of pyrrolines I and II is reported, and the conditions are revealed to achieve max. selectivity in their prepn.  The topog. of the ultimately prepd. pyrrolines depends primarily on the substitution parameters of the starting dienes and on the conditions of rearrangement of their resp. vinylaziridines III and IV.  The former parameter is easily controlled through the vinylogous Reformatsky reaction of Et 4-bromocrotonate with aldehyde precursors.  The latter parameter depends on the choice of thermolytic vs. nucleophilic activation of particular bonds in III and IV.  The flexibility and practicality of this method is exemplified by several convergent approaches to I and II and their conversion to the title pyrrolizidine alkaloids.  Stereospecific prepn. of satd. pyrrolizidines V is also described.  A detailed study of the base-catalyzed elimination of β-acetoxy esters was performed, and the stereochem. consequences are reported for the formation of E- and Z-N3(CH2)3CH:C(CH:CH2)CO2Et.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopTZ3WTERUB7Vg90H21EOLACvtfcHk0ljtyv9HXS7L_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XkvFOktLs%253D&md5=ec1ccd5e33fd2c0dd2998035624ffbe9</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fja00273a033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00273a033%26sid%3Dliteratum%253Aachs%26aulast%3DHudlicky%26aufirst%3DT.%26aulast%3DFrazier%26aufirst%3DJ.%2BO.%26aulast%3DSeoane%26aufirst%3DG.%26aulast%3DTiedje%26aufirst%3DM.%26aulast%3DSeoane%26aufirst%3DA.%26aulast%3DKwart%26aufirst%3DL.%2BD.%26aulast%3DBeal%26aufirst%3DC.%26atitle%3DTopological%2520selectivity%2520in%2520the%2520intramolecular%2520%255B4%2520%252B%25201%255D%2520pyrroline%2520annulation.%2520Formal%2520total%2520stereospecific%2520synthesis%2520of%2520%2528.%252B-.%2529-supinidine%252C%2520%2528.%252B-.%2529-isoretronecanol%252C%2520and%2520%2528.%252B-.%2529-trachelanthamidine%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1986%26volume%3D108%26spage%3D3755%26epage%3D3762%26doi%3D10.1021%2Fja00273a033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brents, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichard, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerman, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moran, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fantegrossi, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prather, P. L.</span></span> <span> </span><span class="NLM_article-title">Phase I Hydroxylated Metabolites of the K2 Synthetic Cannabinoid JWH-018 Retain in vitro and in vivo Cannabinoid 1 Receptor Affinity and Activity</span>. <i>PloS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e21917</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0021917</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1371%2Fjournal.pone.0021917" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=21755008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsFChsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&author=L.+K.+Brentsauthor=E.+E.+Reichardauthor=S.+M.+Zimmermanauthor=J.+H.+Moranauthor=W.+E.+Fantegrossiauthor=P.+L.+Prather&title=Phase+I+Hydroxylated+Metabolites+of+the+K2+Synthetic+Cannabinoid+JWH-018+Retain+in+vitro+and+in+vivo+Cannabinoid+1+Receptor+Affinity+and+Activity&doi=10.1371%2Fjournal.pone.0021917"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity</span></div><div class="casAuthors">Brents, Lisa K.; Reichard, Emily E.; Zimmerman, Sarah M.; Moran, Jeffery H.; Fantegrossi, William E.; Prather, Paul L.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">e21917</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">K2 products are synthetic cannabinoid-laced, marijuana-like drugs of abuse, use of which is often assocd. with clin. symptoms atypical of marijuana use, including hypertension, agitation, hallucinations, psychosis, seizures and panic attacks.  JWH-018, a prevalent K2 synthetic cannabinoid, is structurally distinct from Δ9-THC, the main psychoactive ingredient in marijuana.  Since even subtle structural differences can lead to differential metab., formation of novel, biol. active metabolites may be responsible for the distinct effects assocd. with K2 use.  The present study proposes that K2's high adverse effect occurrence is due, at least in part, to distinct JWH-018 metabolite activity at the cannabinoid 1 receptor (CB1R).  JWH-018, five potential monohydroxylated metabolites (M1-M5), and one carboxy metabolite (M6) were examd. in mouse brain homogenates contg. CB1Rs, first for CB1R affinity using a competition binding assay employing the cannabinoid receptor radioligand [3H]CP-55,940, and then for CB1R intrinsic efficacy using an [35S]GTPγS binding assay.  JWH-018 and M1-M5 bound CB1Rs with high affinity, exhibiting Ki values that were lower than or equiv. to Δ9-THC.  These mols. also stimulated G-proteins with equal or greater efficacy relative to Δ9-THC, a CB1R partial agonist.  Most importantly, JWH-018, M2, M3, and M5 produced full CB1R agonist levels of activation.  CB1R-mediated activation was demonstrated by blockade with O-2050, a CB1R-selective neutral antagonist.  Similar to Δ9-THC, JWH-018 and M1 produced a marked depression of locomotor activity and core body temp. in mice that were both blocked by the CB1R-preferring antagonist/inverse agonist AM251.  Unlike metabolites of most drugs, the studied JWH-018 monohydroxylated compds., but not the carboxy metabolite, retain in vitro and in vivo activity at CB1Rs.  These observations, combined with higher CB1R affinity and activity relative to Δ9-THC, may contribute to the greater prevalence of adverse effects obsd. with JWH-018-contg. products relative to cannabis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHN28ACeRV0LVg90H21EOLACvtfcHk0lgUmAmSrXlRWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsFChsL0%253D&md5=a40b0f6749f9552fd544fa0f6f2dc2ba</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0021917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0021917%26sid%3Dliteratum%253Aachs%26aulast%3DBrents%26aufirst%3DL.%2BK.%26aulast%3DReichard%26aufirst%3DE.%2BE.%26aulast%3DZimmerman%26aufirst%3DS.%2BM.%26aulast%3DMoran%26aufirst%3DJ.%2BH.%26aulast%3DFantegrossi%26aufirst%3DW.%2BE.%26aulast%3DPrather%26aufirst%3DP.%2BL.%26atitle%3DPhase%2520I%2520Hydroxylated%2520Metabolites%2520of%2520the%2520K2%2520Synthetic%2520Cannabinoid%2520JWH-018%2520Retain%2520in%2520vitro%2520and%2520in%2520vivo%2520Cannabinoid%25201%2520Receptor%2520Affinity%2520and%2520Activity%26jtitle%3DPloS%2520One%26date%3D2011%26volume%3D6%26doi%3D10.1371%2Fjournal.pone.0021917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penthala, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prather, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crooks, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, C.-G.</span></span> <span> </span><span class="NLM_article-title">Binding Modes and Selectivity of Cannabinoid 1 (CB1) and Cannabinoid 2 (CB2) Receptor Ligands</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">3455</span>– <span class="NLM_lpage">3463</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.0c00551</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.0c00551" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvFCnsr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=3455-3463&author=J.-F.+Yangauthor=A.+H.+Williamsauthor=N.+R.+Penthalaauthor=P.+L.+Pratherauthor=P.+A.+Crooksauthor=C.-G.+Zhan&title=Binding+Modes+and+Selectivity+of+Cannabinoid+1+%28CB1%29+and+Cannabinoid+2+%28CB2%29+Receptor+Ligands&doi=10.1021%2Facschemneuro.0c00551"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Binding Modes and Selectivity of Cannabinoid 1 (CB1) and Cannabinoid 2 (CB2) Receptor Ligands</span></div><div class="casAuthors">Yang, Jing-Fang; Williams, Alexander H.; Penthala, Narsimha R.; Prather, Paul L.; Crooks, Peter A.; Zhan, Chang-Guo</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3455-3463</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The cannabinoid (CB) receptors (CB1R and CB2R) represent a promising therapeutic target for several indications such as nociception and obesity.  The ligands with nonselectivity can be traced to the high similarity in the binding sites of both cannabinoid receptors.  Therefore, the need for selectivity, potency, and G-protein coupling bias has further complicated the design of desired compds.  The bias of currently studied cannabinoid agonists is seldom investigated, and agonists that do exhibit bias are typically nonselective.  However, certain long-chain endocannabinoids represent a class of selective and potent CB1R agonists.  The binding mode for this class of compds. has remained elusive, limiting the implementation of its binding features to currently studied agonists.  Hence, in the present study, the binding poses for these long-chain cannabinoids, along with other interesting ligands, with the receptors have been detd., by using a combination of mol. docking and mol. dynamics (MD) simulations along with mol. mechanics-Poisson-Boltzmann surface area (MM-PBSA) binding free energy calcns.  The binding poses for the long-chain cannabinoids implicate that a site surrounded by the transmembrane (TM)2, TM7, and extracellular loop (ECL)2 is vital for providing the long-chain ligands with the selectivity for CB1R, esp. I267 of CB1R (corresponding to L182 of CB2R).  Based on the obtained binding modes, the calcd. relative binding free energies and selectivity are all in good agreement with the corresponding exptl. data, suggesting that the detd. binding poses are reasonable.  The computational strategy used in this study may also prove fruitful in applications with other GPCRs or membrane-bound proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzR01wKkDxYrVg90H21EOLACvtfcHk0lgUmAmSrXlRWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvFCnsr3E&md5=193f8e216444351a0c1b297892f7c528</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.0c00551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.0c00551%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.-F.%26aulast%3DWilliams%26aufirst%3DA.%2BH.%26aulast%3DPenthala%26aufirst%3DN.%2BR.%26aulast%3DPrather%26aufirst%3DP.%2BL.%26aulast%3DCrooks%26aufirst%3DP.%2BA.%26aulast%3DZhan%26aufirst%3DC.-G.%26atitle%3DBinding%2520Modes%2520and%2520Selectivity%2520of%2520Cannabinoid%25201%2520%2528CB1%2529%2520and%2520Cannabinoid%25202%2520%2528CB2%2529%2520Receptor%2520Ligands%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2020%26volume%3D11%26spage%3D3455%26epage%3D3463%26doi%3D10.1021%2Facschemneuro.0c00551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, P. C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skillman, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellingson, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M. T.</span></span> <span> </span><span class="NLM_article-title">Conformer generation with OMEGA: algorithm and validation using high quality structures from the Protein Databank and Cambridge Structural Database</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">572</span>– <span class="NLM_lpage">584</span>, <span class="refDoi"> DOI: 10.1021/ci100031x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci100031x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtlaisrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=572-584&author=P.+C.+D.+Hawkinsauthor=A.+G.+Skillmanauthor=G.+L.+Warrenauthor=B.+A.+Ellingsonauthor=M.+T.+Stahl&title=Conformer+generation+with+OMEGA%3A+algorithm+and+validation+using+high+quality+structures+from+the+Protein+Databank+and+Cambridge+Structural+Database&doi=10.1021%2Fci100031x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Conformer Generation with OMEGA: Algorithm and Validation Using High Quality Structures from the Protein Databank and Cambridge Structural Database</span></div><div class="casAuthors">Hawkins, Paul C. D.; Skillman, A. Geoffrey; Warren, Gregory L.; Ellingson, Benjamin A.; Stahl, Matthew T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">572-584</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Here, we present the algorithm and validation for OMEGA, a systematic, knowledge-based conformer generator.  The algorithm consists of three phases: assembly of an initial 3D structure from a library of fragments; exhaustive enumeration of all rotatable torsions using values drawn from a knowledge-based list of angles, thereby generating a large set of conformations; and sampling of this set by geometric and energy criteria.  Validation of conformer generators like OMEGA has often been undertaken by comparing computed conformer sets to exptl. mol. conformations from crystallog., usually from the Protein Databank (PDB).  Such an approach is fraught with difficulty due to the systematic problems with small mol. structures in the PDB.  Methods are presented to identify a diverse set of small mol. structures from cocomplexes in the PDB that has maximal reliability.  A challenging set of 197 high quality, carefully selected ligand structures from well-solved models was obtained using these methods.  This set will provide a sound basis for comparison and validation of conformer generators in the future.  Validation results from this set are compared to the results using structures of a set of druglike mols. extd. from the Cambridge Structural Database (CSD).  OMEGA is found to perform very well in reproducing the crystallog. conformations from both these data sets using two complementary metrics of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqq1SOwPH1NzrVg90H21EOLACvtfcHk0ljWvUVMp81kaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtlaisrY%253D&md5=fb87ecc9c51eddef63b41fffcd9babee</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fci100031x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci100031x%26sid%3Dliteratum%253Aachs%26aulast%3DHawkins%26aufirst%3DP.%2BC.%2BD.%26aulast%3DSkillman%26aufirst%3DA.%2BG.%26aulast%3DWarren%26aufirst%3DG.%2BL.%26aulast%3DEllingson%26aufirst%3DB.%2BA.%26aulast%3DStahl%26aufirst%3DM.%2BT.%26atitle%3DConformer%2520generation%2520with%2520OMEGA%253A%2520algorithm%2520and%2520validation%2520using%2520high%2520quality%2520structures%2520from%2520the%2520Protein%2520Databank%2520and%2520Cambridge%2520Structural%2520Database%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D572%26epage%3D584%26doi%3D10.1021%2Fci100031x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanner, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belew, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodsell, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. J.</span></span> <span> </span><span class="NLM_article-title">AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">2785</span>– <span class="NLM_lpage">2791</span>, <span class="refDoi"> DOI: 10.1002/jcc.21256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1002%2Fjcc.21256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=19399780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=2785-2791&author=G.+M.+Morrisauthor=R.+Hueyauthor=W.+Lindstromauthor=M.+F.+Sannerauthor=R.+K.+Belewauthor=D.+S.+Goodsellauthor=A.+J.+Olson&title=AutoDock4+and+AutoDockTools4%3A+Automated+docking+with+selective+receptor+flexibility&doi=10.1002%2Fjcc.21256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock and AutoDockTools: Automated docking with selective receptor flexibility</span></div><div class="casAuthors">Morris, Garrett M.; Huey, Ruth; Lindstrom, William; Sanner, Michel F.; Belew, Richard K.; Goodsell, David S.; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2785-2791</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">We describe the testing and release of AutoDock4 and the accompanying graphical user interface AutoDockTools.  AutoDock4 incorporates limited flexibility in the receptor.  Several tests are reported here, including a redocking expt. with 188 diverse ligand-protein complexes and a cross-docking expt. using flexible sidechains in 87 HIV protease complexes.  We also report its utility in anal. of covalently bound ligands, using both a grid-based docking method and a modification of the flexible sidechain technique. © 2009 Wiley Periodicals, Inc.  J Comput Chem, 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqktE6WAo4GEbVg90H21EOLACvtfcHk0ljWvUVMp81kaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK&md5=679ce22fc50e9291c9aa16e7a1855845</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21256%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DG.%2BM.%26aulast%3DHuey%26aufirst%3DR.%26aulast%3DLindstrom%26aufirst%3DW.%26aulast%3DSanner%26aufirst%3DM.%2BF.%26aulast%3DBelew%26aufirst%3DR.%2BK.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock4%2520and%2520AutoDockTools4%253A%2520Automated%2520docking%2520with%2520selective%2520receptor%2520flexibility%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2009%26volume%3D30%26spage%3D2785%26epage%3D2791%26doi%3D10.1002%2Fjcc.21256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trott, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. J.</span></span> <span> </span><span class="NLM_article-title">AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">455</span>– <span class="NLM_lpage">461</span>, <span class="refDoi"> DOI: 10.1002/jcc.21334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1002%2Fjcc.21334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=19499576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=455-461&author=O.+Trottauthor=A.+J.+Olson&title=AutoDock+Vina%3A+improving+the+speed+and+accuracy+of+docking+with+a+new+scoring+function%2C+efficient+optimization%2C+and+multithreading&doi=10.1002%2Fjcc.21334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span></div><div class="casAuthors">Trott, Oleg; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">455-461</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">AutoDock Vina, a new program for mol. docking and virtual screening, is presented.  AutoDock Vina achieves an approx. 2 orders of magnitude speed-up compared with the mol. docking software previously developed in the authors' lab (AutoDock 4), while also significantly improving the accuracy of the binding mode predictions, judging by the authors' tests on the training set used in AutoDock 4 development.  Further speed-up is achieved from parallelism, by using multithreading on multicore machines.  AutoDock Vina automatically calcs. the grid maps and clusters the results in a way transparent to the user.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLecOIkUxIlrVg90H21EOLACvtfcHk0ljWvUVMp81kaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O&md5=c6974af8a1235f7aa09918d3e6f70dc4</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21334%26sid%3Dliteratum%253Aachs%26aulast%3DTrott%26aufirst%3DO.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock%2520Vina%253A%2520improving%2520the%2520speed%2520and%2520accuracy%2520of%2520docking%2520with%2520a%2520new%2520scoring%2520function%252C%2520efficient%2520optimization%252C%2520and%2520multithreading%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2010%26volume%3D31%26spage%3D455%26epage%3D461%26doi%3D10.1002%2Fjcc.21334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hua, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vemuri, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shui, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laprairie, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zvonok, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kufareva, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohn, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.-J.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of the human cannabinoid receptor CB1</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>167</i></span>,  <span class="NLM_fpage">750</span>– <span class="NLM_lpage">762.e714</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2016.10.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1016%2Fj.cell.2016.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=27768894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslCrsrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2016&pages=750-762.e714&author=T.+Huaauthor=K.+Vemuriauthor=M.+Puauthor=L.+Quauthor=G.+W.+Hanauthor=Y.+Wuauthor=S.+Zhaoauthor=W.+Shuiauthor=S.+Liauthor=A.+Kordeauthor=R.+B.+Laprairieauthor=E.+L.+Stahlauthor=J.-H.+Hoauthor=N.+Zvonokauthor=H.+Zhouauthor=I.+Kufarevaauthor=B.+Wuauthor=Q.+Zhaoauthor=M.+A.+Hansonauthor=L.+M.+Bohnauthor=A.+Makriyannisauthor=R.+C.+Stevensauthor=Z.-J.+Liu&title=Crystal+structure+of+the+human+cannabinoid+receptor+CB1&doi=10.1016%2Fj.cell.2016.10.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of the Human Cannabinoid Receptor CB1</span></div><div class="casAuthors">Hua, Tian; Vemuri, Kiran; Pu, Mengchen; Qu, Lu; Han, Gye Won; Wu, Yiran; Zhao, Suwen; Shui, Wenqing; Li, Shanshan; Korde, Anisha; Laprairie, Robert B.; Stahl, Edward L.; Ho, Jo-Hao; Zvonok, Nikolai; Zhou, Han; Kufareva, Irina; Wu, Beili; Zhao, Qiang; Hanson, Michael A.; Bohn, Laura M.; Makriyannis, Alexandros; Stevens, Raymond C.; Liu, Zhi-Jie</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">750-762.e14</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Cannabinoid receptor 1 (CB1) is the principal target of Δ9-tetrahydrocannabinol (THC), a psychoactive chem. from Cannabis sativa with a wide range of therapeutic applications and a long history of recreational use.  CB1 is activated by endocannabinoids and is a promising therapeutic target for pain management, inflammation, obesity, and substance abuse disorders.  Here, the authors present the 2.8 Å crystal structure of human CB1 in complex with AM6538, a stabilizing antagonist, synthesized and characterized for this structural study.  The structure of the CB1-AM6538 complex reveals key features of the receptor and crit. interactions for antagonist binding.  In combination with functional studies and mol. modeling, the structure provides insight into the binding mode of naturally occurring CB1 ligands, such as THC, and synthetic cannabinoids.  This enhances the understanding of the mol. basis for the physiol. functions of CB1 and provides new opportunities for the design of next-generation CB1-targeting pharmaceuticals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAuMgAfmO22bVg90H21EOLACvtfcHk0liWRD_Eror-pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslCrsrbI&md5=f4862c31391550ee2b83ef198c9c7b17</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2016.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2016.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DHua%26aufirst%3DT.%26aulast%3DVemuri%26aufirst%3DK.%26aulast%3DPu%26aufirst%3DM.%26aulast%3DQu%26aufirst%3DL.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DShui%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DKorde%26aufirst%3DA.%26aulast%3DLaprairie%26aufirst%3DR.%2BB.%26aulast%3DStahl%26aufirst%3DE.%2BL.%26aulast%3DHo%26aufirst%3DJ.-H.%26aulast%3DZvonok%26aufirst%3DN.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DWu%26aufirst%3DB.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DBohn%26aufirst%3DL.%2BM.%26aulast%3DMakriyannis%26aufirst%3DA.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DLiu%26aufirst%3DZ.-J.%26atitle%3DCrystal%2520structure%2520of%2520the%2520human%2520cannabinoid%2520receptor%2520CB1%26jtitle%3DCell%26date%3D2016%26volume%3D167%26spage%3D750%26epage%3D762.e714%26doi%3D10.1016%2Fj.cell.2016.10.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vemuri, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popov, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benchama, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zvonok, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locke, K. a.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cinar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffey, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohn, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.-J.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of the human cannabinoid receptor CB2</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>176</i></span>,  <span class="NLM_fpage">459</span>– <span class="NLM_lpage">467</span>, e13 <span class="refDoi"> DOI: 10.1016/j.cell.2018.12.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1016%2Fj.cell.2018.12.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=30639103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC1MXovFKktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2019&pages=459-467&author=X.+Liauthor=T.+Huaauthor=K.+Vemuriauthor=J.-H.+Hoauthor=Y.+Wuauthor=L.+Wuauthor=P.+Popovauthor=O.+Benchamaauthor=N.+Zvonokauthor=K.+a.+Lockeauthor=L.+Quauthor=G.+W.+Hanauthor=M.+R.+Iyerauthor=R.+Cinarauthor=N.+J.+Coffeyauthor=J.+Wangauthor=M.+Wuauthor=V.+Katritchauthor=S.+Zhaoauthor=G.+Kunosauthor=L.+M.+Bohnauthor=A.+Makriyannisauthor=R.+C.+Stevensauthor=Z.-J.+Liu&title=Crystal+structure+of+the+human+cannabinoid+receptor+CB2&doi=10.1016%2Fj.cell.2018.12.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of the Human Cannabinoid Receptor CB2</span></div><div class="casAuthors">Li, Xiaoting; Hua, Tian; Vemuri, Kiran; Ho, Jo-Hao; Wu, Yiran; Wu, Lijie; Popov, Petr; Benchama, Othman; Zvonok, Nikolai; Locke, K'ara; Qu, Lu; Han, Gye Won; Iyer, Malliga R.; Cinar, Resat; Coffey, Nathan J.; Wang, Jingjing; Wu, Meng; Katritch, Vsevolod; Zhao, Suwen; Kunos, George; Bohn, Laura M.; Makriyannis, Alexandros; Stevens, Raymond C.; Liu, Zhi-Jie</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">459-467.e13</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The cannabinoid receptor CB2 is predominately expressed in the immune system, and selective modulation of CB2 without the psychoactivity of CB1 has therapeutic potential in inflammatory, fibrotic, and neurodegenerative diseases.  Here, we report the crystal structure of human CB2 in complex with a rationally designed antagonist, AM10257, at 2.8 Å resoln.  The CB2-AM10257 structure reveals a distinctly different binding pose compared with CB1.  However, the extracellular portion of the antagonist-bound CB2 shares a high degree of conformational similarity with the agonist-bound CB1, which led to the discovery of AM10257's unexpected opposing functional profile of CB2 antagonism vs. CB1 agonism.  Further structural anal. using mutagenesis studies and mol. docking revealed the mol. basis of their function and selectivity for CB2 and CB1.  Addnl. analyses of our designed antagonist and agonist pairs provide important insight into the activation mechanism of CB2.  The present findings should facilitate rational drug design toward precise modulation of the endocannabinoid system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFwNUEO0q03LVg90H21EOLACvtfcHk0liWRD_Eror-pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXovFKktw%253D%253D&md5=90ee72a6dc13b74b84fb6799c3aa0471</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2018.12.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2018.12.011%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DHua%26aufirst%3DT.%26aulast%3DVemuri%26aufirst%3DK.%26aulast%3DHo%26aufirst%3DJ.-H.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DPopov%26aufirst%3DP.%26aulast%3DBenchama%26aufirst%3DO.%26aulast%3DZvonok%26aufirst%3DN.%26aulast%3DLocke%26aufirst%3DK.%2Ba.%26aulast%3DQu%26aufirst%3DL.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DIyer%26aufirst%3DM.%2BR.%26aulast%3DCinar%26aufirst%3DR.%26aulast%3DCoffey%26aufirst%3DN.%2BJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DKunos%26aufirst%3DG.%26aulast%3DBohn%26aufirst%3DL.%2BM.%26aulast%3DMakriyannis%26aufirst%3DA.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DLiu%26aufirst%3DZ.-J.%26atitle%3DCrystal%2520structure%2520of%2520the%2520human%2520cannabinoid%2520receptor%2520CB2%26jtitle%3DCell%26date%3D2019%26volume%3D176%26spage%3D459%26epage%3D467%26doi%3D10.1016%2Fj.cell.2018.12.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollman, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Case, D. A.</span></span> <span> </span><span class="NLM_article-title">Antechamber: an accessory software package for molecular mechanical calculations</span>. <i>J. Am. Chem. Soc</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>222</i></span>,  <span class="NLM_fpage">U403</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=222&publication_year=2001&pages=U403&author=J.+Wangauthor=W.+Wangauthor=P.+A.+Kollmanauthor=D.+A.+Case&title=Antechamber%3A+an+accessory+software+package+for+molecular+mechanical+calculations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26aulast%3DCase%26aufirst%3DD.%2BA.%26atitle%3DAntechamber%253A%2520an%2520accessory%2520software%2520package%2520for%2520molecular%2520mechanical%2520calculations%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc%26date%3D2001%26volume%3D222%26spage%3DU403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pearlman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Case, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheatham, T. E.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeBolt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seibel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollman, P.</span></span> <span> </span><span class="NLM_article-title">AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules</span>. <i>Comput. Phys. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">41</span>, <span class="refDoi"> DOI: 10.1016/0010-4655(95)00041-d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=10.1016%2F0010-4655%2895%2900041-D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADyaK2MXps1Wrtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1995&pages=1-41&author=D.+A.+Pearlmanauthor=D.+A.+Caseauthor=J.+W.+Caldwellauthor=W.+S.+Rossauthor=T.+E.+Cheathamauthor=S.+DeBoltauthor=D.+Fergusonauthor=G.+Seibelauthor=P.+Kollman&title=AMBER%2C+a+package+of+computer+programs+for+applying+molecular+mechanics%2C+normal+mode+analysis%2C+molecular+dynamics+and+free+energy+calculations+to+simulate+the+structural+and+energetic+properties+of+molecules&doi=10.1016%2F0010-4655%2895%2900041-d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">"AMBER", a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to stimulate the structural and energetic properties of molecules</span></div><div class="casAuthors">Pearlman, David A.; Case, David A.; Caldwell, James W.; Ross, Wilson S.; Cheatham, Thomas E. III; DeBolt, Steve; Ferguson, David; Seibel, George; Kollman, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Computer Physics Communications</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">1-42</span>CODEN:
                <span class="NLM_cas:coden">CPHCBZ</span>;
        ISSN:<span class="NLM_cas:issn">0010-4655</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">We describe the development, current features, and some directions for future development of the AMBER package of computer programs.  This package has evolved from a program that was constructed to do Assisted Model Building and Energy Refinement to a group of programs embodying a no. of the powerful tools of modern computational chem.-mol. dynamics and free energy calcns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvhHD9oiNecbVg90H21EOLACvtfcHk0lgZ0yMrl1QVZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXps1Wrtrw%253D&md5=8dc71939a46bbc17d5da08782d4e6ec8</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2F0010-4655%2895%2900041-D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0010-4655%252895%252900041-D%26sid%3Dliteratum%253Aachs%26aulast%3DPearlman%26aufirst%3DD.%2BA.%26aulast%3DCase%26aufirst%3DD.%2BA.%26aulast%3DCaldwell%26aufirst%3DJ.%2BW.%26aulast%3DRoss%26aufirst%3DW.%2BS.%26aulast%3DCheatham%26aufirst%3DT.%2BE.%26aulast%3DDeBolt%26aufirst%3DS.%26aulast%3DFerguson%26aufirst%3DD.%26aulast%3DSeibel%26aufirst%3DG.%26aulast%3DKollman%26aufirst%3DP.%26atitle%3DAMBER%252C%2520a%2520package%2520of%2520computer%2520programs%2520for%2520applying%2520molecular%2520mechanics%252C%2520normal%2520mode%2520analysis%252C%2520molecular%2520dynamics%2520and%2520free%2520energy%2520calculations%2520to%2520simulate%2520the%2520structural%2520and%2520energetic%2520properties%2520of%2520molecules%26jtitle%3DComput.%2520Phys.%2520Commun.%26date%3D1995%26volume%3D91%26spage%3D1%26epage%3D41%26doi%3D10.1016%2F0010-4655%2895%2900041-d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, B. R.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGee, T. D.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swails, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Homeyer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gohlke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roitberg, A. E.</span></span> <span> </span><span class="NLM_article-title">MMPBSA py: an efficient program for end-state free energy calculations</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">3314</span>– <span class="NLM_lpage">3321</span>, <span class="refDoi"> DOI: 10.1021/ct300418h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ct300418h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtV2gtrzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=3314-3321&author=B.+R.+Millerauthor=T.+D.+McGeeauthor=J.+M.+Swailsauthor=N.+Homeyerauthor=H.+Gohlkeauthor=A.+E.+Roitberg&title=MMPBSA+py%3A+an+efficient+program+for+end-state+free+energy+calculations&doi=10.1021%2Fct300418h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">MMPBSA.py: An Efficient Program for End-State Free Energy Calculations</span></div><div class="casAuthors">Miller, Bill R., III; McGee, T. Dwight, Jr.; Swails, Jason M.; Homeyer, Nadine; Gohlke, Holger; Roitberg, Adrian E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3314-3321</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">MM-PBSA is a post-processing end-state method to calc. free energies of mols. in soln.  MMPBSA.py is a program written in Python for streamlining end-state free energy calcns. using ensembles derived from mol. dynamics (MD) or Monte Carlo (MC) simulations.  Several implicit solvation models are available with MMPBSA.py, including the Poisson-Boltzmann Model, the Generalized Born Model, and the Ref. Interaction Site Model.  Vibrational frequencies may be calcd. using normal mode or quasi-harmonic anal. to approx. the solute entropy.  Specific interactions can also be dissected using free energy decompn. or alanine scanning.  A parallel implementation significantly speeds up the calcn. by dividing frames evenly across available processors.  MMPBSA.py is an efficient, user-friendly program with the flexibility to accommodate the needs of users performing end-state free energy calcns.  The source code can be downloaded at http://ambermd.org/ with AmberTools, released under the GNU General Public License.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZK3C1jqiSULVg90H21EOLACvtfcHk0lgZ0yMrl1QVZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtV2gtrzP&md5=cc4148bd8f70c7cad94fd3ec6f580e52</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fct300418h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct300418h%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DB.%2BR.%26aulast%3DMcGee%26aufirst%3DT.%2BD.%26aulast%3DSwails%26aufirst%3DJ.%2BM.%26aulast%3DHomeyer%26aufirst%3DN.%26aulast%3DGohlke%26aufirst%3DH.%26aulast%3DRoitberg%26aufirst%3DA.%2BE.%26atitle%3DMMPBSA%2520py%253A%2520an%2520efficient%2520program%2520for%2520end-state%2520free%2520energy%2520calculations%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2012%26volume%3D8%26spage%3D3314%26epage%3D3321%26doi%3D10.1021%2Fct300418h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeLano, W. L.</span></span> <span> </span><span class="NLM_article-title">Pymol: An open-source molecular graphics tool</span>. <i>CCP4 Newsl. protein crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">82</span>– <span class="NLM_lpage">92</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2002&pages=82-92&author=W.+L.+DeLano&title=Pymol%3A+An+open-source+molecular+graphics+tool"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeLano%26aufirst%3DW.%2BL.%26atitle%3DPymol%253A%2520An%2520open-source%2520molecular%2520graphics%2520tool%26jtitle%3DCCP4%2520Newsl.%2520protein%2520crystallogr.%26date%3D2002%26volume%3D40%26spage%3D82%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5XR8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5XR8','PDB','5XR8'); return false;">PDB: 5XR8</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZTY" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZTY','PDB','5ZTY'); return false;">PDB: 5ZTY</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i77"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00442">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_04203"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.1c00442?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00442</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00442/suppl_file/jm1c00442_si_001.csv">CSV</a>)</p></li><li><p class="inline">Graphs correlating experimental and calculated binding energies, copies of <sup>1</sup>H and <sup>13</sup>C NMR spectra and qNMR analysis, and PDB files for docking models (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00442/suppl_file/jm1c00442_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00442/suppl_file/jm1c00442_si_001.csv">jm1c00442_si_001.csv (2.67 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00442/suppl_file/jm1c00442_si_002.pdf">jm1c00442_si_002.pdf (18.2 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.1c00442&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.1c00442%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-9%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.1c00442" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679926a338c93d3c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
